#BioGRID Chemical Interaction ID	BioGRID Gene ID	Entrez Gene ID	Systematic Name	Official Symbol	Synonyms	Organism ID	Organism	Action	Interaction Type	Author	Pubmed ID	BioGRID Publication ID	BioGRID Chemical ID	Chemical Name	Chemical Synonyms	Chemical Brands	Chemical Source	Chemical Source ID	Molecular Formula	Chemical Type	ATC Codes	CAS Number	Curated By	Method	Method Description	Related BioGRID Gene ID	Related Entrez Gene ID	Related Systematic Name	Related Official Symbol	Related Synonyms	Related Organism ID	Related Organism	Related Type	Notes	InChIKey
1	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Eriksson BI (2000)	11055889	171739	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
2	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Warkentin TE (2000)	10912644	171738	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
3	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Szaba FM (2002)	11807012	171737	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
4	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Fabrizio MC (2001)	11467439	171736	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
5	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Turpie AG (1999)	10505536	171735	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
7	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
8	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
29	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
50	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
51	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
58	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
59	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
63	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
64	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
67	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
68	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
78	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
79	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Park YC (1999)	10206649	144893	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
80	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Moreland LW (1999)	10375846	171766	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
81	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Grell M (1999)	10357816	171767	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
82	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Calabrese LH (1999)	10405518	171768	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
83	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Sandborn WJ (1999)	10338381	171769	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
86	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
87	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Gladwell TD (2002)	11833835	171773	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
88	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Scatena R (2000)	11060732	171777	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
89	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Kleiman NS (2002)	11923794	171776	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
90	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Carswell CI (2002)	11929334	171775	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
91	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Bates ER (2001)	11504570	171774	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
158	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Bell WR (2003)	12556741	171818	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
159	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Chang H (2003)	12745435	171796	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
160	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Gamberi G (2003)	12579271	171799	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
161	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Zhang G (2003)	12707394	171817	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
162	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Wielockx B (2003)	12824001	171819	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
269	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
270	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	chaperone	target	Kaufman RJ (1997)	9607108	171871	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
271	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
278	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
279	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Kaufman RJ (1997)	9607108	171871	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
280	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Pipe SW (1998)	9525969	1039	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
281	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
282	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Srour MA (2008)	17899080	171873	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
293	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
294	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
295	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Franchini M (2011)	21391865	171876	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
299	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Do H (2006)	17083033	171889	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
300	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Vannier E (1999)	10210771	171888	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
301	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
302	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Vamvakopoulos J (2002)	12355453	171885	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
303	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Dayer JM (2003)	12817089	171884	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
304	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	So A (2007)	17352828	171887	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
305	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Tang YH (2007)	17498496	171886	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
306	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
307	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
308	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
321	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	binder	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
322	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	binder	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
323	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	binder	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
360	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
361	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
372	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
373	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
374	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
375	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
383	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	unknown	target	Allen S (1997)	9359841	1042	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
397	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Moestrup SK (1993)	8344937	6349	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
398	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Nykjaer A (1992)	1378833	171911	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
399	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Hu K (2006)	16303771	171910	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
494	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Koerner M (2007)	17475961	171979	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
495	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Baggio LL (2007)	17498508	171978	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
496	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Brubaker PL (2003)	12529935	171977	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
497	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Fischer AJ (2007)	17534934	171976	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
561	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Welty DM (2003)	14617145	172016	44	OspA lipoprotein	Outer surface protein A precursor	-	DRUGBANK	DB00045	C1198H2012N322O422S2	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
566	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Smith TJ (2010)	20392809	172020	45	Insulin Lispro	Insulin lispro protamine|Insulin,lispro,human/rDNA|Insulin lispro (genetical recombination)|Insulin lispro recombinant|Insulin lispro protamine recombinant|Insulin,lispro,protamine/rDNA|Insulin lispro (rDNA origin)	humalog mix75/25|humalog mix50	DRUGBANK	DB00046	C257H387N65O76S6	biologic	A10AB04|A10AC04|A10AD04	133107-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
571	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	agonist	target	Smith TJ (2010)	20392809	172020	46	Insulin Glargine	Insulin Glargine (rDNA origin)|Insulin glargine recombinant	soliqua 100/33|lantus solostar	DRUGBANK	DB00047	C267H404N72O78S6	biologic	A10AE04	160337-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
595	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
596	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
605	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
606	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
607	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
608	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
611	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
612	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
615	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
616	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Flendrie M (2003)	14532145	172043	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
617	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Lorenz HM (2002)	12044041	172044	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
618	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Bang LM (2004)	15046527	172045	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
619	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Klinkhoff A (2004)	15200343	172046	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
620	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Aguillon JC (2003)	15022409	172042	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
633	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
634	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
641	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
642	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
648	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
649	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
652	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
653	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
698	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Omar MN (1999)	10463819	172085	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
699	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Cvirn G (2002)	12062545	172064	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
700	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Conway EM (2002)	12208873	172087	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
701	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Gruber A (2002)	12070133	172088	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
702	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Levi M (2002)	12296618	172086	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
709	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
710	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
720	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
721	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
722	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
723	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
727	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
728	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
748	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	binder	target	Ramos-Morales F (1997)	9299436	283	60	Pegademase bovine	Adenosine deaminase|Adenosine aminohydrolase	adagen	DRUGBANK	DB00061	C1821H2834N484O552S14	biologic	-	9026-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
750	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Mojzisova H (2007)	17141733	172116	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
751	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Michaelis K (2006)	16554356	172114	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
752	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Yuan Z (2003)	12860569	172115	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
753	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Yuan ZY (2003)	12887764	172112	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
754	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Yamashita T (2007)	17553935	172113	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
764	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Wang L (2006)	17378158	172130	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
765	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
766	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
767	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Cano NJ (2006)	16441928	172131	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
768	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Mori S (2006)	16622728	172132	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
769	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Danese S (2006)	16456024	172133	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
770	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Magro F (2005)	15674127	172134	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
771	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Popa C (2005)	15804598	172135	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
772	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Shen C (2005)	15691299	172136	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
773	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Mimura T (2007)	17642244	172137	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
774	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Maini RN (2002)	12110154	172138	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
775	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Braun J (2005)	16052578	172139	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
776	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
777	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Sapienza MS (2004)	15481318	172141	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
778	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Tobin AM (2005)	15691217	172140	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
812	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1998)	9850732	172163	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
813	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (2001)	11327694	172166	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
814	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Locci P (1995)	7648625	172165	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
815	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1997)	9435505	172164	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
834	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
835	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Authier F (2002)	11779865	172178	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
836	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
837	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Nunn SE (1997)	9130467	172177	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
838	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Ogino S (1999)	10229502	172179	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
872	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Fottner C (1998)	9846170	172196	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
873	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Zhang Q (1998)	9582514	172197	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
874	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
875	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Sowers JR (1995)	7476290	172195	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
876	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
877	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
878	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
879	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Harada S (1993)	8504733	172200	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
880	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	MARIGO S (1958)	13560210	172198	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
881	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Hsu MC (1998)	9643444	172199	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
882	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
883	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
894	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
895	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
896	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
897	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
899	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
900	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
913	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
914	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
925	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
926	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
927	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
928	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Di Gaetano N (2003)	12874252	172217	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
929	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
933	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
934	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
942	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
943	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
952	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
953	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
954	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
955	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
958	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
959	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
976	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
977	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
986	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
987	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
988	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
989	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
992	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
993	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1007	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1008	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1017	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1018	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1019	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1020	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1023	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1024	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1036	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1037	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1044	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1045	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1046	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1047	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1050	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1051	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1081	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1082	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1089	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1090	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1091	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1092	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1094	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1095	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1129	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1130	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1143	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1144	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1145	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1146	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1151	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1152	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1177	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1178	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1179	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1180	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1183	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1184	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1187	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1188	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1197	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1224	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Seitz R (1999)	10499905	172386	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1225	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Bauer KA (2000)	11019961	172385	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1226	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Butenas S (1999)	10498586	172384	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1227	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Koehler M (1999)	10499904	172383	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1228	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Samis JA (2000)	10648407	172382	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1239	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1240	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1241	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Rohlena J (2003)	12522212	744	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1258	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	unknown	target	Bonner JC (1995)	7541796	172406	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1259	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	unknown	target	Lizonova A (1990)	1697862	172407	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1290	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1291	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1294	109610	3383	-	ICAM1	BB2|CD54|P3.58	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1299	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1300	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1301	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1302	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1308	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1309	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1324	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1325	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1326	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1327	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1330	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1331	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1334	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1335	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1336	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1337	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1347	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1348	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1349	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1350	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1353	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1354	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1371	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1372	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1379	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1380	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1381	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1382	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1385	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1386	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1827	111353	5337	-	PLD1	-	9606	Homo sapiens	product of	target	Lee JS (2005)	16179605	172770	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1828	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Calaf GM (2007)	17390078	172774	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1829	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Amenta F (2006)	16297435	172766	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1830	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Hsieh BC (2007)	17329059	172772	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1831	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Stoytcheva M (2006)	16376069	172773	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1832	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Lurie S (2007)	17636231	172771	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1894	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Haruna Y (2006)	16729278	172866	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1895	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Ishikawa T (2006)	16720041	172867	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1896	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Yang J (2006)	16717106	172864	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1897	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Gautier C (2006)	16690332	172865	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1898	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Akamine EH (2006)	16682803	172863	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
2094	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Tan S (2006)	16547651	172984	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2095	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Mong JA (2005)	16326016	172981	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2096	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Rose C (2005)	16382338	172980	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2097	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Miguel-Hidalgo JJ (2006)	16484281	172983	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2098	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Chatauret N (2006)	16530878	172982	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2126	111310	5292	-	PIM1	PIM	9606	Homo sapiens	product of	target	Imming P (2006)	17016423	171742	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2127	111310	5292	-	PIM1	PIM	9606	Homo sapiens	product of	target	Overington JP (2006)	17139284	171741	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2128	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Mayes MA (2007)	17167165	173052	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2368	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Rutter AR (2000)	11080203	173223	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2369	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2370	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2371	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Rutter AR (2002)	12068077	173225	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2372	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Bresink I (1996)	8886398	173224	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2492	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Yamamoto S (2007)	17284842	173278	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2493	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Scaraffia PY (2006)	16876704	173279	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2494	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Singh U (2006)	16973920	173281	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2495	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Re DB (2006)	16673373	173280	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2512	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Miglio G (2007)	17662248	173213	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2513	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Verkhratsky A (2007)	17229973	173286	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2598	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Kadokawa Y (2007)	17517071	173337	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2599	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Ramachandran K (2007)	17465221	173338	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2695	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Osada Y (2006)	16530182	173407	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2696	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Zhang J (2006)	16371234	173406	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2697	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Yancey PG (2004)	14594995	173405	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2698	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Nakagawa A (2005)	15791597	173404	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2699	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Yan X (2004)	15541376	173408	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2722	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Yu D (2002)	12269833	173425	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2723	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Lopez-Andreo MJ (2005)	16114872	173424	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2724	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Rodriguez-Alfaro JA (2004)	14698304	173426	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2725	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Corbin JA (2007)	17367165	173423	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2768	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2769	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Milutinovic PS (2007)	17646495	173458	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2770	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Gabra BH (2007)	17405869	173454	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2771	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Brosnan RJ (2007)	17513636	173455	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2772	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Liu Y (2007)	17360906	173456	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2773	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Domingues A (2007)	17403555	173457	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2866	119549	51451	CGI-68	LCMT1	LCMT|PPMT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2867	119549	51451	CGI-68	LCMT1	LCMT|PPMT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2945	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	15990700	173594	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2946	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	16190133	173591	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2947	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Thuresson ED (2001)	11121413	173590	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2948	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Levin G (2002)	11939906	173592	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2973	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Giraldi-Guimaraes A (1999)	10681601	173616	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2974	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Perry JM (2000)	10799481	173617	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2975	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Yu W (2000)	10962148	173614	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2976	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Adak S (2000)	10945985	173615	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2977	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Kominami S (1999)	10502685	173613	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2988	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Trovati M (1999)	10440125	173627	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2989	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Hayakawa H (1999)	10403604	173626	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2990	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Tan E (1999)	10690351	173630	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2991	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Abu-Soud HM (2000)	10749853	173629	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2992	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	McDuffie JE (1999)	10460702	173628	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
3312	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3313	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Auclair K (2003)	12699699	60080	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3314	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3315	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Calo LA (2003)	12897089	173760	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3436	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Horia E (2007)	17052999	173829	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3437	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Ramakers JD (2007)	17610002	173828	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3438	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Selvaraj RK (2006)	16702329	173830	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3439	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chambrier C (2002)	12055328	173831	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3440	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Iwata Y (2001)	11552681	173832	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Machida T (2005)	16141635	173820	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee JY (2003)	12562875	173822	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3455	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chene G (2007)	17459764	173843	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3456	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vecchio AJ (2010)	20463020	173819	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3457	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3458	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ait-Said F (2003)	12573452	173842	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3570	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Ganz MB (2000)	10644549	173924	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3571	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3572	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3573	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Wigg SJ (2004)	15184978	173925	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3574	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Huang Y (2002)	11850093	173923	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3575	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3576	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Sylvester PW (2001)	11736999	173926	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3577	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3578	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Azzi A (1997)	9430404	173927	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3579	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Huang Y (2002)	11850093	173923	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3580	111508	5516	-	PPP2CB	PP2Abeta|PP2CB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3581	111508	5516	-	PPP2CB	PP2Abeta|PP2CB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3584	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Taccone-Gallucci M (2006)	16531984	173928	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3588	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3589	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3665	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Wang Z (1995)	7657295	174004	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3666	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	McCarthy DJ (1989)	2922761	174005	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3667	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Szejtli J (1983)	6867080	174002	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3668	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Lee SK (1999)	10469489	174003	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3669	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Casper HH (1989)	2484931	174001	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3675	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3676	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3677	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3682	106665	156	-	ADRBK1	BARK1|BETA-ARK1|GRK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3683	106665	156	-	ADRBK1	BARK1|BETA-ARK1|GRK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3686	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3687	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3688	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3696	116139	10939	-	AFG3L2	SCA28|SPAX5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3697	116139	10939	-	AFG3L2	SCA28|SPAX5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3718	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3719	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3720	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	unknown	target	Zarubica A (2007)	16858612	174023	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3721	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	unknown	target	Porchay I (2006)	17135600	174024	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3722	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	unknown	target	Badeau R (2007)	17224860	174025	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3727	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Van Meter TE (2006)	17041888	174029	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3730	106605	90	-	ACVR1	ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3731	106605	90	-	ACVR1	ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3749	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3750	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3803	112611	6733	-	SRPK2	SFRSK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3862	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3863	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Levitt DG (2006)	16398929	174113	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3864	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3865	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3866	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3867	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Lambert JD (2001)	11318430	174118	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3868	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	West M (2004)	15379894	174119	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3869	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Jeon SB (2005)	15694390	174121	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3870	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Azadzoi KM (2004)	15098224	174120	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3871	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Audouin C (2001)	11277534	174117	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3872	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3873	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hochhaus G (1990)	2386110	174125	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3874	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hoegger P (1998)	9523318	174124	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3875	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Philibert D (1993)	8466638	174127	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3876	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Valotis A (2004)	15285788	174126	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3877	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Johnson M (1998)	9563368	174123	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3878	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Badia L (2001)	11368283	174122	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3887	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3888	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Stringer JL (1999)	10094428	174140	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3889	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3890	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Motalli R (1999)	10444662	174138	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3891	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Ogasawara T (1999)	10494996	174139	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3892	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Mott DD (1999)	10482760	174136	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3893	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Garcia-Gil L (1999)	10386831	174137	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3894	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3895	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3909	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Clarke DE (1982)	7059347	174156	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3921	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3922	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3950	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Olincy A (2006)	16754836	174185	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3951	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Mexal S (2007)	17360707	174184	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3952	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3953	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3954	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3955	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4006	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4007	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Fisher A (1996)	8624083	174199	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4008	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4088	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Rothman RB (1999)	10218558	174235	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4089	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Ulus IH (2000)	10799660	174228	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4090	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Kilpatrick IC (2001)	11673765	174229	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4091	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Rothman RB (1999)	10231134	174226	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4092	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Nandigama RK (2002)	11911838	174227	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4127	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rait JL (1999)	10080340	174264	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4143	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4144	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Demetri GD (1999)	10097144	174284	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4145	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Petrova TV (1999)	10200320	174285	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4146	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Kitamura S (1999)	10076568	174286	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4147	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Baek SJ (2003)	12475986	174281	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4148	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Camp HS (1999)	10214942	174282	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4149	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Satoh T (1999)	10222233	174283	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4245	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4246	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Cornelis MC (2007)	17616786	174343	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4247	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Riksen NP (2007)	17558310	174345	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4248	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Zhao G (2007)	17577101	174344	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4249	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4250	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Cornelis MC (2007)	17616786	174343	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4251	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Riksen NP (2007)	17558310	174345	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4252	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Zhao G (2007)	17577101	174344	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4269	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4270	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4271	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Fisher DM (1999)	10437710	174357	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4313	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	202	Trospium	-	trospium chloride|trospium chl	DRUGBANK	DB00209	C25H30NO3	small molecule	G04BD09|A03DA06	47608-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYYDSUSKLWTMMQ-JKHIJQBDSA-N
4314	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	202	Trospium	-	trospium chloride|trospium chl	DRUGBANK	DB00209	C25H30NO3	small molecule	G04BD09|A03DA06	47608-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYYDSUSKLWTMMQ-JKHIJQBDSA-N
4365	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Bareggi SR (2007)	17916059	174434	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4388	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4389	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Hart GR (1981)	6114720	174453	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4390	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bacaner MB (1982)	6812406	174452	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4408	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4409	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4410	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4411	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eglen RM (1987)	3580704	174466	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4412	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gaulton A (2012)	21948594	174478	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4428	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Pearce DJ (2004)	15764038	174491	216	Diflorasone	(6,11,16)-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Diflorasonum|(6alpha,11beta,16beta)-6,9-Difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Diflorasona	diflorasone diacetate|apexicon	DRUGBANK	DB00223	C22H28F2O5	small molecule	D07AC10	2557-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-XHIJKXOTSA-N
4565	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4566	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4567	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4571	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4572	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4619	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4620	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4621	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4630	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Labeur M (2010)	20920967	174580	233	Alclometasone	7-Chloro-16-methylprednisolone|(7alpha,11beta,16alpha)-7-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione	aclovate|alclometasone dipropi	DRUGBANK	DB00240	C22H29ClO5	small molecule	D07AB10|S01BA10	67452-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJXOGVLKCZQRDN-PHCHRAKRSA-N
4631	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hofmann TG (1998)	9891987	174579	233	Alclometasone	7-Chloro-16-methylprednisolone|(7alpha,11beta,16alpha)-7-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione	aclovate|alclometasone dipropi	DRUGBANK	DB00240	C22H29ClO5	small molecule	D07AB10|S01BA10	67452-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJXOGVLKCZQRDN-PHCHRAKRSA-N
4635	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4636	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4637	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4693	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4694	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Schwab M (2008)	18544567	174605	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4695	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4696	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rousseaux C (2005)	15824083	174607	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4697	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4698	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4699	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4709	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4710	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4711	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4713	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4714	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4715	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4735	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4750	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4794	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4833	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4834	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2006)	16982285	174668	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4835	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Ichikawa K (2001)	11436517	174659	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4836	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4845	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4860	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	246	Medrysone	HMS|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione	hms	DRUGBANK	DB00253	C22H32O3	small molecule	S01BA08	2668-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZENKSODFLBBHQ-ILSZZQPISA-N
4861	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Southren AL (1983)	6336597	174690	246	Medrysone	HMS|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione	hms	DRUGBANK	DB00253	C22H32O3	small molecule	S01BA08	2668-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZENKSODFLBBHQ-ILSZZQPISA-N
4870	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4871	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Baron S (2007)	17317669	116189	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4872	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Hart SA (2007)	17314305	174699	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4873	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kwok KC (2010)	20387803	174698	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4874	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Dixon A (2007)	17308373	174697	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4875	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bains M (2007)	17320868	174696	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4876	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Munoz G (2007)	17306201	174695	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4877	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Unknown Authors (2009)	19101832	174701	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4878	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Geistlinger TR (2004)	15123288	174700	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4922	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Zebrack JS (2009)	19637941	174739	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4965	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4967	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Jordan VC (1983)	6872937	174767	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4968	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Wang JY (2006)	17236558	174766	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4969	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4970	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kupfer D (1990)	2307235	174768	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
5047	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5048	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Pechlivanova DM (2005)	16357952	174830	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5055	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5056	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Kawada T (1999)	10226408	174842	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5057	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Matsuo T (1995)	10608016	174843	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5058	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Sakai M (1999)	10353669	174840	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5059	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Serebruany VL (1999)	10608050	174841	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5060	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Jang IK (1999)	10362188	174844	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5075	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Yamamoto N (1999)	10413067	174865	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5076	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ishida Y (1990)	1690310	174866	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5154	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Stroud FC (2006)	16884174	174936	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5155	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Smith MR (2006)	16985877	174937	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5156	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Hou NN (2006)	16955786	174940	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5157	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Gouva L (2006)	16982590	174938	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5158	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ropero AB (2006)	16876190	174939	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5171	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5172	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5173	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5174	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5175	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5176	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5177	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5191	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5192	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5216	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5217	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5272	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Juchem M (1990)	2175153	175067	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5273	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fuhrmann U (1995)	7750284	175066	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5274	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Rabe T (2000)	10836199	175065	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5284	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5285	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5286	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5381	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5382	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5383	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5411	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5412	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5477	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee YS (2007)	17175104	175138	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5478	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5479	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Weinheimer EM (2007)	17322116	175137	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5480	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2008)	17884974	175136	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5532	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Villard V (2011)	21427517	175190	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5533	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5548	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5552	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5579	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5580	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5581	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5582	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5583	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5584	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Samudre SS (2004)	15684812	175223	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5606	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Cho MC (2003)	12689521	175243	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5607	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Lehmann JM (1997)	9013583	175242	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pilane CM (2005)	15668944	175250	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jerde TJ (2005)	15667901	175249	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yokota A (2005)	15831440	175248	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Armstrong PJ (2005)	15770365	175247	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhang GS (2004)	15730717	175251	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5628	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Wellington K (2005)	15987237	175290	324	Ipratropium bromide	Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide	atroventhfa|combivent udv|atro	DRUGBANK	DB00332	C20H30BrNO3	small molecule	R01AX03|R03AL02|R03AL01|R03BB01	22254-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHLMOSXCXGLMMN-VVQPYUEFSA-M
5662	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5663	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Fernandez J (2005)	15771415	175310	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5664	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5665	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5666	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5693	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5694	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5695	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5713	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5743	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Nuttall SL (2003)	12795776	175328	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5758	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	potentiator	target	Reitamo S (2002)	12113647	175334	329	Pimecrolimus	Pimecrolimusum|Pimecrolimus|33-Epi-chloro-33-desoxyascomycin	elidel	DRUGBANK	DB00337	C43H68ClNO11	small molecule	D11AH02	137071-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KASDHRXLYQOAKZ-XDSKOBMDSA-N
5759	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	potentiator	target	Reitamo S (2002)	12113647	175334	329	Pimecrolimus	Pimecrolimusum|Pimecrolimus|33-Epi-chloro-33-desoxyascomycin	elidel	DRUGBANK	DB00337	C43H68ClNO11	small molecule	D11AH02	137071-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KASDHRXLYQOAKZ-XDSKOBMDSA-N
5768	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5769	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5791	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Yasuda SU (1999)	10212017	175352	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5889	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Gonzalez Villarroel P (2008)	18411198	175429	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5890	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lamberts SW (1985)	2982481	175428	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5891	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Wiedemann K (1998)	9744490	175427	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5892	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chao Y (1997)	9195366	175426	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5893	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Kontula K (1983)	6222739	175425	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5894	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Wermers RA (2004)	15595341	175424	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5904	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5905	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5906	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5907	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Reyes FD (2005)	15930499	175441	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5908	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nargeot R (1999)	10200235	175442	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5912	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5913	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5934	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Gillespie RJ (2008)	18406614	175466	350	Mefloquine	[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina	mefloquine|lariam tab 250mg|me	DRUGBANK	DB00358	C17H16F6N2O	small molecule	P01BF02|P01BC02	53230-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEEQGYMUWCZPDN-UHFFFAOYSA-N
5951	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Huang A (2000)	10749876	175489	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5952	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Gorren AC (2002)	12003347	175488	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5953	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Gorren AC (2000)	10995244	175492	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5954	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Heller R (1999)	10075731	175493	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5955	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Shinozaki K (2000)	11009561	175490	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5956	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Berka V (2000)	10924132	175491	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5978	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5992	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6016	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Szabo S (1995)	8578198	175527	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6017	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Konturek SJ (1990)	1970337	175531	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6018	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Tarnawski A (1995)	8578218	175530	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6019	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Szabo S (1991)	1957124	175528	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6020	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Korman MG (1994)	7948825	175529	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6027	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6028	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6033	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Vereide AB (2006)	16325240	175553	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6034	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Mirkin S (2005)	16084894	175552	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6035	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Vijayanathan V (2006)	16609013	175551	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6036	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Sun D (2007)	17634204	175555	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6037	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Abdel-Aleem H (2005)	16307966	175554	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6046	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6047	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6048	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6049	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6050	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Weinshenker D (2001)	11504801	175566	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6051	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6052	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tarizzo VI (1994)	7969507	175564	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6053	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Sanders VM (1998)	9666280	175565	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6119	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6141	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	de Boer T (1995)	8930006	175620	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6142	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6143	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6196	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6197	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6200	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6201	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6202	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Fuchsjager-Mayrl G (2005)	16205624	175638	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6203	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rotmensch HH (1993)	8103526	175639	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6204	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Van der Graaf PH (1995)	8719802	175636	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6205	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Borger P (1998)	9730867	175637	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6206	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Ferro A (1997)	9088585	175640	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6225	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6226	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6227	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6228	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Freedman SB (1988)	3208836	175651	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6229	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Doerje F (1991)	1994002	175652	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6230	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Prus AJ (2009)	18685832	175654	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6231	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tanda G (2007)	17631384	175655	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6232	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Giachetti A (1986)	2432979	175656	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6315	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Marco JL (2003)	12871155	175702	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6316	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Wang H (1998)	10375753	175703	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6317	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Krustev AD (2006)	17218977	175701	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6318	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Ahmed M (2006)	16860785	175707	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6323	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6324	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Schjelderup L (1988)	3247303	175713	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6325	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6326	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6361	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Larson EW (1991)	2027917	175724	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6362	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Myhrer T (2010)	20624420	175721	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6363	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1990)	2253700	175723	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6364	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6365	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6366	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6400	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Katayama S (1990)	2236897	175768	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6401	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6402	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6403	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Burke RE (1986)	2904117	175767	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6451	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Usmani OS (2005)	15860753	175780	386	Beclomethasone dipropionate	9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate	beclovent rotacaps  -  inh 200	DRUGBANK	DB00394	C28H37ClO7	small molecule	D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01	5534-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUVIULQEHSCUHY-XYWKZLDCSA-N
6452	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Saklatvala J (2002)	12010562	175779	386	Beclomethasone dipropionate	9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate	beclovent rotacaps  -  inh 200	DRUGBANK	DB00394	C28H37ClO7	small molecule	D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01	5534-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUVIULQEHSCUHY-XYWKZLDCSA-N
6453	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	386	Beclomethasone dipropionate	9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate	beclovent rotacaps  -  inh 200	DRUGBANK	DB00394	C28H37ClO7	small molecule	D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01	5534-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUVIULQEHSCUHY-XYWKZLDCSA-N
6457	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ghebeh H (2007)	17415709	175788	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6458	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lessey BA (2006)	17118173	175789	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6459	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yuri T (2007)	17203775	175786	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6460	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Montero Girard G (2007)	17341305	175787	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6461	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kumar AS (2007)	17103262	175785	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6468	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Moya-Huff FA (1987)	2881994	175801	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6469	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	partial agonist	target	Cheng JT (2003)	12873745	175802	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6600	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6610	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Lang A (1994)	7800667	175884	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6611	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Okuyama S (1999)	10562961	175883	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6622	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Weiner DM (2004)	15059034	175896	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6629	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Johnson BA (2000)	10764590	175913	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6630	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Camp HS (2000)	10871190	175912	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6631	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rieusset J (1999)	10548525	175911	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6632	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Kameda N (2000)	10707565	175910	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6633	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6634	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Su JL (1999)	10475242	175909	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6660	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6674	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6675	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6676	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6703	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6704	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6743	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6744	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6745	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6746	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6758	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Fagart J (2010)	20650892	175952	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6821	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6822	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6823	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Huang XP (1998)	9732369	175973	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6913	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eltze M (1989)	2625138	176038	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6978	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6979	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Johnstone JF (2005)	15866114	176102	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6980	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Aida K (2004)	15336699	176103	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6981	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Tanigawa K (2002)	12188035	176104	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
7002	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ozakca I (2007)	17622774	176145	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7003	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lucin KM (2007)	17597612	176144	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7004	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7005	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Prenner L (2007)	17417877	176146	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7006	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	potentiator	target	Nakamura M (1993)	8446367	176143	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7028	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Litovchick A (2001)	11747436	176158	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7029	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Borkow G (2003)	14638394	176159	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7041	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7046	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Hustveit O (1994)	8164394	176164	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7051	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7096	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Toll L (1998)	9686407	176206	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7120	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7154	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7155	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elliott SN (1995)	7615202	176244	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7156	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Roy HK (2001)	11304699	176245	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7157	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hedner T (2004)	15456329	176242	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7158	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Kraaij DJ (2002)	12047490	176243	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7159	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7163	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7164	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7165	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Figueroa KW (2010)	20590642	176251	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7171	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7172	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7173	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7205	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blais V (2002)	12446609	176260	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7206	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568028	176261	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7207	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Padi SS (2004)	15102535	176262	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7208	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hoecherl K (2002)	12110513	176263	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7209	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568029	176264	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7232	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7233	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Galvao RI (2005)	15756931	176291	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7234	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamada M (1997)	9152412	176290	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7235	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yilmaz H (2005)	16245223	176292	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7236	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kothekar V (2001)	11563332	176288	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7237	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ozgocmen S (2005)	15943176	176289	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7251	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Ramires R (2004)	15474500	176302	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7318	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7327	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	unknown	target	Seeman P (1993)	8104554	176336	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7345	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Davies MA (2005)	15765260	176347	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7359	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Marshak DR (1985)	2986673	176354	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7368	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Payvandi F (2004)	15598423	176374	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7369	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Zeldis JB (2003)	12720152	176373	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7370	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sun J (2002)	11861516	176376	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7371	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7372	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Iannone MA (2001)	11500849	112774	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7373	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Zhou W (2002)	11810032	176377	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7374	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Kim IY (2002)	12097269	176375	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7375	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Bryant HU (1999)	10418979	176378	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7376	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Moen MD (2008)	18778124	176379	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7377	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7378	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Matsumoto T (2006)	16951478	176385	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7379	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Khovidhunkit W (1999)	10068418	176383	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7380	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Figtree GA (1999)	10477535	176382	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7381	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Cummings SR (1999)	10376571	176381	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7382	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Scott JA (1999)	10507743	176380	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7383	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bryant HU (1999)	10418979	176378	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7384	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Schafer JI (1999)	10485477	176384	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7390	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7391	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ahmad SR (2002)	12093311	176398	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7392	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Scheiman JM (2002)	12086292	176394	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7393	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Reddy BS (2002)	12086402	176395	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7394	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lu S (2002)	12104042	176396	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7395	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sigthorsson G (2002)	12055598	176397	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7437	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Doggrell SA (1993)	8095397	176448	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7438	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Lowe MD (2002)	11815381	176449	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7439	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Yalcin I (2009)	19259968	176450	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7440	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Joseph SS (2004)	15060759	176446	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7441	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Juberg EN (1985)	2865685	176447	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7479	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Ondetti MA (1988)	2836111	176471	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7480	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7481	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7482	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Sharma S (1999)	11329095	176470	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7505	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Jha S (2007)	18046909	176497	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7506	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Moriya H (1999)	10374898	176500	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7537	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7538	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kennedy JH (2003)	14613550	176516	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7539	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1997)	9253954	176515	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7540	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Burdan F (2004)	15458776	176519	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7541	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1999)	10465690	176518	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7542	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirkova M (2007)	17391279	176520	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7560	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7561	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Gallagher MJ (1998)	9572299	176543	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7562	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Hattori K (2006)	16407246	176542	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7563	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Zhuravliova E (2007)	17092607	176545	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7564	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Gu WH (2007)	17588330	176544	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7565	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Sinor JD (2000)	11102491	176547	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7566	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Steinmetz RD (2002)	11741727	176546	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7567	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7568	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7582	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7583	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7586	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7587	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7588	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Snyder S (1974)	4152054	176563	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7589	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7590	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7630	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7636	111817	5879	MIG5	RAC1	Rac-1|TC-25|p21-Rac1	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7644	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7645	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7646	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chou YC (1999)	10064839	176582	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7654	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Shin EJ (2005)	15723099	176586	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7655	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Shin EJ (2007)	17386960	176587	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7656	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Church AJ (2005)	15716633	176585	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7657	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7668	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Bachrach WH (1972)	4555460	176615	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7669	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7670	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Pace F (2010)	20391952	176617	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7671	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7672	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tittor W (1982)	6897316	176616	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7682	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7683	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7684	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7685	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7686	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1992)	1349493	176626	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7687	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bruck H (2004)	15526107	176627	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7748	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Volpi M (1981)	6262771	176673	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7749	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Sambandam T (1993)	8382768	176676	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7750	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Liu SH (1993)	7680317	176675	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7751	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Muto Y (1983)	6140014	176674	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7774	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Malmstrom K (1999)	10566562	176707	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Matheson AJ (2001)	11398914	176706	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Langman MJ (1999)	10580458	176705	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chakraborti AK (2010)	20166930	176704	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ashok V (2011)	20724158	176703	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Baron JA (2008)	18922570	176702	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7781	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pascucci RA (1999)	10643177	176709	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7782	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hawkey C (2000)	10693877	176708	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7783	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ehrich EW (1999)	10555907	176710	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7814	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Lewis-Wambi JS (2006)	16917142	176743	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7815	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Liu X (2003)	12870885	176742	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7816	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Locci P (2001)	11747628	176741	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7817	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Gennari L (2007)	17503894	176740	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7818	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Shelly W (2008)	18279543	176738	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7819	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Jones KL (2004)	15369444	176739	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7820	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Ariazi EA (2006)	16515478	176736	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7821	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Goldstein LJ (2006)	16595024	176737	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7822	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Smith MR (2006)	17062721	176734	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7823	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Taneja SS (2006)	16503765	176735	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7824	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Chen X (2002)	11752352	171740	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7852	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7861	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	532	Benazepril	Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))-	amlodipine and benazepril hydr	DRUGBANK	DB00542	C24H28N2O5	small molecule	C09AA07|C09BA07	86541-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPCFTKFZXHTYIP-PMACEKPBSA-N
7862	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	532	Benazepril	Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))-	amlodipine and benazepril hydr	DRUGBANK	DB00542	C24H28N2O5	small molecule	C09AA07|C09BA07	86541-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPCFTKFZXHTYIP-PMACEKPBSA-N
7866	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasu R (2000)	11180191	176779	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7889	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7891	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Richelson E (1983)	6130192	176784	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7892	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7935	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	antagonist	target	Servatius RJ (2000)	10869589	176802	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7936	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	antagonist	target	Abou-Donia MB (1996)	8954750	176806	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7937	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	antagonist	target	Somani SM (2000)	10942908	176807	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7970	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lange K (2000)	10754457	176811	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7971	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7972	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7973	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7974	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7975	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
8012	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8013	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8014	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8015	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bugajski J (2001)	11785774	176845	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8016	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Raju J (2002)	11952155	176846	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8017	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Veiga AP (2004)	15464832	176843	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8097	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8102	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8115	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Martinez-Campa C (2006)	16555127	176947	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8116	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Duan L (2007)	17126817	176949	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8117	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Obey TB (2005)	16111654	176948	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8118	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Brantley-Finley C (2003)	12907245	176950	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8119	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Bene A (2004)	15498923	176951	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8141	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8142	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8143	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rouget C (2006)	16177222	176964	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8144	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Isaza C (2005)	16082424	176963	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8145	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Illingworth CJ (2006)	16706406	176962	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8162	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8163	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8164	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8176	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poggi JC (2006)	17050798	176976	563	Fenoprofen	2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid	nalfon tab 600mg|fenoprofen|na	DRUGBANK	DB00573	C15H14O3	small molecule	M01AE04	29679-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDJGLLICXDHJDY-UHFFFAOYSA-N
8219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10715145	177027	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hood WF (2003)	12644588	177026	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jain KK (2000)	11060833	177030	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8222	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (2005)	15494548	177031	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8223	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8224	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2003)	12564662	177029	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8225	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan JJ (2002)	12167567	177028	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8284	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Natesh R (2004)	15236580	177072	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8285	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8286	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8287	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Liu YH (2006)	16424790	177074	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8306	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Whittle BJ (2004)	15525540	177094	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8307	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Charlier C (2003)	12932896	177095	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8308	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Kudo C (2003)	12826271	177096	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2003)	12534640	177083	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8315	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8316	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rowlinson SW (2003)	12925531	177102	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8317	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beubler E (2003)	12705061	177100	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8318	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blomme EA (2003)	12588370	177101	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8324	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hoegger P (1994)	7878687	177114	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8325	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lumry WR (1999)	10518812	177111	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8326	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Johnson M (1996)	8646863	177110	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8327	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Andersson O (1999)	10200007	177113	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8328	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Zhang X (2001)	11730731	177112	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8329	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8332	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Sano A (1999)	10351938	177115	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8333	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Myo S (2004)	15083746	177116	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8353	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8354	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8355	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8378	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Nehme A (2009)	19744340	105018	581	Fluocinolone Acetonide	6alpha-fluorotriamcinolone acetonide|fluocinolon acetonid|actonide de fluocinolone|fluocinoloni acetonidum|6,9-difluoro-16-hydroxyprednisolone 16,17-acetonide|6alpha,9alpha-difluoro-16alpha-hydroxyprednisolone 16,17-acetonide|6-fluorotriamcinolone acetonide|fluocinolone 16,17-acetonide|acetnido de fluocinolona	fluocinolone acetonide oil|syn	DRUGBANK	DB00591	C24H30F2O6	small molecule	D07CC02|S01CA10|D07AC04|S02CA05|C05AA10|S02BA08|D07BC02|S01BA15	67-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEBLZLNTKCEFIT-VSXGLTOVSA-N
8407	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Cejkova J (2005)	15866288	177159	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8408	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Jankun J (2001)	11562773	177158	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8409	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8410	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Luikart S (2002)	12183060	177160	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8411	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Chen YX (2003)	12897821	177161	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8412	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Vakili J (2001)	11544332	177162	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8437	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Mohandas S (2009)	19293512	177179	586	Ulobetasol	Ulobtasol|Halobetasol|21-chloro diflorasone|Ulobetasolum|Ulobetasol	ultravate cream|ultravate oint	DRUGBANK	DB00596	C22H27ClF2O4	small molecule	D07AC21	98651-66-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEHFPXVYPMWYQD-XHIJKXOTSA-N
8438	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hofmann TG (1998)	9891987	174579	586	Ulobetasol	Ulobtasol|Halobetasol|21-chloro diflorasone|Ulobetasolum|Ulobetasol	ultravate cream|ultravate oint	DRUGBANK	DB00596	C22H27ClF2O4	small molecule	D07AC21	98651-66-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEHFPXVYPMWYQD-XHIJKXOTSA-N
8439	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8440	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	van Zwieten PA (1993)	7684671	177184	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8441	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rosendorff C (1993)	8104240	177185	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8442	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Pujos E (2009)	19879818	177182	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8443	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sassard J (1983)	6355664	177183	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8444	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Doggrell SA (1992)	1361547	177180	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8445	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Doggrell SA (1988)	2907566	177181	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8480	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8481	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8482	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8509	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Jain JK (2007)	17094978	177204	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8510	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ghebeh H (2007)	17415709	175788	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8511	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lessey BA (2006)	17118173	175789	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8512	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yuri T (2007)	17203775	175786	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8513	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kumar AS (2007)	17103262	175785	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8520	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8521	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Bach T (2001)	11218067	177209	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8522	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Crema F (1999)	10027842	177208	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8523	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Nagakura Y (1999)	10328995	177212	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8524	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Rahme MM (1999)	10556228	177210	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8525	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Bharucha AE (2000)	11034583	177211	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8550	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2001)	11245463	177238	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8551	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2004)	15548677	177239	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8552	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2003)	12566304	177235	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8553	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Pangburn HA (2005)	16138927	177236	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8554	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2006)	16546990	177237	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8560	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Giuliano F (1999)	10372826	177229	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8561	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yip-Schneider MT (2000)	10657949	177245	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8562	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fosslien E (2000)	11078056	177244	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8563	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Molina MA (1999)	10485483	177247	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Taylor MT (2000)	11118042	177246	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8577	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Jang CH (2006)	16418198	177263	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8578	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Dias-Melicio LA (2007)	17456179	177260	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8579	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Lim EJ (2006)	16870179	177261	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8580	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Rachmilewitz D (2006)	16670522	177259	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8581	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Wozniacka A (2006)	16761500	177262	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8582	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Huang LY (2005)	16148144	177269	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8583	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Rutz M (2004)	15307186	177268	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8584	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Lenert P (2005)	15762869	177267	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8585	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Trevani AS (2003)	14579285	177266	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8586	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Merrell MA (2006)	16849519	177265	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8617	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bruck H (2004)	15526107	176627	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8618	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Motomura S (1990)	1968697	177289	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8619	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brodde OE (1986)	2439795	177288	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8620	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brouri F (2004)	14757145	177290	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8621	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Daul A (1986)	2886573	177291	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8637	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Srethapakdi M (2000)	10919672	177312	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8638	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Yang J (2001)	11358819	177311	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8639	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Neckers L (2000)	10759403	177310	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8640	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Schnaider T (2000)	10701840	177308	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8641	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Muenster PN (2001)	11306472	177309	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8645	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Dumoulin MJ (2001)	11300648	177316	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8646	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Kostova E (2006)	16642666	177315	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8647	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Elsner D (1992)	1386491	177320	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8648	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Hirata Y (1994)	7511759	177321	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8649	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Plamboeck A (2005)	16025254	177317	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8650	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	O'Connell JE (1992)	1315825	177319	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8651	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Sansoe G (2006)	16449355	177318	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8652	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8659	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Dewar AL (2005)	15917650	177323	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8660	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Haberler C (2006)	16205964	177326	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8661	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Agirre X (2005)	15949566	177327	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8662	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Brueggemeier SB (2005)	16153117	177324	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8663	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Hoerth E (2004)	15799618	177325	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8700	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shahin V (2005)	15976447	177375	610	Triamcinolone	9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona	triamcinolone acetonide inject	DRUGBANK	DB00620	C21H27FO6	small molecule	D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|S01BA05|D07XB02|D07BB03	124-94-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFNANZIMVAIWHM-OBYCQNJPSA-N
8701	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Nehme A (2009)	19744340	105018	610	Triamcinolone	9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona	triamcinolone acetonide inject	DRUGBANK	DB00620	C21H27FO6	small molecule	D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|S01BA05|D07XB02|D07BB03	124-94-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFNANZIMVAIWHM-OBYCQNJPSA-N
8702	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	610	Triamcinolone	9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona	triamcinolone acetonide inject	DRUGBANK	DB00620	C21H27FO6	small molecule	D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|S01BA05|D07XB02|D07BB03	124-94-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFNANZIMVAIWHM-OBYCQNJPSA-N
8716	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Thayer SA (1983)	6865927	177390	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8721	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8727	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Edlind T (2002)	12366848	58606	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8728	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kauss H (1981)	16661928	177393	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8729	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kawai M (2001)	11409178	54890	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8730	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mongin AA (1999)	10516112	177395	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8731	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Nakabayashi H (1992)	1515867	177394	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8732	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8733	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8734	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8735	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Van Kampen JM (2000)	11113312	177396	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8742	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Maxfield FR (1979)	42903	177414	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8743	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Gliemann J (1983)	6187372	177415	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8744	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Dickson RB (1981)	6165617	177416	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8745	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Dickson RB (1981)	6162847	177412	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8746	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Hanover JA (1983)	6184373	177413	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8747	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8748	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	inhibitor	target	Medina V (1993)	8484964	177417	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8849	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8850	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Friel PN (2006)	16597193	177469	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8851	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Diez JJ (2007)	17504182	177468	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8852	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Yano A (2006)	17062674	177465	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8853	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Liu BG (2006)	17121036	177467	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8854	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Yano A (2006)	16707595	177466	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8881	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Trincavelli ML (2010)	20370662	177502	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8882	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Ezeamuzie CI (2007)	17321471	177503	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8883	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Buenestado A (2010)	20136829	177500	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8884	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Schenone S (2010)	20370661	177501	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8885	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Kreckler LM (2009)	19749080	177504	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8886	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Kreckler LM (2006)	16339914	177505	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8887	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Funakoshi H (2007)	17438146	177498	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8888	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Haschemi A (2007)	17442976	177499	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
9012	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Schwabe U (1985)	2997628	177567	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9017	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Pal A (2007)	17622576	177568	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9018	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Mamolo MG (2008)	18069094	177569	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9019	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chien CC (1995)	8788445	177572	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9020	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Colabufo NA (2009)	20021350	177571	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9021	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Dun Y (2007)	17898305	177570	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9046	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	645	Estrone	Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone	oestrilin creme vaginale 1mg|e	DRUGBANK	DB00655	C18H22O2	small molecule	G03CA07|G03CC04	53-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNXHEGUUPJUMQT-CBZIJGRNSA-N
9047	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	645	Estrone	Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone	oestrilin creme vaginale 1mg|e	DRUGBANK	DB00655	C18H22O2	small molecule	G03CA07|G03CC04	53-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNXHEGUUPJUMQT-CBZIJGRNSA-N
9048	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Margeat E (2003)	12547192	177584	645	Estrone	Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone	oestrilin creme vaginale 1mg|e	DRUGBANK	DB00655	C18H22O2	small molecule	G03CA07|G03CC04	53-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNXHEGUUPJUMQT-CBZIJGRNSA-N
9095	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9096	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9097	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9098	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9134	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9135	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Labeur M (2010)	20920967	174580	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9136	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9137	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Maier C (2005)	16079279	177640	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9183	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ozakca I (2007)	17622774	176145	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9184	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lucin KM (2007)	17597612	176144	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9185	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9186	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Prenner L (2007)	17417877	176146	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9205	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antagonist	target	van der Poll T (1996)	8609227	177679	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9247	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Pedretti RF (2003)	12717096	177702	660	Pirenzepine	Pirenzpine|Pirenzepinum|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|Pirenzepina|Pirenzepin	gastrozepin tab 50mg	DRUGBANK	DB00670	C19H21N5O2	small molecule	A02BX03	28797-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMHMFHUVIITRHF-UHFFFAOYSA-N
9248	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	660	Pirenzepine	Pirenzpine|Pirenzepinum|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|Pirenzepina|Pirenzepin	gastrozepin tab 50mg	DRUGBANK	DB00670	C19H21N5O2	small molecule	A02BX03	28797-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMHMFHUVIITRHF-UHFFFAOYSA-N
9274	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9275	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9276	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9277	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9278	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9279	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9304	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Giacobini E (2002)	11888344	177726	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9305	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Svoboda Z (2006)	17159811	177727	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9306	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Wilkinson DG (2001)	19811027	177728	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9367	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Mc Ilroy M (2006)	17158759	131588	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9368	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9369	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9370	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Hayes DF (2010)	20827267	177731	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9371	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Gruvberger-Saal SK (2007)	17404078	177730	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9372	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Girault I (2006)	16822624	177733	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9373	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Horner-Glister E (2005)	16326830	177732	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9374	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Chen B (2005)	16010412	177729	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9375	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Mc Ilroy M (2006)	17158759	131588	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9376	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9377	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9378	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Hayes DF (2010)	20827267	177731	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9379	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Gruvberger-Saal SK (2007)	17404078	177730	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9380	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Girault I (2006)	16822624	177733	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9381	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Horner-Glister E (2005)	16326830	177732	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9382	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Chen B (2005)	16010412	177729	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9383	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fabian CJ (2002)	11906441	177735	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9384	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9385	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9386	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Cyrus K (2010)	20512796	177734	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9387	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Fabian CJ (2002)	11906441	177735	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9388	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9389	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9390	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Cyrus K (2010)	20512796	177734	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9392	111576	5590	RP11-181G12.1	PRKCZ	PKC-ZETA|PKC2	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9393	111570	5584	-	PRKCI	DXS1179E|PKCI|nPKC-iota	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9395	111568	5582	-	PRKCG	PKC-gamma|PKCC|PKCG|SCA14	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9396	111567	5581	-	PRKCE	PKCE|nPKC-epsilon	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9397	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9398	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9406	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Kelly SS (1990)	2361169	177758	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9407	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Acey RA (2002)	12459190	177757	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9408	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Pittel Z (1992)	1511344	177756	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9409	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Kamata R (2001)	11405252	177755	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9410	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Miller RB (1991)	1776688	177754	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9425	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Hammock RG (1995)	8720030	177776	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9488	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Zugmaier G (2000)	10667230	177811	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9489	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Pluda JM (1993)	7692072	177812	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9490	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Mucha S (2002)	12375053	177813	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9491	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Jerebtsova M (2007)	17071728	177814	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9492	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	McLeskey SW (1996)	8738610	177808	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9504	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Trune DR (2010)	20800906	177824	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9552	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chrysant SG (2004)	15286086	177842	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9553	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Edling O (1995)	7473177	177841	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9554	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9555	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9611	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9662	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Herz A (1997)	9040115	177911	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9663	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Wee S (2009)	19484223	177910	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9664	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9707	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9708	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Cernak I (1996)	8606397	177968	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9709	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Bach MK (1986)	3004501	177969	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9710	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Davidson D (1992)	1400062	177965	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9711	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Gross NJ (1991)	1886988	177966	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9712	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zunic G (1999)	10518442	177967	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9720	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bayly CI (1999)	10091674	177979	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9721	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2001)	11405284	177978	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9722	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Haeringen NJ (2000)	10977131	177980	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9723	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nivsarkar M (2008)	19066416	177973	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9724	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith T (2000)	11006278	160486	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9725	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hewett SJ (2000)	10773011	177971	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9726	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Basselin M (2007)	17562170	177977	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9753	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9754	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9755	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9756	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Guo H (2002)	12453049	177992	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9774	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9784	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Okada M (2003)	12803546	178008	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9785	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Nishikawa M (2008)	17980980	178007	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9828	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	MacFarlane MD (1975)	1109354	178033	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9834	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9835	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9836	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9837	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9838	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tellez-Sanz R (1998)	9506845	178040	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9869	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Gil L (2000)	11124384	178060	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9870	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9871	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9872	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	George N (2010)	20085574	178061	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9884	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9895	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9901	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Eikmeier G (1990)	1979173	178065	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9928	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9942	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	activator	target	Pohanka M (2009)	18825528	178088	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9943	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	activator	target	Khan S (2001)	11393267	178087	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9984	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9985	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
10018	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10019	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10020	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10021	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10022	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10023	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Berger W (2007)	17394438	178138	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10024	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Hardy DB (1999)	10377029	178139	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10025	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Qian C (2001)	11529688	178143	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10026	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10027	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zouboulis CC (2009)	20436887	178144	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10028	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zouboulis CC (2010)	19645854	178136	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10029	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Coffey MJ (2001)	11561080	178137	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10030	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wenzel SE (1999)	10322101	178141	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10031	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Yamashita M (2000)	10694244	178140	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10032	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wenzel SE (1996)	8826571	178142	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10033	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Guidot DM (1994)	8058773	178145	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10048	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Klinkenberg I (2010)	20398692	178163	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10049	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Murasaki O (2003)	14534362	178162	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10061	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2001)	11275997	178176	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10062	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Svendsen KB (2000)	11009046	178174	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10063	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kusuhara H (1999)	10594327	178175	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10064	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2003)	12824918	178173	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10065	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10066	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10079	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Shioda K (2010)	20655983	178189	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10080	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Wiest SA (1999)	10494892	178188	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10081	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Salsali M (2004)	15049511	178194	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10082	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Todd KG (1995)	8749840	178187	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10083	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Finberg JP (2002)	12504917	178196	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10084	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Gatch MB (2006)	16495723	178197	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10085	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Nolen WA (2003)	14574774	178190	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10086	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Volz HP (1998)	9829163	178186	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10087	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Lang W (2004)	15351283	178192	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10088	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Shioda K (2004)	15276688	178191	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10089	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Cohen C (1999)	10548268	178195	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10090	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Loescher W (1999)	10027835	178193	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10091	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10122	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Fan RS (2005)	15845548	178201	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10123	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Bickler PE (2005)	16129978	178202	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10124	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Sazonova OV (2007)	17229152	178203	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10188	111606	5621	RP5-1068H6.2	PRNP	ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10189	111606	5621	RP5-1068H6.2	PRNP	ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30	9606	Homo sapiens	inhibitor	target	De Luigi A (2008)	18365024	178255	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10245	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Zhang X (2002)	12127907	178288	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10246	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10247	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lumry WR (1999)	10518812	177111	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10248	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Isogai M (1993)	8439518	178286	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10249	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Smith CL (1998)	9793625	178287	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10267	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10268	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10281	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Okada M (2002)	11944917	178307	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10284	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	759	Hydrocortamate	17-Hydroxycorticosterone, 21-(diethylamino)acetate|Hydrocortamatum|Hidrocortamato	-	DRUGBANK	DB00769	C27H41NO6	small molecule	-	76-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWFVLWGEFDIZMJ-FOMYWIRZSA-N
10285	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	759	Hydrocortamate	17-Hydroxycorticosterone, 21-(diethylamino)acetate|Hydrocortamatum|Hidrocortamato	-	DRUGBANK	DB00769	C27H41NO6	small molecule	-	76-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWFVLWGEFDIZMJ-FOMYWIRZSA-N
10294	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	761	Clidinium	3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|Clidinii Bromidum|3-hydroxy-1-methylquinuclidinium benzilate ester|N-methyl quinuclidinyl benzilate|Clidinium bromid|Bromure de Clidinium	corium cap|chlordiazepoxide hy	DRUGBANK	DB00771	C22H26NO3	small molecule	A03CA02	7020-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOSGZJRQIVJSZ-NNBUQUNQSA-N
10295	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	761	Clidinium	3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|Clidinii Bromidum|3-hydroxy-1-methylquinuclidinium benzilate ester|N-methyl quinuclidinyl benzilate|Clidinium bromid|Bromure de Clidinium	corium cap|chlordiazepoxide hy	DRUGBANK	DB00771	C22H26NO3	small molecule	A03CA02	7020-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOSGZJRQIVJSZ-NNBUQUNQSA-N
10296	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	761	Clidinium	3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|Clidinii Bromidum|3-hydroxy-1-methylquinuclidinium benzilate ester|N-methyl quinuclidinyl benzilate|Clidinium bromid|Bromure de Clidinium	corium cap|chlordiazepoxide hy	DRUGBANK	DB00771	C22H26NO3	small molecule	A03CA02	7020-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOSGZJRQIVJSZ-NNBUQUNQSA-N
10297	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Ramos ZR (2006)	16782587	178319	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10298	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Ahmed M (2007)	17364237	178317	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10299	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10300	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	da Silva AP (2006)	16716398	178318	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10301	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10302	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10341	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10342	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10365	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10366	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10371	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10372	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Nolen WA (2003)	14574774	178190	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10373	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Volz HP (1998)	9829163	178186	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10374	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	McIntyre RS (2006)	16370964	178345	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10375	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Wooters TE (2007)	17912044	178344	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10376	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Pickar D (1982)	7092487	178347	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10377	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Chiche F (2009)	19201819	178346	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10378	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Chenu F (2009)	18700056	178343	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10408	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Mokry J (2005)	16080359	178362	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10409	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Saitoh H (1986)	3572714	178361	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10410	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Lukacs VA (1989)	2656175	178360	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10411	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10412	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10413	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Trkulja V (2004)	15337834	178359	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10415	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10416	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Vijayanathan V (2007)	17464340	178364	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10417	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10418	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lehnes K (2007)	17138652	178365	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10419	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10420	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brama M (2007)	17125913	178366	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10426	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2005)	15792781	65577	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10427	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Walton LJ (1999)	10393680	178381	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10428	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (1995)	7832763	178380	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10429	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10430	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2007)	17150210	178382	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10431	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cryer B (1998)	9626023	178378	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10436	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10437	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10444	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10445	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Shinoda K (2003)	12527923	178389	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10446	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Bernardo MM (2002)	11790786	178388	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10447	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10448	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Bourd-Boittin K (2005)	15748894	178385	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10449	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Fanchon S (2004)	15056115	178387	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10450	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Treharne GD (1999)	10460642	178386	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10451	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Nenan S (2007)	17234180	178390	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10452	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Underwood CK (2003)	12763661	178391	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10453	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10501	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10502	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10503	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10504	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10505	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10506	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10509	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Alfakih K (2006)	16370923	178404	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10510	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10511	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10512	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Brugts JJ (2009)	19379059	178403	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10522	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10523	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10524	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10549	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10550	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Schwab M (2008)	18544567	174605	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10551	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10552	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rousseaux C (2005)	15824083	174607	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10553	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10554	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10555	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10618	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10619	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Dhasmana KM (1993)	8103596	178446	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10620	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Zeng C (2009)	19293728	178445	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10677	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10678	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10679	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10680	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Jin CH (2009)	19533734	178460	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10684	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10685	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10700	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Worms P (1989)	2586634	178469	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10701	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Duarte CD (2007)	18045214	178462	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10710	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Kreth S (2010)	19997047	178470	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10725	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Betz AJ (2007)	17594079	178475	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10730	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10731	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10732	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10733	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eltze M (1994)	8081071	178479	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10734	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eltze M (1999)	10370904	178478	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10735	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Pehl C (1998)	9798802	178477	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10736	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Hosoi R (2000)	10907719	178476	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10755	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Takada Y (2004)	15489888	178495	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10756	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Arifah AK (2002)	12213119	178494	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10757	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10758	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tegeder I (1999)	10340919	178510	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poulsen Nautrup B (1999)	10220944	178511	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gross JM (1999)	10567199	178509	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Panara MR (1999)	10381787	178508	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10781	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kimura M (1999)	10490901	178519	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10782	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10783	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Fitch KD (1986)	2870555	178521	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10784	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hu DN (2000)	10973730	178520	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10785	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Singh H (1996)	8760245	178523	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10786	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gelmont DM (1988)	3168573	178522	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10827	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10828	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10829	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brideau C (2001)	11703020	178550	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10830	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narlawar R (2006)	17181139	178551	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10831	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10832	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10836	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10837	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kappus H (1973)	4123746	178556	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10838	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10853	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Linden J (1999)	10496952	178559	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10937	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Torres-Piedra M (2011)	21129983	178592	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10938	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10943	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Gu G (2005)	15909120	178604	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10944	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Aida K (2004)	15336699	176103	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10945	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	LeVan TD (1999)	10796070	178601	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10946	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	de Pablos RM (2006)	16723527	178602	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10947	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Attardi BJ (2004)	15120421	178603	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10964	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10980	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Diener M (1988)	2851449	178622	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10981	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Suzuki T (2000)	10991984	178623	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10982	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mellstrand T (1987)	2820051	178621	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10983	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Daly JW (2000)	10949586	178624	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10984	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Stoll R (1988)	2836258	178625	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10993	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Fadda F (1985)	2985405	178630	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10994	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10995	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Agmo A (1998)	9443561	178632	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10996	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Buchwald P (2008)	18022656	178633	828	Clocortolone	9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona	cloderm|clocortolone pivalate	DRUGBANK	DB00838	C22H28ClFO4	small molecule	D07AB21	4828-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTMADLUXIRMGX-RFPWEZLHSA-N
10997	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Tanigawa K (2002)	12188035	176104	828	Clocortolone	9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona	cloderm|clocortolone pivalate	DRUGBANK	DB00838	C22H28ClFO4	small molecule	D07AB21	4828-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTMADLUXIRMGX-RFPWEZLHSA-N
10998	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Ali A (2008)	18691892	178634	828	Clocortolone	9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona	cloderm|clocortolone pivalate	DRUGBANK	DB00838	C22H28ClFO4	small molecule	D07AB21	4828-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTMADLUXIRMGX-RFPWEZLHSA-N
11003	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tibayan FA (1997)	9279221	178637	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11080	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Baschant U (2010)	20346397	178666	836	Flurandrenolide	Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide	cordran|flurandrenolide cream|	DRUGBANK	DB00846	C24H33FO6	small molecule	D07CC03|D07AC07	1524-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POPFMWWJOGLOIF-XWCQMRHXSA-N
11081	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Fitzgerald P (2006)	16255837	178667	836	Flurandrenolide	Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide	cordran|flurandrenolide cream|	DRUGBANK	DB00846	C24H33FO6	small molecule	D07CC03|D07AC07	1524-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POPFMWWJOGLOIF-XWCQMRHXSA-N
11082	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	836	Flurandrenolide	Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide	cordran|flurandrenolide cream|	DRUGBANK	DB00846	C24H33FO6	small molecule	D07CC03|D07AC07	1524-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POPFMWWJOGLOIF-XWCQMRHXSA-N
11084	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	McIntosh C (1984)	6142843	178675	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11085	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	McIntosh CH (1988)	2901134	178674	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11086	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11087	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	Ahren B (1989)	2653642	178673	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11088	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	Terry LC (1985)	4080089	178672	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11114	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11115	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11116	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11149	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Edlind T (2002)	12366848	58606	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11150	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Natochin YuV (1987)	2885243	178692	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11151	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kawai M (2001)	11409178	54890	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11152	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mongin AA (1999)	10516112	177395	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11153	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Dolzan V (2007)	17455212	178693	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11154	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Farde L (1989)	2573104	178690	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11160	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11161	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11162	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Vansal SS (1999)	10449190	178696	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11172	106958	468	-	ATF4	CREB-2|CREB2|TAXREB67|TXREB	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11174	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11181	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Wu Z (2014)	24365491	178701	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11182	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11211	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Ikonomidis I (2009)	19482847	178735	850	Prednisolone	Prednisolona|delta-dehydrocortisol|delta-hydrocortisone|Prednisolonum|PRDL|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Metacortandralone|Hydroretrocortine|3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene|delta(1)-Hydrocortisone|delta(1)-Dehydrohydrocortisone|delta(1)-Dehydrocortisol|delta-dehydrohydrocortisone|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione	pms-prednisolone sod phos oph 	DRUGBANK	DB00860	C21H28O5	small molecule	S01BB02|S03BA02|S01CA02|H02AB06|D07AA03|D07BA01|D07XA02|V03AB05|S01BA04|D07CA03|A01AC54|C05AA04|R01AD52|S02CA01|S01CB02|R01AD02|A07EA01|S02BA03|S03CA02	50-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIGNJSKKLXVSLS-VWUMJDOOSA-N
11212	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Boudinot FD (1986)	2879901	178736	850	Prednisolone	Prednisolona|delta-dehydrocortisol|delta-hydrocortisone|Prednisolonum|PRDL|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Metacortandralone|Hydroretrocortine|3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene|delta(1)-Hydrocortisone|delta(1)-Dehydrohydrocortisone|delta(1)-Dehydrocortisol|delta-dehydrohydrocortisone|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione	pms-prednisolone sod phos oph 	DRUGBANK	DB00860	C21H28O5	small molecule	S01BB02|S03BA02|S01CA02|H02AB06|D07AA03|D07BA01|D07XA02|V03AB05|S01BA04|D07CA03|A01AC54|C05AA04|R01AD52|S02CA01|S01CB02|R01AD02|A07EA01|S02BA03|S03CA02	50-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIGNJSKKLXVSLS-VWUMJDOOSA-N
11216	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cappon GD (2003)	12852483	178741	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11217	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11218	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Young JM (1996)	8737748	178742	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jeske AH (1999)	10825891	178745	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mao H (2001)	11673972	178744	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Moore PA (2001)	11315375	178743	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11235	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	inhibitor	target	Masri M (2007)	17524933	178762	854	Tacrolimus	Tacrolimus anhydrous|Anhydrous tacrolimus|Tacrolimus, anhydrous	envarsus xr|advagraf|sandoz ta	DRUGBANK	DB00864	C44H69NO12	small molecule	L04AD02|D11AH01	104987-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJJXYPPXXYFBGM-LFZNUXCKSA-N
11236	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	inhibitor	target	Labrande C (2005)	16289353	178761	854	Tacrolimus	Tacrolimus anhydrous|Anhydrous tacrolimus|Tacrolimus, anhydrous	envarsus xr|advagraf|sandoz ta	DRUGBANK	DB00864	C44H69NO12	small molecule	L04AD02|D11AH01	104987-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJJXYPPXXYFBGM-LFZNUXCKSA-N
11248	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brodde OE (1985)	2859531	178778	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11249	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brodde OE (1986)	2439825	178779	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11250	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Abrahamsson T (1986)	2871880	178780	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11257	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11258	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lenselink DR (1994)	8059831	178789	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11259	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bianchetti A (1990)	1976401	178788	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11260	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tanaka N (2001)	11311067	178785	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11261	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Schwarz MK (2003)	12871140	178787	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11262	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lye SJ (1992)	1332478	178786	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11281	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11282	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Llorens O (2002)	11885959	178800	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11283	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11284	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chong LK (2003)	12569076	178802	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11285	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Riether C (2011)	20674738	178803	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11286	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ramer-Quinn DS (2000)	11120594	178806	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11287	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Schaefers RF (1999)	10226872	178807	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11288	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Haahtela T (1991)	2062329	178804	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11289	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hochhaus G (1992)	1358833	178805	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11290	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cooperberg BA (2008)	18782903	178808	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11291	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Zetterlund A (2001)	11256987	178809	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11292	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Nakamura A (2001)	11675405	178810	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11293	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11316	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Druzgala P (1991)	2004037	178824	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11317	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Bodor N (2006)	17020532	178825	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11318	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11319	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Samudre SS (2004)	15684812	175223	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11320	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Szelenyi I (2000)	12861354	178823	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11330	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11331	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11332	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11333	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Reimold M (2007)	17111172	178827	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11335	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11347	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Sehgal SN (2003)	12742462	178847	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11348	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11349	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Sehgal SN (2003)	12742462	178847	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11350	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Sehgal SN (2003)	12742462	178847	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11351	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11352	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Dowling RJ (2010)	20005306	178848	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11353	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Shuuin T (2009)	19620795	178849	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11367	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11368	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11369	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Klutchko S (1986)	3020249	178865	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11370	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Culy CR (2002)	11817979	178866	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11371	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Homburg R (2005)	15878925	178873	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11372	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overbeek A (2009)	19761360	178872	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11373	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kurosawa T (2010)	20379036	178871	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11374	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brown J (2009)	19821295	178870	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11375	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11376	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11377	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Hughes E (2010)	20091498	178868	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11378	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Unknown Authors (2006)	17055820	178869	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11379	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Homburg R (2008)	18320435	178867	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11380	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Homburg R (2005)	15878925	178873	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11381	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Overbeek A (2009)	19761360	178872	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11382	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Kurosawa T (2010)	20379036	178871	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11383	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Brown J (2009)	19821295	178870	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11384	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Sasson S (1991)	2011412	177583	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11385	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11386	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Hughes E (2010)	20091498	178868	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11387	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Unknown Authors (2006)	17055820	178869	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11388	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Homburg R (2008)	18320435	178867	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11400	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Neal B (2002)	12584671	178882	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11401	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Trippodo NC (1999)	10598120	178883	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11402	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Ferdinand KC (2001)	11588409	178881	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11403	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Azizi M (2000)	10856268	178884	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11404	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Heudi O (2002)	12487427	178885	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11405	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Intengan HD (2000)	10856267	178888	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11406	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Troughton RW (2000)	11040230	178889	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11407	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Burrell LM (2000)	11041166	178886	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11408	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	McClean DR (2000)	10933361	178887	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11409	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Azizi M (2000)	10856268	178884	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11433	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Grove RI (1987)	3622377	178918	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11434	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Juriansz RL (1988)	3334987	178919	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11435	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bovee TF (2004)	15276617	178914	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11436	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Maru BS (2009)	18976723	178915	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11437	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chae K (1998)	9558716	178916	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11438	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kuiper GG (1997)	9048584	178917	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11439	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11465	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hochhaus G (1990)	2386110	174125	886	Rimexolone	Rimexolon	vexol|vexol ophthalmic suspens	DRUGBANK	DB00896	C24H34O3	small molecule	H02AB12|S01BA13	49697-38-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTTRZHGPGKRAFB-OOKHYKNYSA-N
11554	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11555	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11556	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Friedel HA (1988)	3278878	178955	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11557	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Wilson AJ (2000)	10796631	178956	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11571	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	van Wijngaarden I (1990)	2164935	178972	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11616	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Carrera MR (2004)	15351386	178995	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11649	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11650	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11651	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murata M (2001)	11755227	179027	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11652	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murata M (2004)	14965331	179030	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11653	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11654	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Okada M (1995)	8991786	179032	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11655	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Okada M (1994)	7856330	179033	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11859	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11869	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Zhang L (2007)	17369473	179062	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11870	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Chen S (2008)	17995453	179061	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11871	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Woollhead AM (2007)	17603555	179060	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11958	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Frang H (2001)	11395517	179127	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11967	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kuromi H (1997)	9100252	179135	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11968	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Lukas TJ (1985)	3994963	179134	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11969	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Suko J (1986)	3758070	179131	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11970	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Earl CQ (1984)	6146911	179133	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11971	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Cimino M (1988)	3134891	179132	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
12073	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12074	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	El-Fakahany E (1983)	6297650	179177	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12075	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Doggrell SA (1981)	6118411	179176	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12105	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12106	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12107	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12108	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vane JR (1971)	5284360	179204	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12109	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12110	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12116	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12117	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Rong Y (1999)	10471277	179215	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12118	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Green SA (2001)	11516429	179216	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12119	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Finney PA (2001)	11250877	179217	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12120	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brogden RN (1992)	1359777	179218	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12121	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Meliton AY (2003)	12897749	179219	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12129	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Boctor AM (1986)	3020588	179225	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12130	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Yu XY (1992)	1539679	179224	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12131	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narsinghani T (2006)	16290292	179228	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12132	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalgutkar AS (2000)	10639181	179223	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12133	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12134	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Traupe T (2002)	12409963	179227	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12135	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith WL (1994)	7825862	179226	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12137	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	930	Methantheline	Methanthelinium|Methanthelinum|Methantheline	-	DRUGBANK	DB00940	C21H26NO3	small molecule	A03AB07	5818-17-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZHFODJQISUKAY-UHFFFAOYSA-N
12138	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	930	Methantheline	Methanthelinium|Methanthelinum|Methantheline	-	DRUGBANK	DB00940	C21H26NO3	small molecule	A03AB07	5818-17-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZHFODJQISUKAY-UHFFFAOYSA-N
12139	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Schuh FR (1976)	948350	179230	931	Hexafluronium	Hexafluorenium|Hexafluorenium ion|Hexamethylenebis(fluoren-9-yldimethylammonium)|Hexafluorenium cation	-	DRUGBANK	DB00941	C36H42N2	small molecule	M03AC05	4844-10-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDZAQYPYABGTCL-UHFFFAOYSA-N
12140	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	931	Hexafluronium	Hexafluorenium|Hexafluorenium ion|Hexamethylenebis(fluoren-9-yldimethylammonium)|Hexafluorenium cation	-	DRUGBANK	DB00941	C36H42N2	small molecule	M03AC05	4844-10-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDZAQYPYABGTCL-UHFFFAOYSA-N
12141	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Vedasiromoni JR (1976)	1267542	179231	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12142	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12143	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12144	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12147	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Gum GG (1993)	8430939	179238	934	Demecarium	Demecarium	-	DRUGBANK	DB00944	C32H52N4O4	small molecule	S01EB04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZVPVOZTJJMNU-UHFFFAOYSA-N
12148	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Meiniel R (1981)	7196602	179237	934	Demecarium	Demecarium	-	DRUGBANK	DB00944	C32H52N4O4	small molecule	S01EB04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZVPVOZTJJMNU-UHFFFAOYSA-N
12156	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	acetylation	target	Alfonso LF (2009)	21475861	179244	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12157	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	binding	target	Deng WG (2001)	11689471	179245	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12164	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12165	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12168	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12169	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12177	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12178	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12179	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12180	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hall MN (2007)	17301265	179255	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12181	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12182	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12183	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	unknown	target	Stevenson MA (1999)	10553090	179248	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12189	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Curran M (2001)	11398912	179274	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12190	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Elkak AE (2002)	11922402	179275	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12191	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Morris C (2002)	12542403	179272	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12192	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Dow KH (2002)	12080538	179273	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12193	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Bundred N (2002)	12113237	179270	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12194	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Kabos P (2010)	20151846	179271	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12195	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12196	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	McKeage K (2004)	15018596	179269	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12197	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Jones SE (2005)	15865850	179268	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12201	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Harty TP (2000)	10690753	179282	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12202	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Luszczki JJ (2008)	18253065	179281	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12203	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chang HR (2008)	18311896	179280	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12204	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12205	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Kleckner NW (1999)	10215667	179279	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12206	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12281	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Pasqualini JR (2003)	14670645	179325	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12282	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Juchem M (1990)	2175153	175067	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12283	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Shields-Botella J (2003)	14672731	175549	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12289	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Juruena MF (2006)	17016711	179339	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12290	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12291	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Quesnell RR (2007)	17251323	179338	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12292	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Owen HC (2007)	17182172	179337	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12293	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Boivin MA (2007)	17068119	179336	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12300	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Wheeldon NM (1991)	1678274	179346	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12301	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1991)	1687398	179347	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12302	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Dejgaard A (1991)	1666931	179350	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12303	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12304	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Rubenstein LA (2006)	16574446	179348	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12305	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1990)	1979630	179349	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12330	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Matienzo D (2006)	16982289	179368	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12331	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Waterbury LD (2006)	16846546	179366	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12332	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chitturi S (2002)	12016548	179367	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12352	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2004)	15617852	179382	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12353	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2007)	17691961	179383	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12354	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Kurtz TW (2008)	18580862	179381	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12355	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Kurtz TW (2005)	15868121	179386	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12356	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Imayama I (2006)	16938288	179384	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12357	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2005)	16154710	179385	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12358	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Tagami T (2009)	19147680	171006	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12430	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brama M (2007)	17125913	178366	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12431	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Micevych PE (2007)	17095591	179458	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12432	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Notch EG (2009)	19237207	179459	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12433	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12434	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lehnes K (2007)	17138652	178365	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12435	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bennink HJ (2009)	19434891	179462	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12436	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Mukai H (2006)	17142999	179461	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12437	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Garcia-Segura LM (2006)	17124377	179460	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12439	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	969	Cyclopentolate	2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate|Ciclopentolato|beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate|(+-)-Cyclopentolate|alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|()-cyclopentolate|Cyclopentolatum|-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate|Cyclopentolate|2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester|1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester	cyclomydril|cyclogyl oph dps 1	DRUGBANK	DB00979	C17H25NO3	small molecule	S01FA54|S01FA04	512-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKYSRIRYMSLOIN-UHFFFAOYSA-N
12440	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	969	Cyclopentolate	2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate|Ciclopentolato|beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate|(+-)-Cyclopentolate|alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|()-cyclopentolate|Cyclopentolatum|-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate|Cyclopentolate|2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester|1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester	cyclomydril|cyclogyl oph dps 1	DRUGBANK	DB00979	C17H25NO3	small molecule	S01FA54|S01FA04	512-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKYSRIRYMSLOIN-UHFFFAOYSA-N
12478	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12479	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Op't Holt TB (2007)	17594727	179504	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12480	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kompa AR (1995)	7675115	179498	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12481	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Faulds D (1991)	1718682	179499	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12482	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cheer SM (2004)	14720051	179496	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12483	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Scola AM (2004)	14662724	179497	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12484	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bartow RA (1998)	9506248	179495	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12485	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ryall JG (2006)	16432501	179500	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12486	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Steiropoulos P (2008)	18686730	179501	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12487	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Handley DA (2002)	12090787	179502	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12488	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Loefdahl CG (1989)	2544117	179503	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12498	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12499	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12500	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12501	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ali-Melkkilae T (1993)	8249551	179514	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12513	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Dolzan V (2007)	17455212	178693	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12514	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Fu W (2007)	17468175	179523	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12515	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12516	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Hoenicka J (2007)	17449449	179524	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12517	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	da Silva Lobo DS (2007)	17394052	179525	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12528	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Huebner H (2000)	10691700	179533	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12541	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Greig NH (2003)	12636181	179548	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12542	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Bassil N (2009)	19374459	179549	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12543	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Birks J (2009)	19370562	179541	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12544	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Lalli S (2008)	18671661	179542	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12545	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Gottwald MD (1999)	11139819	179544	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12546	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Onor ML (2007)	18044073	179545	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12547	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Farlow MR (2003)	14587496	179547	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12548	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Smith DA (2009)	19420308	179550	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12549	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Stahl SM (2000)	11078030	177717	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12550	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9650852	159681	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamazaki R (2002)	12065695	179564	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9831331	179562	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ottonello L (2009)	19338579	179563	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yood MU (2006)	17024689	179560	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhou XP (2009)	19952416	179561	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12604	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12605	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12657	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chong LK (2003)	12569076	178802	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12658	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brouri F (2004)	14757145	177290	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12659	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Choudhry S (2005)	15557128	179610	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12660	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12661	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Yamanishi T (2003)	12808710	179609	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12662	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brichetto L (2003)	12388338	179608	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12703	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12704	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zuniga J (2003)	14513718	179627	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12705	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sommerauer M (2001)	11729362	179635	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12706	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Levoin N (2002)	11814865	179634	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12716	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Harel M (1992)	1438284	179643	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12717	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Saxena A (1997)	9398183	179642	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12732	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Fitzgerald P (2006)	16255837	178667	1003	Clobetasol propionate	clobetasol 17-propionate|21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-propionate|clobetasol 17-propanoate|Clobetasol propionate E	taro-clobetasol topical soluti	DRUGBANK	DB01013	C25H32ClFO5	small molecule	-	25122-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBGUOGMQLZIXBE-KBUOYLHWNA-N
12733	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hofmann TG (1998)	9891987	174579	1003	Clobetasol propionate	clobetasol 17-propionate|21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-propionate|clobetasol 17-propanoate|Clobetasol propionate E	taro-clobetasol topical soluti	DRUGBANK	DB01013	C25H32ClFO5	small molecule	-	25122-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBGUOGMQLZIXBE-KBUOYLHWNA-N
12739	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12740	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Iacucci M (2010)	20151072	179657	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12741	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Tursi A (2009)	19708827	179658	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12742	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12743	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12744	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Rask-Madsen J (1992)	1359745	179659	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12746	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stolfi C (2008)	17981262	179660	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12747	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12748	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12749	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12762	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Nieland TJ (2004)	15102890	179672	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12763	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Agassandian M (2004)	15039140	179670	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12764	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Muehl H (2003)	14660039	179671	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12765	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Reddy ST (2002)	12426219	179667	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12766	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Lamkanfi M (2009)	19805629	179669	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12767	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Alder-Baerens N (2005)	15905177	179668	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12793	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Sanchez Mejia RO (2001)	11383749	179694	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12794	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Vincent JA (2007)	17192486	179695	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12795	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Chen M (2000)	10888929	179696	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12796	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Kim HS (2009)	18977395	179697	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12797	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Steinmeyer J (1998)	9413935	179698	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12798	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Sadowski T (2001)	11246672	179699	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12799	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Amin AR (1996)	8943052	179700	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12800	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Oringer RJ (2002)	12211491	179701	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12805	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Baptiste DC (2004)	15304547	179708	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12806	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Lee SM (2003)	14588118	179706	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12807	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Arvin KL (2002)	12112047	179707	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12808	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Dommergues MA (2003)	14568022	179705	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12809	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Chen M (2000)	10888929	179696	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12810	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Kim HS (2009)	18977395	179697	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12811	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Song Y (2004)	15371729	179711	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12812	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Song Y (2006)	16574083	179710	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12813	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chu LS (2007)	17506934	179709	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12820	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Koistinaho M (2005)	15674236	179720	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12821	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Sutton TA (2005)	15353401	179721	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12822	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Brundula V (2002)	12023318	179717	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12823	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Lee CZ (2006)	16395286	179719	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12824	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Machado LS (2006)	16846501	179718	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12880	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Johnson JD (1987)	2442519	182258	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12881	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Mills JS (1985)	4074665	182259	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12882	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lamers JM (1987)	2964559	182257	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12883	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Walsh MP (1988)	2833901	182260	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12884	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lamers JM (1985)	2933041	179746	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12885	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Bostroem SL (1988)	3178884	179747	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12945	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Zhu ZS (2004)	15133856	179770	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12946	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Cheng SM (2004)	15210574	179769	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
13044	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13045	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13046	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Schneider T (2004)	14769832	179826	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13051	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chrisp P (1991)	1794016	179834	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13052	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1994)	7995016	179835	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13053	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13054	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Deleu D (2002)	11978145	179837	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13055	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Macleod AD (2005)	16034956	179830	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13056	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13057	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Unknown Authors (2002)	12199263	179832	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13058	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1998)	9673855	179833	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13059	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13060	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13061	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13073	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bora G (1968)	4887393	179838	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13074	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Platz AR (1967)	4861216	179839	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13075	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Vinar O (1967)	4889058	179840	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13090	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13091	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Richardson P (2002)	12046682	179856	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13092	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Fu LM (2002)	12102294	179854	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13093	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Vescovo G (2002)	12167383	179855	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13094	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Enomoto N (2002)	12105857	179852	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13095	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Rajkumar SV (2001)	12113124	179853	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13096	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Turk BE (1996)	8755512	179851	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13098	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Kim JH (2011)	21507989	179857	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13099	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Payvandi F (2004)	15598423	176374	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13100	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Hada M (2004)	15446566	179858	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13101	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Horrobin DF (2003)	12710892	179859	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13102	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Wiedmann MW (2005)	15892618	179861	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13103	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Du GJ (2005)	15982930	179860	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13107	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Blanpied TA (1997)	9120573	179867	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13108	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Chen HS (2005)	15901795	179866	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13109	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Maler JM (2005)	16009352	179865	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13110	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	14530799	179868	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13111	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Bresink I (1996)	8886398	173224	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13118	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Blanpied TA (1997)	9120573	179867	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13119	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Maler JM (2005)	16009352	179865	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13120	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Nakazato E (2005)	15452358	179873	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13121	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Kashiwagi K (2002)	11854433	179872	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13122	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	14530799	179868	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13146	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Jessop S (2001)	11279785	179891	1036	Fluocinonide	Lidex|Fluocinonide|Fluocinonido|Vanos|Fluocinonidum	fluocinonide|lidex ont 0.05%|l	DRUGBANK	DB01047	C26H32F2O7	small molecule	D07AC08|C05AA11|D07CC05	356-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJOHZNCJWYWUJD-IUGZLZTKSA-N
13147	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13148	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13149	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13150	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13151	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13152	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13153	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13154	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13218	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13219	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13220	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13221	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13284	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Dill J (2010)	20089905	179904	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13289	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13290	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13291	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gallego-Sandin S (2004)	15481334	179907	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13292	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Murphey LJ (2004)	15494133	179908	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13293	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ouellet M (2004)	14510637	179909	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13294	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Fidalgo S (2004)	15556152	179910	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13316	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1045	Echothiophate	Ecothiopatum|Phospholine|Echothiophate|2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide	phospholine iodide - pws 12.5m	DRUGBANK	DB01057	C9H23NO3PS	small molecule	-	6736-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJOLKYGKSZKIGU-UHFFFAOYSA-N
13317	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Henderson EG (1989)	2481033	179921	1045	Echothiophate	Ecothiopatum|Phospholine|Echothiophate|2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide	phospholine iodide - pws 12.5m	DRUGBANK	DB01057	C9H23NO3PS	small molecule	-	6736-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJOLKYGKSZKIGU-UHFFFAOYSA-N
13327	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Oki T (2007)	17222678	179925	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13328	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13329	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13330	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13331	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Maruyama S (2006)	16406943	179827	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13342	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13343	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13344	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13345	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13346	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Jones SM (2003)	14656380	179930	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13347	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Abraham G (2003)	12963495	179933	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13348	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Teixeira CE (2004)	14752060	179932	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13349	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Odley A (2004)	15105445	179928	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13350	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Uezono Y (2004)	15151902	179929	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13356	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Dubey RK (2004)	15292328	179944	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13357	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Oudit GY (2003)	12963636	179940	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13358	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Vaniotis G (2011)	20732414	179941	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13359	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Azzi M (2003)	13679574	179942	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13360	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Yeh CK (2005)	15689414	179943	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13361	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Adissu HA (2004)	15138589	179939	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13387	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	del Rio B (2004)	15229223	179956	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13388	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Yoo YM (2009)	19796047	179955	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13389	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	unknown	target	Hardeland R (2009)	19449447	179953	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13390	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	unknown	target	Macias M (2003)	12603316	179957	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13401	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Radogna F (2009)	19463840	179949	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13402	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	del Rio B (2004)	15229223	179956	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13403	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13465	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Cohen ME (1986)	3022601	182263	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13466	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	DiPaola M (1984)	6319437	182262	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13467	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Lohr KM (1984)	6092486	182261	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13468	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Luchowski EM (1984)	6433001	182265	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13469	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Scott JA (1986)	3820316	182264	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13471	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13538	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Kamm MA (2002)	11876686	180021	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13539	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Corsetti M (2002)	12150698	180020	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13540	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13541	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Camilleri M (2001)	11207504	180018	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13542	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Cole P (2004)	15645012	180019	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13543	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13544	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Kamm MA (2002)	11876686	180021	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13545	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Corsetti M (2002)	12150698	180020	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13546	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13547	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Camilleri M (2001)	11207504	180018	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13548	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Cole P (2004)	15645012	180019	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13549	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13560	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Tyacke RJ (2010)	20655489	180029	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13608	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13609	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13610	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Figueroa KW (2009)	18824613	180060	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13698	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	antagonist	target	Steeghs N (2007)	17103252	180113	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13699	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	antagonist	target	Pytel D (2009)	19149483	180112	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13700	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	antagonist	target	Fukushima R (2007)	17604599	180110	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13728	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Wang XB (1990)	2120879	182269	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13729	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mody I (1984)	6146939	182270	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13730	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Papadopoulos V (1990)	1965307	182271	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13731	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Strobl JS (1990)	2386945	182272	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13732	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Cimino M (1988)	3134891	179132	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13744	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Abou-Mohamed G (1996)	8723169	180137	1090	Arbutamine	Arbutamina|Arbutaminum	-	DRUGBANK	DB01102	C18H23NO4	small molecule	C01CA22	128470-16-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIRWWTKISYTTBL-SFHVURJKSA-N
13749	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Sastry BV (1999)	10229494	180139	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13750	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Nuttle LC (1999)	10199854	180138	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13751	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Lohmann CH (1999)	10449625	180140	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13752	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Schwartz Z (2000)	10653606	180142	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13753	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Sylvia VL (2001)	11455568	180141	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13759	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Ong WY (2003)	12582837	180148	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13760	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Hellstrand M (2002)	12110374	180149	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13761	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Kim BC (1998)	9480923	180150	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13825	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	allosteric modulator	target	Barker S (2006)	16806905	180192	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13826	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2002)	12209583	180191	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13827	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2006)	17109615	180190	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13835	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	allosteric modulator	target	Barker S (2006)	16806905	180192	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13836	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2002)	12209583	180191	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13837	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2006)	17109615	180190	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13889	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Bogle RG (1994)	7518297	180218	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13890	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Sennequier N (1999)	9873034	180219	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13891	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Dudek RR (1995)	7536941	180220	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13892	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Wolff DJ (1993)	7683652	180217	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13917	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13981	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Valeri AM (1980)	7407200	180272	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13982	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Koehler KA (1974)	4857231	180273	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13983	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	De Cristofaro R (1995)	7837275	180271	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13984	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13985	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Sie P (1991)	1711542	180274	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13986	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Sonder SA (1984)	6722124	180275	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
14027	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Ikonomidis I (2009)	19482847	178735	1118	Prednicarbate	-	dermatop|dermatop emollient cr	DRUGBANK	DB01130	C27H36O8	small molecule	D07AC18	73771-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNPXMHRZILFCKX-KAJVQRHHSA-N
14028	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Boudinot FD (1986)	2879901	178736	1118	Prednicarbate	-	dermatop|dermatop emollient cr	DRUGBANK	DB01130	C27H36O8	small molecule	D07AC18	73771-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNPXMHRZILFCKX-KAJVQRHHSA-N
14035	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Miyazaki Y (2004)	15356026	180300	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14036	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14037	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Lehmann JM (1995)	7768881	180298	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14038	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Willson TM (1996)	8576907	180299	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14039	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Sugii S (2009)	20018750	180296	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14040	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Spiegelman BM (1998)	9568680	180297	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14042	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	inhibitor	target	Murakami H (1997)	9145236	180301	1121	Tiludronate	Tiludronic acid|Acide tiludronique|Tiludronate|Acido tiludronico|Acidum tiludronicum	-	DRUGBANK	DB01133	C7H9ClO6P2S	small molecule	M05BA05	89987-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKJJVAGXPKPDRL-UHFFFAOYSA-N
14056	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Okajima K (2004)	14764656	180306	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14057	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Nichols AJ (1991)	1712335	180307	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14058	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Irodova NL (2002)	12360591	180305	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14059	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Maebara C (2002)	12398570	180308	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14142	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ehlert FJ (1990)	2329499	180337	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14143	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14144	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14145	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14187	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14188	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14189	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Abbiati GA (1988)	3247311	180355	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14223	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Abadie C (1996)	8988485	180370	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14224	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Osadchii OE (2007)	17558518	180367	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14225	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Matsumoto K (1994)	7816863	180368	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14226	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sapena R (1996)	8741184	180369	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14227	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Prenner L (2007)	17417877	176146	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14260	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14261	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14262	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14337	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Perouansky M (1996)	8968191	180413	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14398	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Kietzmann T (2003)	12637567	180441	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14399	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Li J (2003)	12547826	180437	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14400	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Dong Z (2002)	12426127	180438	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14401	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Drobna Z (2003)	12475910	180439	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14402	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Muscarella DE (2002)	12075113	180440	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14403	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Dong Z (2002)	12426127	180438	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14404	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	He Z (2003)	12529330	180442	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14405	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Tsou TC (2005)	16239170	180445	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14406	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Fauconneau B (2002)	12472888	180444	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14407	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Ivanov VN (2005)	15580309	180446	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14408	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Wang ZX (2005)	15916724	180443	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14409	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	He Z (2003)	12529330	180442	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14410	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	inhibitor	target	Lu J (2007)	17640917	173367	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14411	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Fauconneau B (2002)	12472888	180444	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14412	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Tanaka-Kagawa T (2003)	14674888	180447	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14413	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Jung DK (2003)	14516795	180449	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14414	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Mousa SA (2007)	17158527	180448	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14415	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Felix K (2005)	15849723	180450	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14456	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14457	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14458	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14474	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14475	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14492	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14518	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14519	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14520	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14521	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Azhar I (2005)	16431399	180495	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14530	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Farooqui M (2006)	16546975	180500	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14559	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Mayer M (1975)	173192	180518	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14566	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Sledge GW (2000)	10637238	180526	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14567	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Perloff M (1996)	8622076	180527	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14568	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Swain SM (1988)	3058238	180524	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14569	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Pearson OH (1982)	7044524	180525	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14570	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Ingle JN (2006)	16538529	180528	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14607	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14608	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14609	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14680	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Varma DR (1999)	10433496	175645	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14681	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Fraysse B (2005)	16268148	180548	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14682	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Lima JJ (1996)	8968966	180549	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14709	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Ho SM (2004)	14755680	180567	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14710	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Tew KD (1983)	6364362	180571	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14711	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	von Schoultz E (1994)	7703721	180570	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14712	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yoshizumi N (1985)	3989343	180568	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14713	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fernoe M (1987)	3314674	180569	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14714	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Friden B (1991)	1908244	180575	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14715	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Tew KD (1983)	6364362	180571	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14716	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Falconer MM (1989)	2679799	180573	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14717	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Moraga D (1992)	1599956	180572	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14718	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Stearns ME (1991)	1647395	180566	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14719	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Burns RG (1990)	2125244	180574	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14720	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Williams RN (2005)	15993560	180580	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14721	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Brower GL (2007)	17308006	180581	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14722	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Reinhardt D (2002)	12381651	180579	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14723	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Okada M (2008)	19057128	180578	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14724	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Prontera C (1999)	10328230	180577	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14725	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Yamamoto D (2010)	20184869	180576	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14726	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Natesh R (2004)	15236580	177072	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14727	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14728	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Dalkas GA (2010)	20014331	180582	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14729	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tzakos AG (2006)	16889963	180583	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14730	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14731	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14732	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14733	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Williams RN (2005)	15993560	180580	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14734	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Okada M (2008)	19057128	180578	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14735	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Yamamoto D (2008)	18501888	180584	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14736	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Reinhardt D (2002)	12381651	180579	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14802	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14822	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Ozakca I (2007)	17622774	176145	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14823	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14824	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Liu YL (1995)	8574280	180611	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14825	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1994)	7981009	180612	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14826	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Varma DR (1999)	10433496	175645	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14827	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1992)	1349493	176626	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14873	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sharif NA (2001)	11572462	180647	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14874	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Quast U (1984)	6147147	180646	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14875	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brooks AM (1992)	1351412	180645	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14876	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Gonzalez JP (1987)	2892662	180644	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14877	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Harris A (1994)	7928182	180643	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14878	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14879	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Lesar TS (1987)	2891463	174265	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14905	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14906	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14907	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bilcikova L (1987)	2885244	180658	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14908	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Drimal J (1987)	2895037	180659	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14909	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Arai K (2003)	12967722	180660	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14910	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Noack E (1986)	2876128	180657	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
15004	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15018	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Kunz S (2003)	12920235	180706	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15019	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Henriksson G (2001)	11258648	180707	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15020	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Zhang X (2000)	11040338	180705	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15021	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15022	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Zhang X (2001)	11730731	177112	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15023	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Kompella UB (2003)	12601049	180708	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15030	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15063	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15064	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15096	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Kao YJ (1996)	8922768	180725	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15126	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15132	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15133	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1991)	1863523	180744	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15134	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15157	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Guillemot J (2009)	18948374	180759	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15158	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Burger DM (2006)	16466463	180760	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15159	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Hammer D (2005)	15835479	180755	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15160	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15161	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15169	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Vaitkuviene A (2006)	16963802	180771	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15170	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Wang D (2007)	16971495	180770	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15171	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15172	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Warne JP (2006)	16835395	180768	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15173	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Funato H (2006)	16956592	180769	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15174	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15182	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15183	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15184	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15215	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15216	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15238	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15276	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15277	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15278	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15286	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15312	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15313	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	inhibitor	target	Baranczyk-Kuzma A (2001)	11899840	180810	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15314	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	inhibitor	target	Baranczyk-Kuzma A (2004)	15094841	180811	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15334	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	binder	target	Lamers JM (1985)	2933041	179746	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15335	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	binder	target	Lamers JM (1987)	2964559	182257	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15361	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Kettler R (1990)	2248058	180832	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15362	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Mason ST (1985)	4070383	180833	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15379	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15380	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Ito R (2006)	17034586	180845	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15381	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Egan LJ (1998)	9797390	180846	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15394	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	1240	Mitiglinide	-	-	DRUGBANK	DB01252	C19H25NO3	small molecule	A10BX08	145375-43-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPGGHFDDFPHPOB-BBWFWOEESA-N
15400	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	multitarget	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15401	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15402	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15403	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Schittenhelm MM (2006)	16397263	180858	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15404	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Quintas-Cardama A (2006)	17155893	180859	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15405	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15406	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Kamath AV (2008)	17429625	180862	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15407	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Nam S (2005)	16230377	180861	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15408	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Serrels A (2006)	17148760	180860	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15409	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	multitarget	target	Piccaluga PP (2007)	17701954	180863	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15410	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	multitarget	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15411	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15418	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15419	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15420	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Overington JP (2006)	17139284	171741	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15421	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15430	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15431	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15432	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Das J (2006)	17154512	180872	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15436	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Imming P (2006)	17016423	171742	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15437	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15438	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Overington JP (2006)	17139284	171741	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15439	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Rother RP (2007)	17989688	180880	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15440	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Hillmen P (2006)	16990386	180874	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15441	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Dmytrijuk A (2008)	18784156	180875	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15442	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Kelly R (2009)	20011245	180876	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15443	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Luzzatto L (2010)	20378572	180877	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15444	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Singer AL (2009)	19399743	180878	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15445	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Hillmen P (2007)	17702897	180879	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15470	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	1247	Desonide	11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide	tridesilon crm 0.05%|verdeso|t	DRUGBANK	DB01260	C24H32O6	small molecule	S01BA11|D07AB08|D07BB02	638-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBGKWQHBNHJJPZ-LECWWXJVSA-N
15471	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Otte C (2010)	20371666	180892	1247	Desonide	11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide	tridesilon crm 0.05%|verdeso|t	DRUGBANK	DB01260	C24H32O6	small molecule	S01BA11|D07AB08|D07BB02	638-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBGKWQHBNHJJPZ-LECWWXJVSA-N
15472	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Russell GM (2010)	20427668	180893	1247	Desonide	11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide	tridesilon crm 0.05%|verdeso|t	DRUGBANK	DB01260	C24H32O6	small molecule	S01BA11|D07AB08|D07BB02	638-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBGKWQHBNHJJPZ-LECWWXJVSA-N
15558	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15559	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15621	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	binder	target	Chavez CA (2007)	17927214	173188	1259	Alglucosidase alfa	Aglucosidase alfa|Aglucosidase alpha|Acid-alpha glucosidase|alpha-1,4-glucosidase|Acid maltase|Lysosomal Alpha-Glucosidase|Alpha-glucosidase	lumizyme|myozyme	DRUGBANK	DB01272	C4435H6739N1175O1279S32	biologic	A16AB07	420784-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15624	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Mihalak KB (2006)	16766716	180971	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15630	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cazzola M (2005)	16022567	180980	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15631	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cazzola M (2010)	20406080	180978	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15632	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Matera MG (2007)	17352511	180977	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15633	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Unknown Authors (2004)	14725487	180976	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15634	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Op't Holt TB (2007)	17594727	179504	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15635	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kharidia J (2008)	18501650	180979	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15636	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15637	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Baumgartner RA (2007)	17472819	180981	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15653	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Lebovitz HE (2006)	16627399	181004	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15654	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Kolterman OG (2005)	15700891	181005	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15655	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Degn KB (2004)	15331551	180997	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15656	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Briones M (2006)	16722815	180996	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15657	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Barnett AH (2005)	16341288	180995	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15658	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Diamant M (2004)	15495988	181001	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15659	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Wajchenberg BL (2007)	17353295	180999	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15660	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Mack CM (2006)	16534527	180998	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15661	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Hargrove DM (2007)	17292977	181000	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15662	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Mann RJ (2010)	20649595	181002	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15663	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15664	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Geelhoed-Duijvestijn PH (2007)	17379930	181003	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15666	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	agonist	target	Rosenbloom AL (2009)	19198769	181006	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15667	109707	3486	tcag7.703	IGFBP3	BP-53|IBP3	9606	Homo sapiens	unknown	target	Unknown Authors (2005)	15777106	181007	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15668	109707	3486	tcag7.703	IGFBP3	BP-53|IBP3	9606	Homo sapiens	unknown	target	Williams RM (2008)	18363546	181008	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15669	109707	3486	tcag7.703	IGFBP3	BP-53|IBP3	9606	Homo sapiens	unknown	target	Kemp SF (2009)	19627167	181009	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15731	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalbag J (2004)	15177307	181038	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15732	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2004)	14965322	181037	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15733	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Atherton C (2004)	15017615	181036	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15734	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Esser R (2005)	15655513	181035	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15735	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2003)	14552704	181033	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15736	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15746	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Hellman P (2006)	16467980	181051	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15747	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Zhao LF (2006)	16503922	181050	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15748	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Wagner U (2006)	16523405	181048	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15749	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Matejec R (2006)	16534240	181049	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15750	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Dinan TG (2006)	16472586	181047	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15751	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15752	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Boterman M (2006)	16324695	181052	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15753	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Marone G (1984)	6203844	181055	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15754	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Coqueret O (1996)	8777955	181054	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15755	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bouillon T (1996)	8911881	181056	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15756	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	de Vries B (2001)	11730729	181053	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15761	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Leier CV (1982)	7053311	181059	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15762	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hamdad N (1996)	8945911	181058	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15763	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15764	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Carie AE (2007)	17260025	181060	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15767	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15774	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Chen JT (2006)	16431966	181067	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15775	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Sarrazin S (2005)	16155294	181068	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15776	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Lortat-Jacob H (2006)	16709188	181069	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15777	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Chen JT (2006)	17238806	181070	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15778	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Fenton JI (2002)	12405690	181073	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15779	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Dodge GR (2003)	12801482	181072	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15780	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Chu SC (2006)	16756968	181071	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15781	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Mendis E (2006)	16616490	181075	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15782	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Rajapakse N (2007)	17498959	181074	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15783	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Lapaque N (2006)	16469053	181079	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15784	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Chen JT (2006)	16431966	181067	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15785	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Yi HA (2005)	16445576	181077	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15786	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Bitler CM (2005)	15930455	181076	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15787	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Delcommenne M (2002)	12244074	181078	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15811	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15812	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Pechlivanova DM (2005)	16357952	174830	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15913	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Hannedouche T (1992)	1382161	181125	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15914	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Yoshiyama M (1999)	10205231	181124	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15915	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Kihara M (1999)	10398211	181121	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15916	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Mervaala E (1999)	10446934	181120	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15917	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tylicki L (2008)	18423812	181123	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15918	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Rosendorff C (1992)	1382157	181122	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15919	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15955	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Hermida RC (2010)	20524801	181136	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15956	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Maul B (2005)	16126915	181137	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15957	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15958	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15959	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Arend U (2002)	12613273	181138	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15968	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15969	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15970	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15992	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15993	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15994	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16015	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16016	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16017	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16041	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16042	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16043	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16064	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16065	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16066	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16088	109187	2932	-	GSK3B	-	9606	Homo sapiens	inhibitor	target	Borsotto M (2007)	16733521	181143	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16089	109187	2932	-	GSK3B	-	9606	Homo sapiens	inhibitor	target	Adli M (2007)	17628506	181145	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16090	109187	2932	-	GSK3B	-	9606	Homo sapiens	inhibitor	target	O'Brien WT (2009)	19754466	181144	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16101	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Cleuren AC (2010)	20524981	181154	1321	Mestranol	-	ortho-novum 1/50 tablets (28 d	DRUGBANK	DB01357	C21H26O2	small molecule	-	72-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMSSROKUHAOUJS-ZTUUXWJNNA-N
16102	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Dulos J (2010)	20497523	181155	1321	Mestranol	-	ortho-novum 1/50 tablets (28 d	DRUGBANK	DB01357	C21H26O2	small molecule	-	72-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMSSROKUHAOUJS-ZTUUXWJNNA-N
16103	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1321	Mestranol	-	ortho-novum 1/50 tablets (28 d	DRUGBANK	DB01357	C21H26O2	small molecule	-	72-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMSSROKUHAOUJS-ZTUUXWJNNA-N
16106	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Kulkarni RD (1977)	16716	181161	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16107	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Hjorth S (1996)	8982649	181160	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16108	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Sanchez C (1993)	11224195	181163	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16109	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Frishman WH (1990)	2189902	181162	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16110	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Ijzerman AP (1987)	2446632	181158	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16111	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Hjorth S (1993)	8098761	181159	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16112	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Kulkarni RD (1977)	16716	181161	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16113	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Hjorth S (1996)	8982649	181160	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16114	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sanchez C (1993)	11224195	181163	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16115	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Frishman WH (1990)	2189902	181162	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16116	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Ijzerman AP (1987)	2446632	181158	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16117	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Hjorth S (1993)	8098761	181159	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16128	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Vansal SS (1999)	10449190	178696	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16144	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16145	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16176	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16191	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kobayashi M (2002)	12428391	181178	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16192	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Aizawa H (1991)	1684063	181179	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16193	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brodde OE (1990)	1968366	181182	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16194	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Noguchi K (1991)	1682484	181181	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16195	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Yamasaki Y (2004)	15069780	181180	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16196	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16202	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Youdim MB (2001)	12043833	181186	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16203	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16204	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen JJ (2007)	18035186	181189	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16205	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Naoi M (2009)	19673610	181188	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16206	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Youdim MB (2004)	15573406	181190	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16207	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Weinreb O (2010)	20600573	181191	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16208	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chau KY (2010)	20624440	181192	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16209	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Leegwater-Kim J (2010)	20517484	181193	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16210	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Uzun M (2009)	19499843	181194	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16227	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Sosa V (2007)	17537429	182285	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16228	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lo LW (2007)	17612522	182284	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16229	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Schallreuter KU (2007)	17592724	182287	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16230	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Caride AJ (2007)	17595168	182286	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16231	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Zhou Z (2007)	17550897	182288	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16236	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Lee TS (2007)	17515952	181217	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16237	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Liang J (2007)	17612632	181216	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16238	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Friel LA (2007)	17624933	181215	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16239	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Marlatt NM (2007)	17536784	181214	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16245	113259	7416	-	VDAC1	PORIN|VDAC-1	9606	Homo sapiens	inhibitor	target	Zhang DW (1989)	2469483	181222	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16246	113259	7416	-	VDAC1	PORIN|VDAC-1	9606	Homo sapiens	inhibitor	target	Zhang DW (1990)	1694685	181223	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16256	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Schlechte JA (1982)	7062741	181228	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16257	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Schlechte JA (1982)	7054210	181229	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16258	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16259	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16260	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16261	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16262	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16284	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Fitzgerald P (2006)	16255837	178667	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16285	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16286	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16287	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16288	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16289	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16372	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Tenenbaum A (2005)	16168052	181267	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16414	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16415	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16416	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16417	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16418	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16435	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Schaefer MG (2003)	12901032	181297	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16436	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Motsko SP (2006)	16808554	181296	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16437	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stichtenoth DO (1998)	9711054	181295	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16438	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Josephs MD (1999)	10452868	181294	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Simon RA (2004)	14680616	181305	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16471	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16485	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16486	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16489	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antagonist	target	Kim SJ (2007)	17436372	181309	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16490	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antagonist	target	Kim DH (2003)	14642426	181310	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16492	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kim SJ (2007)	17436372	181309	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16493	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yim HW (2005)	15753395	181312	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16494	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Seo JY (2005)	15778128	181313	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16495	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fujimoto J (1995)	7540578	181316	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16496	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Snyder BW (1990)	2326286	181314	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16497	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sanfilippo JS (1985)	4039467	181315	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16498	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16518	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16519	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Sillence MN (1991)	1685013	181329	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16520	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mazzanti G (2007)	17449161	181328	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16521	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Zhu Y (2001)	11720783	181330	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16522	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Choo JJ (1992)	1322047	181331	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16523	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ryall JG (2002)	12388476	181332	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16525	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Izeboud CA (1999)	10071758	181338	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16526	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Laan TT (2005)	16261833	181334	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16527	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Izeboud CA (2004)	15021963	181335	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16528	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	van den Hoven R (2006)	17139543	181336	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16529	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Yoshimura T (2000)	11193379	181337	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16530	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Riaz SS (1999)	11221812	181341	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16531	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Samina Riaz S (2000)	11146120	181339	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16532	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Puls I (1999)	10637819	181343	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16533	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Semkova I (1999)	10525174	181342	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16534	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Culmsee C (1999)	10403429	181340	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16536	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Waldeck B (2002)	12065188	181345	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16537	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Coleman RA (1996)	8885698	181344	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16538	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chou YL (2010)	20012638	181347	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16539	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Rosberg B (1993)	8223836	181346	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16540	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Zhang D (2007)	18065099	181349	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16541	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Svensson LA (1988)	3262993	181348	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16542	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16547	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Barnes PJ (2001)	11281822	181352	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16548	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Barnes PJ (1995)	10188785	181350	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16549	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Hansel TT (2002)	12582447	181351	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16552	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Barnes NC (2007)	17530144	181353	1359	Ciclesonide	-	apo-ciclesonide|alvesco|omnari	DRUGBANK	DB01410	C32H44O7	small molecule	R01AD13|R03BA08	126544-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKZNWIVRBCLON-GXOBDPJESA-N
16570	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Ichiyama T (2003)	12801316	181363	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16571	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Ichiyama T (2007)	17430359	181370	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16572	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Tomari S (2003)	12801315	181364	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16579	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Chou CC (2003)	12602592	181374	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16580	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16581	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Fisone G (2004)	15095008	181372	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16582	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Cornelis MC (2007)	17616786	174343	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16583	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Riksen NP (2007)	17558310	174345	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16584	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Zhao G (2007)	17577101	174344	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16619	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16643	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Kumar A (1999)	10075051	181402	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16644	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Haddad JJ (2002)	11805217	181403	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16645	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Bergman MR (1999)	10444479	181400	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16646	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Marx D (2002)	11969359	181401	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16647	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Giroir BP (1992)	1611705	181399	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16648	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Levine SN (1983)	6186851	182289	1377	Aprindine	Aprindine|Compound 99170|Aprindina|Aprindinum	-	DRUGBANK	DB01429	C22H30N2	small molecule	C01BB04	37640-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZLBHDRPUJLHCE-UHFFFAOYSA-N
16656	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Csaba G (1996)	8820988	181410	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16657	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yuri T (2007)	17203775	175786	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16658	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Montero Girard G (2007)	17341305	175787	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16659	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kumar AS (2007)	17103262	175785	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16660	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ghebeh H (2007)	17415709	175788	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16661	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lessey BA (2006)	17118173	175789	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16673	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brune K (2001)	11695253	181415	1383	Antipyrine	1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon	auralgan eardrops|antipyrine a	DRUGBANK	DB01435	C11H12N2O	small molecule	S02DA03|N02BB51|N02BB71|N02BB01	60-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEQOALNAAJBPNY-UHFFFAOYSA-N
16703	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16760	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Green AL (1980)	6103055	181444	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16761	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Ask AL (1983)	6646243	181443	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16787	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16788	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16789	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16811	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Su TP (2009)	19278957	181451	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16817	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16818	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16819	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16867	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16868	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Geldenhuys WJ (2007)	17157509	181478	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16873	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
17056	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17057	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17094	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17095	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17096	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Fujita H (1998)	9509999	181542	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17097	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Prinz M (2001)	11311890	181541	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17098	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sekut L (1995)	7882570	181540	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17203	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17204	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Rostaing L (2010)	20155724	181558	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17205	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	George S (2009)	19774211	181559	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17206	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Ettenger R (2008)	18466433	181554	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17207	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Coppin C (2010)	20531964	181555	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17208	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Albert S (2010)	20569080	181556	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17209	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Teachey DT (2009)	19344392	181557	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17217	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17218	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17219	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17220	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17301	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Shichiri M (2010)	19427182	181582	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17302	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	de la Llera-Moya M (2010)	20075420	181581	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17303	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Sirtori CR (1991)	1868500	181580	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17304	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Arakawa R (2009)	19458386	181578	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17305	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Yamamoto A (2008)	19075491	181579	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17306	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Favari E (2004)	15514211	181577	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17311	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brandt KD (1990)	2277128	181583	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17312	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17313	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17320	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17328	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	antagonist	target	Trevani AS (2003)	14579285	177266	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17329	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	antagonist	target	Sun S (2007)	18220957	181586	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17346	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17362	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Neeper R (1991)	1678146	181594	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17386	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17397	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17409	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17410	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shultz PJ (1987)	3039860	181603	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17413	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Manzaneque JM (1999)	10222441	181604	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17414	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Lublin H (1991)	1822319	181605	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17430	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chrisp P (1991)	1794016	179834	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17431	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1994)	7995016	179835	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17432	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17433	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Deleu D (2002)	11978145	179837	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17434	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Macleod AD (2005)	16034956	179830	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17435	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17436	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Unknown Authors (2002)	12199263	179832	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17437	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1998)	9673855	179833	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17438	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17439	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17440	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murphy DL (1998)	9564606	181613	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17441	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Fuentes JA (1979)	477738	181612	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17442	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Villeneuve C (2009)	19542488	181611	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan Y (2007)	17691997	181616	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2007)	17164136	181615	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	FitzGerald GA (2007)	17573128	181614	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17457	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1567	SC-74020	-	-	DRUGBANK	DB01630	C29H42N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJNCFXPJICILOK-HHHXNRCGSA-N
17458	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1567	SC-74020	-	-	DRUGBANK	DB01630	C29H42N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJNCFXPJICILOK-HHHXNRCGSA-N
17490	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17491	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17492	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17494	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17495	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17496	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17506	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1588	Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside	-	-	DRUGBANK	DB01651	C10H16O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZVLEQWFATHTF-IJWOWSJNSA-N
17507	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1588	Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside	-	-	DRUGBANK	DB01651	C10H16O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZVLEQWFATHTF-IJWOWSJNSA-N
17517	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17518	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17519	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17552	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1614	RU84687	N-acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]-3-formyl-O-phosphonotyrosinamide	-	DRUGBANK	DB01678	C31H34N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAFPHFWYRLLBFO-IZLXSDGUSA-N
17561	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1621	N,N-dimethylarginine	dimethyl-L-arginine|L-NG,NG-dimethylarginine|N(g)-dimethylarginine|N(omega),N(omega)-dimethyl-l-arginine|Guanidino-n,n-dimethylarginine|ADMA|NG,NG-dimethyl-l-arginine|N(5)-[(dimethylamino)(imino)methyl]-L-ornithine|N(G1),N(G1)-Dimethylarginine|Asymmetric dimethylarginine|N(g),N(g)-dimethylarginine|N(g),N(g)-dimethyl-l-arginine|N(5)-((Dimethylamino)iminomethyl)-L-ornithine	-	DRUGBANK	DB01686	C8H18N4O2	small molecule	-	30315-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDGMGEXADBMOMJ-LURJTMIESA-N
17602	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17603	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17606	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	activator	target	Chen F (2005)	15994348	181621	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17630	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Waterhouse RN (2007)	17447254	181623	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17631	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	binder	target	Chen F (2005)	15994348	181621	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17643	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1647	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester	-	-	DRUGBANK	DB01712	C23H28N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDSSAGSYFVBTG-SFTDATJTSA-N
17656	106706	203	RP11-203J24.1	AK1	HTL-S-58j	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17657	106706	203	RP11-203J24.1	AK1	HTL-S-58j	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17658	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1658	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	-	-	DRUGBANK	DB01723	C38H47NO11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCRAOPQCACRFC-JBOQNHBVSA-N
17659	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1658	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	-	-	DRUGBANK	DB01723	C38H47NO11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCRAOPQCACRFC-JBOQNHBVSA-N
17660	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1658	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	-	-	DRUGBANK	DB01723	C38H47NO11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCRAOPQCACRFC-JBOQNHBVSA-N
17683	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1668	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	-	-	DRUGBANK	DB01734	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQBLKSRRWDWNKQ-UHFFFAOYSA-N
17684	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1668	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	-	-	DRUGBANK	DB01734	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQBLKSRRWDWNKQ-UHFFFAOYSA-N
17685	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1668	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	-	-	DRUGBANK	DB01734	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQBLKSRRWDWNKQ-UHFFFAOYSA-N
17688	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1672	O-Phosphoethanolamine	Colamine phosphoric acid|Phosphorylethanolamine	-	DRUGBANK	DB01738	C3H10NO4P	small molecule	-	1071-23-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUQZVISZELWDNZ-UHFFFAOYSA-N
17689	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1672	O-Phosphoethanolamine	Colamine phosphoric acid|Phosphorylethanolamine	-	DRUGBANK	DB01738	C3H10NO4P	small molecule	-	1071-23-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUQZVISZELWDNZ-UHFFFAOYSA-N
17690	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1672	O-Phosphoethanolamine	Colamine phosphoric acid|Phosphorylethanolamine	-	DRUGBANK	DB01738	C3H10NO4P	small molecule	-	1071-23-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUQZVISZELWDNZ-UHFFFAOYSA-N
17723	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1688	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	-	-	DRUGBANK	DB01754	C10H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJEQMXDNMETQ-UHFFFAOYSA-N
17724	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1688	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	-	-	DRUGBANK	DB01754	C10H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJEQMXDNMETQ-UHFFFAOYSA-N
17725	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1688	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	-	-	DRUGBANK	DB01754	C10H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJEQMXDNMETQ-UHFFFAOYSA-N
17734	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1694	4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine	-	-	DRUGBANK	DB01761	C28H29F3N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QICPQLFMWYQJGX-SFHVURJKSA-N
17735	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1694	4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine	-	-	DRUGBANK	DB01761	C28H29F3N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QICPQLFMWYQJGX-SFHVURJKSA-N
17741	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1698	(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid	-	-	DRUGBANK	DB01765	C17H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INSBKYCYLCEBOD-UHFFFAOYSA-N
17742	111317	5300	-	PIN1	DOD|UBL5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1699	Beta-(2-Naphthyl)-Alanine	-	-	DRUGBANK	DB01766	C13H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPZXHKDZASGCLU-LBPRGKRZSA-N
17743	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1699	Beta-(2-Naphthyl)-Alanine	-	-	DRUGBANK	DB01766	C13H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPZXHKDZASGCLU-LBPRGKRZSA-N
17746	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1700	Hemi-Babim	-	-	DRUGBANK	DB01767	C16H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKJYVDXDZURHMA-UHFFFAOYSA-N
17754	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17755	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17758	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17759	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17761	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1705	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01772	C22H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPGZQOOZHIEPJW-HNNXBMFYSA-N
17762	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1705	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01772	C22H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPGZQOOZHIEPJW-HNNXBMFYSA-N
17763	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1705	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01772	C22H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPGZQOOZHIEPJW-HNNXBMFYSA-N
17766	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1709	M-Cresol	-	-	DRUGBANK	DB01776	C7H8O	small molecule	-	108-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLSSMJSEOOYNOY-UHFFFAOYSA-N
17767	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1709	M-Cresol	-	-	DRUGBANK	DB01776	C7H8O	small molecule	-	108-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLSSMJSEOOYNOY-UHFFFAOYSA-N
17768	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1709	M-Cresol	-	-	DRUGBANK	DB01776	C7H8O	small molecule	-	108-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLSSMJSEOOYNOY-UHFFFAOYSA-N
17772	113363	7531	-	YWHAE	14-3-3E|HEL2|KCIP-1|MDCR|MDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1713	Fusicoccin	-	-	DRUGBANK	DB01780	C36H56O12	small molecule	-	20108-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXTYBXCEQOANSX-MQYZIMMHSA-N
17773	113363	7531	-	YWHAE	14-3-3E|HEL2|KCIP-1|MDCR|MDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1713	Fusicoccin	-	-	DRUGBANK	DB01780	C36H56O12	small molecule	-	20108-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXTYBXCEQOANSX-MQYZIMMHSA-N
17774	113363	7531	-	YWHAE	14-3-3E|HEL2|KCIP-1|MDCR|MDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1713	Fusicoccin	-	-	DRUGBANK	DB01780	C36H56O12	small molecule	-	20108-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXTYBXCEQOANSX-MQYZIMMHSA-N
17775	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17777	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17778	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17779	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17780	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17799	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1724	I-5	-	-	DRUGBANK	DB01793	C17H10Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONVZFCHLOZUXRP-UHFFFAOYSA-N
17800	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1724	I-5	-	-	DRUGBANK	DB01793	C17H10Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONVZFCHLOZUXRP-UHFFFAOYSA-N
17801	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1724	I-5	-	-	DRUGBANK	DB01793	C17H10Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONVZFCHLOZUXRP-UHFFFAOYSA-N
17814	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1737	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB01807	C20H21ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGHHVFLTANTIZ-PTGBLXJZSA-N
17815	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1737	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB01807	C20H21ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGHHVFLTANTIZ-PTGBLXJZSA-N
17816	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1737	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB01807	C20H21ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGHHVFLTANTIZ-PTGBLXJZSA-N
17866	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1750	Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide	-	-	DRUGBANK	DB01820	C29H31N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UESXELNYBIOROE-HSZRJFAPSA-N
17867	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1750	Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide	-	-	DRUGBANK	DB01820	C29H31N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UESXELNYBIOROE-HSZRJFAPSA-N
17868	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17869	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17870	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17871	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17872	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17873	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17885	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1760	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	-	-	DRUGBANK	DB01830	C30H41N3O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPSGYTWOIGAABK-RPBOFIJWSA-N
17886	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1760	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	-	-	DRUGBANK	DB01830	C30H41N3O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPSGYTWOIGAABK-RPBOFIJWSA-N
17892	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1763	L-2-Amino-4-(Guanidinooxy)Butyric Acid	-	-	DRUGBANK	DB01833	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBIGDSBMBYOPN-VKHMYHEASA-N
17893	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1763	L-2-Amino-4-(Guanidinooxy)Butyric Acid	-	-	DRUGBANK	DB01833	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBIGDSBMBYOPN-VKHMYHEASA-N
17894	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1763	L-2-Amino-4-(Guanidinooxy)Butyric Acid	-	-	DRUGBANK	DB01833	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBIGDSBMBYOPN-VKHMYHEASA-N
17895	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17896	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17958	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17959	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17979	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1796	RU79256	-	-	DRUGBANK	DB01866	C8H8O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USNMCXDGQQVYSW-SSDOTTSWSA-N
18009	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1805	N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide	-	-	DRUGBANK	DB01877	C13H19N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLWCTMBGWSVFC-JOYOIKCWSA-N
18010	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1805	N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide	-	-	DRUGBANK	DB01877	C13H19N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLWCTMBGWSVFC-JOYOIKCWSA-N
18017	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1815	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	-	-	DRUGBANK	DB01888	C23H33N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDIWBYRNTPTYQI-QAQDUYKDSA-N
18018	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1815	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	-	-	DRUGBANK	DB01888	C23H33N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDIWBYRNTPTYQI-QAQDUYKDSA-N
18022	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18023	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18024	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18028	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18029	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1820	N6-Benzyl Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01893	C17H21N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRHGMAGSDAQUFH-HVOFVXBASA-N
18030	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1820	N6-Benzyl Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01893	C17H21N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRHGMAGSDAQUFH-HVOFVXBASA-N
18047	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1832	2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB01905	C15H15N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFCKHJJALHETHG-UHFFFAOYSA-O
18048	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1834	RU85493	-	-	DRUGBANK	DB01908	C32H36N3O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWEWSHNGVWABKG-SXOMAYOGSA-N
18049	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1834	RU85493	-	-	DRUGBANK	DB01908	C32H36N3O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWEWSHNGVWABKG-SXOMAYOGSA-N
18050	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1834	RU85493	-	-	DRUGBANK	DB01908	C32H36N3O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWEWSHNGVWABKG-SXOMAYOGSA-N
18060	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18061	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18075	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1844	Pentanal	-	-	DRUGBANK	DB01919	C5H10O	small molecule	-	110-62-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBOYTHUEUWSSQ-UHFFFAOYSA-N
18076	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1844	Pentanal	-	-	DRUGBANK	DB01919	C5H10O	small molecule	-	110-62-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBOYTHUEUWSSQ-UHFFFAOYSA-N
18077	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1844	Pentanal	-	-	DRUGBANK	DB01919	C5H10O	small molecule	-	110-62-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBOYTHUEUWSSQ-UHFFFAOYSA-N
18100	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1865	Balanol Analog 2	-	-	DRUGBANK	DB01940	C27H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQLYTJZXRRDERK-LADGPHEKSA-N
18101	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1865	Balanol Analog 2	-	-	DRUGBANK	DB01940	C27H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQLYTJZXRRDERK-LADGPHEKSA-N
18102	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1865	Balanol Analog 2	-	-	DRUGBANK	DB01940	C27H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQLYTJZXRRDERK-LADGPHEKSA-N
18126	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18127	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18128	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18129	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18138	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1871	RU78262	-	-	DRUGBANK	DB01947	C7H7O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYNSFVCWJXZPOW-UHFFFAOYSA-N
18139	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1872	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	-	-	DRUGBANK	DB01948	C26H22Cl2F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXIYTVJEIXMAQF-UHFFFAOYSA-N
18140	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1872	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	-	-	DRUGBANK	DB01948	C26H22Cl2F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXIYTVJEIXMAQF-UHFFFAOYSA-N
18141	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1873	2-Amino-N,3,3-Trimethylbutanamide	-	-	DRUGBANK	DB01949	C7H16N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKJNEIOHOEWLO-RXMQYKEDSA-N
18142	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1873	2-Amino-N,3,3-Trimethylbutanamide	-	-	DRUGBANK	DB01949	C7H16N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKJNEIOHOEWLO-RXMQYKEDSA-N
18143	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1874	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	-	-	DRUGBANK	DB01950	C12H12N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEMHJKFIIIULI-UHFFFAOYSA-N
18144	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1874	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	-	-	DRUGBANK	DB01950	C12H12N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEMHJKFIIIULI-UHFFFAOYSA-N
18145	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1874	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	-	-	DRUGBANK	DB01950	C12H12N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEMHJKFIIIULI-UHFFFAOYSA-N
18146	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1875	Gpi-1046	-	-	DRUGBANK	DB01951	C20H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQAHHWOPVDDWHD-INIZCTEOSA-N
18147	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1877	Inhibitor of P38 Kinase	-	-	DRUGBANK	DB01953	C15H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUEYCHLWAOBOHG-UHFFFAOYSA-N
18148	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1877	Inhibitor of P38 Kinase	-	-	DRUGBANK	DB01953	C15H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUEYCHLWAOBOHG-UHFFFAOYSA-N
18149	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1877	Inhibitor of P38 Kinase	-	-	DRUGBANK	DB01953	C15H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUEYCHLWAOBOHG-UHFFFAOYSA-N
18185	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18186	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18230	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1901	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB01977	C18H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPTICWHONWNW-UHFFFAOYSA-N
18231	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1901	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB01977	C18H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPTICWHONWNW-UHFFFAOYSA-N
18232	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1901	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB01977	C18H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPTICWHONWNW-UHFFFAOYSA-N
18241	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1912	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	-	-	DRUGBANK	DB01988	C30H27N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFSFNKVFXLIZIY-MHZLTWQESA-N
18242	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1912	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	-	-	DRUGBANK	DB01988	C30H27N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFSFNKVFXLIZIY-MHZLTWQESA-N
18268	108918	2648	-	KAT2A	GCN5|GCN5L2|PCAF-b|hGCN5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18282	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1920	3-Methylpyridine	-	-	DRUGBANK	DB01996	C6H7N	small molecule	-	108-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITQTTZVARXURQS-UHFFFAOYSA-N
18283	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1920	3-Methylpyridine	-	-	DRUGBANK	DB01996	C6H7N	small molecule	-	108-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITQTTZVARXURQS-UHFFFAOYSA-N
18286	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18287	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18288	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18292	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18293	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18294	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18322	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18323	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18328	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18329	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18330	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18331	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18336	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18337	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18342	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18343	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18346	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1937	Compound 9	5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid	-	DRUGBANK	DB02014	C21H16FNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKHWJUMLYAYZFS-ONEGZZNKSA-N
18347	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1937	Compound 9	5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid	-	DRUGBANK	DB02014	C21H16FNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKHWJUMLYAYZFS-ONEGZZNKSA-N
18348	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1937	Compound 9	5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid	-	DRUGBANK	DB02014	C21H16FNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKHWJUMLYAYZFS-ONEGZZNKSA-N
18365	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18366	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18367	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18368	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18369	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18370	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18379	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18380	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18381	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18393	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1966	N-(3-(Aminomethyl)Benzyl)Acetamidine	-	-	DRUGBANK	DB02044	C10H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RODUKNYOEVZQPR-UHFFFAOYSA-N
18395	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1966	N-(3-(Aminomethyl)Benzyl)Acetamidine	-	-	DRUGBANK	DB02044	C10H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RODUKNYOEVZQPR-UHFFFAOYSA-N
18401	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1970	1,2,4-Triazole-Carboxamidine	-	-	DRUGBANK	DB02048	C3H6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDIOIIJXUJXYPB-UHFFFAOYSA-O
18402	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1970	1,2,4-Triazole-Carboxamidine	-	-	DRUGBANK	DB02048	C3H6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDIOIIJXUJXYPB-UHFFFAOYSA-O
18403	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1970	1,2,4-Triazole-Carboxamidine	-	-	DRUGBANK	DB02048	C3H6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDIOIIJXUJXYPB-UHFFFAOYSA-O
18405	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18406	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18407	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18408	114376	8851	-	CDK5R1	CDK5P35|CDK5R|NCK5A|p23|p25|p35|p35nck5a	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18409	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18410	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18411	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18412	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18413	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18437	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18438	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18439	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18459	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1992	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02072	C10H9NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPDVRWNOCOREGF-UHFFFAOYSA-N
18460	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1992	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02072	C10H9NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPDVRWNOCOREGF-UHFFFAOYSA-N
18461	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1992	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02072	C10H9NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPDVRWNOCOREGF-UHFFFAOYSA-N
18467	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18468	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18469	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18478	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18479	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18480	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18481	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18482	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18483	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18484	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1998	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	-	-	DRUGBANK	DB02078	C8H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFNKIDBQEZZDLK-UHFFFAOYSA-N
18507	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2010	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	-	-	DRUGBANK	DB02090	C20H37N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLEGVELHGVWFGG-BBWFWOEESA-N
18508	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2010	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	-	-	DRUGBANK	DB02090	C20H37N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLEGVELHGVWFGG-BBWFWOEESA-N
18509	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2010	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	-	-	DRUGBANK	DB02090	C20H37N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLEGVELHGVWFGG-BBWFWOEESA-N
18510	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18511	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18512	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18544	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2028	2-Aminoethanimidic Acid	-	-	DRUGBANK	DB02108	C2H6N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXQVKDQRBAXYBP-UHFFFAOYSA-N
18545	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2028	2-Aminoethanimidic Acid	-	-	DRUGBANK	DB02108	C2H6N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXQVKDQRBAXYBP-UHFFFAOYSA-N
18568	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18569	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18570	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18571	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18572	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18573	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18574	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18600	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2060	S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	-	-	DRUGBANK	DB02141	C12H18N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZWGDUUJDZCYJR-UHFFFAOYSA-N
18609	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18610	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18611	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18614	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18615	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18616	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18636	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2072	Balanol Analog 8	-	-	DRUGBANK	DB02155	C32H36N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLMXAUKCDSMMW-WBZRNCBQSA-N
18637	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2072	Balanol Analog 8	-	-	DRUGBANK	DB02155	C32H36N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLMXAUKCDSMMW-WBZRNCBQSA-N
18638	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2072	Balanol Analog 8	-	-	DRUGBANK	DB02155	C32H36N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLMXAUKCDSMMW-WBZRNCBQSA-N
18657	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2085	9,10-Deepithio-9,10-Didehydroacanthifolicin	-	-	DRUGBANK	DB02169	C44H68O13	small molecule	-	78111-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNDVLZJODHBUFM-NHKYITFXSA-N
18658	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2085	9,10-Deepithio-9,10-Didehydroacanthifolicin	-	-	DRUGBANK	DB02169	C44H68O13	small molecule	-	78111-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNDVLZJODHBUFM-NHKYITFXSA-N
18659	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2085	9,10-Deepithio-9,10-Didehydroacanthifolicin	-	-	DRUGBANK	DB02169	C44H68O13	small molecule	-	78111-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNDVLZJODHBUFM-NHKYITFXSA-N
18660	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2086	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	-	-	DRUGBANK	DB02170	C13H7NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOHCDJRFYXKEQW-UHFFFAOYSA-N
18663	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18664	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18665	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18695	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2109	2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB02193	C14H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDVCRKGBQLPJRQ-ZROIWOOFSA-O
18696	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2109	2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB02193	C14H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDVCRKGBQLPJRQ-ZROIWOOFSA-O
18697	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2111	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	-	-	DRUGBANK	DB02195	C18H12FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSMYZLKEZDYVPI-UHFFFAOYSA-N
18698	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2111	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	-	-	DRUGBANK	DB02195	C18H12FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSMYZLKEZDYVPI-UHFFFAOYSA-N
18699	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2111	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	-	-	DRUGBANK	DB02195	C18H12FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSMYZLKEZDYVPI-UHFFFAOYSA-N
18713	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2113	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB02197	C17H14N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKORVPQBJCGYEC-UHFFFAOYSA-N
18714	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2113	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB02197	C17H14N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKORVPQBJCGYEC-UHFFFAOYSA-N
18715	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2113	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB02197	C17H14N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKORVPQBJCGYEC-UHFFFAOYSA-N
18724	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18725	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18726	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18732	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18733	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18740	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2124	N-Methyl-N-Propargyl-1(R)-Aminoindan	-	-	DRUGBANK	DB02211	C13H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSVGVHNFFZWQJU-CYBMUJFWSA-N
18742	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18743	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18744	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18776	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18777	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18778	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18779	106848	351	-	APP	AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2146	L-methionine (R)-S-oxide	Methionine Sulfoxide	-	DRUGBANK	DB02235	C5H11NO3S	small molecule	-	62697-73-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFRNWWLZKMPFJ-ZXPFJRLXSA-N
18812	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2168	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide	-	-	DRUGBANK	DB02259	C23H18Br2N2O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSYGXLAJQDAWCZ-UHFFFAOYSA-N
18813	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2168	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide	-	-	DRUGBANK	DB02259	C23H18Br2N2O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSYGXLAJQDAWCZ-UHFFFAOYSA-N
18842	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Ouellet M (1995)	7864817	181626	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18864	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2186	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	-	-	DRUGBANK	DB02277	C15H19ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWIJKWMXNHRSRO-UHFFFAOYSA-N
18865	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2186	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	-	-	DRUGBANK	DB02277	C15H19ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWIJKWMXNHRSRO-UHFFFAOYSA-N
18866	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2186	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	-	-	DRUGBANK	DB02277	C15H19ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWIJKWMXNHRSRO-UHFFFAOYSA-N
18889	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2204	2-Amino-6-Chloropyrazine	-	-	DRUGBANK	DB02297	C4H4ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPXVCKCLBROOJ-UHFFFAOYSA-N
18890	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2204	2-Amino-6-Chloropyrazine	-	-	DRUGBANK	DB02297	C4H4ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPXVCKCLBROOJ-UHFFFAOYSA-N
18915	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2218	Methyl Methylsulfinylmethyl Sulfide	-	-	DRUGBANK	DB02311	C3H8OS2	small molecule	-	33577-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTKFCIVOVKCFHR-ZCFIWIBFSA-N
18916	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2218	Methyl Methylsulfinylmethyl Sulfide	-	-	DRUGBANK	DB02311	C3H8OS2	small molecule	-	33577-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTKFCIVOVKCFHR-ZCFIWIBFSA-N
18917	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2218	Methyl Methylsulfinylmethyl Sulfide	-	-	DRUGBANK	DB02311	C3H8OS2	small molecule	-	33577-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTKFCIVOVKCFHR-ZCFIWIBFSA-N
18961	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2240	2-Aminothiazoline	-	-	DRUGBANK	DB02335	C3H6N2S	small molecule	-	1779-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REGFWZVTTFGQOJ-UHFFFAOYSA-N
18962	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2240	2-Aminothiazoline	-	-	DRUGBANK	DB02335	C3H6N2S	small molecule	-	1779-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REGFWZVTTFGQOJ-UHFFFAOYSA-N
18963	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2240	2-Aminothiazoline	-	-	DRUGBANK	DB02335	C3H6N2S	small molecule	-	1779-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REGFWZVTTFGQOJ-UHFFFAOYSA-N
18964	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2241	RU83876	-	-	DRUGBANK	DB02336	C30H35N3O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCMLXBUNHNAMNH-FTJBHMTQSA-N
18965	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2241	RU83876	-	-	DRUGBANK	DB02336	C30H35N3O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCMLXBUNHNAMNH-FTJBHMTQSA-N
18966	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2241	RU83876	-	-	DRUGBANK	DB02336	C30H35N3O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCMLXBUNHNAMNH-FTJBHMTQSA-N
18969	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18970	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18971	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
19008	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2255	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	-	-	DRUGBANK	DB02350	C15H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYYCSKFJEOSZTF-CYBMUJFWSA-N
19009	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2255	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	-	-	DRUGBANK	DB02350	C15H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYYCSKFJEOSZTF-CYBMUJFWSA-N
19010	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2255	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	-	-	DRUGBANK	DB02350	C15H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYYCSKFJEOSZTF-CYBMUJFWSA-N
19011	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2256	Hirulog	-	-	DRUGBANK	DB02351	C98H138N24O33	small molecule	-	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
19012	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19013	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19014	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19023	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2264	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB02359	C18H23N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPFZLLAIQRZNJE-UHFFFAOYSA-N
19024	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2265	Bis-Napthyl Beta-Ketophosphonic Acid	-	-	DRUGBANK	DB02360	C22H17O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHMUASCSJJNNA-JOCHJYFZSA-N
19025	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2265	Bis-Napthyl Beta-Ketophosphonic Acid	-	-	DRUGBANK	DB02360	C22H17O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHMUASCSJJNNA-JOCHJYFZSA-N
19026	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2265	Bis-Napthyl Beta-Ketophosphonic Acid	-	-	DRUGBANK	DB02360	C22H17O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHMUASCSJJNNA-JOCHJYFZSA-N
19037	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2272	(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine	-	-	DRUGBANK	DB02367	C16H25N3O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDXUWXTVRRUND-SWLSCSKDSA-N
19038	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2272	(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine	-	-	DRUGBANK	DB02367	C16H25N3O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDXUWXTVRRUND-SWLSCSKDSA-N
19054	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2283	MMI-175	-	-	DRUGBANK	DB02378	C38H62N6O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJAPFAZHNSZLJE-KXZVVICLSA-N
19055	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2283	MMI-175	-	-	DRUGBANK	DB02378	C38H62N6O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJAPFAZHNSZLJE-KXZVVICLSA-N
19128	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2293	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB02388	C27H34Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQFRSHRWRKYNDE-UHFFFAOYSA-N
19129	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2293	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB02388	C27H34Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQFRSHRWRKYNDE-UHFFFAOYSA-N
19141	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2301	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02398	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBDETRVUYOIHQ-UHFFFAOYSA-N
19142	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2301	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02398	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBDETRVUYOIHQ-UHFFFAOYSA-N
19143	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2301	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02398	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBDETRVUYOIHQ-UHFFFAOYSA-N
19154	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19155	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19156	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19162	113170	7322	-	UBE2D2	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2321	(R,R)-2,3-Butanediol	-	-	DRUGBANK	DB02418	C4H10O2	small molecule	-	24347-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWBTYPJTUOEWEK-ZXZARUISSA-N
19163	113170	7322	-	UBE2D2	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2321	(R,R)-2,3-Butanediol	-	-	DRUGBANK	DB02418	C4H10O2	small molecule	-	24347-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWBTYPJTUOEWEK-ZXZARUISSA-N
19164	113170	7322	-	UBE2D2	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2321	(R,R)-2,3-Butanediol	-	-	DRUGBANK	DB02418	C4H10O2	small molecule	-	24347-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWBTYPJTUOEWEK-ZXZARUISSA-N
19166	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2323	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	-	-	DRUGBANK	DB02420	C9H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKILOCCSAVHHJT-UHFFFAOYSA-N
19167	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2323	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	-	-	DRUGBANK	DB02420	C9H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKILOCCSAVHHJT-UHFFFAOYSA-N
19172	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19173	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19174	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19175	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19176	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19194	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2335	RU90395	-	-	DRUGBANK	DB02432	C35H36FN3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLAUERCSKPFGD-FQLXRVMXSA-N
19195	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2335	RU90395	-	-	DRUGBANK	DB02432	C35H36FN3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLAUERCSKPFGD-FQLXRVMXSA-N
19196	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2335	RU90395	-	-	DRUGBANK	DB02432	C35H36FN3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLAUERCSKPFGD-FQLXRVMXSA-N
19200	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2339	2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid	-	-	DRUGBANK	DB02436	C27H33N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKONADSQADEJJP-NHCUHLMSSA-N
19201	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2339	2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid	-	-	DRUGBANK	DB02436	C27H33N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKONADSQADEJJP-NHCUHLMSSA-N
19225	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2350	3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid	-	-	DRUGBANK	DB02449	C28H28N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUWISPSREJFEEW-HHHXNRCGSA-N
19226	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2350	3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid	-	-	DRUGBANK	DB02449	C28H28N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUWISPSREJFEEW-HHHXNRCGSA-N
19259	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2367	L-methionine (S)-S-oxide	-	-	DRUGBANK	DB02467	C5H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFRNWWLZKMPFJ-MFXDVPHUSA-N
19260	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2368	12-Phenylheme	-	-	DRUGBANK	DB02468	C40H38FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYZKGXFDXHPSJI-YLQNXEDKSA-L
19261	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2368	12-Phenylheme	-	-	DRUGBANK	DB02468	C40H38FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYZKGXFDXHPSJI-YLQNXEDKSA-L
19272	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2373	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02473	C24H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRHANBWAKSYPEN-UHFFFAOYSA-N
19273	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2373	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02473	C24H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRHANBWAKSYPEN-UHFFFAOYSA-N
19274	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2373	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02473	C24H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRHANBWAKSYPEN-UHFFFAOYSA-N
19284	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19285	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19286	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19292	111554	5567	RP11-82H13.1	PRKACB	PKA C-beta|PKACB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19293	111554	5567	RP11-82H13.1	PRKACB	PKA C-beta|PKACB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19294	111554	5567	RP11-82H13.1	PRKACB	PKA C-beta|PKACB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19295	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19296	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19297	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19340	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2394	L-Alpha-Glycerophosphorylserine	-	-	DRUGBANK	DB02497	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWZWYGMENQVNFU-WHFBIAKZSA-N
19341	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2394	L-Alpha-Glycerophosphorylserine	-	-	DRUGBANK	DB02497	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWZWYGMENQVNFU-WHFBIAKZSA-N
19342	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2394	L-Alpha-Glycerophosphorylserine	-	-	DRUGBANK	DB02497	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWZWYGMENQVNFU-WHFBIAKZSA-N
19357	111512	5520	-	PPP2R2A	B55A|B55ALPHA|PR52A|PR55A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19358	111510	5518	-	PPP2R1A	PP2A-Aalpha|PP2AAALPHA|PR65A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19359	111493	5499	-	PPP1CA	PP-1A|PP1A|PP1alpha|PPP1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19361	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19367	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2406	Farnesol	-	-	DRUGBANK	DB02509	C15H26O	small molecule	-	4602-84-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CRDAMVZIKSXKFV-FBXUGWQNSA-N
19394	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2423	CRA_10655	-	-	DRUGBANK	DB02526	C19H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCFWDBPDMBXMTQ-UHFFFAOYSA-N
19418	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2435	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	-	-	DRUGBANK	DB02538	C14H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCRPPLDDHBLUES-UHFFFAOYSA-N
19419	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2435	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	-	-	DRUGBANK	DB02538	C14H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCRPPLDDHBLUES-UHFFFAOYSA-N
19420	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2435	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	-	-	DRUGBANK	DB02538	C14H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCRPPLDDHBLUES-UHFFFAOYSA-N
19428	113162	7314	-	UBB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2439	(4s)-5-Fluoro-L-Leucine	-	-	DRUGBANK	DB02542	C6H12FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHOARJRQRXAPOF-WHFBIAKZSA-N
19429	113162	7314	-	UBB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2439	(4s)-5-Fluoro-L-Leucine	-	-	DRUGBANK	DB02542	C6H12FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHOARJRQRXAPOF-WHFBIAKZSA-N
19430	113162	7314	-	UBB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2439	(4s)-5-Fluoro-L-Leucine	-	-	DRUGBANK	DB02542	C6H12FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHOARJRQRXAPOF-WHFBIAKZSA-N
19433	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Xu WS (2007)	17694093	181632	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
19444	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2447	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB02550	C20H21ClFN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCIOVTSUEXGUFJ-UHFFFAOYSA-N
19445	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2448	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02551	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNMYQLXKMSQTG-AWEZNQCLSA-N
19446	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2448	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02551	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNMYQLXKMSQTG-AWEZNQCLSA-N
19447	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2448	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02551	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNMYQLXKMSQTG-AWEZNQCLSA-N
19458	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2453	D-Phenylalanine	-	-	DRUGBANK	DB02556	C9H11NO2	small molecule	-	673-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-MRVPVSSYSA-N
19459	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2454	Phosphoramidon	-	-	DRUGBANK	DB02557	C23H34N3O10P	small molecule	-	36357-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPHBZEQOLSRPAK-XLCYBJAPSA-N
19460	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2455	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	-	-	DRUGBANK	DB02558	C21H24N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNILVMARPONFBX-JCGIZDLHSA-N
19461	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2455	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	-	-	DRUGBANK	DB02558	C21H24N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNILVMARPONFBX-JCGIZDLHSA-N
19462	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2455	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	-	-	DRUGBANK	DB02558	C21H24N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNILVMARPONFBX-JCGIZDLHSA-N
19499	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2483	Se-Ethyl-Isoselenourea	-	-	DRUGBANK	DB02589	C3H8N2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFKYNFXDBBLWGF-UHFFFAOYSA-N
19500	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2483	Se-Ethyl-Isoselenourea	-	-	DRUGBANK	DB02589	C3H8N2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFKYNFXDBBLWGF-UHFFFAOYSA-N
19501	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2483	Se-Ethyl-Isoselenourea	-	-	DRUGBANK	DB02589	C3H8N2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFKYNFXDBBLWGF-UHFFFAOYSA-N
19517	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2491	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	-	-	DRUGBANK	DB02597	C19H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOIYKVXXGCPHQU-BPUTZDHNSA-N
19518	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2491	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	-	-	DRUGBANK	DB02597	C19H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOIYKVXXGCPHQU-BPUTZDHNSA-N
19519	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2491	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	-	-	DRUGBANK	DB02597	C19H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOIYKVXXGCPHQU-BPUTZDHNSA-N
19526	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2497	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	-	-	DRUGBANK	DB02603	C13H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPUIDVRYMVIXGO-UHFFFAOYSA-N
19527	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2497	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	-	-	DRUGBANK	DB02603	C13H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPUIDVRYMVIXGO-UHFFFAOYSA-N
19528	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2497	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	-	-	DRUGBANK	DB02603	C13H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPUIDVRYMVIXGO-UHFFFAOYSA-N
19540	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2504	Balanol Analog 1	-	-	DRUGBANK	DB02611	C20H22N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZJQHARRQUNVGZ-QZTJIDSGSA-N
19548	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19549	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19550	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19551	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19553	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2512	Sp7343-Sp7964	-	-	DRUGBANK	DB02620	C19H27N5O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMSKFAYIWROESZ-HDJSIYSDSA-N
19554	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2512	Sp7343-Sp7964	-	-	DRUGBANK	DB02620	C19H27N5O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMSKFAYIWROESZ-HDJSIYSDSA-N
19557	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2514	2-(Oxalyl-Amino)-Benzoic Acid	-	-	DRUGBANK	DB02622	C9H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBYNNSFEMMNINN-UHFFFAOYSA-N
19558	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2514	2-(Oxalyl-Amino)-Benzoic Acid	-	-	DRUGBANK	DB02622	C9H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBYNNSFEMMNINN-UHFFFAOYSA-N
19559	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2514	2-(Oxalyl-Amino)-Benzoic Acid	-	-	DRUGBANK	DB02622	C9H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBYNNSFEMMNINN-UHFFFAOYSA-N
19582	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19583	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19609	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2534	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	-	-	DRUGBANK	DB02643	C17H38NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZWSFJTYBVKZNK-UHFFFAOYSA-O
19610	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2534	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	-	-	DRUGBANK	DB02643	C17H38NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZWSFJTYBVKZNK-UHFFFAOYSA-O
19611	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19612	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19613	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19620	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2538	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	-	-	DRUGBANK	DB02647	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUCORKWTQSQFFU-UHFFFAOYSA-N
19621	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2538	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	-	-	DRUGBANK	DB02647	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUCORKWTQSQFFU-UHFFFAOYSA-N
19622	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2538	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	-	-	DRUGBANK	DB02647	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUCORKWTQSQFFU-UHFFFAOYSA-N
19629	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2542	{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)	-	-	DRUGBANK	DB02651	C29H23F6N3O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTAGTGWPDROBMG-UHFFFAOYSA-N
19630	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2542	{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)	-	-	DRUGBANK	DB02651	C29H23F6N3O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTAGTGWPDROBMG-UHFFFAOYSA-N
19633	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19634	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19635	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19667	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2553	Novo Nordisk a/S Compound	-	-	DRUGBANK	DB02662	C9H6INO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSWHSQPJKMCPN-UHFFFAOYSA-N
19668	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2553	Novo Nordisk a/S Compound	-	-	DRUGBANK	DB02662	C9H6INO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSWHSQPJKMCPN-UHFFFAOYSA-N
19669	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2553	Novo Nordisk a/S Compound	-	-	DRUGBANK	DB02662	C9H6INO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSWHSQPJKMCPN-UHFFFAOYSA-N
19701	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2575	3-Methylphenylalanine	-	-	DRUGBANK	DB02685	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRBSTONIYRNRI-VIFPVBQESA-N
19702	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2575	3-Methylphenylalanine	-	-	DRUGBANK	DB02685	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRBSTONIYRNRI-VIFPVBQESA-N
19710	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19711	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19712	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19713	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19714	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19715	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19723	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2586	Hydroxyaminovaline	-	-	DRUGBANK	DB02697	C5H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSBBYRBOWZYSB-SCSAIBSYSA-N
19724	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2586	Hydroxyaminovaline	-	-	DRUGBANK	DB02697	C5H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSBBYRBOWZYSB-SCSAIBSYSA-N
19738	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2594	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02705	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DARQQJKHXPXSRO-QFIPXVFZSA-N
19739	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2594	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02705	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DARQQJKHXPXSRO-QFIPXVFZSA-N
19740	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2594	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02705	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DARQQJKHXPXSRO-QFIPXVFZSA-N
19744	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19756	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2603	Compound 18	-	-	DRUGBANK	DB02715	C27H29NO4S	small molecule	-	31112-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19757	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2603	Compound 18	-	-	DRUGBANK	DB02715	C27H29NO4S	small molecule	-	31112-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19776	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2611	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide	-	-	DRUGBANK	DB02723	C22H32N6O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHTSUHWLPAEEQB-OALUTQOASA-N
19777	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2611	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide	-	-	DRUGBANK	DB02723	C22H32N6O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHTSUHWLPAEEQB-OALUTQOASA-N
19802	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19803	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19804	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19813	112611	6733	-	SRPK2	SFRSK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19814	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19815	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19816	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19817	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19818	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19851	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19852	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19853	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19854	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19855	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19856	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19857	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19871	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2647	RU79072	-	-	DRUGBANK	DB02762	C10H7N2O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQLPTOOPFMPCHQ-UHFFFAOYSA-N
19911	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2666	N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid	-	-	DRUGBANK	DB02784	C18H23BrN4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYAWTDCWUJJPHZ-CYBMUJFWSA-N
19912	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2666	N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid	-	-	DRUGBANK	DB02784	C18H23BrN4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYAWTDCWUJJPHZ-CYBMUJFWSA-N
19976	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2709	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02827	C18H14N2O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDYIGSPVMWSFEZ-JTQLQIEISA-N
19977	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2709	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02827	C18H14N2O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDYIGSPVMWSFEZ-JTQLQIEISA-N
19978	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2709	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02827	C18H14N2O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDYIGSPVMWSFEZ-JTQLQIEISA-N
19986	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
19987	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
19988	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
20004	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20005	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20006	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20017	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2728	L-thioproline	(4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid	-	DRUGBANK	DB02846	C4H7NO2S	small molecule	-	2756-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLNHFMRPBPULJ-VKHMYHEASA-N
20018	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2728	L-thioproline	(4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid	-	DRUGBANK	DB02846	C4H7NO2S	small molecule	-	2756-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLNHFMRPBPULJ-VKHMYHEASA-N
20019	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2728	L-thioproline	(4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid	-	DRUGBANK	DB02846	C4H7NO2S	small molecule	-	2756-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLNHFMRPBPULJ-VKHMYHEASA-N
20032	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2737	N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline	N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline	-	DRUGBANK	DB02855	C18H31N3O6	small molecule	-	134448-10-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDNIFTKCMDIXFC-ABHRYQDASA-N
20041	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2742	Calyculin A	(-)-calyculin A	-	DRUGBANK	DB02860	C50H81N4O15P	small molecule	-	101932-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKAWLXNLHHIHLA-YCBIHMBMSA-N
20042	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2742	Calyculin A	(-)-calyculin A	-	DRUGBANK	DB02860	C50H81N4O15P	small molecule	-	101932-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKAWLXNLHHIHLA-YCBIHMBMSA-N
20051	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2750	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	-	-	DRUGBANK	DB02868	C46H55ClN5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20052	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2750	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	-	-	DRUGBANK	DB02868	C46H55ClN5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20053	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2750	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	-	-	DRUGBANK	DB02868	C46H55ClN5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20061	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2755	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	-	-	DRUGBANK	DB02873	C24H20Cl2F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAWZIQKDHQIHOS-UHFFFAOYSA-N
20062	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2755	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	-	-	DRUGBANK	DB02873	C24H20Cl2F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAWZIQKDHQIHOS-UHFFFAOYSA-N
20063	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2755	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	-	-	DRUGBANK	DB02873	C24H20Cl2F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAWZIQKDHQIHOS-UHFFFAOYSA-N
20076	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2768	FKB-001	-	-	DRUGBANK	DB02888	C35H42F2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBYCDVVSYOMFMS-VMPREFPWSA-N
20077	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2768	FKB-001	-	-	DRUGBANK	DB02888	C35H42F2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBYCDVVSYOMFMS-VMPREFPWSA-N
20078	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2768	FKB-001	-	-	DRUGBANK	DB02888	C35H42F2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBYCDVVSYOMFMS-VMPREFPWSA-N
20095	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2778	5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone	-	-	DRUGBANK	DB02898	C10H11N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKHIYHEECHGIB-RXMQYKEDSA-N
20096	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2778	5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone	-	-	DRUGBANK	DB02898	C10H11N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKHIYHEECHGIB-RXMQYKEDSA-N
20103	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20104	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20105	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20112	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2788	RU78783	-	-	DRUGBANK	DB02908	C7H10O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRLTXWJJMCIUNT-UHFFFAOYSA-N
20113	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2788	RU78783	-	-	DRUGBANK	DB02908	C7H10O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRLTXWJJMCIUNT-UHFFFAOYSA-N
20114	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2788	RU78783	-	-	DRUGBANK	DB02908	C7H10O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRLTXWJJMCIUNT-UHFFFAOYSA-N
20126	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2791	2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine	-	-	DRUGBANK	DB02911	C12H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEKRIXRQADJFAG-QMMMGPOBSA-N
20127	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20128	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20129	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20146	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2807	K201	-	-	DRUGBANK	DB02929	C25H32N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCWGETCFOVJEPI-UHFFFAOYSA-N
20185	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20186	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20187	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20188	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20189	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20190	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20192	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2829	Alpha-Aminoisobutyric Acid	-	-	DRUGBANK	DB02952	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUOOLUPWFVMBKG-UHFFFAOYSA-N
20200	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2840	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	-	-	DRUGBANK	DB02963	C13H11ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNXHNRYPADEAD-UHFFFAOYSA-N
20201	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2840	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	-	-	DRUGBANK	DB02963	C13H11ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNXHNRYPADEAD-UHFFFAOYSA-N
20202	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2840	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	-	-	DRUGBANK	DB02963	C13H11ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNXHNRYPADEAD-UHFFFAOYSA-N
20215	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2850	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	-	-	DRUGBANK	DB02973	C14H9BrN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWTHJLODYBOEIY-VHEBQXMUSA-N
20216	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2850	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	-	-	DRUGBANK	DB02973	C14H9BrN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWTHJLODYBOEIY-VHEBQXMUSA-N
20217	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2850	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	-	-	DRUGBANK	DB02973	C14H9BrN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWTHJLODYBOEIY-VHEBQXMUSA-N
20221	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2854	PNU177836	-	-	DRUGBANK	DB02977	C31H47N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVFJFYADATXBBE-ZKBMQHRLSA-N
20222	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2854	PNU177836	-	-	DRUGBANK	DB02977	C31H47N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVFJFYADATXBBE-ZKBMQHRLSA-N
20223	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2856	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	-	-	DRUGBANK	DB02979	C18H38N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOKDMHHZKWLWKO-UHFFFAOYSA-N
20224	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2856	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	-	-	DRUGBANK	DB02979	C18H38N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOKDMHHZKWLWKO-UHFFFAOYSA-N
20225	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2856	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	-	-	DRUGBANK	DB02979	C18H38N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOKDMHHZKWLWKO-UHFFFAOYSA-N
20230	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20231	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20232	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20233	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2861	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB02984	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSDVOSGGMBSMK-UHFFFAOYSA-N
20234	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2861	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB02984	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSDVOSGGMBSMK-UHFFFAOYSA-N
20235	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2861	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB02984	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSDVOSGGMBSMK-UHFFFAOYSA-N
20247	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2868	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	-	-	DRUGBANK	DB02991	C10H11F3N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCMOXIFARISMOH-UHFFFAOYSA-N
20253	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20254	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20255	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20271	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20272	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20273	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20323	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2893	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB03019	C8H5Cl2N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAPYICJQRHSQGK-UHFFFAOYSA-N
20324	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2893	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB03019	C8H5Cl2N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAPYICJQRHSQGK-UHFFFAOYSA-N
20331	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20333	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20334	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20335	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20348	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2901	1h-Benoximidazole-2-Carboxylic Acid	-	-	DRUGBANK	DB03028	C8H5N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20349	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2901	1h-Benoximidazole-2-Carboxylic Acid	-	-	DRUGBANK	DB03028	C8H5N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20350	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2901	1h-Benoximidazole-2-Carboxylic Acid	-	-	DRUGBANK	DB03028	C8H5N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20357	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2906	1-Methyloxy-4-Sulfone-Benzene	-	-	DRUGBANK	DB03033	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUNSZADDFLWFOL-UHFFFAOYSA-N
20358	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2906	1-Methyloxy-4-Sulfone-Benzene	-	-	DRUGBANK	DB03033	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUNSZADDFLWFOL-UHFFFAOYSA-N
20361	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2908	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	-	-	DRUGBANK	DB03035	C14H7NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIYCICFDXLNQPV-UHFFFAOYSA-N
20375	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2916	Doramapimod	DSSTOX_RID_83151|KINOME_2137|CCG-264915|1-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|ZINC24044436|DORAMAPIMOD1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|NSC785337|AKOS005256489|S1574|ALBB-035131|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|MLS006010153|NCGC00241104-07|BIRB 0796|NSC-785337|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|1-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-3-(4-(2-(MORPHOLIN-4-YL)ETHOXY)NAPHTHALEN-1-YL)UREA|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA.|CS-0219|BIRB796|1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|BIRB 796BS|MFCD09752957|BIRB 796 (DORAMAPIMOD)|UNII-HO1A8B3YVV|SR-00000002531|Q-101419|B96|EX-A4530|DB03044|D03736|TOX21_113386_1|AS-19375|BIRB 796 BS|SW219700-1|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-PYRAZOLYL]-3-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|285983-48-4|UREA, N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-(2-(4-MORPHOLINYL)ETHOXY)-1-NAPHTHALENYL)-|UREA, N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-|BIRB-796 BS|DORAMAPIMOD (BIRB-796)|BIRB-796, 3|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3(4-(2-MORPHOLIN-4-YL-ETHOXY)NAPHTHALEN-1-YL)UREA|BIRB-796|FT-0667779|DSSTOX_GSID_48957|NCGC00241104-01|BIRB 796|BCPP000333|DORAMAPIMOD|BCP01896|1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|CID_156422|BRD-K74065929-001-01-5|N-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA|TOX21_113386|GTPL5668|SMR004458704|1KV2|P38 MAP KINASE INHIBITOR X, BIRB 796 - CAS 285983-48-4|1-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]- N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-UREA|NCGC00241104-02|DSSTOX_CID_28883|DORAMAPIMOD [INN]|BIRB 796,DORAMAPIMOD|DORAMAPIMOD [USAN]|HMS3295M15|DORAMAPIMOD (USAN/INN)|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|DTXSID2048957|DIARYL UREA COMPOUND 10|HMS3747G11|HO1A8B3YVV|DORAMAPIMOD (BIRB 796)|SR-00000002531-1|DORAMAPIMOD [WHO-DD]|BCP9000416|US8933228, BIRB 796|HY-10320|BIBR-796|AC-24379|HMS3655C07|DORAMAPIMOD [USAN:INN]|A819503|SB16634|Q27077098|BIRB-0796|3-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-1-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|3-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-1-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA	-	DRUGBANK	DB03044	C31H37N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVCOAUNKQVWQHZ-UHFFFAOYSA-N
20376	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2916	Doramapimod	DSSTOX_RID_83151|KINOME_2137|CCG-264915|1-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|ZINC24044436|DORAMAPIMOD1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|NSC785337|AKOS005256489|S1574|ALBB-035131|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|MLS006010153|NCGC00241104-07|BIRB 0796|NSC-785337|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|1-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-3-(4-(2-(MORPHOLIN-4-YL)ETHOXY)NAPHTHALEN-1-YL)UREA|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA.|CS-0219|BIRB796|1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|BIRB 796BS|MFCD09752957|BIRB 796 (DORAMAPIMOD)|UNII-HO1A8B3YVV|SR-00000002531|Q-101419|B96|EX-A4530|DB03044|D03736|TOX21_113386_1|AS-19375|BIRB 796 BS|SW219700-1|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-PYRAZOLYL]-3-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|285983-48-4|UREA, N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-(2-(4-MORPHOLINYL)ETHOXY)-1-NAPHTHALENYL)-|UREA, N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-|BIRB-796 BS|DORAMAPIMOD (BIRB-796)|BIRB-796, 3|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3(4-(2-MORPHOLIN-4-YL-ETHOXY)NAPHTHALEN-1-YL)UREA|BIRB-796|FT-0667779|DSSTOX_GSID_48957|NCGC00241104-01|BIRB 796|BCPP000333|DORAMAPIMOD|BCP01896|1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|CID_156422|BRD-K74065929-001-01-5|N-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA|TOX21_113386|GTPL5668|SMR004458704|1KV2|P38 MAP KINASE INHIBITOR X, BIRB 796 - CAS 285983-48-4|1-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]- N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-UREA|NCGC00241104-02|DSSTOX_CID_28883|DORAMAPIMOD [INN]|BIRB 796,DORAMAPIMOD|DORAMAPIMOD [USAN]|HMS3295M15|DORAMAPIMOD (USAN/INN)|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|DTXSID2048957|DIARYL UREA COMPOUND 10|HMS3747G11|HO1A8B3YVV|DORAMAPIMOD (BIRB 796)|SR-00000002531-1|DORAMAPIMOD [WHO-DD]|BCP9000416|US8933228, BIRB 796|HY-10320|BIBR-796|AC-24379|HMS3655C07|DORAMAPIMOD [USAN:INN]|A819503|SB16634|Q27077098|BIRB-0796|3-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-1-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|3-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-1-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA	-	DRUGBANK	DB03044	C31H37N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVCOAUNKQVWQHZ-UHFFFAOYSA-N
20377	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2918	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB03046	C16H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQUXAFOLFXHVQN-UHFFFAOYSA-N
20378	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2918	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB03046	C16H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQUXAFOLFXHVQN-UHFFFAOYSA-N
20379	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2918	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB03046	C16H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQUXAFOLFXHVQN-UHFFFAOYSA-N
20415	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2936	7-Nitroindazole-2-Carboxamidine	-	-	DRUGBANK	DB03065	C8H7N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFYAZUABYOOPCN-UHFFFAOYSA-N
20429	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2949	PASBN	-	-	DRUGBANK	DB03078	C14H13O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWDTUFYQEUEVQD-UHFFFAOYSA-N
20430	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20431	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20432	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20436	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2953	6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide	-	-	DRUGBANK	DB03082	C23H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSWQJKHBMACTGB-UHFFFAOYSA-N
20437	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2953	6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide	-	-	DRUGBANK	DB03082	C23H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSWQJKHBMACTGB-UHFFFAOYSA-N
20439	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2955	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB03084	C25H30Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTKFTOEAKJMII-UHFFFAOYSA-N
20440	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2955	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB03084	C25H30Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTKFTOEAKJMII-UHFFFAOYSA-N
20475	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2964	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03093	C14H14FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWHAHELTVGJGFJ-UHFFFAOYSA-N
20478	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2967	N-Aminoethylmorpholine	-	-	DRUGBANK	DB03096	C6H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWIVICVCHVMHMU-UHFFFAOYSA-N
20479	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2967	N-Aminoethylmorpholine	-	-	DRUGBANK	DB03096	C6H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWIVICVCHVMHMU-UHFFFAOYSA-N
20480	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2967	N-Aminoethylmorpholine	-	-	DRUGBANK	DB03096	C6H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWIVICVCHVMHMU-UHFFFAOYSA-N
20484	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20485	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20491	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2973	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB03102	C10H9NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNOZMNTPOIDSI-UHFFFAOYSA-N
20492	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2973	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB03102	C10H9NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNOZMNTPOIDSI-UHFFFAOYSA-N
20493	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2973	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB03102	C10H9NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNOZMNTPOIDSI-UHFFFAOYSA-N
20497	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2975	RU82129	-	-	DRUGBANK	DB03104	C33H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKMPOVPTYDXGEC-HMIUAYQISA-N
20498	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2975	RU82129	-	-	DRUGBANK	DB03104	C33H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKMPOVPTYDXGEC-HMIUAYQISA-N
20499	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2975	RU82129	-	-	DRUGBANK	DB03104	C33H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKMPOVPTYDXGEC-HMIUAYQISA-N
20505	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2981	2-Chlorophenol	-	-	DRUGBANK	DB03110	C6H5ClO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISPYQTSUDJAMAB-UHFFFAOYSA-N
20506	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2981	2-Chlorophenol	-	-	DRUGBANK	DB03110	C6H5ClO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISPYQTSUDJAMAB-UHFFFAOYSA-N
20509	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2985	PAS219	-	-	DRUGBANK	DB03114	C14H19O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBEVTZVQKMYQPM-UHFFFAOYSA-N
20525	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2993	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	-	-	DRUGBANK	DB03124	C20H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBAHOXPDTNUYCX-INIZCTEOSA-N
20526	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2993	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	-	-	DRUGBANK	DB03124	C20H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBAHOXPDTNUYCX-INIZCTEOSA-N
20527	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2993	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	-	-	DRUGBANK	DB03124	C20H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBAHOXPDTNUYCX-INIZCTEOSA-N
20540	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20541	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20542	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20548	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20549	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20553	111634	5653	-	KLK6	Bssp|Klk7|PRSS18|PRSS9|SP59|hK6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20554	111634	5653	-	KLK6	Bssp|Klk7|PRSS18|PRSS9|SP59|hK6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20569	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3004	4-Iodobenzo[B]Thiophene-2-Carboxamidine	-	-	DRUGBANK	DB03136	C9H8IN2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YERQOXAYAFWFEJ-UHFFFAOYSA-O
20570	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3004	4-Iodobenzo[B]Thiophene-2-Carboxamidine	-	-	DRUGBANK	DB03136	C9H8IN2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YERQOXAYAFWFEJ-UHFFFAOYSA-O
20571	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3005	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03137	C19H20FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOYVWKKOKERSW-UHFFFAOYSA-N
20581	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20582	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20583	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20589	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20590	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20591	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20622	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20623	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20624	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20666	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20667	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20668	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20682	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3022	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	-	-	DRUGBANK	DB03154	C12H10F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHKBLEYUHBIBNR-UHFFFAOYSA-N
20683	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3022	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	-	-	DRUGBANK	DB03154	C12H10F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHKBLEYUHBIBNR-UHFFFAOYSA-N
20684	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3022	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	-	-	DRUGBANK	DB03154	C12H10F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHKBLEYUHBIBNR-UHFFFAOYSA-N
20694	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3027	CRA_8696	-	-	DRUGBANK	DB03159	C21H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAVRMVQHHVMXFD-UHFFFAOYSA-N
20695	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3027	CRA_8696	-	-	DRUGBANK	DB03159	C21H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAVRMVQHHVMXFD-UHFFFAOYSA-N
20769	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3085	DPI59	-	-	DRUGBANK	DB03217	C11H11O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXIBZLYWMBUYRV-NSHDSACASA-N
20796	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20797	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20831	112344	6446	RP1-188K17.1	SGK1	SGK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20851	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20852	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20853	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20874	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3134	RU82197	-	-	DRUGBANK	DB03268	C32H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKTQBTSOHBKBRW-WDYNHAJCSA-N
20875	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3134	RU82197	-	-	DRUGBANK	DB03268	C32H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKTQBTSOHBKBRW-WDYNHAJCSA-N
20876	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3134	RU82197	-	-	DRUGBANK	DB03268	C32H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKTQBTSOHBKBRW-WDYNHAJCSA-N
20889	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3142	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	-	-	DRUGBANK	DB03276	C37H45N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHYFMOCFCFUTNH-GZNVFMSSSA-N
20890	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3142	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	-	-	DRUGBANK	DB03276	C37H45N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHYFMOCFCFUTNH-GZNVFMSSSA-N
20891	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3142	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	-	-	DRUGBANK	DB03276	C37H45N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHYFMOCFCFUTNH-GZNVFMSSSA-N
20926	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3163	Phenylphosphate	-	-	DRUGBANK	DB03298	C6H7O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMPQUABWPXYYSH-UHFFFAOYSA-N
20927	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3163	Phenylphosphate	-	-	DRUGBANK	DB03298	C6H7O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMPQUABWPXYYSH-UHFFFAOYSA-N
20928	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3163	Phenylphosphate	-	-	DRUGBANK	DB03298	C6H7O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMPQUABWPXYYSH-UHFFFAOYSA-N
20929	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3170	N5-Iminoethyl-L-Ornithine	-	-	DRUGBANK	DB03305	C7H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYZFAUAYFLEHRC-ZCFIWIBFSA-N
20930	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3170	N5-Iminoethyl-L-Ornithine	-	-	DRUGBANK	DB03305	C7H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYZFAUAYFLEHRC-ZCFIWIBFSA-N
20931	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3170	N5-Iminoethyl-L-Ornithine	-	-	DRUGBANK	DB03305	C7H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYZFAUAYFLEHRC-ZCFIWIBFSA-N
20932	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3171	RU78300	-	-	DRUGBANK	DB03306	C8H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGEZBCISRKFHLZ-UHFFFAOYSA-N
20933	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3172	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB03307	C10H11N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFVVRPJERUECT-UHFFFAOYSA-N
20934	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3172	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB03307	C10H11N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFVVRPJERUECT-UHFFFAOYSA-N
20935	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3172	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB03307	C10H11N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFVVRPJERUECT-UHFFFAOYSA-N
20945	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3176	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide	-	-	DRUGBANK	DB03311	C26H19Br2N3O7S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXKBTDJJEQQEGE-UHFFFAOYSA-N
20946	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3176	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide	-	-	DRUGBANK	DB03311	C26H19Br2N3O7S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXKBTDJJEQQEGE-UHFFFAOYSA-N
20983	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20984	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20985	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20991	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3196	5,6-Cyclic-Tetrahydropteridine	-	-	DRUGBANK	DB03332	C8H9N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAZOBOCYEGBXHD-GSVOUGTGSA-N
20992	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3196	5,6-Cyclic-Tetrahydropteridine	-	-	DRUGBANK	DB03332	C8H9N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAZOBOCYEGBXHD-GSVOUGTGSA-N
20993	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3196	5,6-Cyclic-Tetrahydropteridine	-	-	DRUGBANK	DB03332	C8H9N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAZOBOCYEGBXHD-GSVOUGTGSA-N
21002	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3201	Heptyl-Beta-D-Glucopyranoside	-	-	DRUGBANK	DB03338	C13H26O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIDYWHLDTIVRJT-UJPOAAIJSA-N
21040	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3227	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB03365	C16H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNDYIYYKEIXHNK-UHFFFAOYSA-N
21041	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3227	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB03365	C16H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNDYIYYKEIXHNK-UHFFFAOYSA-N
21042	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3227	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB03365	C16H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNDYIYYKEIXHNK-UHFFFAOYSA-N
21046	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3229	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	-	-	DRUGBANK	DB03368	C17H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTBMLCLTYAPKIF-UHFFFAOYSA-N
21047	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3229	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	-	-	DRUGBANK	DB03368	C17H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTBMLCLTYAPKIF-UHFFFAOYSA-N
21048	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3229	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	-	-	DRUGBANK	DB03368	C17H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTBMLCLTYAPKIF-UHFFFAOYSA-N
21057	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3235	3,5-Diiodotyrosine	-	-	DRUGBANK	DB03374	C9H9I2NO3	small molecule	-	300-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYPYHUZRZVSYKL-ZETCQYMHSA-N
21076	112530	6647	-	SOD1	ALS|ALS1|HEL-S-44|IPOA|SOD|hSod1|homodimer	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3241	S-Oxy Cysteine	-	-	DRUGBANK	DB03382	C3H6NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLKIIDDWGJYRSN-REOHCLBHSA-N
21078	107290	840	RP11-211N11.6	CASP7	CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3243	Fica	-	-	DRUGBANK	DB03384	C11H11FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFUIHGAGFMFNRD-UHFFFAOYSA-N
21079	107290	840	RP11-211N11.6	CASP7	CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3243	Fica	-	-	DRUGBANK	DB03384	C11H11FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFUIHGAGFMFNRD-UHFFFAOYSA-N
21080	107290	840	RP11-211N11.6	CASP7	CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3243	Fica	-	-	DRUGBANK	DB03384	C11H11FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFUIHGAGFMFNRD-UHFFFAOYSA-N
21186	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21187	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21188	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21189	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21190	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21191	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21244	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3300	(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime	-	-	DRUGBANK	DB03444	C16H10BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLZLOKCJHBUHD-WAVHTBQISA-N
21253	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3305	N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine	-	-	DRUGBANK	DB03449	C20H20ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVGLDBDDYESAB-UHFFFAOYSA-N
21335	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21336	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21337	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21353	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3331	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	-	-	DRUGBANK	DB03476	C20H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRIWXVAIWPBEM-OALUTQOASA-N
21354	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3331	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	-	-	DRUGBANK	DB03476	C20H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRIWXVAIWPBEM-OALUTQOASA-N
21355	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3331	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	-	-	DRUGBANK	DB03476	C20H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRIWXVAIWPBEM-OALUTQOASA-N
21356	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3332	1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole	-	-	DRUGBANK	DB03477	C16H11BrF3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYZKFVIVPRQRQQ-UHFFFAOYSA-N
21365	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3338	4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid	-	-	DRUGBANK	DB03483	C32H34F4N4O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJIWNECQGQOIKP-UBFVSLLYSA-N
21366	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3338	4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid	-	-	DRUGBANK	DB03483	C32H34F4N4O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJIWNECQGQOIKP-UBFVSLLYSA-N
21367	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3339	L-Alpha-Glycerophosphorylethanolamine	-	-	DRUGBANK	DB03484	C5H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZNWSCPGTDBMEW-YFKPBYRVSA-N
21368	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3339	L-Alpha-Glycerophosphorylethanolamine	-	-	DRUGBANK	DB03484	C5H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZNWSCPGTDBMEW-YFKPBYRVSA-N
21369	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3339	L-Alpha-Glycerophosphorylethanolamine	-	-	DRUGBANK	DB03484	C5H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZNWSCPGTDBMEW-YFKPBYRVSA-N
21384	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3345	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	-	-	DRUGBANK	DB03490	C15H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHOACLCXCKJMAK-UHFFFAOYSA-N
21385	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3345	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	-	-	DRUGBANK	DB03490	C15H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHOACLCXCKJMAK-UHFFFAOYSA-N
21386	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3345	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	-	-	DRUGBANK	DB03490	C15H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHOACLCXCKJMAK-UHFFFAOYSA-N
21391	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21400	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21401	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Zvelebil MJ (1998)	18465538	182075	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21403	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21417	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3359	9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03504	C19H24ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVPCTHKPOPQMSX-UHFFFAOYSA-N
21439	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3379	RU79073	-	-	DRUGBANK	DB03525	C9H12NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSJSAHCLJYVEDM-UHFFFAOYSA-N
21490	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3406	N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid	-	-	DRUGBANK	DB03557	C32H41F4N5O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKZDIBIDJQPGC-WXFUMESZSA-N
21491	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3406	N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid	-	-	DRUGBANK	DB03557	C32H41F4N5O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKZDIBIDJQPGC-WXFUMESZSA-N
21512	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21513	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21514	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21521	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21522	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21535	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3431	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	-	-	DRUGBANK	DB03583	C22H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYOAIABDFUJDKQ-SQJPUDIVSA-N
21536	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3431	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	-	-	DRUGBANK	DB03583	C22H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYOAIABDFUJDKQ-SQJPUDIVSA-N
21537	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3431	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	-	-	DRUGBANK	DB03583	C22H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYOAIABDFUJDKQ-SQJPUDIVSA-N
21546	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21547	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21548	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21553	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3439	RU82209	-	-	DRUGBANK	DB03591	C31H34F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVZDQVATAQEMCX-IZLXSDGUSA-N
21554	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3439	RU82209	-	-	DRUGBANK	DB03591	C31H34F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVZDQVATAQEMCX-IZLXSDGUSA-N
21555	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3439	RU82209	-	-	DRUGBANK	DB03591	C31H34F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVZDQVATAQEMCX-IZLXSDGUSA-N
21576	111082	5045	-	FURIN	FUR|PACE|PCSK3|SPC1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3448	Decanoic Acid	Capric acid	-	DRUGBANK	DB03600	C10H20O2	small molecule	-	334-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHVNFZFCNZKVNT-UHFFFAOYSA-N
21604	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3468	L-709,587	-	-	DRUGBANK	DB03621	C52H76N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APSPCHLQXFEUHG-ZOQAXNDZSA-N
21605	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3468	L-709,587	-	-	DRUGBANK	DB03621	C52H76N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APSPCHLQXFEUHG-ZOQAXNDZSA-N
21606	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3468	L-709,587	-	-	DRUGBANK	DB03621	C52H76N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APSPCHLQXFEUHG-ZOQAXNDZSA-N
21610	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3470	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	-	-	DRUGBANK	DB03623	C18H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUSSGTWHFMSCOY-UHFFFAOYSA-N
21611	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3470	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	-	-	DRUGBANK	DB03623	C18H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUSSGTWHFMSCOY-UHFFFAOYSA-N
21612	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3470	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	-	-	DRUGBANK	DB03623	C18H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUSSGTWHFMSCOY-UHFFFAOYSA-N
21620	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3475	ISO24	-	-	DRUGBANK	DB03628	C9H12NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGNSYMGWPCEFDZ-UHFFFAOYSA-N
21653	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3497	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	-	-	DRUGBANK	DB03650	C14H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJASRZFZRYISET-UHFFFAOYSA-N
21654	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3497	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	-	-	DRUGBANK	DB03650	C14H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJASRZFZRYISET-UHFFFAOYSA-N
21655	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3497	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	-	-	DRUGBANK	DB03650	C14H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJASRZFZRYISET-UHFFFAOYSA-N
21668	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21669	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21674	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3510	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	-	-	DRUGBANK	DB03663	C10H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEXUQVHWMLPYKY-UHFFFAOYSA-N
21675	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3510	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	-	-	DRUGBANK	DB03663	C10H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEXUQVHWMLPYKY-UHFFFAOYSA-N
21676	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3510	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	-	-	DRUGBANK	DB03663	C10H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEXUQVHWMLPYKY-UHFFFAOYSA-N
21686	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3516	2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid	-	-	DRUGBANK	DB03670	C10H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIBMATWHOAGNTR-UHFFFAOYSA-N
21687	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3516	2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid	-	-	DRUGBANK	DB03670	C10H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIBMATWHOAGNTR-UHFFFAOYSA-N
21688	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3518	9-N-Phenylmethylamino-Tacrine	-	-	DRUGBANK	DB03672	C20H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYJAEHAURXXPSD-UHFFFAOYSA-N
21689	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3518	9-N-Phenylmethylamino-Tacrine	-	-	DRUGBANK	DB03672	C20H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYJAEHAURXXPSD-UHFFFAOYSA-N
21690	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3518	9-N-Phenylmethylamino-Tacrine	-	-	DRUGBANK	DB03672	C20H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYJAEHAURXXPSD-UHFFFAOYSA-N
21706	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3529	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	-	-	DRUGBANK	DB03683	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFMOJNDZFCHHPV-SSDOTTSWSA-N
21707	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3529	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	-	-	DRUGBANK	DB03683	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFMOJNDZFCHHPV-SSDOTTSWSA-N
21708	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3529	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	-	-	DRUGBANK	DB03683	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFMOJNDZFCHHPV-SSDOTTSWSA-N
21731	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3531	S-(P-Nitrobenzyl)Glutathione	-	-	DRUGBANK	DB03686	C17H22N4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWORKDPTSAMBZ-QWHCGFSZSA-N
21732	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3531	S-(P-Nitrobenzyl)Glutathione	-	-	DRUGBANK	DB03686	C17H22N4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWORKDPTSAMBZ-QWHCGFSZSA-N
21733	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3531	S-(P-Nitrobenzyl)Glutathione	-	-	DRUGBANK	DB03686	C17H22N4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWORKDPTSAMBZ-QWHCGFSZSA-N
21766	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3551	S-Ethyl-N-Phenyl-Isothiourea	-	-	DRUGBANK	DB03707	C9H12N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAXNJIWNBHHMDO-UHFFFAOYSA-N
21767	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3551	S-Ethyl-N-Phenyl-Isothiourea	-	-	DRUGBANK	DB03707	C9H12N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAXNJIWNBHHMDO-UHFFFAOYSA-N
21775	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21776	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21777	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21781	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3556	RU85053	-	-	DRUGBANK	DB03712	C33H35N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEKLBQMULVLLTD-WDYNHAJCSA-N
21782	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3556	RU85053	-	-	DRUGBANK	DB03712	C33H35N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEKLBQMULVLLTD-WDYNHAJCSA-N
21783	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3556	RU85053	-	-	DRUGBANK	DB03712	C33H35N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEKLBQMULVLLTD-WDYNHAJCSA-N
21784	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3557	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	-	-	DRUGBANK	DB03714	C17H17F2N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWCIKSGGKYNHT-ZDUSSCGKSA-N
21785	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3557	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	-	-	DRUGBANK	DB03714	C17H17F2N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWCIKSGGKYNHT-ZDUSSCGKSA-N
21786	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3557	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	-	-	DRUGBANK	DB03714	C17H17F2N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWCIKSGGKYNHT-ZDUSSCGKSA-N
21793	111899	5967	-	REG1A	ICRF|P19|PSP|PSPS|PSPS1|PTP|REG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21794	111899	5967	-	REG1A	ICRF|P19|PSP|PSPS|PSPS1|PTP|REG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21810	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3572	2-Amino-5-Hydroxy-Benzimidazole	-	-	DRUGBANK	DB03729	C7H6N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21811	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3572	2-Amino-5-Hydroxy-Benzimidazole	-	-	DRUGBANK	DB03729	C7H6N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21826	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3580	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	-	-	DRUGBANK	DB03737	C20H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAKYKJWUUUKCCW-MPLBGYFPSA-N
21827	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3580	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	-	-	DRUGBANK	DB03737	C20H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAKYKJWUUUKCCW-MPLBGYFPSA-N
21828	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3580	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	-	-	DRUGBANK	DB03737	C20H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAKYKJWUUUKCCW-MPLBGYFPSA-N
21835	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21836	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21843	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3585	Compound 4-D	-	-	DRUGBANK	DB03742	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWZNCTCQAGRUGQ-KAYWLYCHSA-N
21844	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3585	Compound 4-D	-	-	DRUGBANK	DB03742	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWZNCTCQAGRUGQ-KAYWLYCHSA-N
21850	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21851	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21852	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21876	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3600	Radicicol	-	-	DRUGBANK	DB03758	C18H23ClO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPBJMOGBFQDN-YMYQVXQQSA-N
21911	111570	5584	-	PRKCI	DXS1179E|PKCI|nPKC-iota	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21913	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21914	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21915	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21917	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3622	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	-	-	DRUGBANK	DB03782	C19H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQPLKJCBEOVDBS-CSVIQDERSA-N
21918	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3622	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	-	-	DRUGBANK	DB03782	C19H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQPLKJCBEOVDBS-CSVIQDERSA-N
21919	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3622	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	-	-	DRUGBANK	DB03782	C19H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQPLKJCBEOVDBS-CSVIQDERSA-N
21926	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3630	(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid	-	-	DRUGBANK	DB03791	C33H37ClF3NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVXMWVZLCQSTKR-GDLZYMKVSA-N
21927	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3630	(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid	-	-	DRUGBANK	DB03791	C33H37ClF3NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVXMWVZLCQSTKR-GDLZYMKVSA-N
21979	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21980	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21985	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3641	1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB03802	C29H33N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGHFWBDHZZKWSI-GGXMVOPNSA-N
21986	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3641	1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB03802	C29H33N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGHFWBDHZZKWSI-GGXMVOPNSA-N
21993	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3647	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB03809	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWLWUGBHOXIUBP-UHFFFAOYSA-N
22011	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22012	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22039	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3666	RU78299	-	-	DRUGBANK	DB03828	C9H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAYNUXXSJZLKPW-UHFFFAOYSA-N
22056	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22057	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22058	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22061	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3685	Benzenesulfonyl	-	-	DRUGBANK	DB03848	C6H6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEHKKBHWRAXMCH-UHFFFAOYSA-N
22062	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3685	Benzenesulfonyl	-	-	DRUGBANK	DB03848	C6H6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEHKKBHWRAXMCH-UHFFFAOYSA-N
22078	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3697	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	-	-	DRUGBANK	DB03860	C34H55NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVVFOLSZMQVDKV-ILEXQBCSSA-N
22079	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3697	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	-	-	DRUGBANK	DB03860	C34H55NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVVFOLSZMQVDKV-ILEXQBCSSA-N
22080	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3697	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	-	-	DRUGBANK	DB03860	C34H55NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVVFOLSZMQVDKV-ILEXQBCSSA-N
22087	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3702	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB03865	C21H17ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEKRWNWZMOSVBX-UHFFFAOYSA-O
22088	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3702	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB03865	C21H17ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEKRWNWZMOSVBX-UHFFFAOYSA-O
22090	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3703	Prostaglandin G2	-	-	DRUGBANK	DB03866	C20H32O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUKUZOVHSFKPH-YNNPMVKQSA-N
22094	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3713	Thieno[2,3-B]Pyridine-2-Carboxamidine	-	-	DRUGBANK	DB03876	C8H8N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZEJMYFXZMUAEC-UHFFFAOYSA-O
22097	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3715	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	-	-	DRUGBANK	DB03878	C22H18N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWQVBESSYLICRX-UHFFFAOYSA-N
22113	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Norata GD (2010)	20557886	182158	3719	5-Alpha-Androstane-3-Beta,17beta-Diol	-	-	DRUGBANK	DB03882	C19H32O2	small molecule	-	571-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBMYJHIOYJEBSB-YSZCXEEOSA-N
22127	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22128	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22129	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22133	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3731	N-Propargyl-1(S)-Aminoindan	-	-	DRUGBANK	DB03894	C12H13N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-LBPRGKRZSA-N
22137	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3736	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB03899	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVYATAJRTRFKSW-UHFFFAOYSA-N
22146	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22147	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22148	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3739	Oxalic Acid	-	-	DRUGBANK	DB03902	C2H2O4	small molecule	-	144-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUBZPKHOEPUJKR-UHFFFAOYSA-N
22149	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3739	Oxalic Acid	-	-	DRUGBANK	DB03902	C2H2O4	small molecule	-	144-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUBZPKHOEPUJKR-UHFFFAOYSA-N
22150	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3739	Oxalic Acid	-	-	DRUGBANK	DB03902	C2H2O4	small molecule	-	144-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUBZPKHOEPUJKR-UHFFFAOYSA-N
22156	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22157	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22158	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22164	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3743	2-Phenylheme	-	-	DRUGBANK	DB03906	C40H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHCCVTLDOSIQDM-NULOGZTHSA-L
22165	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3743	2-Phenylheme	-	-	DRUGBANK	DB03906	C40H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHCCVTLDOSIQDM-NULOGZTHSA-L
22186	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3747	S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	-	-	DRUGBANK	DB03910	C12H18N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEUSLPIIQGZHQB-UHFFFAOYSA-N
22190	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3755	6S-5,6,7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB03918	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-ZMIZWQJLSA-N
22191	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3755	6S-5,6,7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB03918	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-ZMIZWQJLSA-N
22192	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3755	6S-5,6,7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB03918	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-ZMIZWQJLSA-N
22197	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3760	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	-	-	DRUGBANK	DB03924	C14H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVEMRPAUHFWHRV-UHFFFAOYSA-N
22214	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22215	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22216	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22217	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22218	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22238	107791	1401	RP11-419N10.4	CRP	PTX1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22239	107791	1401	RP11-419N10.4	CRP	PTX1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22270	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22271	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22272	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22277	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22278	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22288	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22289	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22290	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22291	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22292	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22305	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3808	L-Homoarginine	-	-	DRUGBANK	DB03974	C7H17N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUOGESRFPZDMMT-YFKPBYRVSA-O
22306	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3808	L-Homoarginine	-	-	DRUGBANK	DB03974	C7H17N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUOGESRFPZDMMT-YFKPBYRVSA-O
22307	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3808	L-Homoarginine	-	-	DRUGBANK	DB03974	C7H17N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUOGESRFPZDMMT-YFKPBYRVSA-O
22320	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22321	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22322	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22329	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3814	4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole	-	-	DRUGBANK	DB03980	C17H16FN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYXQGDDCDXJK-UHFFFAOYSA-N
22330	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22331	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22332	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22333	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22334	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22337	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3816	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	-	-	DRUGBANK	DB03982	C19H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQWCUHJIERBOSM-UHFFFAOYSA-N
22338	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3816	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	-	-	DRUGBANK	DB03982	C19H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQWCUHJIERBOSM-UHFFFAOYSA-N
22339	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3816	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	-	-	DRUGBANK	DB03982	C19H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQWCUHJIERBOSM-UHFFFAOYSA-N
22363	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3835	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	-	-	DRUGBANK	DB04001	C11H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHWMERGBWWROMM-UHFFFAOYSA-N
22364	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3835	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	-	-	DRUGBANK	DB04001	C11H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHWMERGBWWROMM-UHFFFAOYSA-N
22365	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3835	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	-	-	DRUGBANK	DB04001	C11H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHWMERGBWWROMM-UHFFFAOYSA-N
22369	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3837	(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid	-	-	DRUGBANK	DB04003	C29H38N3O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUGQWABROMTDA-GAJHUEQPSA-N
22370	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3837	(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid	-	-	DRUGBANK	DB04003	C29H38N3O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUGQWABROMTDA-GAJHUEQPSA-N
22373	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3840	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	-	-	DRUGBANK	DB04006	C21H13F2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUGJIPFLBOATGL-UHFFFAOYSA-N
22374	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3840	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	-	-	DRUGBANK	DB04006	C21H13F2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUGJIPFLBOATGL-UHFFFAOYSA-N
22375	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3840	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	-	-	DRUGBANK	DB04006	C21H13F2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUGJIPFLBOATGL-UHFFFAOYSA-N
22383	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3846	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine	-	-	DRUGBANK	DB04012	C18H26N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFEHACHKMVZGNQ-HOTGVXAUSA-N
22387	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22388	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22389	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22390	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22391	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22396	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3850	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	-	-	DRUGBANK	DB04016	C40H35N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJQPDQURBZEGJ-KXQOOQHDSA-N
22397	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3850	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	-	-	DRUGBANK	DB04016	C40H35N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJQPDQURBZEGJ-KXQOOQHDSA-N
22401	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3852	S-Isopropyl-Isothiourea	-	-	DRUGBANK	DB04018	C4H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSSNABKEYXKKMK-UHFFFAOYSA-N
22402	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3852	S-Isopropyl-Isothiourea	-	-	DRUGBANK	DB04018	C4H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSSNABKEYXKKMK-UHFFFAOYSA-N
22403	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3852	S-Isopropyl-Isothiourea	-	-	DRUGBANK	DB04018	C4H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSSNABKEYXKKMK-UHFFFAOYSA-N
22404	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3853	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol	-	-	DRUGBANK	DB04020	C24H29ClN6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIBKIFHSQQYXLG-UHFFFAOYSA-N
22405	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3853	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol	-	-	DRUGBANK	DB04020	C24H29ClN6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIBKIFHSQQYXLG-UHFFFAOYSA-N
22438	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3886	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04054	C18H22FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PASRTKOWXJDFFV-UHFFFAOYSA-N
22446	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3891	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB04059	C15H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRQLDCHTDNYVQI-UHFFFAOYSA-N
22447	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3891	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB04059	C15H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRQLDCHTDNYVQI-UHFFFAOYSA-N
22448	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3891	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB04059	C15H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRQLDCHTDNYVQI-UHFFFAOYSA-N
22462	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3901	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	-	-	DRUGBANK	DB04069	C12H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKVREUJWFZJEJK-UHFFFAOYSA-N
22463	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3901	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	-	-	DRUGBANK	DB04069	C12H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKVREUJWFZJEJK-UHFFFAOYSA-N
22464	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3901	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	-	-	DRUGBANK	DB04069	C12H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKVREUJWFZJEJK-UHFFFAOYSA-N
22493	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22494	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22521	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3912	RU78191	-	-	DRUGBANK	DB04080	C9H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYDYZMNFQIYPT-UHFFFAOYSA-N
22540	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3920	N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)	Compound 6	-	DRUGBANK	DB04088	C34H35N3O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJBRKLISQICDU-XMMPIXPASA-N
22541	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3920	N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)	Compound 6	-	DRUGBANK	DB04088	C34H35N3O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJBRKLISQICDU-XMMPIXPASA-N
22552	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3926	4-Hydroxy-2-Butanone	-	-	DRUGBANK	DB04094	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVSQXDHWDCMMRJ-UHFFFAOYSA-N
22553	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3926	4-Hydroxy-2-Butanone	-	-	DRUGBANK	DB04094	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVSQXDHWDCMMRJ-UHFFFAOYSA-N
22554	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3926	4-Hydroxy-2-Butanone	-	-	DRUGBANK	DB04094	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVSQXDHWDCMMRJ-UHFFFAOYSA-N
22557	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3930	Balanol	-	-	DRUGBANK	DB04098	C28H26N2O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYUFCXJZFZPEJD-PGRDOPGGSA-N
22558	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3930	Balanol	-	-	DRUGBANK	DB04098	C28H26N2O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYUFCXJZFZPEJD-PGRDOPGGSA-N
22559	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3930	Balanol	-	-	DRUGBANK	DB04098	C28H26N2O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYUFCXJZFZPEJD-PGRDOPGGSA-N
22568	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22569	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22570	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3933	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	-	-	DRUGBANK	DB04101	C10H11N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVKZTPFHUYGZBI-UHFFFAOYSA-N
22571	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3933	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	-	-	DRUGBANK	DB04101	C10H11N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVKZTPFHUYGZBI-UHFFFAOYSA-N
22572	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3933	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	-	-	DRUGBANK	DB04101	C10H11N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVKZTPFHUYGZBI-UHFFFAOYSA-N
22577	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3938	Fotemustine	Fotemustinum|(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate|Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate|Fotemustina	-	DRUGBANK	DB04106	C9H19ClN3O5P	small molecule	L01AD05	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAKWPXVTIGTRJH-QMMMGPOBSA-N
22578	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3938	Fotemustine	Fotemustinum|(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate|Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate|Fotemustina	-	DRUGBANK	DB04106	C9H19ClN3O5P	small molecule	L01AD05	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAKWPXVTIGTRJH-QMMMGPOBSA-N
22600	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22601	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22602	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22609	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3958	N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane	-	-	DRUGBANK	DB04126	C15H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBIWEWPGBHKYML-RYUDHWBXSA-N
22614	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22615	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22616	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22625	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3967	Lysophosphotidylserine	-	-	DRUGBANK	DB04136	C21H44NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPZLJDFLPRHXGM-SLFFLAALSA-N
22626	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3967	Lysophosphotidylserine	-	-	DRUGBANK	DB04136	C21H44NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPZLJDFLPRHXGM-SLFFLAALSA-N
22627	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3967	Lysophosphotidylserine	-	-	DRUGBANK	DB04136	C21H44NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPZLJDFLPRHXGM-SLFFLAALSA-N
22636	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22637	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22638	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22647	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22648	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22649	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22663	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3971	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	-	-	DRUGBANK	DB04140	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUSMVCKSLVPRCL-QGZVFWFLSA-N
22664	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3971	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	-	-	DRUGBANK	DB04140	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUSMVCKSLVPRCL-QGZVFWFLSA-N
22665	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3971	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	-	-	DRUGBANK	DB04140	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUSMVCKSLVPRCL-QGZVFWFLSA-N
22683	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3973	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide	-	-	DRUGBANK	DB04142	C19H17Br2NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEYGJZKVMASWJB-UHFFFAOYSA-N
22684	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3973	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide	-	-	DRUGBANK	DB04142	C19H17Br2NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEYGJZKVMASWJB-UHFFFAOYSA-N
22688	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22761	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4002	[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine	-	-	DRUGBANK	DB04172	C32H48N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WATXEHGLYJKXOF-MUUNZHRXSA-N
22762	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4002	[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine	-	-	DRUGBANK	DB04172	C32H48N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WATXEHGLYJKXOF-MUUNZHRXSA-N
22781	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4015	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	-	-	DRUGBANK	DB04186	C17H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLVYMYQTRZCMLE-CYBMUJFWSA-N
22782	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4015	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	-	-	DRUGBANK	DB04186	C17H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLVYMYQTRZCMLE-CYBMUJFWSA-N
22783	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4015	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	-	-	DRUGBANK	DB04186	C17H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLVYMYQTRZCMLE-CYBMUJFWSA-N
22803	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4032	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	-	-	DRUGBANK	DB04204	C18H20F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRHSAABKYJDBDV-UHFFFAOYSA-N
22804	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4032	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	-	-	DRUGBANK	DB04204	C18H20F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRHSAABKYJDBDV-UHFFFAOYSA-N
22805	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4032	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	-	-	DRUGBANK	DB04204	C18H20F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRHSAABKYJDBDV-UHFFFAOYSA-N
22824	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22836	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22837	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Raman CS (2001)	11695891	181780	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22838	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22849	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4060	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	-	-	DRUGBANK	DB04232	C20H23N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNGGPLKVDUPXFN-GOSISDBHSA-N
22850	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4060	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	-	-	DRUGBANK	DB04232	C20H23N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNGGPLKVDUPXFN-GOSISDBHSA-N
22851	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4060	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	-	-	DRUGBANK	DB04232	C20H23N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNGGPLKVDUPXFN-GOSISDBHSA-N
22902	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4081	8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04254	C17H18FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARWHTQLGMWHTAZ-UHFFFAOYSA-N
22926	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4097	(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid	-	-	DRUGBANK	DB04270	C25H25NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUZIMDSVRIBNNI-DEOSSOPVSA-N
22939	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22940	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22941	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22984	107273	823	PIG30	CAPN1	CANP|CANP1|CANPL1|muCANP|muCL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4103	N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine	-	-	DRUGBANK	DB04276	C15H30N5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPQNJAXBPHVASB-QWRGUYRKSA-O
22996	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4112	{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid	-	-	DRUGBANK	DB04285	C31H25F2N4O3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBLDYRVJENYQNH-GHGCAVAYSA-N
22997	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4112	{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid	-	-	DRUGBANK	DB04285	C31H25F2N4O3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBLDYRVJENYQNH-GHGCAVAYSA-N
23004	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4115	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	-	-	DRUGBANK	DB04288	C23H31N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTVILUUAQWQWBK-IYARVYRRSA-N
23005	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4115	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	-	-	DRUGBANK	DB04288	C23H31N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTVILUUAQWQWBK-IYARVYRRSA-N
23006	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4115	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	-	-	DRUGBANK	DB04288	C23H31N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTVILUUAQWQWBK-IYARVYRRSA-N
23028	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4133	5-Hydroxy-N-Propargyl-1(R)-Aminoindan	-	-	DRUGBANK	DB04307	C12H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRSDGDXUWMMUEV-GFCCVEGCSA-N
23058	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23071	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23072	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23073	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23161	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23162	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23163	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23164	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23165	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4164	Carbocisteine	S-carboxymethylcysteine	-	DRUGBANK	DB04339	C5H9NO4S	small molecule	R05CB03	638-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBFLZEXEOZUWRN-VKHMYHEASA-N
23166	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4164	Carbocisteine	S-carboxymethylcysteine	-	DRUGBANK	DB04339	C5H9NO4S	small molecule	R05CB03	638-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBFLZEXEOZUWRN-VKHMYHEASA-N
23167	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4164	Carbocisteine	S-carboxymethylcysteine	-	DRUGBANK	DB04339	C5H9NO4S	small molecule	R05CB03	638-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBFLZEXEOZUWRN-VKHMYHEASA-N
23210	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4187	Arecoline	-	-	DRUGBANK	DB04365	C8H13NO2	small molecule	-	63-75-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJJPJSXJAXAIPN-UHFFFAOYSA-N
23211	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4187	Arecoline	-	-	DRUGBANK	DB04365	C8H13NO2	small molecule	-	63-75-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJJPJSXJAXAIPN-UHFFFAOYSA-N
23269	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23270	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23271	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23276	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23277	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23291	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23292	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23299	112611	6733	-	SRPK2	SFRSK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23300	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23301	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23302	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23303	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23305	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23312	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23313	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23318	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23319	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23350	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4225	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04407	C15H15N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTMLAWRVLMYMDF-UHFFFAOYSA-N
23351	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4225	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04407	C15H15N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTMLAWRVLMYMDF-UHFFFAOYSA-N
23352	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4225	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04407	C15H15N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTMLAWRVLMYMDF-UHFFFAOYSA-N
23362	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4232	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	-	-	DRUGBANK	DB04416	C20H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJKGJGURDPRKGW-LJQANCHMSA-N
23363	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4232	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	-	-	DRUGBANK	DB04416	C20H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJKGJGURDPRKGW-LJQANCHMSA-N
23364	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4232	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	-	-	DRUGBANK	DB04416	C20H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJKGJGURDPRKGW-LJQANCHMSA-N
23425	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23426	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23427	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23474	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23475	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23476	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23483	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23499	113164	7316	-	UBC	HMG20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23521	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Reed CA (2005)	15846122	181889	4282	Afimoxifene	4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT	-	DRUGBANK	DB04468	C26H29NO2	small molecule	-	68392-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXUZVZSFRXZGTL-QPLCGJKRSA-N
23522	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Reed CA (2005)	15846122	181889	4282	Afimoxifene	4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT	-	DRUGBANK	DB04468	C26H29NO2	small molecule	-	68392-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXUZVZSFRXZGTL-QPLCGJKRSA-N
23526	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4285	2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB04471	C28H32N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMWVCTJKLAVRPB-MUUNZHRXSA-N
23527	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4285	2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB04471	C28H32N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMWVCTJKLAVRPB-MUUNZHRXSA-N
23545	109839	3627	-	CXCL10	C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4300	N-Methylleucine	-	-	DRUGBANK	DB04487	C7H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJODGRWDFZVTKW-ZCFIWIBFSA-N
23546	109839	3627	-	CXCL10	C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4300	N-Methylleucine	-	-	DRUGBANK	DB04487	C7H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJODGRWDFZVTKW-ZCFIWIBFSA-N
23564	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4308	RU81843	-	-	DRUGBANK	DB04495	C30H34N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPXNASQNUOIPB-IZLXSDGUSA-N
23565	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4308	RU81843	-	-	DRUGBANK	DB04495	C30H34N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPXNASQNUOIPB-IZLXSDGUSA-N
23566	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4308	RU81843	-	-	DRUGBANK	DB04495	C30H34N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPXNASQNUOIPB-IZLXSDGUSA-N
23570	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4318	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04505	C20H22ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUJFGZAAFADPSF-UHFFFAOYSA-N
23581	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4325	N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide	-	-	DRUGBANK	DB04513	C16H21ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDEHCMNLNCJQST-UHFFFAOYSA-N
23592	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4330	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04518	C15H14N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJDRRZFRTKZLFT-UHFFFAOYSA-N
23593	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4330	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04518	C15H14N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJDRRZFRTKZLFT-UHFFFAOYSA-N
23594	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4330	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04518	C15H14N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJDRRZFRTKZLFT-UHFFFAOYSA-N
23598	114750	9344	UNQ2971/PRO7431	TAOK2	MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23601	111899	5967	-	REG1A	ICRF|P19|PSP|PSPS|PSPS1|PTP|REG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23606	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23607	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23608	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23609	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23610	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23625	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4337	2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid	-	-	DRUGBANK	DB04525	C30H37N3O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUAJYWYRZTYQKS-DHIUTWEWSA-N
23626	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4337	2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid	-	-	DRUGBANK	DB04525	C30H37N3O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUAJYWYRZTYQKS-DHIUTWEWSA-N
23643	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23644	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23647	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23648	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23649	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23660	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23661	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23683	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	unknown	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23687	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Alpert E (2007)	17098211	138173	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23688	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23689	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Diao HL (2007)	17485303	182008	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23700	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4369	N-(Chlorophenyl)-N'-Hydroxyguanidine	-	-	DRUGBANK	DB04559	C7H8ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYBXKTLYOMPMQY-UHFFFAOYSA-N
23730	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Mishra RG (2006)	16199482	181911	4383	Estriol	16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol	-	DRUGBANK	DB04573	C18H24O3	small molecule	G03CA04|G03CC06	50-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-ZXXIGWHRSA-N
23731	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	4383	Estriol	16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol	-	DRUGBANK	DB04573	C18H24O3	small molecule	G03CA04|G03CC06	50-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-ZXXIGWHRSA-N
23732	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4383	Estriol	16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol	-	DRUGBANK	DB04573	C18H24O3	small molecule	G03CA04|G03CC06	50-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-ZXXIGWHRSA-N
23733	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23734	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Vijayanathan V (2007)	17464340	178364	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23735	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23736	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lehnes K (2007)	17138652	178365	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23737	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23738	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brama M (2007)	17125913	178366	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23739	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Imming P (2006)	17016423	171742	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23740	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Chen X (2002)	11752352	171740	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23741	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Overington JP (2006)	17139284	171741	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23742	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Shyu C (2011)	21075131	182176	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23743	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23744	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23745	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23746	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Shyu C (2011)	21075131	182176	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23752	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4389	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-	-	-	DRUGBANK	DB04579	C16H28N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUAMLRIDHTYTCM-WKLONVCASA-N
23755	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4398	N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB04588	C17H15ClN4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOHYJGNSESWEFT-UHFFFAOYSA-N
23756	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4400	N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE	-	-	DRUGBANK	DB04591	C22H23F2N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYJOAYZRCNHDNG-GOSISDBHSA-N
23766	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4413	5-iodotubercidin	-	-	DRUGBANK	DB04604	C11H13IN4O4	small molecule	-	24386-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHSIXKUPQCKWBY-IOSLPCCCSA-N
23767	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4416	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	-	-	DRUGBANK	DB04607	C20H14Cl2N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQAWGIKJINAKIZ-UHFFFAOYSA-N
23786	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4438	4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE	-	-	DRUGBANK	DB04632	C24H26FN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHHBGNIRSUTQAS-UHFFFAOYSA-N
23804	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4467	OLOMOUCINE II	-	-	DRUGBANK	DB04662	C19H26N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDUVSANREQEDRE-CQSZACIVSA-N
23806	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4474	TRIAZOLOPYRIMIDINE	-	-	DRUGBANK	DB04669	C17H14BrN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWBFPKPWMSWWEA-UHFFFAOYSA-O
23811	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4481	N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE	-	-	DRUGBANK	DB04677	C13H19N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVYBGDRWIWQPOV-GFCCVEGCSA-N
23826	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23828	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23829	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23835	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4519	IMIDAZOPYRIDAZIN 1	-	-	DRUGBANK	DB04715	C18H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVUBNTNWKIPCPS-UHFFFAOYSA-N
23839	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4520	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	-	-	DRUGBANK	DB04716	C18H16FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDWQCSOSCCWIP-UHFFFAOYSA-N
23841	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4523	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	-	-	DRUGBANK	DB04719	C9H7Br4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLPJGDQJLTYWCI-UHFFFAOYSA-N
23842	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4524	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	-	-	DRUGBANK	DB04720	C8H4Br4N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIGJZZDDPXRGTL-UHFFFAOYSA-N
23843	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4525	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	-	-	DRUGBANK	DB04721	C10H7Br4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHCZROILDUNGRT-UHFFFAOYSA-N
23844	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4526	2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE	-	-	DRUGBANK	DB04722	C22H20Cl2F2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISTCYDGUBPNUDF-CQSZACIVSA-N
23845	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4527	2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID	-	-	DRUGBANK	DB04723	C10H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHBCRXAIIVZWEW-MRVPVSSYSA-N
23847	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23848	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23849	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23858	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Maynes JT (2006)	16343532	181923	4541	Motuporin	nodularin-V	-	DRUGBANK	DB04738	C40H63N5O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MESJISIEDVKBAM-NSKZDGTMSA-N
23862	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rainsford KD (2006)	16846549	181954	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23863	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23864	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4554	Purvalanol A	6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv	-	DRUGBANK	DB04751	C19H25ClN6O	small molecule	-	212844-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXCMJLOPOFPBT-HNNXBMFYSA-N
23866	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4554	Purvalanol A	6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv	-	DRUGBANK	DB04751	C19H25ClN6O	small molecule	-	212844-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXCMJLOPOFPBT-HNNXBMFYSA-N
23895	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Monteiro RQ (2004)	15203120	181850	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23910	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4599	Triazolopyridine	-	-	DRUGBANK	DB04797	C18H15FN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCXRBARSPBVMC-UHFFFAOYSA-N
23924	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Hovevey-Sion D (1989)	2506486	181654	4622	Nialamide	2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum	-	DRUGBANK	DB04820	C16H18N4O2	small molecule	N06AF02	51-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOIIUHRQUVNIDD-UHFFFAOYSA-N
23931	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Egashira T (1999)	10580379	181743	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23933	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lamers JM (1985)	2933041	179746	4627	Prenylamine	N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-1-propanamine|Prenilamina|N-(3'-Phenyl-2-propyl)-1,1-diphenyl-3-propyloamine|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin|N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine|DL-prenylamine|1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane|Prenylaminum|N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine	-	DRUGBANK	DB04825	C24H27N	small molecule	C01DX52|C01DX02	390-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFFPICMESYHZPQ-UHFFFAOYSA-N
23941	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Egashira T (1999)	10580379	181743	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
23976	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23977	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23997	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ochillo RF (1982)	7122991	181681	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23998	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tsai CS (1989)	2791613	181660	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23999	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tsai CS (1995)	7623487	181685	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
24014	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Cerqueira MD (2006)	16524538	181933	4654	Binodenoson	2-((Cyclohexylmethylene)hydrazino)adenosine|MRE 0470	-	DRUGBANK	DB04853	C17H25N7O4	small molecule	-	144348-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJFMHMFFBSOEPR-DNZQAUTHSA-N
24015	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Hodgson JM (2007)	17531571	182017	4654	Binodenoson	2-((Cyclohexylmethylene)hydrazino)adenosine|MRE 0470	-	DRUGBANK	DB04853	C17H25N7O4	small molecule	-	144348-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJFMHMFFBSOEPR-DNZQAUTHSA-N
24030	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Nuttall SL (2003)	12795776	175328	4661	Nebivolol	alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol	byvalson|nebivolol|bystolic	DRUGBANK	DB04861	C22H25F2NO4	small molecule	C07FB12|C07BB12|C07AB12	118457-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOHIRBRYDXPAMZ-UHFFFAOYSA-N
24039	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	unknown	target	Elkin M (2000)	11099465	181766	4666	Halofuginone	Tempostatin (Collgard Biopharmaceuticals)	-	DRUGBANK	DB04866	C16H17BrClN3O3	small molecule	-	55837-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVASCWIMLIKXLA-YSSOQSIOSA-N
24042	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Maekawa T (2007)	17929114	182055	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24043	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17715389	182041	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24044	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Weisberg E (2006)	16721371	181947	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24045	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Swords R (2009)	19920925	182135	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24046	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Rosti G (2009)	19822896	182130	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24048	107247	796	-	CALCA	CALC1|CGRP|CGRP-I|CGRP1|CT|KC	9606	Homo sapiens	unknown	target	Recober A (2007)	17665333	182035	4669	Olcegepant	-	-	DRUGBANK	DB04869	C38H47Br2N9O5	small molecule	-	204697-65-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITIXDWVDFFXNEG-JHOUSYSJSA-N
24052	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	unknown	target	McCullough JL (2006)	16495076	180022	4673	Piboserod	-	-	DRUGBANK	DB04873	C22H31N3O2	small molecule	-	152811-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVCSJPATKXABRQ-UHFFFAOYSA-N
24053	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	unknown	target	Darblade B (2005)	15902472	181892	4673	Piboserod	-	-	DRUGBANK	DB04873	C22H31N3O2	small molecule	-	152811-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVCSJPATKXABRQ-UHFFFAOYSA-N
24054	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Ross J (2007)	17845807	182047	4675	Pralnacasan	HMR 3480	-	DRUGBANK	DB04875	C26H29N5O7	small molecule	-	192755-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXAGHAZMQSCAKJ-WAHHBDPQSA-N
24094	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Janas AM (2005)	15620572	181876	4692	Phenserine	(-)-eseroline phenylcarbamate|(-)-phenserine	-	DRUGBANK	DB04892	C20H23N3O2	small molecule	-	101246-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBHFNBQPZCRWQP-QUCCMNQESA-N
24110	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24111	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24112	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24113	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24120	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Ersdal E (2007)	17532684	182018	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24121	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Testa L (2007)	17688383	182037	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24122	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24123	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Bergqvist D (2007)	17516699	182013	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24124	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Ho SJ (2007)	17319469	181988	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24148	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Drummond GS (2004)	15686268	181882	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24149	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Cannon JB (1993)	8321837	181696	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24150	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Boeni RE (1993)	8265722	181695	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24151	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Nalos M (2003)	12785007	181819	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24152	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Wagner KR (2000)	10872746	181754	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24154	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	unknown	target	Craig DA (1991)	1364818	181639	4715	Renzapride	-	-	DRUGBANK	DB04917	C16H22ClN3O2	small molecule	-	112727-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFUAYKVMQVBSNG-UHFFFAOYSA-N
24173	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Bianchi G (1993)	8405101	181699	4729	Defibrotide	-	defitelio	DRUGBANK	DB04932	-	biologic	B01AX01	83712-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24180	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Wurz GT (2005)	16153821	181910	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24181	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Komi J (2004)	15255284	181854	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24182	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Wurz GT (2005)	16153821	181910	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24183	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Komi J (2004)	15255284	181854	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24208	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24213	111082	5045	-	FURIN	FUR|PACE|PCSK3|SPC1	9606	Homo sapiens	unknown	target	Burghardt I (2007)	17234158	181983	4745	Pirfenidone	-	esbriet	DRUGBANK	DB04951	C12H11NO	small molecule	L04AX05	53179-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISWRGOKTTBVCFA-UHFFFAOYSA-N
24232	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Vincent JL (2000)	10829362	181750	4750	Afelimomab	MAK 195F|Fab 2	-	DRUGBANK	DB04956	-	biologic	L04AB03	156227-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24255	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Rosen LS (2003)	12738715	181816	4764	Canfosfamide	-	-	DRUGBANK	DB04972	C26H40Cl4N5O10PS	small molecule	-	158382-37-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLHWPALWODJPQ-QNWVGRARSA-N
24256	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Kavanagh JJ (2005)	16014111	181898	4764	Canfosfamide	-	-	DRUGBANK	DB04972	C26H40Cl4N5O10PS	small molecule	-	158382-37-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLHWPALWODJPQ-QNWVGRARSA-N
24282	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	ligand	target	Kedei N (2004)	15126366	181848	4800	Ingenol Mebutate	3-Ingenyl Angelate|Picato|ingenol mebutate|PEP005|Ingenol 3-angelate	picato	DRUGBANK	DB05013	C25H34O6	small molecule	D06BX02	75567-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDJHFHXMUKFKET-WDUFCVPESA-N
24285	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cazzola M (2005)	16022567	180980	4826	Indacaterol	QAB-149|5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one|QAB149|QAB 149	arcapta neohaler|ultibro breez	DRUGBANK	DB05039	C24H28N2O3	small molecule	R03AL04|R03AC18	312753-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZZUEBNBZAPZLX-QFIPXVFZSA-N
24286	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Almansa C (2004)	15481993	181866	4878	Cimicoxib	-	-	DRUGBANK	DB05095	C16H13ClFN3O3S	small molecule	-	265114-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYXDNECMRLFQMZ-UHFFFAOYSA-N
24303	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	antagonist	target	Eby G (2005)	16122880	181906	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24327	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24330	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5211	PX-12	1-methylpropyl 2-imidazolyl disulfide	-	DRUGBANK	DB05448	C7H12N2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPBPYQWMFCTCNG-UHFFFAOYSA-N
24331	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5222	TLK-199	-	-	DRUGBANK	DB05460	C27H35N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GWEJFLVSOGNLSS-WPFOTENUSA-N
24348	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Pavlov VA (2007)	17334244	181992	5295	GTS-21	Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine	-	DRUGBANK	DB05708	C19H20N2O2	small molecule	-	148372-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPYWXZCFYPVCNQ-RVDMUPIBSA-N
24349	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Kim SW (2007)	17591554	182021	5295	GTS-21	Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine	-	DRUGBANK	DB05708	C19H20N2O2	small molecule	-	148372-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPYWXZCFYPVCNQ-RVDMUPIBSA-N
24350	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Stokes C (2004)	15213292	181853	5295	GTS-21	Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine	-	DRUGBANK	DB05708	C19H20N2O2	small molecule	-	148372-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPYWXZCFYPVCNQ-RVDMUPIBSA-N
24362	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	inhibitor	target	Albert JS (2009)	21544959	182186	5500	CTS-21166	-	-	DRUGBANK	DB06073	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24363	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	inhibitor	target	Panza F (2009)	19655822	182121	5500	CTS-21166	-	-	DRUGBANK	DB06073	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24399	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24400	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24407	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Church LD (2009)	19169963	182096	5521	Canakinumab	ACZ-885|ACZ885	ilaris	DRUGBANK	DB06168	C6452H9958N1722O2010S42	biologic	L04AC08	914613-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24428	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Zoghbi GJ (2012)	22130964	182196	5532	Regadenoson	Regadenoson anhydrous	lexiscan	DRUGBANK	DB06213	C15H18N8O5	small molecule	C01EB21	313348-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZPZPHGJDAGEJZ-AKAIJSEGSA-N
24460	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Fagiolini A (2013)	23356509	182227	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24461	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24466	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24467	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24476	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24477	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24478	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24479	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tarizzo VI (1994)	7969507	175564	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24480	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Sanders VM (1998)	9666280	175565	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24548	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	5545	Temsirolimus	42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel	gd-temsirolimus|torisel	DRUGBANK	DB06287	C56H87NO16	small molecule	L01XE09	162635-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBPNZQVSJQDFBE-FUXHJELOSA-N
24549	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Radulovic S (2007)	17935273	182057	5545	Temsirolimus	42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel	gd-temsirolimus|torisel	DRUGBANK	DB06287	C56H87NO16	small molecule	L01XE09	162635-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBPNZQVSJQDFBE-FUXHJELOSA-N
24550	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Patard JJ (2008)	18265991	182064	5545	Temsirolimus	42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel	gd-temsirolimus|torisel	DRUGBANK	DB06287	C56H87NO16	small molecule	L01XE09	162635-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBPNZQVSJQDFBE-FUXHJELOSA-N
24563	109768	3552	-	IL1A	IL-1A|IL1|IL1-ALPHA|IL1F1	9606	Homo sapiens	binder	target	Tran TH (2013)	23553601	182241	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24564	109768	3552	-	IL1A	IL-1A|IL1|IL1-ALPHA|IL1F1	9606	Homo sapiens	binder	target	Cronstein BN (2013)	23319019	182226	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24567	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Tran TH (2013)	23553601	182241	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24568	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Cronstein BN (2013)	23319019	182226	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24569	110205	4023	-	LPL	HDLCQ11|LIPD	9606	Homo sapiens	inhibitor	target	Sato K (1997)	9406449	181723	5554	Tyloxapol	-	-	DRUGBANK	DB06439	-	small molecule	R05CA01	25301-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UTFVNNPSMPINLE-UHFFFAOYSA-N
24570	110205	4023	-	LPL	HDLCQ11|LIPD	9606	Homo sapiens	inhibitor	target	Rodrigues B (1992)	1493594	181640	5554	Tyloxapol	-	-	DRUGBANK	DB06439	-	small molecule	R05CA01	25301-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UTFVNNPSMPINLE-UHFFFAOYSA-N
24571	110205	4023	-	LPL	HDLCQ11|LIPD	9606	Homo sapiens	inhibitor	target	Levine S (2006)	16839786	181953	5554	Tyloxapol	-	-	DRUGBANK	DB06439	-	small molecule	R05CA01	25301-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UTFVNNPSMPINLE-UHFFFAOYSA-N
24588	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Remsing Rix LL (2009)	19039322	182092	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
24614	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Larsen PJ (2008)	18333889	182069	5567	Liraglutide	NN-2211|Liraglutidum|N-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide|Victoza|NN2211|N-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide|NN 2211|Liraglutide recombinant|Arg34Lys26-(N--(-Glu(N--hexadecanoyl)))-GLP-1[7-37]|NNC 90-1170|Liraglutida	xultophy 100/3.6|saxenda|victo	DRUGBANK	DB06655	C172H265N43O51	biologic	A10BX07|A10AE56	204656-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24615	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Bock T (2003)	14678021	181841	5567	Liraglutide	NN-2211|Liraglutidum|N-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide|Victoza|NN2211|N-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide|NN 2211|Liraglutide recombinant|Arg34Lys26-(N--(-Glu(N--hexadecanoyl)))-GLP-1[7-37]|NNC 90-1170|Liraglutida	xultophy 100/3.6|saxenda|victo	DRUGBANK	DB06655	C172H265N43O51	biologic	A10BX07|A10AE56	204656-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24624	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Mittal M (2010)	21079302	182177	5569	Golimumab	-	simponi aria|simponi i.v.|simp	DRUGBANK	DB06674	C6530H10068N1752O2026S44	biologic	L04AB06	476181-74-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24656	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Liesenfeld KH (2006)	17061960	181973	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSGXQBZTULBEEQ-UHFFFAOYSA-N
24657	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Karthikeyan G (2010)	20424539	182153	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSGXQBZTULBEEQ-UHFFFAOYSA-N
24658	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Squizzato A (2009)	19756950	182126	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSGXQBZTULBEEQ-UHFFFAOYSA-N
24713	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nilvebrant L (2002)	12076307	181796	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24785	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Renner RM (2010)	20399943	182151	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24786	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rose P (2007)	17516707	182014	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24787	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Berg J (1999)	10450786	181738	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24788	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bianchi M (2002)	11846620	181788	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24789	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Zimmerman TJ (1979)	37605	181633	5606	Bufuralol	Bufuralolum	-	DRUGBANK	DB06726	C16H23NO2	small molecule	-	54340-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSEBTPPFLLCUMN-UHFFFAOYSA-N
24799	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24800	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24809	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24810	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24833	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Jamal KN (2009)	19668594	182122	5635	Difluprednate	DFBA|Durezol|Difluoroprednisolone butyrate acetate	durezol	DRUGBANK	DB06781	C27H34F2O7	small molecule	D07AC19	23674-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYQPLTPSGFELIB-JTQPXKBDSA-N
24834	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Tajika T (2010)	20509750	182155	5635	Difluprednate	DFBA|Durezol|Difluoroprednisolone butyrate acetate	durezol	DRUGBANK	DB06781	C27H34F2O7	small molecule	D07AC19	23674-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYQPLTPSGFELIB-JTQPXKBDSA-N
24839	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gamache DA (2000)	10850857	181753	5639	Nepafenac	AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac	ilevro|nevanac	DRUGBANK	DB06802	C15H14N2O2	small molecule	S01BC10	78281-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFAQIPZVLVERP-UHFFFAOYSA-N
24840	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Uy GL (2008)	18847313	182086	5642	Plerixafor	Mozobil|AMD3100|LM3100	mozobil	DRUGBANK	DB06809	C28H54N8	small molecule	L03AX16	110078-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YIQPUIGJQJDJOS-UHFFFAOYSA-N
24841	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Jujo K (2013)	23204107	182222	5642	Plerixafor	Mozobil|AMD3100|LM3100	mozobil	DRUGBANK	DB06809	C28H54N8	small molecule	L03AX16	110078-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YIQPUIGJQJDJOS-UHFFFAOYSA-N
24844	112288	6387	-	CXCL12	IRH|PBSF|SCYB12|SDF1|TLSF|TPAR1	9606	Homo sapiens	binder	target	Koo CY (2008)	18991783	182089	5647	Tinzaparin	Tinzaparin sodium	innohep multi-dose vial- 10000	DRUGBANK	DB06822	-	small molecule	B01AB10	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24850	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5650	4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB06829	C19H20BrNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXDVFLTWXCTCEX-UHFFFAOYSA-N
24854	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5653	2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL	-	-	DRUGBANK	DB06832	C15H10FNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQIMZDXIAHJKQP-UHFFFAOYSA-N
24857	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5655	N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide	-	-	DRUGBANK	DB06834	C21H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZRYCTLOGNCQDG-UHFFFAOYSA-N
24858	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5656	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	-	-	DRUGBANK	DB06835	C22H31N2O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTQDLSDUHUFBQW-LEWJYISDSA-N
24862	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5659	methyl L-phenylalaninate	-	-	DRUGBANK	DB06838	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSDUZFOSJDMAFZ-VIFPVBQESA-N
24864	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5662	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide	-	-	DRUGBANK	DB06841	C21H32ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWPACVJPAFGBEQ-IKGGRYGDSA-O
24870	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5665	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	-	-	DRUGBANK	DB06844	C21H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBXKBJLIESPLIK-UHFFFAOYSA-N
24873	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5666	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB06845	C20H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXYKSWZWRHMJTE-KRWDZBQOSA-N
24878	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5671	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB06850	C21H31N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYKFVFFOIYLADT-SFHVURJKSA-N
24880	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5673	4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB06852	C23H22ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOVBBVMDHIRCTG-LJQANCHMSA-N
24882	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5674	N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06853	C22H33N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYTJPDBCLWUEBU-IBGZPJMESA-N
24883	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5675	2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06854	C20H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMGQGPVCSYOMNS-UHFFFAOYSA-N
24884	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5675	2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06854	C20H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMGQGPVCSYOMNS-UHFFFAOYSA-N
24885	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5676	6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06855	C18H19FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSUDDASMRZSVON-UHFFFAOYSA-N
24886	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5677	6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06856	C22H24FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYQYLFFFNSAAX-BUXKBTBVSA-N
24887	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5678	N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE	-	-	DRUGBANK	DB06857	C15H13ClIN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKGFTDAISIBIBV-UHFFFAOYSA-N
24889	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5679	N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06858	C23H35N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMLOIDMSBRJZAE-FQEVSTJZSA-N
24890	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5680	N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE	-	-	DRUGBANK	DB06859	C19H27ClN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWIUMAPBZWNFNV-UHFFFAOYSA-N
24891	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5682	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	-	-	DRUGBANK	DB06861	C12H22N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCDJKFJACUMSOZ-AXFHLTTASA-N
24892	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5683	2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID	-	-	DRUGBANK	DB06862	C9H11NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCQUNSCHVXCSCJ-UHFFFAOYSA-N
24894	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5685	6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	-	-	DRUGBANK	DB06865	C22H26N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSRRBAKATXAISL-LMNJBCLMSA-N
24895	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5686	6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	-	-	DRUGBANK	DB06866	C23H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMOUMGFCBOWPAB-RZUBCFFCSA-N
24896	111317	5300	-	PIN1	DOD|UBL5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5687	3,6,9,12,15,18-HEXAOXAICOSANE	-	-	DRUGBANK	DB06867	C14H30O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXFAFGFZFQHRLB-UHFFFAOYSA-N
24897	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5688	N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide	-	-	DRUGBANK	DB06868	C18H25ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQUULPKGCNPPBX-INIZCTEOSA-N
24898	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5689	1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE	-	-	DRUGBANK	DB06869	C24H35ClN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMHVHOJXEQTIEA-SIKLNZKXSA-N
24901	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5691	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	-	-	DRUGBANK	DB06871	C19H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQMQOMRDADWGJJ-GBESFXJTSA-N
24904	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5695	3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE	-	-	DRUGBANK	DB06875	C17H10FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSSOSHDCWCMNDM-UHFFFAOYSA-N
24906	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5696	N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE	-	-	DRUGBANK	DB06876	C24H24N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJWJKKXGAPWLGT-UHFFFAOYSA-N
24907	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5697	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB06877	C16H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPBUUQBZKJSWTN-UHFFFAOYSA-N
24908	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5698	1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB06878	C16H22ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTYYXGRJXJFTCD-KGLIPLIRSA-N
24911	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5702	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	-	-	DRUGBANK	DB06882	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJWMLCDGRWWLAQ-UHFFFAOYSA-N
24912	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5702	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	-	-	DRUGBANK	DB06882	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJWMLCDGRWWLAQ-UHFFFAOYSA-N
24913	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5703	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea	-	-	DRUGBANK	DB06883	C20H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHNYNLNKNQJSHF-UHFFFAOYSA-N
24916	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5707	3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER	-	-	DRUGBANK	DB06887	C16H23N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPSSYXOFPICMQD-ZDUSSCGKSA-N
24917	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5708	(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE	-	-	DRUGBANK	DB06888	C22H21N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBLPHMRCKHFBJB-OLZOCXBDSA-N
24924	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5717	4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol	-	-	DRUGBANK	DB06898	C13H12N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJXOCBVCWTJFP-UHFFFAOYSA-N
24930	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5724	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	-	-	DRUGBANK	DB06905	C20H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJVCHYDYCYBBQX-HLTLHRPFSA-N
24932	111510	5518	-	PPP2R1A	PP2A-Aalpha|PP2AAALPHA|PR65A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5724	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	-	-	DRUGBANK	DB06905	C20H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJVCHYDYCYBBQX-HLTLHRPFSA-N
24933	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5727	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	-	-	DRUGBANK	DB06908	C24H23ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAWOPJKHTZCKMT-QFIPXVFZSA-N
24936	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5730	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB06911	C18H26ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHVBVJXZKNCSLP-CVEARBPZSA-N
24938	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5733	1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE	-	-	DRUGBANK	DB06914	C15H17ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPIOYRIZNLPLDH-UHFFFAOYSA-N
24942	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5738	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB06919	C21H24ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJHLRGCXPGIPCB-MOPGFXCFSA-N
24944	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5740	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID	-	-	DRUGBANK	DB06921	C20H27N2O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNZHLCNFXRRIIC-RBUKOAKNSA-N
24948	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5744	3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB06925	C23H17F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEIASMOUYNOXGA-UHFFFAOYSA-N
24949	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5745	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	-	-	DRUGBANK	DB06926	C18H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNICUWMFWZBIFP-IRQZEAMPSA-N
24950	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5746	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	-	-	DRUGBANK	DB06927	C16H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKJVCUXZMYKTLT-UHFFFAOYSA-N
24951	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5746	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	-	-	DRUGBANK	DB06927	C16H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKJVCUXZMYKTLT-UHFFFAOYSA-N
24954	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5748	1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06929	C17H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYAZZWWVNUWKNB-AWEZNQCLSA-N
24955	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5749	N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide	-	-	DRUGBANK	DB06930	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLDNAVUCUAGDP-UHFFFAOYSA-N
24958	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5752	N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide	-	-	DRUGBANK	DB06933	C24H24N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJTCKUKIFXWJKG-UHFFFAOYSA-N
24959	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5755	N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide	-	-	DRUGBANK	DB06936	C19H28N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKJCSNKYXWOAQ-INIZCTEOSA-N
24960	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5756	4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB06937	C13H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBTXJDAHLMMIGY-UHFFFAOYSA-N
24963	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5759	N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide	-	-	DRUGBANK	DB06940	C19H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZTMFGIGOADCFX-UHFFFAOYSA-N
24964	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5760	(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide	-	-	DRUGBANK	DB06941	C13H19N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAASZVAHBVMHCO-NXVVXOECSA-N
24965	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5761	N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide	-	-	DRUGBANK	DB06942	C22H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNZKCCPFUWHBFY-IBGZPJMESA-N
24966	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5762	(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol	-	-	DRUGBANK	DB06943	C14H17NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLIQFUCBRCDFAI-ZDUSSCGKSA-N
24967	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5763	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	-	-	DRUGBANK	DB06944	C18H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIGZCVNCFXYBEG-UHFFFAOYSA-N
24970	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5766	1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06947	C17H25N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHAMQFKGUUSJMU-KGLIPLIRSA-N
24971	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5767	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	-	-	DRUGBANK	DB06948	C18H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWWRLKIBRPJQJX-UHFFFAOYSA-N
24977	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5775	N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB06956	C18H14ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTTFXKUTBNGQTP-UHFFFAOYSA-N
24978	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5776	4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB06957	C21H23ClN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDFJIEMVNDLSTB-UHFFFAOYSA-N
24979	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5777	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB06958	C16H20ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SORAKBHHTGVZCS-UHFFFAOYSA-N
24980	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5778	(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE	-	-	DRUGBANK	DB06959	C25H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUCZDJYEOAQTHL-VXKWHMMOSA-N
24982	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5780	5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide	-	-	DRUGBANK	DB06961	C23H24ClN3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APGOABVITLQCKW-UHFFFAOYSA-N
24985	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5783	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB06964	C19H17ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXPCDMPJCKNLBY-UHFFFAOYSA-N
24987	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5788	2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide	-	-	DRUGBANK	DB06969	C21H23Cl2N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJUNQSYQHHIVFX-UHFFFAOYSA-N
24991	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5794	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA	-	-	DRUGBANK	DB06976	C19H22N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWOOJEZSDPRYAZ-WFASDCNBSA-N
24992	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5795	(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE	-	-	DRUGBANK	DB06977	C23H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAASENZOSQYNPX-WMZHIEFXSA-N
24997	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5801	(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol	-	-	DRUGBANK	DB06983	C19H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RBLKWWBHDUBPFN-UHFFFAOYSA-N
25004	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5809	N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide	-	-	DRUGBANK	DB06991	C17H22N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYOUIHFZUAKCEF-LLVKDONJSA-N
25009	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5814	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06996	C19H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFNMDMGNNKIXBT-CVEARBPZSA-N
25014	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5819	(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine	-	-	DRUGBANK	DB07001	C10H14N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIIBOYBTIWHZFJ-ZETCQYMHSA-N
25017	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5822	2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide	-	-	DRUGBANK	DB07004	C13H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUKZXTKQBXLMDO-UHFFFAOYSA-N
25018	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5823	D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide	-	-	DRUGBANK	DB07005	C22H28N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZFTWWJAUZOJDH-MOPGFXCFSA-O
25022	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5827	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL	-	-	DRUGBANK	DB07009	C17H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHOZVRGNIYFYHE-UHFFFAOYSA-N
25024	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5828	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07010	C21H17ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDJZASCRQRBYQS-UHFFFAOYSA-N
25025	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5828	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07010	C21H17ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDJZASCRQRBYQS-UHFFFAOYSA-N
25028	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5832	2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole	-	-	DRUGBANK	DB07014	C17H13FN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUTZKAQTSPMEBI-UHFFFAOYSA-N
25030	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5834	(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline	-	-	DRUGBANK	DB07016	C10H13NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVVJJANGXMGMGC-SSDOTTSWSA-N
25032	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5837	N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE	-	-	DRUGBANK	DB07019	C24H33N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDOKZPZLWNULU-MZNJEOGPSA-N
25033	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5838	N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide	-	-	DRUGBANK	DB07020	C20H14N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMDMJDCLPIVGQD-UHFFFAOYSA-N
25037	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5842	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	-	-	DRUGBANK	DB07024	C19H17NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEXBEGBNDJVZPK-UHFFFAOYSA-N
25038	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5843	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07025	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBIHHEGEALBUMT-UHFFFAOYSA-N
25040	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5845	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB07027	C21H24FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGZSVYZIJHGHMA-MOPGFXCFSA-N
25045	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5850	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	-	-	DRUGBANK	DB07032	C14H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNNDCMXZYWCCI-UHFFFAOYSA-N
25047	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5852	2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID	-	-	DRUGBANK	DB07034	C17H13NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKATEXROYSXDW-UHFFFAOYSA-N
25048	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5854	(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	-	-	DRUGBANK	DB07036	C20H20F2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPFRMIHXGMVMGF-BZSNNMDCSA-N
25049	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5855	(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL	-	-	DRUGBANK	DB07037	C12H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBZPCTWLFNYBND-QMMMGPOBSA-N
25050	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5856	2-(cyclohexylamino)benzoic acid	-	-	DRUGBANK	DB07038	C13H17NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSXMFCCPQQJLCR-UHFFFAOYSA-N
25052	109544	3312	-	HSPA8	HEL-33|HEL-S-72p|HSC54|HSC70|HSC71|HSP71|HSP73|HSPA10|LAP-1|LAP1|NIP71	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5863	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	-	-	DRUGBANK	DB07045	C17H18Cl2N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBJKVZXRYLCYGQ-XNIJJKJLSA-N
25053	107049	573	RP11-326F20.2	BAG1	BAG-1|HAP|RAP46	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5863	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	-	-	DRUGBANK	DB07045	C17H18Cl2N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBJKVZXRYLCYGQ-XNIJJKJLSA-N
25059	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5871	2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	-	-	DRUGBANK	DB07053	C24H23F3N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWVYNPULGKGJOS-UHFFFAOYSA-N
25060	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5872	(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL	-	-	DRUGBANK	DB07054	C22H23F4N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSCWQKTUILTARV-MRXNPFEDSA-N
25063	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5876	5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione	-	-	DRUGBANK	DB07058	C16H12N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBVJMUOTMRYUKR-UHFFFAOYSA-N
25069	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5883	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB07065	C19H12Cl2N6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHPKUZJCNHGFQA-UHFFFAOYSA-N
25079	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5893	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE	-	-	DRUGBANK	DB07075	C23H24N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBKUBPBCFYCSRT-UHFFFAOYSA-N
25080	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5894	6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE	-	-	DRUGBANK	DB07076	C23H23N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWTQOPWAMQXIMI-UHFFFAOYSA-N
25082	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5896	(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE	-	-	DRUGBANK	DB07078	C20H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYSXURJZVXBSRV-WJDWOHSUSA-N
25083	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5897	3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol	-	-	DRUGBANK	DB07079	C13H16O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CARKQNSZFCLNKM-UHFFFAOYSA-N
25085	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25089	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25091	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5900	1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL	-	-	DRUGBANK	DB07082	C11H8F9NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHDRSZOHKKZOQF-UHFFFAOYSA-N
25092	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5901	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	-	-	DRUGBANK	DB07083	C23H29N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZKKJPDVZGOOPU-PZJWPPBQSA-N
25095	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5904	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07086	C16H20O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXIFNRNIQJKFLP-XHSDSOJGSA-N
25097	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5905	4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07087	C17H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMSZEVAWRFDVQX-GHVWTTSJSA-N
25099	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5906	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07088	C20H28N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWXWAYUCJVQHOR-KRWDZBQOSA-N
25100	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5907	N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide	-	-	DRUGBANK	DB07089	C22H22ClN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZSMTBLDWPKVRW-UHFFFAOYSA-N
25102	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5909	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07091	C21H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWPMQJKXKKKSEY-SFHVURJKSA-N
25107	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5913	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07095	C21H30N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNCHHUFGEOJCNH-SFHVURJKSA-N
25110	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5918	4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB07100	C13H15ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFPHEBUOQYYPDO-UHFFFAOYSA-N
25114	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5923	2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE	-	-	DRUGBANK	DB07105	C18H20ClN5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEEYGOJDTRVYGR-HNNXBMFYSA-N
25116	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5925	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	-	-	DRUGBANK	DB07107	C23H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGHXFHRRWFLILP-XJDXJNMNSA-N
25118	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5926	4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID	-	-	DRUGBANK	DB07108	C13H9FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXWNTLBMNCXRQN-UHFFFAOYSA-N
25119	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5928	4-(4-FLUOROBENZYL)PIPERIDINE	-	-	DRUGBANK	DB07110	C12H16FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLAKCHGEEBPDQI-UHFFFAOYSA-N
25120	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5929	(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid	-	-	DRUGBANK	DB07111	C22H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFRKCNPQVIJFAQ-HBUOOPIGSA-N
25126	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5935	5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE	-	-	DRUGBANK	DB07117	C24H22N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMKQJGOROFNCGM-UHFFFAOYSA-N
25127	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5937	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	-	-	DRUGBANK	DB07119	C16H11ClO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHEHVRSGKUYDON-UHFFFAOYSA-N
25129	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5938	N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE	-	-	DRUGBANK	DB07120	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLXOHIUDKNRVBZ-UHFFFAOYSA-N
25130	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5939	4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07121	C17H23N3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANXPIMDONQTQF-HNNXBMFYSA-N
25131	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5940	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	-	-	DRUGBANK	DB07122	C15H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MERNPSIIBFTCAI-UHFFFAOYSA-N
25132	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5942	(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB07124	C22H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCIACUJJBPSOHE-KRWDZBQOSA-N
25134	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5944	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	-	-	DRUGBANK	DB07126	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWXORKPNCHJYOF-UHFFFAOYSA-N
25137	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5946	N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE	-	-	DRUGBANK	DB07128	C17H21ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTYBIJUAAWLJNU-UHFFFAOYSA-N
25138	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5947	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	-	-	DRUGBANK	DB07129	C11H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-SNVBAGLBSA-N
25139	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5948	4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07130	C13H9BrO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVDWLRCTJUXCCB-UHFFFAOYSA-N
25141	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5949	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07131	C22H32N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOTBZTLJSXFKCP-IBGZPJMESA-N
25143	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5951	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB07133	C22H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHKWABXWPATIIG-UXHICEINSA-N
25144	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5952	5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	-	-	DRUGBANK	DB07134	C12H9ClN2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCPRWBWCEGWNKF-UHFFFAOYSA-N
25146	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5954	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	-	-	DRUGBANK	DB07136	C23H33N2O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFFOOKSVFDUPDH-FCHUYYIVSA-N
25147	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5955	(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE	-	-	DRUGBANK	DB07137	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPAWNIKVRIVDBT-PORMKJMCSA-N
25149	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5956	5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one	-	-	DRUGBANK	DB07138	C19H9Cl2F2N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEPKQEUBKLEPRA-UHFFFAOYSA-N
25154	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5961	D-phenylalanyl-N-benzyl-L-prolinamide	-	-	DRUGBANK	DB07143	C21H25N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEPJWLFTTFHOQO-MOPGFXCFSA-N
25156	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5963	(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE	-	-	DRUGBANK	DB07145	C25H27N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDMIPBHQKFOFQW-NSYGIPOTSA-N
25157	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5964	2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE	-	-	DRUGBANK	DB07146	C25H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUIQCYFSBGOBKE-UHFFFAOYSA-N
25158	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5965	methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate	-	-	DRUGBANK	DB07147	C24H24N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJWMYFBKJRVWJY-YKSBVNFPSA-N
25160	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5967	(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	-	-	DRUGBANK	DB07149	C13H14FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCBAQTCTQXHTJG-ZETCQYMHSA-N
25161	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5968	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	-	-	DRUGBANK	DB07150	C17H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYQQTWUZKPWPRL-WOJGMQOQSA-N
25163	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5969	4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one	-	-	DRUGBANK	DB07151	C17H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZXKZZMGLACNIJ-UHFFFAOYSA-N
25166	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5974	(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione	-	-	DRUGBANK	DB07156	C21H20BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFEKAVPMVOLVTH-UNOMPAQXSA-N
25167	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5975	(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE	-	-	DRUGBANK	DB07157	C21H27N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTFGEFWZCFCODU-RBUKOAKNSA-N
25168	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5976	5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE	-	-	DRUGBANK	DB07158	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASEHARDUZDZEKS-UHFFFAOYSA-N
25169	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5977	6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one	-	-	DRUGBANK	DB07159	C22H23FN6O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHHQJBCNYHBUSI-UHFFFAOYSA-N
25170	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5978	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE	-	-	DRUGBANK	DB07160	C12H19NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZJYLQZZISBOTF-JBDRJPRFSA-N
25171	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5979	5-phenyl-1H-indazol-3-amine	-	-	DRUGBANK	DB07161	C13H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCUSNQPYUNLATP-UHFFFAOYSA-N
25172	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5980	4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide	-	-	DRUGBANK	DB07162	C17H20N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFJCXIOVAGJCKB-UHFFFAOYSA-N
25173	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5981	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	-	-	DRUGBANK	DB07163	C17H15FN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQCXWWWNUFQYJS-UHFFFAOYSA-N
25174	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5982	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	-	-	DRUGBANK	DB07164	C13H12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAGHIASAHLPQMS-UHFFFAOYSA-N
25176	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5983	N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE	-	-	DRUGBANK	DB07165	C22H23Cl2N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOBGXPPOYFFGTK-UGKGYDQZSA-N
25180	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5989	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	-	-	DRUGBANK	DB07172	C20H30O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTAGQROYQYQRHF-CBVHGRPESA-N
25183	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5992	N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide	-	-	DRUGBANK	DB07175	C18H18N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXQRKICWSCAUGW-UHFFFAOYSA-N
25186	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5996	3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide	-	-	DRUGBANK	DB07179	C19H16BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXUJQXZHHGJMFM-UHFFFAOYSA-N
25189	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5999	(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID	-	-	DRUGBANK	DB07182	C19H24N3O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFRHWTYCVGKGIE-KRWDZBQOSA-N
25194	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6006	(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid	-	-	DRUGBANK	DB07189	C29H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFZXMIUWGSTUAL-ZSOKXDGFSA-N
25195	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6007	3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB07190	C21H30ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGFCNVHEEMBVJG-MOPGFXCFSA-N
25197	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6011	2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide	-	-	DRUGBANK	DB07194	C20H23N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGXADGTBNRSGV-ZDUSSCGKSA-N
25199	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6012	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07195	C18H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTZWKYVREFMAJA-QXWBOSQLSA-N
25201	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6014	4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07197	C13H9BrO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZWUMLLRAVGBHC-UHFFFAOYSA-N
25202	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6015	5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE	-	-	DRUGBANK	DB07198	C15H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEKOZPXKBYLNK-UHFFFAOYSA-N
25205	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6020	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	-	-	DRUGBANK	DB07203	C18H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUEGMEMDEAOAEG-UHFFFAOYSA-N
25207	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6021	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	-	-	DRUGBANK	DB07204	C24H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQIXTEDFNFZMCM-SFHVURJKSA-N
25210	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6023	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE	-	-	DRUGBANK	DB07206	C15H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSHSZKRWKLQZBV-UHFFFAOYSA-N
25213	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6025	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	-	-	DRUGBANK	DB07208	C18H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFOOCZBVPQYRS-PSDPTOBYSA-N
25214	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6026	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	-	-	DRUGBANK	DB07209	C18H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLHUENSFQCPBQH-ZBKJIUGYSA-N
25215	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6027	3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB07210	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JECHSYMSTXETFI-UHFFFAOYSA-N
25216	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6028	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE	-	-	DRUGBANK	DB07211	C18H24ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMJHMJLNQLVUAV-GHYUOPHCSA-N
25219	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6030	(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL	-	-	DRUGBANK	DB07213	C24H25N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNWHPLLNMLOZTL-UHFFFAOYSA-N
25224	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6033	N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide	-	-	DRUGBANK	DB07217	C16H13FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVYPYORTKAIUGJ-UHFFFAOYSA-N
25225	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6034	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	-	-	DRUGBANK	DB07218	C12H10ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYKGPCNWPACUQV-UHFFFAOYSA-N
25226	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6034	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	-	-	DRUGBANK	DB07218	C12H10ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYKGPCNWPACUQV-UHFFFAOYSA-N
25227	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6035	BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	-	-	DRUGBANK	DB07219	C25H35N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMQNYWZURFTFHE-MQBSTWLZSA-N
25228	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6036	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	-	-	DRUGBANK	DB07220	C23H27N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXYIRNXOAJYLCU-UHFFFAOYSA-N
25230	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6039	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	-	-	DRUGBANK	DB07223	C19H31N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWSRLSPWIEMLQ-YTFOTSKYSA-N
25231	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6040	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE	-	-	DRUGBANK	DB07224	C15H24N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCIQOJEDMDETP-QHZLYTNSSA-N
25232	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6041	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE	-	-	DRUGBANK	DB07225	C18H30N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFABOFMUPCWOPC-LHEWDLALSA-N
25237	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6044	1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA	-	-	DRUGBANK	DB07228	C17H22ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIAYFZLMPSVQDV-NSHDSACASA-N
25239	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6046	3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE	-	-	DRUGBANK	DB07230	C15H9BrO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHPCBFMFERFZLR-UHFFFAOYSA-N
25241	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6047	N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE	-	-	DRUGBANK	DB07231	C22H29N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MERYMLLGRCNRKE-HILJTLORSA-N
25244	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6049	N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan	-	-	DRUGBANK	DB07233	C22H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFVPXERGVLDWIS-OAQYLSRUSA-N
25246	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6051	N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07235	C19H19Cl2N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHOVRZGUSBMKKU-ZDUSSCGKSA-N
25247	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6052	3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL	-	-	DRUGBANK	DB07236	C17H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCGSYJVWLGYWTD-UHFFFAOYSA-N
25252	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6058	(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	-	-	DRUGBANK	DB07242	C18H18Cl2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGUIMGJMQKZRGM-LLVKDONJSA-N
25253	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6059	(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE	-	-	DRUGBANK	DB07243	C16H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQGFCATXRXQKNB-GDNZZTSVSA-N
25255	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6060	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07244	C19H19F2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRRWXMSVQYQCRX-UHFFFAOYSA-N
25256	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6061	6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE	-	-	DRUGBANK	DB07245	C20H20N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEVBKBAFFJKFJZ-UHFFFAOYSA-N
25257	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6062	(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE	-	-	DRUGBANK	DB07246	C16H15F3N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKRPIBSCGZAUCH-OAHLLOKOSA-N
25275	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6079	[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid	-	-	DRUGBANK	DB07263	C22H18BrF2O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDTMVBQZDFMOIK-GOSISDBHSA-N
25276	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6080	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07264	C22H17Cl2FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMUYGRBBEDYUOP-HXUWFJFHSA-N
25280	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6084	2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE	-	-	DRUGBANK	DB07268	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHPKKGUGRGRSGA-UHFFFAOYSA-N
25281	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6085	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID	-	-	DRUGBANK	DB07269	C22H29N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFUOOKBZBVUDBC-VQTJNVASSA-N
25284	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6088	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	-	-	DRUGBANK	DB07272	C18H19BrN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKODDLYLEKSDJL-UHFFFAOYSA-N
25285	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6088	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	-	-	DRUGBANK	DB07272	C18H19BrN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKODDLYLEKSDJL-UHFFFAOYSA-N
25287	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6092	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07276	C18H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGKZYFYGCWXMN-UHFFFAOYSA-N
25288	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6092	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07276	C18H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGKZYFYGCWXMN-UHFFFAOYSA-N
25289	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6093	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE	-	-	DRUGBANK	DB07277	C17H24ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAUZEBLXCOCAFL-JSGCOSHPSA-N
25291	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6094	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE	-	-	DRUGBANK	DB07278	C17H22ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACEFOQMQINFMRW-DYCFVMESSA-N
25293	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6095	N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE	-	-	DRUGBANK	DB07279	C21H29N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMPSZYHYDMQFEO-KRWDZBQOSA-N
25295	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6097	N~3~-BENZYLPYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07281	C12H13N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUKAGFLFIMVSQN-UHFFFAOYSA-N
25296	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6100	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07284	C17H16N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQSBHBFOOVYRNM-UHFFFAOYSA-N
25297	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6101	(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID	-	-	DRUGBANK	DB07285	C11H12F2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQLOVWIRUXBAW-SECBINFHSA-N
25300	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6105	5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07289	C20H16BrNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEQPGVUGYAUMSA-UHFFFAOYSA-N
25303	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6111	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	-	-	DRUGBANK	DB07295	C19H13NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGOULVZYQKJJKC-UHFFFAOYSA-N
25305	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6113	5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB07297	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTILEOLOGGMFCS-UHFFFAOYSA-N
25306	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6114	3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07298	C10H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGZSWLHKOMFYHS-UHFFFAOYSA-N
25309	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6118	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	-	-	DRUGBANK	DB07302	C18H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPDSHTNEKLQQIJ-UINYOVNOSA-N
25310	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6119	N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07303	C18H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGAWZMRRCVSRIM-UHFFFAOYSA-N
25314	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6123	N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide	-	-	DRUGBANK	DB07307	C26H23N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GQXMJOSCBRZMKE-UHFFFAOYSA-N
25318	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6127	18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE	-	-	DRUGBANK	DB07311	C16H17ClN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRSWWYITYIOHOP-UHFFFAOYSA-N
25321	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6130	1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA	-	-	DRUGBANK	DB07314	C14H12ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URQYPXQXSVUVRG-UHFFFAOYSA-N
25324	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6133	(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one	-	-	DRUGBANK	DB07317	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKXNPYSVWOVZGX-CMDGGOBGSA-N
25326	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6135	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB07319	C13H10BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXSSKAZHCZWJPP-UHFFFAOYSA-N
25327	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6136	4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID	-	-	DRUGBANK	DB07320	C25H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEDLHZCDTXWLOC-SGNKCFNYSA-N
25331	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6140	3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE	-	-	DRUGBANK	DB07324	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUJWSOPIDUWELP-UHFFFAOYSA-N
25332	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6141	N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07325	C17H19N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCOKUBHAJVTVNG-FMIVXFBMSA-N
25339	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6151	3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL	-	-	DRUGBANK	DB07335	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWYBBCLGEHZSCP-UHFFFAOYSA-N
25341	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6152	4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL	-	-	DRUGBANK	DB07336	C21H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYPHGCGOSZJXOT-UHFFFAOYSA-N
25347	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6158	1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone	-	-	DRUGBANK	DB07342	C15H20N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBCQJSMDKDHVKG-BVMXXOESSA-N
25349	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6161	4-(2-aminoethyl)-2-cyclohexylphenol	-	-	DRUGBANK	DB07345	C14H21NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOCCSEDGBYCYLS-UHFFFAOYSA-N
25350	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6162	4-(2-aminoethyl)-2-ethylphenol	-	-	DRUGBANK	DB07346	C10H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDAFQVRTSOETPE-UHFFFAOYSA-N
25361	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6169	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	-	-	DRUGBANK	DB07353	C11H18N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTBBVHAOBBELOH-KOLCDFICSA-N
25371	114376	8851	-	CDK5R1	CDK5P35|CDK5R|NCK5A|p23|p25|p35|p35nck5a	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6180	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	-	-	DRUGBANK	DB07364	C16H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRIGRJPRGZCFAS-UHFFFAOYSA-N
25372	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6180	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	-	-	DRUGBANK	DB07364	C16H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRIGRJPRGZCFAS-UHFFFAOYSA-N
25373	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6182	2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER	-	-	DRUGBANK	DB07366	C17H26N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOCIXHUQBOUBAK-HNNXBMFYSA-N
25393	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6192	5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)	-	-	DRUGBANK	DB07376	C12H13NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBEQQKBWUHCIOU-UHFFFAOYSA-N
25407	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6203	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	-	-	DRUGBANK	DB07388	C14H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNRMJBWADUSJTA-UHFFFAOYSA-N
25409	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6205	2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE	-	-	DRUGBANK	DB07390	C13H15N5O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKWXKADYTDWZIJ-VIFPVBQESA-N
25417	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6214	1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE	-	-	DRUGBANK	DB07400	C21H33N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEHSFPPTWRQOFS-MSOLQXFVSA-N
25438	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6229	4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine	-	-	DRUGBANK	DB07415	C19H19FN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFLOFHKRBGKCOB-AWEZNQCLSA-N
25453	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6244	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	-	-	DRUGBANK	DB07431	C13H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXYKBKYDFZQOCB-SSDOTTSWSA-N
25459	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6252	4-TERT-BUTYLBENZENESULFONIC ACID	-	-	DRUGBANK	DB07440	C10H14O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZQMCUIWYRQLOG-UHFFFAOYSA-N
25463	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6255	6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	-	-	DRUGBANK	DB07444	C19H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PKPNSCZPIWCHMW-UHFFFAOYSA-N
25474	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6269	3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE	-	-	DRUGBANK	DB07458	C27H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBFDERUQORUFIN-KRWDZBQOSA-N
25475	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6270	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	-	-	DRUGBANK	DB07459	C19H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVLSCZSVTCNAQX-UHFFFAOYSA-N
25477	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6272	3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	-	-	DRUGBANK	DB07461	C15H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVDDTUQPPBUQDD-DZGCQCFKSA-N
25484	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6282	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	-	-	DRUGBANK	DB07471	C22H20ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHCHLTQBLNUYRT-GFCCVEGCSA-N
25486	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6285	3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE	-	-	DRUGBANK	DB07474	C22H19N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLTRPHMPCVLOJS-UHFFFAOYSA-N
25502	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6288	BIPHENYL-4-YL-ACETALDEHYDE	-	-	DRUGBANK	DB07477	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRZAKQDHEVVFRX-UHFFFAOYSA-N
25504	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6291	4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN	-	-	DRUGBANK	DB07480	C13H14O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LGSCVLKUKMBYNC-UHFFFAOYSA-N
25516	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6304	(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE	-	-	DRUGBANK	DB07493	C16H9BrN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEQQJQHHJMQETK-YPKPFQOOSA-N
25518	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6306	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07495	C19H18ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNAOTXNHVALTN-UHFFFAOYSA-N
25523	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6312	(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07501	C21H24BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEIJADBULOETOV-KRWDZBQOSA-N
25524	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6313	4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol	-	-	DRUGBANK	DB07502	C13H8BrNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZACPHWPRDKUPK-UHFFFAOYSA-N
25526	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6315	(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07504	C21H24BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEIJADBULOETOV-QGZVFWFLSA-N
25529	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6319	4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE	-	-	DRUGBANK	DB07508	C22H21N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEUAVGJWGDPTLF-UHFFFAOYSA-N
25530	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6320	difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron	-	-	DRUGBANK	DB07509	C22H31BF2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKJCLYKBRBEKW-UHFFFAOYSA-N
25531	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6323	7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE	-	-	DRUGBANK	DB07512	C17H11ClO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOCADHRNWNJARU-UHFFFAOYSA-N
25532	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6324	7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE	-	-	DRUGBANK	DB07513	C18H16ClNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMGUSOLCNQVZCT-UHFFFAOYSA-N
25534	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6326	1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL	-	-	DRUGBANK	DB07515	C20H30ClF2N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHPMJMCBRFLML-BCXHYRKLSA-N
25535	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6330	(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	-	-	DRUGBANK	DB07519	C21H25N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDFBMQAUECXNKR-OAQYLSRUSA-N
25537	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6332	6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL	-	-	DRUGBANK	DB07521	C22H31Cl2N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHTGPUXGIBWHPN-WEYGHZABSA-N
25538	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6333	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE	-	-	DRUGBANK	DB07522	C20H22N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSSWSEQPKCCATQ-VQTJNVASSA-N
25539	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6334	N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine	-	-	DRUGBANK	DB07524	C13H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQFGXDQUQWRXLE-UHFFFAOYSA-N
25541	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6337	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07527	C20H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HORGTFOBJRCVMO-ZWKOTPCHSA-N
25543	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6339	2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE	-	-	DRUGBANK	DB07529	C9H7N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHGOQMPIWSCKBA-FNORWQNLSA-N
25546	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6341	4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07531	C14H10N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNPRTUHVCHGFHJ-GHXNOFRVSA-N
25547	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6343	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07533	C15H13N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJJJERLTHDXEPT-JYRVWZFOSA-N
25549	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6344	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07534	C14H11N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKUMVXIXUVYKDQ-GHXNOFRVSA-N
25551	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6345	2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one	-	-	DRUGBANK	DB07535	C14H14N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRAZIAJSKFRSIP-UHFFFAOYSA-N
25553	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6348	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07538	C15H10F3N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGVVHQNJKUNSFQ-WDZFZDKYSA-N
25555	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6349	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	-	-	DRUGBANK	DB07539	C15H10N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRKRQCTYQGDKJ-GHXNOFRVSA-N
25557	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6350	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07540	C15H13N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKFVRSQELXTCFW-JYRVWZFOSA-N
25559	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6352	5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID	-	-	DRUGBANK	DB07542	C16H31NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INCRGCAIRMMQQJ-ILXRZTDVSA-N
25560	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6353	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	-	-	DRUGBANK	DB07543	C18H22N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQXQGZPYHWWCEB-ZDUSSCGKSA-N
25564	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6358	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE	-	-	DRUGBANK	DB07548	C20H19F3N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXHWVKOKYDAROD-UHFFFAOYSA-N
25565	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6359	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE	-	-	DRUGBANK	DB07549	C21H23F3N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOYBPRBUPLYTPY-UHFFFAOYSA-P
25566	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6360	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE	-	-	DRUGBANK	DB07550	C20H17ClF3N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIGSBBKEPNQXRG-UHFFFAOYSA-N
25577	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6371	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	-	-	DRUGBANK	DB07562	C17H19N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGGSNQOBRJVAKL-UHFFFAOYSA-N
25580	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6375	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	-	-	DRUGBANK	DB07567	C28H31NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPVKGTWRXBSJKO-LHXLBICKSA-N
25582	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6381	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	-	-	DRUGBANK	DB07573	C15H23NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVMGGHDPXHODHE-AWEZNQCLSA-N
25589	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6386	BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE	-	-	DRUGBANK	DB07579	C16H24N2O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAVIIPIIAVTNFO-YBHVHWSKSA-N
25590	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6387	BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE	-	-	DRUGBANK	DB07580	C18H26N2O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNQQJZKGGHOMBD-CCNNFCOFSA-N
25591	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6390	(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB07583	C21H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLNNFNGBXLTQOB-RBUKOAKNSA-N
25593	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6391	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	-	DRUGBANK	DB07584	C15H13N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKGCSZUKOGMZAL-UHFFFAOYSA-N
25594	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6391	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	-	DRUGBANK	DB07584	C15H13N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKGCSZUKOGMZAL-UHFFFAOYSA-N
25595	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6392	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	-	-	DRUGBANK	DB07585	C12H11ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFFJXGRXFASBDL-UHFFFAOYSA-N
25596	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6392	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	-	-	DRUGBANK	DB07585	C12H11ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFFJXGRXFASBDL-UHFFFAOYSA-N
25603	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6401	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	-	-	DRUGBANK	DB07594	C20H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWPMENVYXDJDOW-UHFFFAOYSA-N
25604	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6401	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	-	-	DRUGBANK	DB07594	C20H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWPMENVYXDJDOW-UHFFFAOYSA-N
25605	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6402	(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE	-	-	DRUGBANK	DB07595	C18H15BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSIQKQLAGWVKSL-UHFFFAOYSA-O
25609	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6407	4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol	-	-	DRUGBANK	DB07601	C19H20ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLIRVZVVCCIAKG-UHFFFAOYSA-N
25613	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6412	6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE	-	-	DRUGBANK	DB07606	C20H15Cl3N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPRAIFVPXXVXDL-UHFFFAOYSA-N
25614	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6413	4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE	-	-	DRUGBANK	DB07607	C21H16IN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXDZANYWRNIAOR-HHHXNRCGSA-N
25615	108192	1859	-	DYRK1A	DYRK|DYRK1|HP86|MNB|MNBH|MRD7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6414	N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide	-	-	DRUGBANK	DB07608	C24H22ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDGOPNUGILVNJZ-IBGZPJMESA-N
25617	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6418	6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE	-	-	DRUGBANK	DB07612	C19H19F3N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQKJVNGGVLHNLA-UHFFFAOYSA-N
25623	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6424	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	-	-	DRUGBANK	DB07618	C24H31N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AITZHKQVQNLKHI-UHFFFAOYSA-N
25626	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6428	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	-	-	DRUGBANK	DB07622	C21H23N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKQVGZXTNLQSV-UHFFFAOYSA-N
25629	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6431	4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide	-	-	DRUGBANK	DB07625	C21H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTPPZCTHZHCQD-UHFFFAOYSA-N
25630	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6432	4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	-	-	DRUGBANK	DB07626	C24H32ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKBBGCJYKCLKHE-UHFFFAOYSA-N
25631	107273	823	PIG30	CAPN1	CANP|CANP1|CANPL1|muCANP|muCL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6433	(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE	-	-	DRUGBANK	DB07627	C17H25N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBPWWBMTZYJGGV-KKUMJFAQSA-N
25643	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6444	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07638	C18H16F2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJSMFUTULGSHNQ-ZOBUZTSGSA-N
25644	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6444	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07638	C18H16F2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJSMFUTULGSHNQ-ZOBUZTSGSA-N
25645	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6445	3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER	-	-	DRUGBANK	DB07639	C26H31N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOYXUXZQQVEADT-ZEQRLZLVSA-N
25653	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6453	(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL	-	-	DRUGBANK	DB07647	C21H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBASHTSSQNDDAS-CQSZACIVSA-N
25654	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6454	(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL	-	-	DRUGBANK	DB07648	C21H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWEONIHFGKSPLC-MRXNPFEDSA-N
25655	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6457	N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE	-	-	DRUGBANK	DB07651	C21H24F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPMMESISHWWXNM-ROUUACIJSA-N
25657	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6459	N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE	-	-	DRUGBANK	DB07653	C20H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXTCEUDVOCLEJG-UHFFFAOYSA-N
25658	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6460	(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC	-	-	DRUGBANK	DB07654	C21H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDJWWYRYKMXMKA-UHFFFAOYSA-N
25659	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6461	3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	-	-	DRUGBANK	DB07655	C20H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPJYGQHMIFDQIN-UHFFFAOYSA-N
25662	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6464	AC-(D)PHE-PRO-BOROLYS-OH	-	-	DRUGBANK	DB07658	C21H33BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCQIHCRMWNRFNP-QYZOEREBSA-N
25663	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6465	AC-(D)PHE-PRO-BOROHOMOLYS-OH	-	-	DRUGBANK	DB07659	C22H35BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AILSWIBFGYYZTK-AABGKKOBSA-N
25664	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6466	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	-	-	DRUGBANK	DB07660	C20H31BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKWKWNKWBGQECF-SQNIBIBYSA-N
25665	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6468	N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE	-	-	DRUGBANK	DB07662	C17H13BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTUBKQUPEREOGA-UHFFFAOYSA-N
25668	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6470	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	-	-	DRUGBANK	DB07664	C15H13F2N7O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIOBGGRZJITQX-UHFFFAOYSA-N
25673	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6471	N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide	-	-	DRUGBANK	DB07665	C19H20F3N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STHCHQXQLDMISY-UHFFFAOYSA-N
25682	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6481	Ragaglitazar	NN-622|(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID(-) DRF 2725|Q27088511|DRF-2725|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|NNC-61-0029|(2S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YLETHOXY)PHENYL]PROPANOIC ACID|1NYX|DRF|(-)-DRF-2725|DRF2725|(S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|DB07675|RAGAGLITAZAR|GTPL2664|BDBM50109551	-	DRUGBANK	DB07675	C25H25NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMUIIGVAWPWQAW-DEOSSOPVSA-N
25683	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6482	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	-	-	DRUGBANK	DB07676	C20H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLAPOFDFZKCPB-LBPRGKRZSA-N
25687	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6484	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	-	-	DRUGBANK	DB07678	C22H30O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANAMDWGJXBYJEB-SHKDNAECSA-N
25689	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6487	DODECANESULFONATE ION	-	-	DRUGBANK	DB07681	C12H25O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMOEFOXLIZJOW-UHFFFAOYSA-M
25692	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6490	4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07685	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMAZGYDYIYLSLJ-UHFFFAOYSA-N
25693	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6491	4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07686	C17H21N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPOGRVWIIVMWRI-UHFFFAOYSA-N
25694	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6492	4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07687	C17H22N8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRKQJAEQWVSCM-HAQNSBGRSA-N
25695	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6493	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07688	C17H20N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPJIMTALCNCQLV-UHFFFAOYSA-N
25703	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6501	methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate	-	-	DRUGBANK	DB07696	C11H19NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKEQESWFLCEUCV-QMMMGPOBSA-N
25709	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6506	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	-	-	DRUGBANK	DB07702	C18H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-PNVOZDDCSA-N
25712	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6511	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	-	-	DRUGBANK	DB07707	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEOPSILMAOYZBO-IUTAEKPZSA-N
25714	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6512	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	-	-	DRUGBANK	DB07708	C13H9ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNHQDSBJVFFIAK-UHFFFAOYSA-N
25718	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6515	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	-	-	DRUGBANK	DB07712	C15H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMVVMYGKMGLJX-UHFFFAOYSA-N
25721	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6518	Emodin	3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE|Emodin|Emodol|Frangula Emodin|Schuttgelb|1,3,8-Trihydroxy-6-Methylanthracene-9,10-Dione|Rheum Emodin|Archin	-	DRUGBANK	DB07715	C15H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHMXXJGYXNZAPX-UHFFFAOYSA-N
25725	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6521	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	-	-	DRUGBANK	DB07718	C9H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKADPXVIOXHVKN-UHFFFAOYSA-N
25726	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6522	3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER	-	-	DRUGBANK	DB07719	C16H23N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPSSYXOFPICMQD-CYBMUJFWSA-N
25728	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6526	3-(5-methoxy-1H-indol-3-yl)propanoic acid	-	-	DRUGBANK	DB07723	C12H13NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLSZCJIWILJKMR-UHFFFAOYSA-N
25731	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6527	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	-	-	DRUGBANK	DB07724	C19H19NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMPALHOKRBVHOJ-UHFFFAOYSA-N
25735	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6531	5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE	-	-	DRUGBANK	DB07730	C9H7NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJABEDRGNJSWCC-UHFFFAOYSA-N
25736	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6532	4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL	-	-	DRUGBANK	DB07731	C9H10N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYZRKFOEZQBUEA-OUKQBFOZSA-N
25737	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6534	1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE	-	-	DRUGBANK	DB07733	C10H10F3N3OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDKGQVZBBSICLG-UHFFFAOYSA-N
25738	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6535	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	-	-	DRUGBANK	DB07734	C16H24N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNIXPLIQGKQSIE-UHFFFAOYSA-N
25739	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6536	N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	-	-	DRUGBANK	DB07735	C18H28N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUDVORCZGBAHNA-UHFFFAOYSA-N
25740	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6537	(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide	-	-	DRUGBANK	DB07736	C14H20FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEXXKSSFAKABEN-ZDUSSCGKSA-N
25741	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6538	(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide	-	-	DRUGBANK	DB07737	C15H22FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYTFYWWLBPDTNS-AWEZNQCLSA-N
25742	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6539	N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	-	-	DRUGBANK	DB07738	C18H27BrN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HESMISSJMKCCAV-UHFFFAOYSA-N
25745	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6542	4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE	-	-	DRUGBANK	DB07741	C24H27F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPNYXOTTXAXSIH-SXYSDOLCSA-N
25747	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6545	3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID	-	-	DRUGBANK	DB07744	C21H29N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYBAOBDVBPVSDJ-OWQGQXMQSA-N
25751	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6551	(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07750	C21H23Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNLAGGCSJGJECE-MRXNPFEDSA-N
25752	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6552	(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07751	C21H23F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVSBKYYVBCKDBO-HNNXBMFYSA-N
25763	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6556	(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07755	C21H23Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNLAGGCSJGJECE-INIZCTEOSA-N
25765	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6558	(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one	-	-	DRUGBANK	DB07757	C17H19BrO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTEBGBCQCYMDPH-KRWDZBQOSA-N
25769	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6562	(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07761	C21H23F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVSBKYYVBCKDBO-OAHLLOKOSA-N
25783	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6567	(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}	-	-	DRUGBANK	DB07766	C20H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUMZEVCWKZXFV-YOCZKUTFSA-N
25816	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6587	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	-	-	DRUGBANK	DB07788	C19H22O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEQZWEXWOFPKOT-RCPUWQGCSA-N
25818	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6589	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07790	C20H26N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDXLQEXLXZCYSR-UHFFFAOYSA-N
25819	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6590	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07791	C18H20N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZWCVBFANHIPTJ-UHFFFAOYSA-N
25822	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6593	5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE	-	-	DRUGBANK	DB07794	C18H13N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVECMUKVOMUNLE-UHFFFAOYSA-N
25824	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6595	(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE	-	-	DRUGBANK	DB07796	C23H24FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJYCQHGTXMVIBG-MUGJNUQGSA-O
25828	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6600	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	-	-	DRUGBANK	DB07802	C10H6Br2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSOLROYRAHCJNK-UHFFFAOYSA-N
25832	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6607	4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB07809	C21H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBJYEMUMDMGQQC-UHFFFAOYSA-N
25833	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6609	N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide	-	-	DRUGBANK	DB07811	C21H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBVTVSINEVHYSY-UHFFFAOYSA-N
25834	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6610	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	-	-	DRUGBANK	DB07812	C20H18N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWYNGDRSMHRPSY-MRXNPFEDSA-N
25847	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6626	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	-	-	DRUGBANK	DB07829	C14H10FN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BILJSHVAAVZERY-UHFFFAOYSA-N
25849	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6628	2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB07831	C23H22F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSORWZDEKFFLP-UHFFFAOYSA-N
25850	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6629	4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde	-	-	DRUGBANK	DB07832	C20H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQPTVJDZIILPG-UHFFFAOYSA-N
25851	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6630	N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide	-	-	DRUGBANK	DB07833	C24H18N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMMLSQFPBFKLHH-UHFFFAOYSA-N
25852	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6631	N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide	-	-	DRUGBANK	DB07834	C21H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOHZGCHKLPIBBX-UHFFFAOYSA-N
25853	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6632	N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide	-	-	DRUGBANK	DB07835	C22H24N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPSUAHGQHFKGG-UHFFFAOYSA-N
25855	112344	6446	RP1-188K17.1	SGK1	SGK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6634	[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid	-	-	DRUGBANK	DB07837	C25H18N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWXKLXXVFMYMDP-UHFFFAOYSA-N
25866	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6639	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB07842	C17H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJMVTSLLWMPEKQ-INIZCTEOSA-N
25869	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6642	2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide	-	-	DRUGBANK	DB07845	C22H21FN6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGYXXQRDIVRILX-UHFFFAOYSA-N
25873	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6646	S-NONYL-CYSTEINE	-	-	DRUGBANK	DB07849	C12H25NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYQGIUKEPYHDNY-NSHDSACASA-N
25876	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6649	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	-	-	DRUGBANK	DB07852	C10H7Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZTNDZALWLHXBA-UHFFFAOYSA-N
25881	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6651	N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	-	-	DRUGBANK	DB07854	C13H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRGSDHJXBVCQEL-UHFFFAOYSA-N
25883	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6652	(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	-	-	DRUGBANK	DB07855	C18H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWHMAWBXRCDOEB-HNNXBMFYSA-N
25885	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6653	6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE	-	-	DRUGBANK	DB07856	C22H20ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPWBHQIUIBFTQC-UHFFFAOYSA-N
25887	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6654	(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB07857	C17H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWVGILTYGZFGLR-QGZVFWFLSA-N
25889	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6655	(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB07858	C17H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWVGILTYGZFGLR-KRWDZBQOSA-N
25891	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6656	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	-	-	DRUGBANK	DB07859	C20H20ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZMOSYUFVYJEPY-UHFFFAOYSA-N
25892	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6656	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	-	-	DRUGBANK	DB07859	C20H20ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZMOSYUFVYJEPY-UHFFFAOYSA-N
25895	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6657	(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE	-	-	DRUGBANK	DB07860	C14H14ClN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNKKPFLBOWGVSF-CQSZACIVSA-N
25900	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6660	2-chloro-5-nitro-N-phenylbenzamide	-	-	DRUGBANK	DB07863	C13H9ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNTSIBUQMRRYIU-UHFFFAOYSA-N
25905	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6671	(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	-	-	DRUGBANK	DB07874	C19H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOCXPOKEPYGTJ-IBGZPJMESA-N
25907	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6673	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	-	-	DRUGBANK	DB07876	C16H21N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWDORCFLUJZUQS-ZDUSSCGKSA-N
25909	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6673	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	-	-	DRUGBANK	DB07876	C16H21N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWDORCFLUJZUQS-ZDUSSCGKSA-N
25910	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6674	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	-	-	DRUGBANK	DB07877	C18H21BrN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGWLDJLENCVRQ-UHFFFAOYSA-N
25911	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6674	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	-	-	DRUGBANK	DB07877	C18H21BrN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGWLDJLENCVRQ-UHFFFAOYSA-N
25919	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6686	1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL	-	-	DRUGBANK	DB07889	C23H26N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCPXSBULBDYRLT-SFHVURJKSA-N
25923	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6694	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	-	-	DRUGBANK	DB07897	C9H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJEVZMRZAJQYFZ-UHFFFAOYSA-N
25929	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6701	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	-	-	DRUGBANK	DB07905	C19H22O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSNQAUBBJYCSMY-KNTMUCJRSA-N
25937	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6712	3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID	-	-	DRUGBANK	DB07916	C24H25N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXMPYGCWDMKRMF-IRXDYDNUSA-N
25956	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6725	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	-	-	DRUGBANK	DB07929	C23H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGJACZABNQGPMT-UHFFFAOYSA-N
25960	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6728	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate	-	-	DRUGBANK	DB07932	C22H18O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CRLQCBACIMUGDZ-BGYRXZFFSA-N
25961	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6729	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07933	C18H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIESSJVMWNJCGZ-VKJFTORMSA-N
25962	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6729	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07933	C18H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIESSJVMWNJCGZ-VKJFTORMSA-N
25963	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6730	[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE	-	-	DRUGBANK	DB07934	C22H36N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMUXFASJKPVMGU-HXUWFJFHSA-O
25964	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6732	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	-	-	DRUGBANK	DB07936	C24H30FN7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BACSZMCLZIDTIO-IBGZPJMESA-N
25965	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6736	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	-	-	DRUGBANK	DB07940	C20H19IN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUCWQTWGZGIYPV-UHFFFAOYSA-N
25966	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6737	3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide	-	-	DRUGBANK	DB07941	C22H19BrF2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCAJXIDMCNPGHZ-UHFFFAOYSA-N
25967	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6738	2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine	-	-	DRUGBANK	DB07942	C14H9F2N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJCHZVXSPFPKMX-UHFFFAOYSA-N
25968	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6739	2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol	-	-	DRUGBANK	DB07943	C20H20ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CATQHDWESBRRQA-UHFFFAOYSA-N
25969	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6740	N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE	-	-	DRUGBANK	DB07944	C20H22N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPTWCWHNLVMCRW-UHFFFAOYSA-O
25970	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6742	N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide	-	-	DRUGBANK	DB07946	C19H21ClF3N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZEJHPMTDNDECN-UHFFFAOYSA-N
25971	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6743	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	-	-	DRUGBANK	DB07947	C20H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUHWQSZMVMMRLM-UHFFFAOYSA-N
25972	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6743	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	-	-	DRUGBANK	DB07947	C20H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUHWQSZMVMMRLM-UHFFFAOYSA-N
25991	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6754	3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE	-	-	DRUGBANK	DB07959	C14H10N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTKFRFMSUBOCIQ-UHFFFAOYSA-N
25993	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6759	(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07964	C17H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVZIHNYAZLXRRS-HNNXBMFYSA-N
25995	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6761	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile	-	-	DRUGBANK	DB07966	C22H19N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVMCVWOODOWOLT-UHFFFAOYSA-N
26009	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6777	2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol	-	-	DRUGBANK	DB07982	C23H29N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVTKDXZNSUHUMO-UHFFFAOYSA-N
26013	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6781	[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID	-	-	DRUGBANK	DB07986	C19H22N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNSLACGSDSJAIQ-UHFFFAOYSA-N
26014	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6782	[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER	-	-	DRUGBANK	DB07987	C19H18N4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWAKNMKLVLWIIQ-OAHLLOKOSA-N
26015	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6783	2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE	-	-	DRUGBANK	DB07988	C13H10F5N5O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZAXNPDJVFUGDS-BYPYZUCNSA-N
26016	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6786	N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE	-	-	DRUGBANK	DB07991	C26H26N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APLJSSOXDWUNGV-GOSISDBHSA-N
26017	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6788	N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07993	C20H18N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPQUIIHPUGDHJK-UHFFFAOYSA-N
26018	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6789	N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07994	C26H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMBPJSHPAXOXBT-UHFFFAOYSA-N
26019	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6790	N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE	-	-	DRUGBANK	DB07995	C20H20BrN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZXNDJNWUTGDK-NSCUHMNNSA-N
26022	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6791	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine|1-(5-Isoquinolinesulfonyl)-2-methylpiperazine	-	DRUGBANK	DB07996	C14H17N3O2S	small molecule	-	84477-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDVFVCGFMNCYPV-UHFFFAOYSA-N
26024	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6792	N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE	-	-	DRUGBANK	DB07997	C12H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWUXKNZVMEPPH-UHFFFAOYSA-N
26028	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6795	5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID	-	-	DRUGBANK	DB08001	C22H19NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQSRCEFDWMQCCV-GQCTYLIASA-N
26029	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6796	ISOTHIAZOLIDINONE ANALOG	-	-	DRUGBANK	DB08003	C23H26N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UILYPHAKDBTKQV-UFYCRDLUSA-N
26031	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6798	4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide	-	-	DRUGBANK	DB08005	C20H23ClN6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARMFMDYRYOKSOW-UHFFFAOYSA-N
26036	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6803	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime	-	-	DRUGBANK	DB08010	C25H19FN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDHASJXGNUWZTM-ZLEWNXFRSA-N
26037	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6804	(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime	-	-	DRUGBANK	DB08011	C17H12F2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXIHOIDYHQSQKJ-HMMYKYKNSA-N
26038	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6808	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime	-	-	DRUGBANK	DB08015	C23H17FN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZYREAUDQRVVLV-DAFNUICNSA-N
26039	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6811	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	-	-	DRUGBANK	DB08018	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDRSQGJWTVRNGM-QFBILLFUSA-N
26040	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6811	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	-	-	DRUGBANK	DB08018	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDRSQGJWTVRNGM-QFBILLFUSA-N
26041	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6812	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	-	-	DRUGBANK	DB08019	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWCMAGONQJHIJZ-LPHOPBHVSA-N
26042	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6812	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	-	-	DRUGBANK	DB08019	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWCMAGONQJHIJZ-LPHOPBHVSA-N
26043	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6813	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB08020	C20H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQLNMNKTIOREN-AOIWGVFYSA-N
26044	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6813	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB08020	C20H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQLNMNKTIOREN-AOIWGVFYSA-N
26045	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6814	5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide	-	-	DRUGBANK	DB08021	C18H17BrClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFJFXHHHNDHEN-UHFFFAOYSA-N
26046	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6815	(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile	-	-	DRUGBANK	DB08022	C20H16N6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCYPVQCPYKNSTG-OAHLLOKOSA-N
26047	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6816	N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine	-	-	DRUGBANK	DB08023	C18H21N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYNNWLVWJXWXFO-UHFFFAOYSA-N
26049	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6818	N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08025	C24H25FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGBFWCBVIXTPZ-OQIWPSSASA-N
26050	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6819	2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide	-	-	DRUGBANK	DB08026	C19H23N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLILYAPRHIFAS-UHFFFAOYSA-N
26052	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6822	N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide	-	-	DRUGBANK	DB08029	C16H18N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQDWEVONJRXVDB-UHFFFAOYSA-N
26053	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6823	3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide	-	-	DRUGBANK	DB08030	C16H14N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWFHJUEAVOHHG-UHFFFAOYSA-N
26059	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6832	Su6656	330161-87-0|NCGC00094279-01|B5839|HMS3648O08|NCGC00015981-09|N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|2,3-DIHYDRO-N,N-DIMETHYL-2-OXO-3-[(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE]-1H-INDOLE-5-SULFONAMIDE|EX-A584|4071AH|AKOS015994571|MLS002153475|HMS2232C04|INSOLUTION&TRADE; SU6656|LOPAC0_000979|EU-0100979|NCGC00261664-01|S7774|Q7394936|NCGC00015981-03|1240328-42-0|SU 6656|SR-01000076237-6|HMS3263C19|(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE|CCG-205059|SU-6656|SU6656|ES-0024|SU 6656, >=98% (HPLC)|SDCCGSBI-0050952.P003|NCGC00015981-04|NCGC00094279-02|LOPAC-S-9692|NCGC00015981-02|HSCI1_000124|SR-01000076237-1|HMS3229I04|SR-01000076237|CS-3943|GTPL6044|TOX21_500979|DB08039|(Z)-N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|MFCD10565928|NCGC00015981-05|NCGC00015981-01|NCGC00015981-06|ZINC3875028|2-OXO-3-[1-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)-METH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOLE-5-SULFONIC ACID DIMETHYLAMIDE|SMR001230828|S 9692|LP00979|BRD-K97354755-001-01-5|HY-B0789|BDBM50307127	-	DRUGBANK	DB08039	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOGJQOUIVKBFGH-YBEGLDIGSA-N
26063	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6836	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	-	-	DRUGBANK	DB08043	C19H14F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDDLGNOZDKDSEG-UHFFFAOYSA-N
26065	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6838	4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL	-	-	DRUGBANK	DB08045	C18H18ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDGJOIYZAMLBW-UHFFFAOYSA-N
26068	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6840	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol	-	-	DRUGBANK	DB08047	C17H13F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDUDMCQPFKPISO-UHFFFAOYSA-N
26070	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6841	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB08048	C13H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLDZDEMGKFWJNR-UHFFFAOYSA-N
26073	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6845	1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08052	C17H17N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVRXTLZYXZNATH-UHFFFAOYSA-N
26074	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6846	1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08053	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITOYZJGFTNTKKR-UHFFFAOYSA-N
26075	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6847	1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08054	C17H16N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEZALMMCQYDFML-UHFFFAOYSA-N
26076	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6848	N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	-	-	DRUGBANK	DB08055	C18H13ClN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNBICZMPIJMWGC-UHFFFAOYSA-N
26077	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6849	N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	-	-	DRUGBANK	DB08056	C20H18N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKYYLKPGILUPOA-UHFFFAOYSA-N
26078	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6850	N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine	-	-	DRUGBANK	DB08057	C22H23ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWJPPYCULHDHBB-HNNXBMFYSA-N
26085	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6854	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	-	-	DRUGBANK	DB08061	C14H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GELALLNTKKLQLM-UHFFFAOYSA-N
26086	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6855	3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE	-	-	DRUGBANK	DB08062	C9H8ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXVAYMRODBYXIQ-UHFFFAOYSA-N
26088	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6856	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE	-	-	DRUGBANK	DB08063	C24H20N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLZMYWLMBBLASX-UHFFFAOYSA-N
26089	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6857	N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA	-	-	DRUGBANK	DB08064	C20H22ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTMADESEDXKNFZ-UHFFFAOYSA-N
26092	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6859	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	-	-	DRUGBANK	DB08066	C17H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPKSFXFWECAIBR-UHFFFAOYSA-N
26093	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6860	4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM	-	-	DRUGBANK	DB08067	C19H24N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOLPPWBBNUVNQZ-UHFFFAOYSA-O
26094	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6861	N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-	-	-	DRUGBANK	DB08068	C23H25ClFN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQJVDUKATDECHF-ICSRJNTNSA-N
26095	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6863	2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB08070	C12H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILTOXASLQDKYJW-UHFFFAOYSA-N
26097	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6865	4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB08072	C18H20Cl2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYKUIRSGEMLIFT-UHFFFAOYSA-N
26098	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6866	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB08073	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTBGJGMTBHQTM-IBGZPJMESA-N
26099	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6866	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB08073	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTBGJGMTBHQTM-IBGZPJMESA-N
26112	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6875	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	-	-	DRUGBANK	DB08082	C9H10ClNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBARCMIFTACERW-UHFFFAOYSA-N
26119	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6884	3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE	-	-	DRUGBANK	DB08091	C26H25FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIUFYIOMUILESI-UHFFFAOYSA-N
26120	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6885	3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide	-	-	DRUGBANK	DB08092	C19H18FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMLSXFMXUNVCSK-UHFFFAOYSA-N
26121	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6886	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	-	-	DRUGBANK	DB08093	C16H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZANYTFSQVBOBA-UHFFFAOYSA-N
26122	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6887	(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE	-	-	DRUGBANK	DB08094	C18H21F2N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRNJNYBQQYBCLE-UHFFFAOYSA-N
26123	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6888	3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA	-	-	DRUGBANK	DB08095	C23H26ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWYFTKPEHRQCCW-HNNXBMFYSA-N
26124	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6889	8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM	-	-	DRUGBANK	DB08096	C19H15ClF2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWKOUFZHPNIQSH-UHFFFAOYSA-N
26125	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6890	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	-	-	DRUGBANK	DB08097	C20H16F3N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWSGDLIXOEZJG-UHFFFAOYSA-N
26134	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6906	3-pyridin-4-yl-1H-indazole	-	-	DRUGBANK	DB08113	C12H9N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSRXUUDVRNWSTN-UHFFFAOYSA-N
26136	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6907	5-benzyl-1,3-thiazol-2-amine	-	-	DRUGBANK	DB08114	C10H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJIMLXBJUVLMMN-UHFFFAOYSA-N
26140	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6913	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB08121	C21H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZTPJJNNACUQQR-FQEVSTJZSA-N
26141	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6914	N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB08122	C16H15N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKASAFLVQIJQOK-UVTDQMKNSA-N
26142	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6915	N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE	-	-	DRUGBANK	DB08123	C17H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEWPSTLKJDIUHW-UHFFFAOYSA-N
26143	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6916	3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE	-	-	DRUGBANK	DB08124	C20H15N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTQYGMLRLRXBPT-IDUWFGFVSA-N
26144	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6917	4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB08125	C18H14N4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOMPRXSVSIPRDT-PTNGSMBKSA-N
26145	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6918	3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	-	-	DRUGBANK	DB08126	C16H15N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMCRNUMVSATRTP-LCYFTJDESA-N
26150	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6924	5-hydroxynaphthalene-1-sulfonamide	-	-	DRUGBANK	DB08132	C10H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFVBVKHGDDDCEA-UHFFFAOYSA-N
26151	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6925	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	-	-	DRUGBANK	DB08133	C14H12N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNHPHKFLWAPNOV-UHFFFAOYSA-N
26152	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6926	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	-	-	DRUGBANK	DB08134	C10H9ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSNSGNZRUMHXAY-UHFFFAOYSA-N
26153	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6927	N-phenyl-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08135	C10H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMZYZYFPPQOFKY-UHFFFAOYSA-N
26154	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6928	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08136	C12H11FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWQKPKYIMQTGJK-UHFFFAOYSA-N
26155	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6929	(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08137	C17H13FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMWYSLJBNJUCRK-UHFFFAOYSA-N
26156	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6930	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08138	C17H11F3N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDRDBXXWQDFXEC-UHFFFAOYSA-N
26157	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6931	5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile	-	-	DRUGBANK	DB08139	C10H10ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFTLYNKTSANXFA-UHFFFAOYSA-N
26158	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6932	5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE	-	-	DRUGBANK	DB08140	C16H23N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOESVLPZMGVWBM-JOCQHMNTSA-N
26159	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6933	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08141	C16H17F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOMNQBZWMCFDTQ-VIFPVBQESA-N
26160	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6934	4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08142	C16H17Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVPNQJVDAFNBDN-UHFFFAOYSA-N
26165	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6939	4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid	-	-	DRUGBANK	DB08147	C24H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVENXKUQXLPW-UHFFFAOYSA-N
26166	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6940	1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	-	-	DRUGBANK	DB08148	C18H20ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOZMRRGNAZNWDN-UHFFFAOYSA-N
26168	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6941	1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	-	-	DRUGBANK	DB08149	C19H22ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCWPSUKJCKZEAO-UHFFFAOYSA-N
26170	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6942	4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium	-	-	DRUGBANK	DB08150	C18H21ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZIDZIGAXXNODG-UHFFFAOYSA-O
26173	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6944	{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate	-	-	DRUGBANK	DB08152	C20H27ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONXGIEJBNQLITK-INIZCTEOSA-N
26174	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6945	(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE	-	-	DRUGBANK	DB08153	C18H21ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZTAZMSAAIUZJV-HWKANZROSA-N
26182	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26184	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26185	114860	9475	-	ROCK2	ROCK-II	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26189	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6958	(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	-	-	DRUGBANK	DB08166	C17H17ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPFQFJAOMCGYCP-GFCCVEGCSA-N
26201	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6967	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	-	-	DRUGBANK	DB08175	C16H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNYBEULOKRVZKY-ATCPXPEISA-N
26202	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6968	(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE	-	-	DRUGBANK	DB08176	C11H12FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFVUPEQWSFCCFT-UHFFFAOYSA-N
26203	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6970	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08178	C12H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEWEQJWGGJUHO-UHFFFAOYSA-N
26208	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6974	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08182	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHMRPXZRUZLCNL-UHFFFAOYSA-N
26212	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6975	3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile	-	-	DRUGBANK	DB08183	C16H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLAWZDWDVHWOW-YPMHNXCESA-N
26216	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6979	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	-	-	DRUGBANK	DB08187	C22H34N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDSVGJAUFNXYRR-WCIQWLHISA-N
26218	112344	6446	RP1-188K17.1	SGK1	SGK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6982	4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid	-	-	DRUGBANK	DB08191	C20H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSFDVNIKNYXUIP-UHFFFAOYSA-N
26219	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6983	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	-	-	DRUGBANK	DB08192	C16H18N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCUGCUQZFBURHR-LBPRGKRZSA-N
26220	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6985	4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine	-	-	DRUGBANK	DB08194	C8H11N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZWAEXRMZGFAN-UHFFFAOYSA-N
26222	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6988	(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime	-	-	DRUGBANK	DB08197	C20H18FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYIXUSLGFINPTC-WVFAEZDRSA-N
26224	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6991	(1R)-MENTHYL HEXYL PHOSPHONATE GROUP	-	-	DRUGBANK	DB08200	C16H33O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAVIZOVSJOXCKT-OWCLPIDISA-N
26225	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6992	(1S)-MENTHYL HEXYL PHOSPHONATE GROUP	-	-	DRUGBANK	DB08201	C16H33O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAVIZOVSJOXCKT-XHSDSOJGSA-N
26230	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7004	1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE	-	-	DRUGBANK	DB08213	C20H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFAYCUAUBOGVDX-AWEZNQCLSA-N
26234	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7009	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	-	-	DRUGBANK	DB08218	C19H15N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLQVWKCQWFFUFJ-FCDQGJHFSA-N
26236	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7010	4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE	-	-	DRUGBANK	DB08219	C18H20N6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPSZSAKYXPWBRR-RELWKKBWSA-N
26246	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7019	[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID	-	-	DRUGBANK	DB08229	C20H23N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMMFVVACJREFE-KRWDZBQOSA-N
26247	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7020	5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE	-	-	DRUGBANK	DB08230	C15H10O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARSRJFRKVXALTF-UHFFFAOYSA-N
26248	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26255	111526	5534	-	PPP3R1	CALNB1|CNB|CNB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26257	111522	5530	-	PPP3CA	CALN|CALNA|CALNA1|CCN1|CNA1|PPP2B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26262	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26264	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26267	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26268	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26273	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7023	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	-	-	DRUGBANK	DB08233	C18H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFSDQDHHBKYQOD-UHFFFAOYSA-N
26294	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7031	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	-	-	DRUGBANK	DB08241	C19H22N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUUOIINPNMNPIU-UHFFFAOYSA-N
26296	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7032	N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide	-	-	DRUGBANK	DB08242	C20H18N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYTBZXSFNNAVKU-UHFFFAOYSA-N
26299	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7036	6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE	-	-	DRUGBANK	DB08247	C15H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JABXNQUXGJTKRO-UHFFFAOYSA-N
26300	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7037	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	-	-	DRUGBANK	DB08248	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKDUVKJYBJDZQW-UHFFFAOYSA-N
26304	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7040	4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID	-	-	DRUGBANK	DB08251	C17H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNRAPROKLOUIRA-AWEZNQCLSA-N
26306	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7043	2-NAPHTHALENESULFONIC ACID	-	-	DRUGBANK	DB08254	C10H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVBGVZZKJNLNJU-UHFFFAOYSA-N
26317	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7059	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	-	-	DRUGBANK	DB08271	C13H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIRXORZYIXSWOB-UHFFFAOYSA-N
26325	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7073	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	-	-	DRUGBANK	DB08285	C19H26N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQUNOCMDMIQIQK-OAHLLOKOSA-N
26330	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7079	(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	-	-	DRUGBANK	DB08292	C16H17ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQKZYZQONWDDLS-IWQZZHSRSA-N
26331	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7080	(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	-	-	DRUGBANK	DB08293	C16H17ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQKZYZQONWDDLS-HNQUOIGGSA-N
26341	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7089	3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid	-	-	DRUGBANK	DB08302	C16H15NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRHZCQDCMUWUKV-RAXLEYEMSA-N
26346	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7096	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	-	-	DRUGBANK	DB08309	C23H32N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMFGILNPFBVREA-UHFFFAOYSA-N
26348	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7098	6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB08312	C11H17N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGWXOLHKVGDQLN-UHFFFAOYSA-N
26356	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7106	DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE	-	-	DRUGBANK	DB08320	C24H24O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHKDFDHHMHBFLG-COPRSSIGSA-N
26380	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7124	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	-	-	DRUGBANK	DB08338	C19H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIJNSOUPEZHEMC-UHFFFAOYSA-N
26381	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7125	6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE	-	-	DRUGBANK	DB08339	C21H16Cl2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIQFYVPVJZEOFS-UHFFFAOYSA-N
26382	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7126	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB08340	C17H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLYYAUZAGCZEKV-UHFFFAOYSA-N
26383	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7127	4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	-	-	DRUGBANK	DB08341	C19H25F3N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAUFYHKGKDJMQG-HZPDHXFCSA-N
26388	122538	79090	-	TRAPPC6A	TRS33	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26390	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7130	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08345	C17H15N9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUUKHQIKFHWIW-UHFFFAOYSA-N
26391	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7131	(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE	-	-	DRUGBANK	DB08346	C17H19ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUZYDHRGGDTZLG-DUXPYHPUSA-N
26396	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7134	N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide	-	-	DRUGBANK	DB08349	C24H21F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMEYCLAVMZKZCS-UHFFFAOYSA-N
26397	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7135	5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08350	C22H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYQRHHQPEMOLKH-UHFFFAOYSA-N
26398	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7136	N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide	-	-	DRUGBANK	DB08351	C25H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNEXDVSJIUQQRH-UHFFFAOYSA-N
26399	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7137	6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine	-	-	DRUGBANK	DB08352	C19H16FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQYJTHIYAQQJAB-UHFFFAOYSA-N
26400	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7138	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08353	C19H21N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCVMTHVSAJMOPI-UHFFFAOYSA-N
26401	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7139	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08354	C19H14ClN7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCVULERVJOYHCP-UHFFFAOYSA-N
26402	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7140	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	-	-	DRUGBANK	DB08355	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOBRPBVIEUWYJR-UHFFFAOYSA-N
26410	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7145	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08360	C18H20N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIFHJPUTQBOBGJ-UHFFFAOYSA-N
26411	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7146	2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide	-	-	DRUGBANK	DB08361	C18H24N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZNTWOVDIXCHHS-LSDHHAIUSA-N
26412	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7147	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	-	-	DRUGBANK	DB08362	C20H16N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVKXQLGRDOMAGC-UHFFFAOYSA-N
26413	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7148	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	-	-	DRUGBANK	DB08363	C16H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBPNOEAFWYTTEB-UHFFFAOYSA-N
26418	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7155	S-(4-BROMOBENZYL)CYSTEINE	-	-	DRUGBANK	DB08370	C10H12BrNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZGWXEMBSFZEBK-VIFPVBQESA-N
26420	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7156	PARA-(BENZOYL)-PHENYLALANINE	-	-	DRUGBANK	DB08371	C16H15NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVIDEEHSOPHZBR-AWEZNQCLSA-N
26437	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7176	2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL	-	-	DRUGBANK	DB08392	C22H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARBUGBBNEFAECO-UHFFFAOYSA-N
26438	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7177	2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL	-	-	DRUGBANK	DB08393	C20H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHINZSKNAAVOZ-UHFFFAOYSA-N
26440	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7179	2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE	-	-	DRUGBANK	DB08395	C22H18FN3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSOXFJURLPCSOO-UHFFFAOYSA-N
26441	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7181	6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB08397	C12H9F2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKGNOWNPXBURRW-UHFFFAOYSA-N
26443	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7182	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE	-	-	DRUGBANK	DB08398	C13H12N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQVKZNNCIHJZLS-UHFFFAOYSA-N
26450	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7186	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	-	-	DRUGBANK	DB08402	C18H11Cl2N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDRRWBKNSHALL-UHFFFAOYSA-N
26467	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7204	[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE	-	-	DRUGBANK	DB08422	C21H27N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEIDRYBJURDUSW-MOPGFXCFSA-N
26468	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7205	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE	-	-	DRUGBANK	DB08423	C21H21FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKZZJXRGCHXIAI-UHFFFAOYSA-N
26469	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7206	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE	-	-	DRUGBANK	DB08424	C19H18FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJDQETGUEUJVTB-HNNXBMFYSA-N
26475	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7217	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	-	-	DRUGBANK	DB08435	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRUMKCAEVRUBK-XOVNXQNQSA-N
26476	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7218	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	-	-	DRUGBANK	DB08436	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCDXXNIRWRRGBX-UHFFFAOYSA-N
26492	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7223	6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE	-	-	DRUGBANK	DB08441	C13H14BrN5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWSQADBSXFTFKL-UHFFFAOYSA-N
26493	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7224	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	-	-	DRUGBANK	DB08442	C18H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWODFUZHWYZBHZ-MRXNPFEDSA-N
26494	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7225	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	-	-	DRUGBANK	DB08443	C11H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYGSNHBTZDYVSS-UHFFFAOYSA-N
26513	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7243	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE	-	-	DRUGBANK	DB08462	C17H14N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGWHILNNHLDARR-UHFFFAOYSA-N
26514	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7244	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	-	-	DRUGBANK	DB08463	C24H29N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOCBJBNQIQQQGT-LJQANCHMSA-N
26516	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7245	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	-	-	DRUGBANK	DB08464	C18H18ClNO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUVWEHNRWHNDRF-UHFFFAOYSA-N
26518	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7246	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	-	-	DRUGBANK	DB08465	C18H20ClNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFYGLJKFZQGYPA-UHFFFAOYSA-N
26522	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7254	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	-	-	DRUGBANK	DB08473	C12H12Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHSQDZXAVJRBMX-DDHJBXDOSA-N
26528	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7261	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	-	-	DRUGBANK	DB08480	C12H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFWOPQIDDNCCLL-KAQJVSAMSA-N
26538	106747	246	-	ALOX15	12-LOX|15-LOX-1|15LOX-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7272	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	-	-	DRUGBANK	DB08492	C17H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRDSGPLHVQJFLM-BUHFOSPRSA-N
26541	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7276	(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	-	-	DRUGBANK	DB08497	C19H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKBDSMREMMRFSI-INIZCTEOSA-N
26542	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7277	(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	-	-	DRUGBANK	DB08498	C19H13ClN2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVSAMUIBGQSLDC-INIZCTEOSA-N
26543	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7278	N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide	-	-	DRUGBANK	DB08499	C21H18FN3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQXBKUVWJSZHSI-UHFFFAOYSA-N
26548	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7286	N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID	-	-	DRUGBANK	DB08507	C20H27N2O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGUVBHLPMGERAT-NIYFSFCBSA-N
26551	109874	3667	-	IRS1	HIRS-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7292	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	-	-	DRUGBANK	DB08513	C20H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAIQRYUOBBCBSE-UHFFFAOYSA-N
26552	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7292	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	-	-	DRUGBANK	DB08513	C20H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAIQRYUOBBCBSE-UHFFFAOYSA-N
26567	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7295	(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]	-	-	DRUGBANK	DB08516	C17H17FN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJJDIVMWGWHPFE-QDBSGRMGSA-N
26569	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7298	(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE	-	-	DRUGBANK	DB08520	C24H39NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCSBBBCFXBFFY-IBGZPJMESA-N
26570	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7299	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	-	-	DRUGBANK	DB08521	C21H16FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDMGBJANTYXAIV-HHHXNRCGSA-N
26571	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7299	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	-	-	DRUGBANK	DB08521	C21H16FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDMGBJANTYXAIV-HHHXNRCGSA-N
26572	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7300	4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE	-	-	DRUGBANK	DB08522	C18H16FN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROKOFZNQCIIJMI-UHFFFAOYSA-N
26575	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7305	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08527	C15H12N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGAKLLFPOGATII-UHFFFAOYSA-N
26579	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7309	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08531	C18H13Cl2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVYWYUAQFJMLEO-UHFFFAOYSA-N
26580	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7310	6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	-	-	DRUGBANK	DB08532	C18H14FN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCNPGRRMPFCHEO-UHFFFAOYSA-N
26581	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7311	3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	-	-	DRUGBANK	DB08533	C13H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXRVAGIYXNQOKP-UHFFFAOYSA-N
26582	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7312	5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08534	C18H14FN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIYYXVHGBMLEC-UHFFFAOYSA-N
26583	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7313	3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08535	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMIZFGZXFDGISG-UHFFFAOYSA-N
26584	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7314	3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine	-	-	DRUGBANK	DB08536	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBUPHWYGVDAASU-UHFFFAOYSA-N
26585	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7315	3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine	-	-	DRUGBANK	DB08537	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZLKFNBMXXLTLX-UHFFFAOYSA-N
26586	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7316	N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08538	C19H17F2N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQPVGVSQPQVZLD-UHFFFAOYSA-N
26587	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7317	3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08539	C21H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCDIUVLNHCGSMH-UHFFFAOYSA-N
26589	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7324	4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB08546	C24H24N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CETLUACQMGBMFH-ZALSBGIRSA-N
26592	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7327	(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER	-	-	DRUGBANK	DB08549	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDBNNQUDZFSES-KRWDZBQOSA-N
26597	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7333	1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline	-	-	DRUGBANK	DB08555	C16H13BrClNO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKGXHBGCVQTQBH-UHFFFAOYSA-N
26598	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7335	2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide	-	-	DRUGBANK	DB08557	C22H23N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQKFKSJUBJPOLY-UHFFFAOYSA-N
26601	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7338	3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE	-	-	DRUGBANK	DB08560	C19H13F2N3O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GULUFDCOGAXLEP-UHFFFAOYSA-N
26606	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7341	(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide	-	-	DRUGBANK	DB08564	C20H20BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCIXBBSRVLSRJQ-QPJJXVBHSA-N
26609	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7345	(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE	-	-	DRUGBANK	DB08568	C22H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPNUQXPIQBZCMR-IBGZPJMESA-N
26611	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7346	3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE	-	-	DRUGBANK	DB08569	C22H21BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPMRZSKJUTRBQ-IBGZPJMESA-N
26613	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7349	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	-	-	DRUGBANK	DB08572	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBKLJTXDSBEVRV-UHFFFAOYSA-N
26617	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7352	2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM	-	-	DRUGBANK	DB08575	C15H16N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCUCDCAIOMIBEA-GFCCVEGCSA-O
26619	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7360	2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide	-	-	DRUGBANK	DB08583	C21H22N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INAGORZAOFUKOZ-UHFFFAOYSA-N
26623	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7368	5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	-	-	DRUGBANK	DB08591	C15H14N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGXKSKWHHHYBFM-UHFFFAOYSA-N
26624	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7370	1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE	-	-	DRUGBANK	DB08593	C8H8N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDCZCUKQWRZSDT-UHFFFAOYSA-N
26627	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7372	4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB08595	C17H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBZPJHFECDCNGT-BPUTZDHNSA-N
26629	106605	90	-	ACVR1	ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7374	6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine	-	-	DRUGBANK	DB08597	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHBVYDAKJHETMP-UHFFFAOYSA-N
26630	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7374	6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine	-	-	DRUGBANK	DB08597	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHBVYDAKJHETMP-UHFFFAOYSA-N
26651	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7400	BENZOTHIAZOLE	-	-	DRUGBANK	DB08624	C13H17N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAJHCCQPIDXPAN-QMMMGPOBSA-N
26652	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	7401	Thiorphan	-	-	DRUGBANK	DB08626	C12H15NO3S	small molecule	-	76721-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJJKNPQAGWVLDQ-SNVBAGLBSA-N
26665	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7417	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	-	-	DRUGBANK	DB08643	C24H31N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFAWBPLETHINFK-UNMCSNQZSA-N
26672	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7429	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	-	-	DRUGBANK	DB08655	C14H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIGJEXKBUJPKJF-UHFFFAOYSA-N
26673	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7432	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	-	-	DRUGBANK	DB08658	C6H16NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUNFIZRDIMDMIH-UHFFFAOYSA-N
26675	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7434	1,2,5,8-tetrahydroxyanthracene-9,10-dione	-	-	DRUGBANK	DB08660	C14H8O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBHKTXLEJZIDJF-UHFFFAOYSA-N
26684	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7447	4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE	-	-	DRUGBANK	DB08673	C12H15N3O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPQUJAANWFHCJV-UHFFFAOYSA-N
26690	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7451	N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE	-	-	DRUGBANK	DB08677	C13H15N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZOOPQQADNJEG-UHFFFAOYSA-N
26692	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7457	REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE	-	-	DRUGBANK	DB08683	C24H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTPNDVKVEAIXTI-IYBDPMFKSA-N
26721	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7468	9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol	-	-	DRUGBANK	DB08694	C14H11N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHKPHCVZVYDFN-UHFFFAOYSA-N
26726	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7471	4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	-	-	DRUGBANK	DB08697	C22H28ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDYIYIRPQKMWMM-UHFFFAOYSA-N
26730	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7479	6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE	-	-	DRUGBANK	DB08705	C18H11BrN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SVSYJTYGPLVUOZ-UHFFFAOYSA-N
26731	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7481	4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine	-	-	DRUGBANK	DB08707	C17H11ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQVFETGXIRKVAQ-UHFFFAOYSA-N
26732	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7482	N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine	-	-	DRUGBANK	DB08708	C18H18F3N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYYDXQCAYXOGQT-UHFFFAOYSA-N
26733	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7483	2,3-diphenyl-1H-indole-7-carboxylic acid	-	-	DRUGBANK	DB08709	C21H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUDUXWVPIEHDA-UHFFFAOYSA-N
26736	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7503	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	-	-	DRUGBANK	DB08730	C26H25FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPFBZMFUCGHBAP-UHFFFAOYSA-N
26740	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7510	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL	-	-	DRUGBANK	DB08737	C18H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSYFYSFYUHBIHE-GLJUWKHASA-N
26743	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7513	CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE	-	-	DRUGBANK	DB08740	C14H29NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGYZGGUJJIVOQX-MELADBBJSA-N
26750	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7522	3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE	-	-	DRUGBANK	DB08749	C25H30N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTRFBFMYAJOXLG-UHFFFAOYSA-N
26755	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26757	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26758	114860	9475	-	ROCK2	ROCK-II	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26761	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7533	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB08760	C15H13ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPBLTMSKPQDJPW-AWEZNQCLSA-N
26768	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7541	N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE	-	-	DRUGBANK	DB08768	C10H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYVABZIGRDEKCD-UHFFFAOYSA-N
26769	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7542	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	-	-	DRUGBANK	DB08770	C16H15N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWTBZOIUWZOPFT-UHFFFAOYSA-N
26774	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7545	RALOXIFENE CORE	-	-	DRUGBANK	DB08773	C14H10O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDGWZLQPNOETLH-UHFFFAOYSA-N
26775	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7546	1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine	-	-	DRUGBANK	DB08774	C17H19N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBRZCAKSBYWZTC-ZDUSSCGKSA-N
26777	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7548	N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE	-	-	DRUGBANK	DB08776	C9H11N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYHOEDBNAJPFKK-UHFFFAOYSA-N
26778	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7549	5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE	-	-	DRUGBANK	DB08777	C10H10N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMMOEJUJKIXUQZ-UHFFFAOYSA-N
26779	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7550	[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone	-	-	DRUGBANK	DB08778	C14H17N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEHNGAHNKVLUSC-UHFFFAOYSA-N
26780	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7551	2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol	-	-	DRUGBANK	DB08779	C9H10N2OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWYGHJVEZLVLSU-UHFFFAOYSA-N
26781	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7552	6-MORPHOLIN-4-YL-9H-PURINE	-	-	DRUGBANK	DB08780	C9H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEOMXKNIFWDDGZ-UHFFFAOYSA-N
26782	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7553	1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE	-	-	DRUGBANK	DB08781	C11H14BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJUBFXSKTBULRW-ZETCQYMHSA-N
26784	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7555	(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid	-	-	DRUGBANK	DB08783	C16H23NO6Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUSGDKNGCAEAX-ZDUSSCGKSA-N
26786	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7558	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	-	-	DRUGBANK	DB08786	C8H13N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCJHOFUOIQHNBC-UHFFFAOYSA-N
26787	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7559	4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine	-	-	DRUGBANK	DB08787	C16H11Cl2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJMNJFPEVJCQK-GHVJWSGMSA-N
26788	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7560	3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB08788	C17H15N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOPQHPBCVYHSFF-UHFFFAOYSA-N
26789	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7561	2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	-	-	DRUGBANK	DB08789	C15H12Cl2N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPEOXUOUTBMBCX-UHFFFAOYSA-N
26807	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Wheeldon NM (1991)	1678274	179346	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26808	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1991)	1687398	179347	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26809	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Dejgaard A (1991)	1666931	179350	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26810	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26811	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Rubenstein LA (2006)	16574446	179348	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26812	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1990)	1979630	179349	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26825	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Lenard NR (2003)	12606631	181811	7579	Bupranolol	Bupranol	-	DRUGBANK	DB08808	C14H22ClNO2	small molecule	C07AA19	14556-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQIRNZOQPUAHHV-UHFFFAOYSA-N
26832	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Alarcon-de-la-Lastra Romero C (1997)	9211565	181721	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26833	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Alarcon de la Lastra C (1998)	9562338	181726	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26844	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	inhibitor	target	Sustar V (2009)	19261492	182099	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26845	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	inhibitor	target	Nagy Z (2009)	19757196	182127	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26892	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Furuta S (1993)	8513851	181700	7600	Temocapril	Temocaprilum	-	DRUGBANK	DB08836	C23H28N2O5S2	small molecule	C09AA14	111902-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIQOFIRCTOWDOW-BJLQDIEVSA-N
26905	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Cozza G (2006)	16610779	181936	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26906	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Sekiguchi Y (2009)	19414254	182103	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26908	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	inhibitor, competitive	target	Wang BH (1998)	9581512	181727	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26910	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	inhibitor, competitive	target	Wang BH (1998)	9581512	181727	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26911	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	inhibitor, competitive	target	Wang BH (1998)	9581512	181727	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26918	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	inhibitor	target	Cozza G (2006)	16610779	181936	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26944	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	inhibitor	target	Yang LP (2012)	23061804	182213	7621	Ruxolitinib	INCB424|INCB018424	jakafi|jakavi	DRUGBANK	DB08877	C17H18N6	small molecule	L01XE18	941678-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFNKQEVNSGCOJV-OAHLLOKOSA-N
26945	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	inhibitor	target	Cervantes F (2013)	23514013	182236	7621	Ruxolitinib	INCB424|INCB018424	jakafi|jakavi	DRUGBANK	DB08877	C17H18N6	small molecule	L01XE18	941678-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFNKQEVNSGCOJV-OAHLLOKOSA-N
26965	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	inhibitor	target	O'Hare T (2009)	19878872	182132	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26966	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Iqbal Z (2013)	23409026	182230	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26978	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	inhibitor	target	Gushwa NN (2012)	23190395	182219	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26980	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	neutralizer	target	Chimenti MS (2013)	23620660	182248	7648	Certolizumab pegol	CDP870	cimzia	DRUGBANK	DB08904	C2115H3252N556O673S16	biologic	L04AB05	428863-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26984	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Gertz MA (2013)	22917017	182210	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26988	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ferguson GD (2007)	17308870	159982	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26995	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26996	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Cavender MA (2010)	20653327	182161	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
27011	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Seppaelae T (1988)	3365283	181667	7690	Ifenprodil	-	-	DRUGBANK	DB08954	C21H27NO2	small molecule	C04AX28	23210-56-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYNVMODNBIQBMV-UHFFFAOYNA-N
27014	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Ring RM (2013)	23863923	182253	7747	Captodiame	Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine	-	DRUGBANK	DB09014	C21H29NS2	small molecule	N05BB02	486-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLPZXSZLLELBJ-UHFFFAOYNA-N
27034	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Walker N (2014)	25517706	182256	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27035	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Houlihan LM (2001)	11553677	181776	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27039	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27040	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27041	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Danesh J (1999)	10361047	172127	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27042	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27043	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27044	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Grehan S (1997)	9200475	172129	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27045	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Danesh J (2000)	10903648	172128	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27375	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1998)	9850732	172163	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27376	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (2001)	11327694	172166	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27377	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Locci P (1995)	7648625	172165	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27378	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1997)	9435505	172164	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27381	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Briejer MR (2001)	11438309	188518	7774	Prucalopride	-	resotran	DRUGBANK	DB06480	C18H26ClN3O3	small molecule	A06AX05	179474-81-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPMNHBXQOOVQJL-UHFFFAOYSA-N
27422	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10794682	188524	7221	Parecoxib	-	-	DRUGBANK	DB08439	C19H18N2O4S	small molecule	M01AH04	198470-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZRHLKRLEZJVIJ-UHFFFAOYSA-N
27457	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antagonist	target	van Zaanen HC (1996)	8823310	188534	7799	Siltuximab	-	sylvant	DRUGBANK	DB09036	C6450H9932N1688O2016S50	biologic	L04AC11	541502-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27458	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antibody	target	van Zaanen HC (1996)	8823310	188534	7799	Siltuximab	-	sylvant	DRUGBANK	DB09036	C6450H9932N1688O2016S50	biologic	L04AC11	541502-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27464	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Trujillo JM (2014)	25136065	188538	7806	Albiglutide	-	eperzan|tanzeum	DRUGBANK	DB09043	C3232H5032N864O979S41	biologic	A10BX13	782500-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27465	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Sanford M (2014)	25367716	188539	7807	Dulaglutide	-	trulicity	DRUGBANK	DB09045	C2646H4044N704O836S18	biologic	A10BX14	923950-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27485	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Salmon M (2013)	23435542	188552	7823	Umeclidinium	1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane	incruse ellipta|anoro ellipta	DRUGBANK	DB09076	C29H34NO2	small molecule	R03BB07|R03AL03	869185-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTWTVQXNAJTQP-UHFFFAOYSA-N
27502	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27504	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27506	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bouyssou T (2010)	20371707	188555	7827	Olodaterol	-	inspiolto respimat|stiolto res	DRUGBANK	DB09080	C21H26N2O5	small molecule	R03AL06|R03AC19	868049-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COUYJEVMBVSIHV-SFHVURJKSA-N
27521	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	McCann ME (2004)	15077695	188559	7961	Firocoxib	-	-	DRUGBANK	DB09217	C17H20O5S	small molecule	-	189954-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FULAPETWGIGNMT-UHFFFAOYSA-N
27526	129116	255738	PSEC0052	PCSK9	FH3|HCHOLA3|LDLCQ1|NARC-1|NARC1|PC9	9606	Homo sapiens	inhibitor	target	Devito F (2015)	26455563	188563	8046	Alirocumab	-	praluent	DRUGBANK	DB09302	C6472H9996N1736O2032S42	biologic	-	1245916-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27527	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27560	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Shiraishi M (2002)	12010769	174247	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
27561	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Rogers KR (1992)	1621972	174356	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
27562	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Fiacchino F (1990)	2272786	174354	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
27563	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Marshall CG (1990)	2133043	174355	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
27582	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27585	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zheng L (2007)	17259377	181291	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
27587	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Aracava Y (2005)	15522999	179864	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
27621	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Pagan OR (2001)	11551210	181477	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
27638	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27679	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hayashi T (2007)	17141277	188508	7761	Celiprolol	RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea	-	DRUGBANK	DB04846	C20H33N3O4	small molecule	C07AB08	56980-93-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOATXPAWOHTVSZ-UHFFFAOYSA-N
27688	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Cerqueira MD (2006)	16524538	181933	4796	Apadenoson	-	-	DRUGBANK	DB05009	C23H30N6O6	small molecule	-	250386-15-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLEVIENZILQUKB-XTWQNQIISA-N
27691	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Cugno M (2001)	11460008	6756	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27698	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27704	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
27713	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27714	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Stringer JL (1999)	10094428	174140	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27715	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27716	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Motalli R (1999)	10444662	174138	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27717	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Ogasawara T (1999)	10494996	174139	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27718	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Mott DD (1999)	10482760	174136	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27719	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Garcia-Gil L (1999)	10386831	174137	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27720	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27721	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27730	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27731	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Stringer JL (1999)	10094428	174140	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27732	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27733	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Motalli R (1999)	10444662	174138	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27734	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Ogasawara T (1999)	10494996	174139	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27735	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Mott DD (1999)	10482760	174136	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27736	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Garcia-Gil L (1999)	10386831	174137	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27737	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27738	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27739	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Cugno M (2001)	11460008	6756	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27768	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heal DJ (2013)	23539642	196018	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
27795	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Birks J (2006)	16437532	195965	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
27796	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Naik RS (2009)	19470293	195992	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
27797	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Magyar K (1984)	6441926	196045	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
27800	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Magyar K (1984)	6441926	196045	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
27822	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27840	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Gruber C (2004)	15535430	195962	7770	Bazedoxifene	bazedoxifene/conjugated estrogens	duavee|duavive	DRUGBANK	DB06401	C30H34N2O3	small molecule	G03XC02|G03CC07	198481-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJGJABZCDBEDK-UHFFFAOYSA-N
27841	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Gruber C (2004)	15535430	195962	7770	Bazedoxifene	bazedoxifene/conjugated estrogens	duavee|duavive	DRUGBANK	DB06401	C30H34N2O3	small molecule	G03XC02|G03CC07	198481-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJGJABZCDBEDK-UHFFFAOYSA-N
27866	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27892	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Gemzell-Danielsson K (2013)	23437846	196017	8104	Ulipristal	-	ella|fibristal	DRUGBANK	DB08867	C28H35NO3	small molecule	G03XB02|G03AD02	159811-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKDLNTKNLJPAIY-WKWWZUSTSA-N
27905	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Escande A (2009)	19464167	195991	8113	Tibolone	17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one|tibolona|tibolonum	-	DRUGBANK	DB09070	C21H28O2	small molecule	G03CX01	5630-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZDGZWOAQTVYBX-XOINTXKNSA-N
27921	106848	351	-	APP	AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2	9606	Homo sapiens	binder	target	Choi SR (2009)	19837759	195994	7894	Florbetapir (18F)	florbetapir-fluorine-18|18F-AV-45|4-{(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline|Florbetapir F-18|Florbetapir F18	amyvid	DRUGBANK	DB09149	C20H25FN2O3	small molecule	V09AX05	956103-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNDIAUKFXKEXSV-CRYLGTRXSA-N
27922	106848	351	-	APP	AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2	9606	Homo sapiens	binder	target	Beach TG (2016)	27031469	196039	7896	Flutemetamol (18F)	[18F]-Flutemetamol|2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|Flutemetamol F-18|flutemetamol (18F)|Flutemetamol F18|Flutemetamol F 18	vizamyl	DRUGBANK	DB09151	C14H11FN2OS	small molecule	V09AX04	765922-62-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVECGOCJFKTUAX-HUYCHCPVSA-N
27984	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Kraft SL (2014)	24038727	198172	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
27985	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Holt A (1992)	1359073	198173	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
28010	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Sansoe G (2005)	16085334	198179	8300	Candoxatrilat	Candoxatrilate	-	DRUGBANK	DB11623	C20H33NO7	small molecule	-	123122-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACZWIDANLCXHBM-HRCADAONSA-N
28011	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Alabaster CT (1989)	2611529	198180	8300	Candoxatrilat	Candoxatrilate	-	DRUGBANK	DB11623	C20H33NO7	small molecule	-	123122-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACZWIDANLCXHBM-HRCADAONSA-N
28019	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Itoh Y (2011)	22014751	142167	8427	Bivalent ligand 3	Bivalent_ligand_3|SNIPER 13	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER 13(cIAP1:BE04 --- ER:estrone)	-
28035	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Lai AC (2016)	26593377	191787	8449	Bivalent ligand 11	Bivalent_ligand_11|DAS-VHL	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: DAS-VHL(VHL:HIF-1alpha hydroxyproline derived small molecule --- c-ABL:dasatinib)	-
28037	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Lai AC (2016)	26593377	191787	8452	Bivalent ligand 12	Bivalent_ligand_12|DAS-CRBN	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: DAS-CRBN(CRBN:pomalidomide --- BCR-ABL:dasatinib)	-
28039	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Lai AC (2016)	26593377	191787	8402	Bivalent ligand 43	Bivalent_ligand_43|BOS-CRBN	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: BOS-CRBN(CRBN:pomalidomide --- BCR-ABL:bosutinib)	-
28041	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Demizu Y (2016)	27666635	199362	8451	Bivalent ligand 13	Bivalent_ligand_13|SNIPER(ABL)2,3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER(ABL)2,3(cIAP1:methyl bestatin --- BCR-ABL:imatinib derivative)	-
28061	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Sakamoto KM (2003)	14525958	111475	8447	Bivalent ligand 17	Bivalent_ligand_17|Protac-2|Protac 2	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: Protac-2(Beta-TrCP:IkBalpha phosphopeptide --- ER:estradiol)	-
28063	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Rodriguez-Gonzalez A (2008)	18794799	85962	8458	Bivalent ligand 18	Bivalent_ligand_18|Protac-B	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: Protac-B(VHL:HIF1a pentapeptide --- ER:estradiol)	-
28065	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Cyrus K (2010)	20572252	211420	8457	Bivalent ligand 19	Bivalent_ligand_19|PROTAC 5	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC 5(VHL:HIF1a pentapeptide --- ER:estradiol (2 molecules))	-
28067	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Demizu Y (2012)	22277276	211397	8412	Bivalent ligand 20	Bivalent_ligand_20|SNIPER (ER) 5,6,7	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER (ER) 5,6,7(cIAP1:bestatin --- ER:4-hydroxytamoxifen)	-
28069	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Okuhira K (2013)	23992566	211367	8413	Bivalent ligand 21	Bivalent_ligand_21|SNIPER(ER)-3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER(ER)-3(cIAP1:methyl bestatin  --- ER:4-hydroxytamoxifen)	-
28077	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Ohoka N (2017)	28154167	211362	8415	Bivalent ligand 23	Bivalent_ligand_23|SNIPER(ER)-87	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER(ER)-87(XIAP:LCL161 --- ER:4-hydroxytamoxifen)	-
28081	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Ohoka N (2017)	28154167	211362	8417	Bivalent ligand 25	Bivalent_ligand_25|SNIPER(ABL)-38	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER(ABL)-38(XIAP:LCL161 --- BCR-ABL:dasatinib)	-
28089	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Winter GE (2015)	25999370	211411	8410	Bivalent ligand 29	Bivalent_ligand_29|dFKBP-1|dFKBP-2|dFKBP-1/dFKBP-2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: dFKBP-1/dFKBP-2(CRBN:thalidomide --- FKBP12:SLF)	-
28097	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Zhang D (2004)	14741260	211348	8411	Bivalent ligand 33	Bivalent_ligand_33|E2-SMPI/E2-octa|E2-SMPI|E2-octa	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: E2-SMPI/E2-octa(VHL:HIF-1alpha octapeptide --- ER:estradiol)	-
28099	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Bargagna-Mohan P (2005)	15876533	211350	8456	Bivalent ligand 34	Bivalent_ligand_34|E2-penta	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: E2-penta(VHL:HIF-1alpha pentapeptide --- ER:estradiol)	-
28121	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	degradation	target	Tomoshige S (2015)	26338696	191691	8399	Bivalent ligand 48	Bivalent_ligand_48|compound 1b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: compound 1b(cIAP1:BE04 --- HaloTag-c-jun)	-
28123	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	degradation	target	Tomoshige S (2016)	27236416	205947	8400	Bivalent ligand 49	Bivalent_ligand_49|Compound 4a/4b|Compound 4a|Compound 4b|4a|4b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: Compound 4a/4b(IAP pan-ligand:MV1 --- HaloTag-TNFalpha)	-
28127	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	degradation	target	Buckley DL (2015)	26070106	211383	8438	Bivalent ligand 50	Bivalent_ligand_50|HaloPROTAC3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: HaloPROTAC3(VHL:degradation moiety B --- HaloTag7-ERK1)	-
28149	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Jiang Y (2018)	29271628	211419	8405	Bivalent ligand 60	Bivalent_ligand_60|TD-PROTAC	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: TD-PROTAC(VHL:HIF1a pentapeptide --- ER: stabilized peptide TD-PERM)	-
28163	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MAPK14:foretinib)	-
28169	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- EPHB2:foretinib)	-
28171	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MARK4:foretinib)	-
28189	108176	1843	-	DUSP1	CL100|HVH1|MKP-1|MKP1|PTPN10	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- DUSP1:foretinib)	-
28199	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ABL2:foretinib)	-
28215	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ABL1:foretinib)	-
28227	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- EPHB2:foretinib)	-
28233	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ABL2:foretinib)	-
28237	106832	335	-	APOA1	-	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- APOA1:foretinib)	-
28259	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ABL1:foretinib)	-
28303	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- A2M:foretinib)	-
28309	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- F2:foretinib)	-
28394	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	Soucy TA (2009)	19360080	209255	8353	Pevonedistat	MLN4924|MLN 4924|[(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl]methyl sulfamate|Pevonedistat|[(1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate|S3AZD8D215|9605|MLN4924	-	CHEMSPIDER	17625129	C21H25N5O4S	small molecule	-	905579-51-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MPUQHZXIXSTTDU-QXGSTGNESA-N
28437	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	An H (2015)	28717502	211368	8341	ABP-A3	N-(3-Ethynylphenyl)-5'-O-sulfamoyladenosine|Adenosine, 5'-O-(aminosulfonyl)-N-(3-ethynylphenyl)-	-	CHEMSPIDER	57643654	C18H18N6O6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LZNFQRSVDZCPTR-SCFUHWHPSA-N
28476	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	Swords RT (2010)	20203261	211410	8353	Pevonedistat	MLN4924|MLN 4924|[(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl]methyl sulfamate|Pevonedistat|[(1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate|S3AZD8D215|9605|MLN4924	-	CHEMSPIDER	17625129	C21H25N5O4S	small molecule	-	905579-51-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MPUQHZXIXSTTDU-QXGSTGNESA-N
28483	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Sodji Q (2014)	25240614	211381	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
28583	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Yang K (2018)	29871848	223608	8529	Bivalent ligand 46	dHDAC6|Bivalent_ligand_46	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dHDAC6(CRBN:pomalidomide --- HDAC6:pan-HDAC inhibitor AB3)	-
28601	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	degradation	target	Smith BE (2019)	30631068	219514	8512	Bivalent ligand 72	SJFa PROTAC|Bivalent_ligand_72	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	SJFalpha PROTAC|Standardized BVL Name: (VHL:ligand 7 ---MAPK1:Foretinib)	-
28603	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	degradation	target	Smith BE (2019)	30631068	219514	8511	Bivalent ligand 73	SJFd PROTAC|Bivalent_ligand_73	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	SJFDelta PROTAC|Standardized BVL Name: (VHL:ligand 7 ---MAPK1:Foretinib)	-
28645	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Zhang X (2019)	31209349	220534	8545	Bivalent ligand 91	KB02-SLF|Bivalent_ligand_91	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	recruited e3 ligase	small molecule|Standardized BVL Name: KB02-SLF (DCAF16:KB02 --- FKBP12:SLF)	-
28659	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Zhao Q (2019)	31539241	220727	8502	Bivalent ligand 97	SIAIS178|Bivalent_ligand_97	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SIAIS178 (VHL:VHL1 --- BCR-ABL:dasatinib)	-
28663	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Burslem GM (2019)	31311809	223347	8506	Bivalent ligand 100	GMB-475|Bivalent_ligand_100	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: GMB-475(VHL:VHL1 --- BCR-ABL1:GNF-5)	-
28685	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation	target	Khan S (2019)	31792461	223622	8499	Bivalent ligand 108	DT2216|Bivalent_ligand_108	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DT2216 (VHL:VHL-L --- BCL2L1:ABT263)	-
28711	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- PTK2B:TL13-87)	-
28737	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- MARK2:TL13-87)	-
28743	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK17:TL13-87)	-
28747	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK5:TL13-87)	-
28751	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK2:TL13-87)	-
28757	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- PRKAA1:TL13-87)	-
28765	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- LCK:TL13-87)	-
28781	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	degradation	target	Lebraud H (2016)	28058282	223632	8531	Bivalent ligand 126	ERK-CLIPTAC|Bivalent_ligand_126	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	CLIPTAC	PROTAC variant formed in cells by click chemistry; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ERK-CLIPTAC (CRBN:Tz-thalidomide --- MAPK3:Probe 1)	-
28783	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	degradation	target	Lebraud H (2016)	28058282	223632	8531	Bivalent ligand 126	ERK-CLIPTAC|Bivalent_ligand_126	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	CLIPTAC	PROTAC variant formed in cells by click chemistry; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ERK-CLIPTAC (CRBN:Tz-thalidomide --- MAPK1:Probe 1)	-
28895	118953	29904	-	EEF2K	HSU93850|eEF-2K	9606	Homo sapiens	degradation	target	Liu Y (2020)	32717479	223647	8565	Bivalent ligand 147	Compound 11|Bivalent_ligand_147	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 11l (CRBN:thalidomide --- EEF2K:A484954)	-
28896	111105	5071	KB-152G3.1	PARK2	AR-JP|LPRS2|PDJ|PRKN	9606	Homo sapiens	degradation	recruited e3 ligase	Schiedel M (2020)	32672888	223648	8566	Bivalent ligand 148	chloroalkylated SirReal 11|Bivalent_ligand_148	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	target	Standardized BVL Name: chloroalkylated SirReal 11 (HaloTag-PRKN--- SIRT2:SirReal3)	-
28913	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donoghue C (2020)	32634680	223652	8548	Bivalent ligand 152	NR-7h|Bivalent_ligand_152	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NR-7h (CRBN:thalidomide --- MAPK14:PH-797804)	-
28915	111586	5600	-	MAPK11	P38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta	9606	Homo sapiens	degradation	target	Donoghue C (2020)	32634680	223652	8548	Bivalent ligand 152	NR-7h|Bivalent_ligand_152	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NR-7h (CRBN:thalidomide --- MAPK11:PH-797804)	-
28917	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Tong B (2020)	32568522	223653	8547	Bivalent ligand 153	BT1|Bivalent_ligand_153	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120991	55905	-	RNF114	PSORS12|ZNF313	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BT1 (RNF114:nimbolide --- BCR-ABL:dasatinib)	-
28919	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	degradation	target	Liao H (2020)	32550000	223654	8554	Bivalent ligand 154	xStAx-VHLL|Bivalent_ligand_154	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: xStAx-VHLL (VHL:VHL ligand --- CTNNB1:xStAx)	-
28921	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Burslem GM (2020)	32519703	223655	8553	Bivalent ligand 155	GMB-805|Bivalent_ligand_155	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: GMB-805 (VHL:VHL1 --- BCR-ABL:ABL001)	-
28927	109314	3064	-	HTT	HD|IT15	9606	Homo sapiens	degradation	target	Li Z (2020)	31690177	223658	8556	Bivalent ligand 158	ATTEC|Bivalent_ligand_158	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	autophagy-targeting protein	Standardized BVL Name: ATTEC (MAP1LC3B --- mHTT)	-
28975	110913	4851	-	NOTCH1	AOS5|AOVD1|TAN1|hN1	9606	Homo sapiens	degradation	target	Ohoka N (2017)	29050782	208402	8471	Bivalent ligand 171	peptide 5|Bivalent_ligand_171	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: peptide 5 (BIRC2:MV1 --- NOTCH1:CSL)	-
28977	110913	4851	-	NOTCH1	AOS5|AOVD1|TAN1|hN1	9606	Homo sapiens	degradation	target	Ohoka N (2017)	29050782	208402	8471	Bivalent ligand 171	peptide 5|Bivalent_ligand_171	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: peptide 5 (BIRC3:MV1 --- NOTCH1:CSL)	-
28979	110913	4851	-	NOTCH1	AOS5|AOVD1|TAN1|hN1	9606	Homo sapiens	degradation	target	Ohoka N (2017)	29050782	208402	8471	Bivalent ligand 171	peptide 5|Bivalent_ligand_171	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: peptide 5 (XIAP1:MV1 --- NOTCH1:CSL)	-
29199	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2014)	25261927	224778	9249	N-[4-[3-Chloro-4-[(3S)-oxolan-3-yl]oxyanilino]thieno[2,3-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide	BDBM50102566	-	PUBCHEM	118715746	C24H28ClN5O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DHVTZWIWZWPIFU-INIZCTEOSA-N
29200	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2014)	25261927	224778	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29201	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2014)	25233084	224779	9250	8-Mercapto-octanoic acid phenylamide	8-MERCAPTO-OCTANOIC ACID PHENYLAMIDE|ZINC13609343|N-PHENYL-8-SULFANYLOCTANAMIDE|8-MERCAPTO-N-PHENYLOCTANAMIDE|BDBM50027601	-	PUBCHEM	11149404	C14H21NOS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VTVJPXWTXILBGK-UHFFFAOYSA-N
29202	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2014)	25233084	224779	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29265	110309	4139	-	MARK1	MARK|Par-1c|Par1c	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29266	110309	4139	-	MARK1	MARK|Par-1c|Par1c	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29272	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29273	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29274	124084	84446	-	BRSK1	hSAD1	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29275	124084	84446	-	BRSK1	hSAD1	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29276	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29277	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29278	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29279	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29283	127260	150094	-	SIK1	MSK|SIK|SNF1LK	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29284	127260	150094	-	SIK1	MSK|SIK|SNF1LK	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29285	127260	150094	-	SIK1	MSK|SIK|SNF1LK	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
29286	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29287	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29292	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi Q (2007)	18029178	224793	9310	3-[4-[3-[(1R)-1-[(5-Chloro-3-methyl-1-benzothiophene-2-carbonyl)amino]ethyl]-5-fluorophenoxy]-2-ethylphenyl]propanoic acid	(R)-3-(4-(3-(1-(5-CHLORO-3-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDO)ETHYL)-5-FLUOROPHENOXY)-2-ETHYLPHENYL)PROPANOIC ACID|BDBM50227754	-	PUBCHEM	44434362	C29H27ClFNO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WQCJKMGDGUHOFD-QGZVFWFLSA-N
29293	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi Q (2007)	18029178	224793	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29299	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dropinski JF (2005)	16153845	224795	9316	1-(4-Tert-butylphenyl)-3-[3-(trifluoromethyl)phenoxy]indole-2-carboxylic acid	1-(4-TERT-BUTYL-PHENYL)-3-(3-TRIFLUOROMETHYL-PHENOXY)-1H-INDOLE-2-CARBOXYLIC ACID|BDBM50173359	-	PUBCHEM	11546956	C26H22F3NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QEDIKMQCSOVILD-UHFFFAOYSA-N
29308	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Nalawansha DA (2017)	27977115	224801	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29309	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Nalawansha DA (2017)	27977115	224801	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29310	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Miyake Y (2016)	27454931	224802	9324	(2E,4S,5E)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,5-dienamide	S-TSA|BDBM197337	-	PUBCHEM	122198566	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ALCVRKZFLFWUAZ-CSFUQHBASA-N
29311	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Miyake Y (2016)	27454931	224802	9325	(2E,4R,5E)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,5-dienamide	R-TSA|BDBM197336	-	PUBCHEM	122198565	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ALCVRKZFLFWUAZ-LSSUCPAZSA-N
29312	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li J (2016)	27235003	224803	4802	Belinostat	UNII-F4H96P17NZ|NSC-726630|ZINC3818726|ABP000140|866323-14-0|SC-71101|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|SW219445-1|NSC726630|BELEODAQ|BCPP000351|EX-A180|PX 105684|QCR-181|BCP01741|BRD-K17743125-001-01-9|GTPL7496|(E)-N-HYDROXY-3-(3-(N-PHENYLSULFAMOYL)PHENYL)ACRYLAMIDE|BELINOSTAT - PXD101|SB16466|CC-489|AOB87787|BELINOSTAT|AX8144528|MLS006011091|AC-25046|AB0007889|BELINOSTAT (PXD101)|BELINOSTAT,PXD101, PX105684|W-5363|(E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|414864-00-9|D08870|(E)-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENEHYDROXAMIC ACID|BELINOSTAT [USAN:INN]|SMR004702879|Q4882925|E-BELINOSTAT|BELINOSTAT (PXD101)|PXD101|PXD 101|N-HYDROXY-3-(3-PHENYLSULPHAMOYLPHENYL)ACRYLAMIDE|API0003555|BELINOSTAT (USAN/INN)|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]ACRYLAMIDE|BELEODAQ (TN)|PUBCHEM22405|NCGC00263155-05|(E)-N-HYDROXY-3-(3-PHENYLSULFAMOYL-PHENYL)-ACRYLAMIDE|PXD-101|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PR|S1085|LS41098|PX-105684|BELINOSTAT PH3|N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE|EC-000.2286|BELINOSTAT/PXD101,PX105684/|5OG|DTXSID60194378|2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-, (2E)-|BCP9000386|PX105684|F4H96P17NZ|N-HYDROXY-3-[(PHENYLAMINO)SULFONYL]-TRANS-CINNAMAMIDE|AS-17068|BELINOSTAT(RANDOM CONFIGURATION)|A25012|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE|AKOS025401741|N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE|CCG-208758|2-PROPENAMIDE, N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-, (2E)-|DB05015|J-523584|BDBM25150	beleodaq	DRUGBANK	DB05015	C15H14N2O4S	small molecule	L01XX49	866323-14-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NCNRHFGMJRPRSK-MDZDMXLPSA-N
29313	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li J (2016)	27235003	224803	9326	(E)-N-Hydroxy-3-[3-[[(1S)-2-(naphthalen-1-ylamino)-2-oxo-1-phenylethyl]sulfamoyl]phenyl]prop-2-enamide	(S,E)-N-HYDROXY-3-(3-(N-(2-(NAPHTHALEN-1-YLAMINO)-2-OXO-1-PHENYLETHYL)SULFAMOYL)PHENYL)ACRYLAMIDE (10S)|BDBM198192	-	PUBCHEM	122198640	C27H23N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JCEFNCFZXQDHRY-ZOGILVBSSA-N
29319	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yoo J (2016)	27060764	224805	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29320	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yoo J (2016)	27060764	224805	9332	N-Hydroxy-4-[2-[(E)-2-phenylethenyl]-1,3-thiazol-4-yl]butanamide	ONC(CCCC=1N=C(SC=1)\C=C\C1=CC=CC=C1)=O|BDBM50156678	-	PUBCHEM	102514716	C15H16N2O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HJPIJALRLZVGMS-MDZDMXLPSA-N
29321	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yoo J (2016)	27060764	224805	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29322	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Flick AC (2016)	27020685	224806	9333	Lobeglitazone sulfate	CKD 501|LOBEGLITAZONE SULFATE|CKD-501|2,4-THIAZOLIDINEDIONE, 5-((4-(2-((6-(4-METHOXYPHENOXY)-4- PYRIMIDINYL)METHYLAMINO)ETHOXY)PHENYL)METHYL)-, SULFATE (1:1)|SB16870|Q27271778|BDBM50152829	-	PUBCHEM	15951505	C24H26N4O9S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IFBYQAMJTBOBHB-UHFFFAOYSA-N
29323	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Waszkielewicz AM (2016)	26988801	224807	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29335	124084	84446	-	BRSK1	hSAD1	9606	Homo sapiens	unknown	target	Simov V (2016)	26927423	224809	9342	BDBM50152595	-	-	CHEMBL	CHEMBL3780091	C18H21N5O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLWGOAGEDWMEBT-TXEJJXNPSA-N
29336	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Mariano M (2016)	26896709	224810	4571	5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione	5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINEDIONE|ZINC12504504|S1410|2A5U|SR-02000000919|GTPL6023|(5Z)-5-(QUINOXALIN-6-YLMETHYLIDENE)-1,3-THIAZOLIDINE-2,4-DIONE|ABP000101|AOB3848|AS605240|NCGC00261632-01|BCP9000323|5-QUINOXALIN-6-YLMETHYLENETHIAZOLIDINE-2,4-DIONE|BCP02097|CCG-101300|1287651-14-2|J-516278|HMS3650I15|AS 605240,5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINE-2,4-DIONE|(Z)-5-(QUINOXALIN-6-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE|AS 605240|HMS3262N16|SDCCGSBI-0086699.P002|TOX21_500947|AS-605240/AS605240|CC-118|LP00947|5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE|Q27088381|PI 3-KGAMMA INHIBITOR|QYT|648450-29-7|DB04769|SR-02000000919-2|HY-10109|5-[(QUINOXALIN-6-YL)METHYLIDENE]-1,3-THIAZOLIDINE-2,4-DIONE|BRD-K76773351-001-01-9|(5E)-5-(QUINOXALIN-6-YLMETHYLENE)-1,3-THIAZOLIDINE-2,4-DIONE|CS-0084|AS605240, >=98% (HPLC)|5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINE-2,4-DIONE|5-(QUINOXALIN-6-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE|SB19245|AKOS024457698|AS-16768|W-5475|NCGC00186030-01|AS-605240|PI 3-KG INHIBITOR|HMS3229I19|BDBM50324735	-	DRUGBANK	DB04769	C12H7N3O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SQWZFLMPDUSYGV-POHAHGRESA-N
29337	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Mariano M (2016)	26896709	224810	9343	(3E)-3-(1,3-Benzothiazol-6-ylmethylidene)oxolan-2-one	BDBM50154348	-	PUBCHEM	127032014	C12H9NO2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FMOOGIYSVBVFIT-WEVVVXLNSA-N
29338	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Mariano M (2016)	26896709	224810	9344	(5Z)-5-(Quinolin-6-ylmethylidene)-2-sulfanylidene-1,3-thiazolidin-4-one	5-[1-QUINOLIN-6-YL-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE|(5Z)-5-(QUINOLIN-6-YLMETHYLIDENE)-2-SULFANYLIDENE-1,3-THIAZOLIDIN-4-ONE|ZINC9908493|BDBM50154342	-	PUBCHEM	11666231	C13H8N2OS2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZFGAUFCQRUSRCF-XFFZJAGNSA-N
29339	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9345	5-Benzyl-2-(1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151283	-	PUBCHEM	126582837	C20H18F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JJZFDILZILDRTQ-UHFFFAOYSA-N
29340	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9346	5-Cyclopropyl-2-(5-methyl-1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151282	-	PUBCHEM	126582839	C17H18F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GJSCCYDUKNGSLB-UHFFFAOYSA-N
29341	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9347	5-Cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151281	-	PUBCHEM	126582843	C20H22F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZUPRHDPCDWVJDA-UHFFFAOYSA-N
29342	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9348	5-(2-Methylpropyl)-2-(1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151280	-	PUBCHEM	126582841	C17H20F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AZLBBFOVLFWKTC-UHFFFAOYSA-N
29343	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9349	5-Cyclopropyl-2-(1,3-thiazol-2-yl)-N-(5,5,5-trifluoro-4-oxopentyl)-1,3-thiazole-4-carboxamide	BDBM50151278	-	PUBCHEM	126582908	C15H14F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UVCSQKKFUYQSGT-UHFFFAOYSA-N
29344	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9350	5-Cyclopropyl-2-(1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151277	-	PUBCHEM	91938063	C16H16F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OHRUWOKDVPCLPC-UHFFFAOYSA-N
29345	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9351	5-Cyclopropyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide	BDBM50020897	-	PUBCHEM	71468161	C15H18N4O3S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVJAEZIEZVJAFM-UHFFFAOYSA-N
29346	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9352	3-Pyrazin-2-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144216	-	PUBCHEM	127028943	C14H19N5OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYWQCXUVPDWXRB-UHFFFAOYSA-N
29347	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9353	3-(1H-Indol-3-yl)-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144214	-	PUBCHEM	137174935	C18H22N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QTJRTUWSBZMZMT-UHFFFAOYSA-N
29348	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9354	N-(6-Sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144212	-	PUBCHEM	127026695	C10H17N3OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OJQALHBLSWWPHJ-UHFFFAOYSA-N
29349	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9355	3-Phenyl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144210	-	PUBCHEM	127027677	C16H21N3OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SZTCVPCNBUBKBA-UHFFFAOYSA-N
29350	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9356	3-(3,4-Dimethoxyphenyl)-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144209	-	PUBCHEM	127027679	C18H25N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KATIKUFCGSOWFA-UHFFFAOYSA-N
29351	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9357	N-(6-Sulfanylhexyl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazole-5-carboxamide	BDBM50144208	-	PUBCHEM	127027680	C19H27N3O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIUNIEQHYXYXSL-UHFFFAOYSA-N
29352	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9358	3-Pyridin-4-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50143997	-	PUBCHEM	127027995	C15H20N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KYZMEJZVXICXQX-UHFFFAOYSA-N
29353	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9359	3-Pyridin-3-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50143996	-	PUBCHEM	127025178	C15H20N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMHAIDYPJKYSES-UHFFFAOYSA-N
29354	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9360	3-Pyridin-2-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50143995	-	PUBCHEM	127028973	C15H20N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VRGLHLDCWONREK-UHFFFAOYSA-N
29355	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29356	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9361	7-Mercapto-heptanoic acid phenylamide	ZINC13609304|7-MERCAPTO-HEPTANOIC ACID PHENYLAMIDE|N-PHENYL-7-SULFANYLHEPTANAMIDE|THIOL-SAHA (T-SAHA)|BDBM152692	-	PUBCHEM	11379392	C13H19NOS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CFKBMXXDXYFDET-UHFFFAOYSA-N
29357	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Ghosh B (2016)	26804233	224813	9362	N'-Hydroxy-N-[(E)-(4-pyridin-3-ylphenyl)methylideneamino]heptanediamide	BRD-K51966546-001-02-2|BDBM50143887	-	PUBCHEM	73707550	C19H22N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SOSXJHXYTVYMTE-FYJGNVAPSA-N
29358	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Ghosh B (2016)	26804233	224813	9363	N'-Hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]heptanediamide	J3.581.861H|7-OXO-7-[2-[(Z)-(BIPHENYL-4-YL)METHYLENE]HYDRAZINO]HEPTANEHYDROXAMIC ACID|BRD-K35010406-001-01-1|BDBM50143884	-	PUBCHEM	25118059	C20H23N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AEIVDBATQVVQFS-RCCKNPSSSA-N
29359	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Peng FW (2016)	26741358	224814	9364	7-[4-(4-Bromoanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide	BDBM50142796	-	PUBCHEM	127028030	C22H25BrN4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BNWIAUUKBJSRSZ-UHFFFAOYSA-N
29368	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dixit VA (2016)	26708109	224818	9373	5-{[4-(Benzyloxy)phenyl]methylene}-2,4,6(1H,3H,5H)-pyrimidinetrione	5-{[4-(PHENYLMETHOXY)PHENYL]METHYLENE}-1,3-DIHYDROPYRIMIDINE-2,4,6-TRIONE|242473-63-8|5-[4-(BENZYLOXY)BENZYLIDENE]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE|AKOS000514744|5-{[4-(BENZYLOXY)PHENYL]METHYLENE}-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE|KS-00001T0W|ZINC3139774|5-[(4-PHENYLMETHOXYPHENYL)METHYLIDENE]-1,3-DIAZINANE-2,4,6-TRIONE|ST50170955|MCULE-1677643513|12P-135|STK804651|5-[4-(BENZYLOXY)BENZYLIDENE]BARBITURIC ACID|5-{[4-(BENZYLOXY)PHENYL]METHYLIDENE}-1,3-DIAZINANE-2,4,6-TRIONE|BDBM50137109	-	PUBCHEM	2851123	C18H14N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RPNLKHSBSLHOSQ-UHFFFAOYSA-N
29369	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dixit VA (2016)	26708109	224818	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29370	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	9374	4-[3-(4-Fluorophenyl)-5-(6-sulfanylhexylcarbamoyl)pyrazol-1-yl]butanoic acid	BDBM50143530	-	PUBCHEM	127026737	C20H26FN3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GUKWYUINVSHUKE-UHFFFAOYSA-N
29371	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	9375	2-[3-(4-Fluorophenyl)-5-(6-sulfanylhexylcarbamoyl)pyrazol-1-yl]acetic acid	BDBM50143508	-	PUBCHEM	127026735	C18H22FN3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KDSZJUGHUQDOGC-UHFFFAOYSA-N
29372	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	9376	(1R,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone	ROMIDEPSIN (FK228, DEPSIPEPTIDE)|ZINC136702520|128517-07-7|BDBM50048864	-	PUBCHEM	11947684	C24H36N4O6S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QSVHVVLASA-N
29373	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29374	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9377	4-[(E)-N-[[4-(Dimethylamino)benzoyl]-methylamino]-C-methylcarbonimidoyl]-N-hydroxybenzamide	BDBM50146080	-	PUBCHEM	127025647	C19H22N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JCTMSWPCFNKFGT-DEDYPNTBSA-N
29375	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9378	4-[(E)-N-[[4-(Dimethylamino)benzoyl]amino]-C-methylcarbonimidoyl]-N-hydroxybenzamide	BDBM50146079	-	PUBCHEM	122601076	C18H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YBJMRJLHXVKOOB-XDHOZWIPSA-N
29376	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9379	4-[(E)-[[4-(Dimethylamino)benzoyl]-methylhydrazinylidene]methyl]-N-hydroxybenzamide	BDBM50146077	-	PUBCHEM	127025646	C18H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YOJNZHSNJLHVML-XDHOZWIPSA-N
29377	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9380	4-[(E)-[[4-(Dimethylamino)benzoyl]hydrazinylidene]methyl]-N-hydroxybenzamide	BDBM50146076	-	PUBCHEM	122601008	C17H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HHDICTUTXIOTBC-WOJGMQOQSA-N
29378	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29379	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9381	4-[(2S)-1-[5-(3,5-Dimethyl-1,2-oxazol-4-yl)-2-(2-phenylethyl)benzimidazol-1-yl]propan-2-yl]morpholine	BDBM50151662	-	PUBCHEM	127031779	C27H32N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SAMCWHOXZPKYQG-IBGZPJMESA-N
29380	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9382	[[(3R)-4-[[3-[2-[2-[[(5S)-5-Acetamido-6-amino-6-oxohexyl]amino]-2-oxoethyl]sulfanylethylamino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate	AC-LYS(COA)-NH2|BDBM50255529	-	PUBCHEM	44571034	C31H53N10O19P3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YGZKIOPJGFQDSR-QGSWMBNESA-N
29381	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9383	(2S)-2-[2-[[(1S)-1-Carboxy-3-[5-[(Z)-[(5S)-5-[3-(diaminomethylideneamino)propyl]-3,6-dioxopiperazin-2-ylidene]methyl]-2-hydroxyphenoxy]propyl]amino]-2-oxoethyl]-2-hydroxybutanedioic acid	BDBM50151656	-	PUBCHEM	127033885	C25H32N6O12	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GRAFKVRBLJRCBH-NCBISDQCSA-N
29382	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9384	(2S)-2-[[(3S)-3-Carboxy-5-[[(1S)-1-carboxy-3-[5-[(Z)-[(5S)-5-[3-(diaminomethylideneamino)propyl]-3,6-dioxopiperazin-2-ylidene]methyl]-2-hydroxyphenoxy]propyl]amino]-3-hydroxy-5-oxopentanoyl]amino]butanedioic acid	NK-13650A|BDBM50151655	-	PUBCHEM	71481176	C29H37N7O15	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CVSHHZDMYAPZPV-DFYJTYCZSA-N
29383	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9385	Tert-butyl N-[5-[[2-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]acetyl]amino]pentyl]carbamate	BDBM50151651	-	PUBCHEM	50899265	C33H58N9O19P3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XQXLJFXFNXYRML-HSJNEKGZSA-N
29384	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kachhadia V (2016)	26689485	224822	9386	(E)-3-[4-[(E)-3-(Cyclopropylamino)-2-(4-fluorophenyl)prop-1-enyl]phenyl]-N-hydroxyprop-2-enamide	BDBM50143215	-	PUBCHEM	25269097	C21H21FN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NODIYCZWVUUEMT-HTZRGULJSA-N
29385	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kachhadia V (2016)	26689485	224822	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29386	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Reddy DN (2016)	26681404	224823	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29387	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Reddy DN (2016)	26681404	224823	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29388	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Reddy DN (2016)	26681404	224823	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29389	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29390	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9387	N-Hydroxy-2-naphthalen-2-yl-1,3-oxazole-4-carboxamide	BDBM50148620	-	PUBCHEM	127027175	C14H10N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SAZKVZYUJRPYFI-UHFFFAOYSA-N
29391	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9388	2-(4-Chlorophenyl)-N-hydroxy-1,3-oxazole-4-carboxamide	BDBM50148617	-	PUBCHEM	127025656	C10H7ClN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KHHYTDYDQPEPGS-UHFFFAOYSA-N
29392	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9389	N-Hydroxy-2-(4-phenylphenyl)-1,3-oxazole-4-carboxamide	BDBM50148613	-	PUBCHEM	127028391	C16H12N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TXHNXBSXQZDEJE-UHFFFAOYSA-N
29393	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9390	2-(4-Bromophenyl)-N-hydroxy-1,3-oxazole-4-carboxamide	N-HYDROXY-2-(4-BROMOPHENYL)OXAZOLE-4-CARBOXAMIDE|P7V|J3.601.433D|2-(4-BROMOPHENYL)-N-HYDROXY-1,3-OXAZOLE-4-CARBOXAMIDE|BDBM50148612	-	PUBCHEM	127027171	C10H7BrN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KHPRTOQUGAUDCM-UHFFFAOYSA-N
29394	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29395	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Thaler F (2016)	26629860	224825	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29396	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Romero FA (2016)	26572217	224826	9391	Sgc-cbp30	Q27088793|GTPL7529|C28H33CLN4O3|4-[(2S)-1-[2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZIMIDAZOL-1-YL]PROPAN-2-YL]MORPHOLINE|HY-15826|(S)-4-(1-(2-(3-CHLORO-4-METHOXYPHENETHYL)-5-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-1-YL)PROPAN-2-YL)MORPHOLINE|S7256|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-1,3-BENZODIAZOLE|AOB4800|5-(3,5-DIMETHYLISOXAZOLE-4-YL)-2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-1-[(S)-2-MORPHOLINOPROPYL]-1H-BENZOIMIDAZOLE|EX-A2159|SGC-CBP30|CCG-269770|AKOS024458401|NCGC00351475-07|A13227|ZINC96170456|CS-2096|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-BENZIMIDAZOLE|SW219645-1|2LO|AS-56079|SGC-CBP30, >=98% (HPLC)|2715AH|1613695-14-9|BDBM188519	-	PUBCHEM	72201027	C28H33ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GEPYBHCJBORHCE-SFHVURJKSA-N
29397	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Ni M (2015)	26481659	224827	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29398	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Peng FW (2015)	26475519	224828	9392	6-[4-(2,4-Dichloroanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyhexanamide	BDBM50132484	-	PUBCHEM	122195536	C21H22Cl2N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HQVSMMXKDYANJJ-UHFFFAOYSA-N
29399	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9393	Ricolinostat	SW219836-1|ZINC89630354|W-5979|AS-73344|D10661|ROCILINOSTAT (ACY-1215)|GTPL7010|ROCILINOSTAT|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]PYRIMIDINE-5-CARBOXAMIDE|ACY-63|DTXSID40157148|RICOLINOSTAT (USAN/INN)|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)-|CCG-269054|AK151416|7-{[2-(DIPHENYLAMINO)PYRIMIDIN-5-YL]FORMAMIDO}-N-HYDROXYHEPTANAMIDE|SMR004702950|EX-A139|UNII-WKT909C62B|ACN-030031|S8001|AH4|CS-0965|DB12376|Q27088553|NS00073045|ACY-1215|1316214-52-4|SB17054|CC-661|HMS3426C09|US8609678, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE [26]|AB0032517|BCP06028|A11940|X5832|AC-30258|2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE|MLS006011181|N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-2-(N-PHENYLANILINO)PYRIMIDINE-5-CARBOXAMIDE|HY-16026|WKT909C62B|NCGC00345802-05|J-690127|ACY1215|AX8288032|AKOS024259260|RICOLINOSTAT (ACY-1215)|RICOLINOSTAT [USAN:INN]|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-5-PYRIMIDINECARBOXAMIDE|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-|NCGC00345802-01|RICOLINOSTAT|HMS3653F17|KS-00000SAV|BDBM50439674	-	PUBCHEM	53340666	C24H27N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QGZYDVAGYRLSKP-UHFFFAOYSA-N
29400	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9394	N-Hydroxy-6-[4-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]hexanamide	ONC(CCCCCOC1=CC=C(C=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)=O|BDBM50151381	-	PUBCHEM	122550126	C22H26N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YHQAMQHTTOJBPC-UHFFFAOYSA-N
29401	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9395	N-Hydroxy-5-[4-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]pentanamide	ONC(CCCCOC1=CC=C(C=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)=O|BDBM50151380	-	PUBCHEM	122550235	C21H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VINHTOOQEORVNT-UHFFFAOYSA-N
29402	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9396	N-Hydroxy-2-[4-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]acetamide	ONC(COC1=CC=C(C=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)=O|BDBM50151378	-	PUBCHEM	122550234	C18H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MPMPKDWQOVDGGV-UHFFFAOYSA-N
29403	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9397	N-Hydroxy-6-[2-methoxy-5-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]hexanamide	ONC(CCCCCOC1=C(C=CC(=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)OC)=O|BDBM50151377	-	PUBCHEM	122550213	C23H28N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOLDSRJBCFTJIA-UHFFFAOYSA-N
29404	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9398	Hdac6-IN-1	HY-18947|CS-0014660|SKLB-23BB|S8743|N-HYDROXY-4-[2-METHOXY-5-[METHYL(2-METHYLQUINAZOLINE-4-YL)AMINO]PHENOXY]BUTANAMIDE|ONC(CCCOC1=C(C=CC(=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)OC)=O|J3.553.794E|1815580-06-3|HDAC6-IN-1|BDBM50151375	-	PUBCHEM	122550211	C21H24N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FWXZZFONXWYSEF-UHFFFAOYSA-N
29405	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9399	N-Hydroxy-6-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]hexanamide	BDBM50151325	-	PUBCHEM	127031757	C21H28N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YUAKVYNOFMVTES-UHFFFAOYSA-N
29406	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9400	N-Hydroxy-5-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]pentanamide	BDBM50151324	-	PUBCHEM	127030500	C20H26N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZRIVRHBHISBBGJ-UHFFFAOYSA-N
29407	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9401	N-Hydroxy-4-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]butanamide	BDBM50150960	-	PUBCHEM	127031734	C19H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMJDOVVCXHTCNO-UHFFFAOYSA-N
29408	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9402	N-Hydroxy-2-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]acetamide	BDBM50150959	-	PUBCHEM	127031756	C17H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZDRSRLVZCRYVJO-UHFFFAOYSA-N
29409	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9403	N-Hydroxy-6-[4-[methyl(quinazolin-4-yl)amino]phenoxy]hexanamide	ONC(CCCCCOC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150955	-	PUBCHEM	122550135	C21H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NXBDQDGEFPQVSI-UHFFFAOYSA-N
29410	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9404	N-Hydroxy-5-[4-[methyl(quinazolin-4-yl)amino]phenoxy]pentanamide	ONC(CCCCOC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150954	-	PUBCHEM	122550134	C20H22N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TYGPIYZPTOOAMW-UHFFFAOYSA-N
29411	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9405	N-Hydroxy-4-[4-[methyl(quinazolin-4-yl)amino]phenoxy]butanamide	ONC(CCCOC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150953	-	PUBCHEM	122550129	C19H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MGPSFMYVFDFUJS-UHFFFAOYSA-N
29412	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9406	N-Hydroxy-2-[4-[methyl(quinazolin-4-yl)amino]phenoxy]acetamide	ONC(COC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150951	-	PUBCHEM	122550132	C17H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WKPDRDKNRMYFAG-UHFFFAOYSA-N
29413	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
29414	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29415	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Musso L (2015)	26376355	224830	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29419	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2015)	26331334	224832	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29420	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Muthyala R (2015)	26264503	224833	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29421	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Muthyala R (2015)	26264503	224833	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29423	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9411	N-[1-(2-Chloro-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-CHLORO-4-METHYLPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109015	-	PUBCHEM	122184850	C24H27ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IJGUAWCQKOESOS-UHFFFAOYSA-N
29424	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9412	N-[1-(2-Bromo-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-BROMO-4-METHYLPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109014	-	PUBCHEM	122184851	C24H27BrN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QNXRAIMDOJFMKD-UHFFFAOYSA-N
29425	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9413	N'-Hydroxy-N-[1-(4-methylanilino)isoquinolin-7-yl]octanediamide	N-[1-[(4-METHYLPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109013	-	PUBCHEM	122184847	C24H28N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DHMRFGYKNXQOFG-UHFFFAOYSA-N
29426	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9414	N'-Hydroxy-N-[1-(naphthalen-2-ylamino)isoquinolin-7-yl]octanediamide	BDBM50109011	-	PUBCHEM	122184848	C27H28N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HUKJAHRJEYMMCE-UHFFFAOYSA-N
29427	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9415	N-[1-(4-Bromo-2-fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-FLUORO-4-BROMOPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109010	-	PUBCHEM	122184845	C23H24BrFN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DFKQAHYOXDWTAQ-UHFFFAOYSA-N
29428	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9416	(E)-N-Hydroxy-3-[4-[[[1-(4-methylanilino)isoquinolin-7-yl]amino]methyl]phenyl]prop-2-enamide	BDBM50109009	-	PUBCHEM	122185150	C26H24N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KPLJHTZFLSOICT-MDWZMJQESA-N
29429	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9417	N-[1-(3-Chloro-2-fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-FLUORO-3-CHLOROPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109008	-	PUBCHEM	122184846	C23H24ClFN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LYWPEQFLYUJPIU-UHFFFAOYSA-N
29430	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9418	N'-Hydroxy-N-(1-morpholin-4-ylisoquinolin-7-yl)octanediamide	BDBM50109006	-	PUBCHEM	122184854	C21H28N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DTLWMGPSWXSCIY-UHFFFAOYSA-N
29431	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9419	N'-Hydroxy-N-[1-(4-propan-2-ylpiperazin-1-yl)isoquinolin-7-yl]octanediamide	BDBM50109004	-	PUBCHEM	122184855	C24H35N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KUEFYQRLDVPNAG-UHFFFAOYSA-N
29432	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9420	N-[1-(2-Fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-FLUOROPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109002	-	PUBCHEM	122184852	C23H25FN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AGZGHJKLKCIIAU-UHFFFAOYSA-N
29433	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9421	N-[2-[(2,4-Dimethoxyphenyl)methyl]-1-oxoisoquinolin-7-yl]-N'-hydroxyoctanediamide	BDBM50109000	-	PUBCHEM	122185147	C26H31N3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIKBCAFOYUWQMO-UHFFFAOYSA-N
29434	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9422	N-[1-(2-Fluoro-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	BDBM50108999	-	PUBCHEM	122184849	C24H27FN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLJIGRZNVRDVNW-UHFFFAOYSA-N
29435	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9423	N'-Hydroxy-N-[2-(3-methylbutyl)-1-oxoisoquinolin-7-yl]octanediamide	BDBM50108184	-	PUBCHEM	122185146	C22H31N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FSIYMAGFRRSGGY-UHFFFAOYSA-N
29436	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9424	N-[2-[2-(Diethylamino)ethyl]-1-oxoisoquinolin-7-yl]-N'-hydroxyoctanediamide	BDBM50108162	-	PUBCHEM	122184858	C23H34N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZAKBEXUJXNNGOJ-UHFFFAOYSA-N
29437	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9425	N-(2-Butyl-1-oxoisoquinolin-7-yl)-N'-hydroxyoctanediamide	BDBM50108142	-	PUBCHEM	122184857	C21H29N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIMZZSMMMYOQJV-UHFFFAOYSA-N
29438	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9426	N'-Hydroxy-N-[1-(3-methoxypropylamino)isoquinolin-7-yl]octanediamide	BDBM50108129	-	PUBCHEM	122184856	C21H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MGLLPZGTTQFMEG-UHFFFAOYSA-N
29439	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29441	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Zhan P (2015)	26086931	224837	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29442	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Zhan P (2015)	26086931	224837	9391	Sgc-cbp30	Q27088793|GTPL7529|C28H33CLN4O3|4-[(2S)-1-[2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZIMIDAZOL-1-YL]PROPAN-2-YL]MORPHOLINE|HY-15826|(S)-4-(1-(2-(3-CHLORO-4-METHOXYPHENETHYL)-5-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-1-YL)PROPAN-2-YL)MORPHOLINE|S7256|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-1,3-BENZODIAZOLE|AOB4800|5-(3,5-DIMETHYLISOXAZOLE-4-YL)-2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-1-[(S)-2-MORPHOLINOPROPYL]-1H-BENZOIMIDAZOLE|EX-A2159|SGC-CBP30|CCG-269770|AKOS024458401|NCGC00351475-07|A13227|ZINC96170456|CS-2096|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-BENZIMIDAZOLE|SW219645-1|2LO|AS-56079|SGC-CBP30, >=98% (HPLC)|2715AH|1613695-14-9|BDBM188519	-	PUBCHEM	72201027	C28H33ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GEPYBHCJBORHCE-SFHVURJKSA-N
29443	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Zhan P (2015)	26086931	224837	9391	Sgc-cbp30	Q27088793|GTPL7529|C28H33CLN4O3|4-[(2S)-1-[2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZIMIDAZOL-1-YL]PROPAN-2-YL]MORPHOLINE|HY-15826|(S)-4-(1-(2-(3-CHLORO-4-METHOXYPHENETHYL)-5-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-1-YL)PROPAN-2-YL)MORPHOLINE|S7256|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-1,3-BENZODIAZOLE|AOB4800|5-(3,5-DIMETHYLISOXAZOLE-4-YL)-2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-1-[(S)-2-MORPHOLINOPROPYL]-1H-BENZOIMIDAZOLE|EX-A2159|SGC-CBP30|CCG-269770|AKOS024458401|NCGC00351475-07|A13227|ZINC96170456|CS-2096|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-BENZIMIDAZOLE|SW219645-1|2LO|AS-56079|SGC-CBP30, >=98% (HPLC)|2715AH|1613695-14-9|BDBM188519	-	PUBCHEM	72201027	C28H33ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GEPYBHCJBORHCE-SFHVURJKSA-N
29444	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Clausen DJ (2015)	26054247	224838	9428	(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3-thia-7,14,17,21-tetrazatricyclo[14.3.1.12,5]henicosa-1(20),2(21),16,18-tetraene-6,9,13-trione	BDBM50098420	-	PUBCHEM	122181882	C23H30N4O4S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YSQNJKVHVWRCPW-FXHDEUNJSA-N
29445	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Clausen DJ (2015)	26054247	224838	9429	(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3-thia-7,14,20,21-tetrazatricyclo[14.3.1.12,5]henicosa-1(19),2(21),16(20),17-tetraene-6,9,13-trione	(4R)-4,2-[CARBONYLIMINO[(S)-2-OXO-1-ISOPROPYLETHYLENE]OXY[(S)-1-OXO-7-MERCAPTO-4-HEPTENE-3,1-DIYL]IMINOMETHYLENE(PYRIDINE-2,6-DIYL)]-4BETA-METHYL-4,5-DIHYDROTHIAZOLE|BDBM50098418	-	PUBCHEM	25257993	C23H30N4O4S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	USYOVMNNRIHXJQ-BEIBECRVSA-N
29446	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Clausen DJ (2015)	26054247	224838	9430	(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione	(4R)-4,2'-[CARBONYLIMINO[(S)-1-OXO-3-METHYLBUTANE-2,1-DIYL]OXY[(S)-1-OXO-7-MERCAPTO-4-HEPTENE-3,1-DIYL]IMINOMETHYLENE]-4BETA-METHYL-4,5-DIHYDRO-2,4'-BITHIAZOLE|(2S,5S,17R)-2-ISOPROPYL-5-[(E)-4-MERCAPTO-1-BUTENYL]-17-METHYL-13,10:17,14-DIEPINITRILO-4-OXA-11,15-DITHIA-1,8-DIAZACYCLOOCTADECA-12-ENE-3,7,18-TRIONE|BDBM50098414	-	PUBCHEM	24938735	C21H28N4O4S3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VEDPEVJAYWVUSJ-BNVDZZMOSA-N
29447	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Yadav RR (2015)	26048785	224839	9431	5-(4-Pyridin-3-ylthiophen-2-yl)-1,3-thiazole	BDBM50105913	-	PUBCHEM	122184057	C12H8N2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WNKQZLFWZLQFOH-UHFFFAOYSA-N
29448	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang C (2015)	25993269	224840	9432	Naphthalen-1-yl 6-[4-[[8-(hydroxyamino)-8-oxooctanoyl]amino]phenyl]-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	BDBM50094760	-	PUBCHEM	122181047	C36H36N2O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PQXAOJPTBDMVNK-UHFFFAOYSA-N
29449	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang C (2015)	25993269	224840	9433	8-[4-[6-(3-Hydroxyphenoxy)sulfonyl-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl]anilino]-8-oxooctanoic acid	BDBM50094750	-	PUBCHEM	122180823	C32H33NO9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HNLHZLHXGMYVNW-UHFFFAOYSA-N
29450	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang C (2015)	25993269	224840	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29451	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Du G (2015)	25978962	224841	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29452	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Daniel KB (2015)	25974739	224842	9434	N-Phenyl-N'-[(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methoxy]octanediamide	BDBM50089657	-	PUBCHEM	122177622	C24H30N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HXFDEOSGMWWMSA-UHFFFAOYSA-N
29453	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Daniel KB (2015)	25974739	224842	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29454	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	unknown	target	Henry JR (2015)	25965804	224843	9435	LY-3009120	AS-74984|LY 3009120|GTPL8943|1GDT36RARO|UNII-1GDT36RARO|KS-00001CZH|3-(3,3-DIMETHYLBUTYL)-1-{2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL}UREA|J3.580.324F|AC-30240|LY-3009120|S7842|1454682-72-4|DP 4978|NCGC00481604-01|UREA, N-(3,3-DIMETHYLBUTYL)-N'-[2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL]-|UREA, N-(3,3-DIMETHYLBUTYL)-N'-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO(2,3-D)PYRIMIDIN-6-YL)PHENYL)-|1-(3,3-DIMETHYLBUTYL)-3-[2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL]UREA|SB16924|DP-4978|4Z5|1-(3,3-DIMETHYLBUTYL)-3-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO(2,3-D)PYRIMIDIN-6-YL)PHENYL)UREA|LY3009120|QC-11801|AK173776|BCP23869|1-(3,3-DIMETHYLBUTYL)-3-{2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL}UREA|N-(3,3-DIMETHYLBUTYL)-N'-[2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL]UREA|EX-A1638|ZINC205861291|1-(2-FLUORO-4-METHYL-5-(2-METHYLAMINO-7-METHYLPYRIDO[2,3-D]PYRIMIDINE-6-YL)PHENYL)-3-(3,3-DIMETHYLBUTYL)UREA|DP-4978;LY-3009120|Q27082823|HY-12558|CCG-268937|1-(3,3-DIMETHYLBUTYL)-3-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL)PHENYL)UREA|BDBM50096279	-	PUBCHEM	71721540	C23H29FN6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HHCBMISMPSAZBF-UHFFFAOYSA-N
29455	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Duan W (2015)	25906087	224844	9436	6-[[4-(Benzenesulfonyl)-5-oxido-1,2,5-oxadiazol-5-ium-3-yl]oxy]-N-hydroxyhexanamide	BDBM50087853	-	PUBCHEM	118737455	C14H17N3O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AGDGTFUFKSHWRN-UHFFFAOYSA-N
29456	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Duan W (2015)	25906087	224844	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29457	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Di Pompo G (2015)	25905694	224845	9437	N-Hydroxy-5-[[6-oxo-4-(4-phenylphenyl)-1H-pyrimidin-2-yl]sulfanyl]pentanamide	MC1742|MC 1742|5-{[4-(BIPHENYL-4-YL)-6-OXO-1,6-DIHYDROPYRIMIDIN-2-YL]SULFANYL}-N-HYDROXYPENTANAMIDE|ZINC140782936|5-[[6-OXO-4-(4-PHENYLPHENYL)-1H-PYRIMIDIN-2-YL]SULFANYL]PENTANEHYDROXAMIC ACID|AKOS027470271|1776116-74-5|BDBM50087845	-	PUBCHEM	136173089	C21H21N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AOFVDNFTELWRHV-UHFFFAOYSA-N
29458	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Di Pompo G (2015)	25905694	224845	9438	N-[6-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]pyridin-3-yl]-2,3-diphenylpropanamide	J3.561.771J|MC-2625|BDBM50087841	-	PUBCHEM	118737400	C23H21N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UQSIPNLHOWORHA-BUHFOSPRSA-N
29459	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9439	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[6-(hydroxyamino)-6-oxohexyl]benzamide	BDBM50080071	-	PUBCHEM	136961657	C20H24N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LAPSXONRKCNPMH-UHFFFAOYSA-N
29460	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9440	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-hydroxybenzamide	BDBM50080008	-	PUBCHEM	136961654	C14H13N7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DUXRBKWTYAMJCH-UHFFFAOYSA-N
29461	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9441	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide	BDBM50080007	-	PUBCHEM	136961658	C21H26N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FDKBZGYHEWRDAU-UHFFFAOYSA-N
29462	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9442	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[8-(hydroxyamino)-8-oxooctyl]benzamide	BDBM50080006	-	PUBCHEM	136961659	C22H28N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMZXWCBRVCVILS-UHFFFAOYSA-N
29463	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9443	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[9-(hydroxyamino)-9-oxononyl]benzamide	BDBM50080005	-	PUBCHEM	136961660	C23H30N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QJGGEUHIPSSJGP-UHFFFAOYSA-N
29464	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	He S (2015)	25815139	224847	9444	N-Hydroxy-7-[3-[4-[[(7-hydroxy-21-methyl-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7,15(20),16,18-heptaen-17-yl)amino]methyl]phenyl]-1,2,4-oxadiazol-5-yl]heptanamide	BDBM50089085	-	PUBCHEM	122177957	C35H37N7O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FTVNKVXRXIRGTC-UHFFFAOYSA-N
29465	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	He S (2015)	25815139	224847	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29481	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9460	4-[[(3S)-1-(4-Chlorophenyl)-3-methyl-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	J3.522.188C|4-[[(3S)-1-(4-CHLOROPHENYL)-2-OXO-3-METHYLPYRROLIDINE-3-YL]AMINO]BENZHYDROXIMIC ACID|BDBM50078748	-	PUBCHEM	118733374	C18H18ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMBODOHYRWZQEW-SFHVURJKSA-N
29482	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9461	N-Hydroxy-4-[(3-methyl-2-oxo-1-quinolin-6-ylpyrrolidin-3-yl)amino]benzamide	N-HYDROXY-4-[(3-METHYL-2-OXO-1-QUINOLIN-6-YLPYRROLIDIN-3-YL)AMINO]BENZAMIDE|BDBM50078747	-	PUBCHEM	57524107	C21H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RSKIXUXUCRJFFV-UHFFFAOYSA-N
29483	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9462	4-[[1-(4-Chlorophenyl)-3-methyl-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(4-CHLOROPHENYL)-3-METHYL-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|1390618-15-1|BDBM50078695	-	PUBCHEM	57524021	C18H18ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMBODOHYRWZQEW-UHFFFAOYSA-N
29484	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9463	4-[[1-(4-Cyanophenyl)-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(4-CYANOPHENYL)-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|BDBM50078690	-	PUBCHEM	57524835	C18H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YOFSZHJBQOKORL-UHFFFAOYSA-N
29485	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9464	4-[[1-(3,4-Dichlorophenyl)-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(3,4-DICHLOROPHENYL)-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|BDBM50078687	-	PUBCHEM	57524908	C17H15Cl2N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BVYKJJVMJBRGCE-UHFFFAOYSA-N
29486	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9465	4-[[1-(3-Chlorophenyl)-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(3-CHLOROPHENYL)-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|BDBM50078680	-	PUBCHEM	57524666	C17H16ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TZTDSVDQFPJDKR-UHFFFAOYSA-N
29487	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9466	(7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide	(R)-7BETA-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOHYDROXIMIC ACID|BDBM50027662	-	PUBCHEM	92045024	C20H19N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWLFQRZKKHIDTM-QGZVFWFLSA-N
29488	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29489	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9467	N-Hydroxy-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-1,2,3,4-tetrahydroquinoline-6-carboxamide	US8716285, 53|BDBM120996	-	PUBCHEM	56933019	C19H18N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YWYZSTJJOZEEKF-UHFFFAOYSA-N
29490	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9468	10-Bromo-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097868	-	PUBCHEM	122181014	C16H9BrN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PCUWPDUAQBAWHT-UHFFFAOYSA-N
29491	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9469	10-Chloro-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097867	-	PUBCHEM	122181013	C16H9ClN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ABRIIMZXUFHPCH-UHFFFAOYSA-N
29492	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9470	10-Chloro-2-(3-methoxyphenyl)-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097863	-	PUBCHEM	122181024	C23H15ClN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VCFPJHJKTXRDGD-UHFFFAOYSA-N
29493	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9471	10-Bromo-3-methoxy-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097855	-	PUBCHEM	122181018	C17H11BrN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ARYGGCNDASPYNG-UHFFFAOYSA-N
29494	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9472	10-Chloro-3-methoxy-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097854	-	PUBCHEM	122181017	C17H11ClN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WXMYTQDKBPDSSR-UHFFFAOYSA-N
29495	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Milite C (2015)	25730130	224851	9473	1,3,5-Tribenzylpyrimidine-2,4,6(1H,3H,5H)-trione	1,3,5-TRIBENZYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE|ZINC1701219|CTK7H0853|NSC109117|NSC-109117|BDBM50081172	-	PUBCHEM	268735	C25H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SFFBIIMMBIRGKT-UHFFFAOYSA-N
29496	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Milite C (2015)	25730130	224851	9474	5-Benzoyl-1,3-dibenzyl-1,3-diazinane-2,4,6-trione	BDBM50081171	-	PUBCHEM	118735269	C25H20N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ILBMLQVDTUJJKC-UHFFFAOYSA-N
29497	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9475	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)pyrimidin-2-yl]pyrrolidine-3-carboxylic acid	BDBM50377302	-	PUBCHEM	10347566	C29H27F3N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ABIFPJDABNXEMK-GGAORHGYSA-N
29498	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9476	(3R,4S)-4-[[3-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)pyrimidin-2-yl]pyrrolidine-3-carboxylic acid	BDBM50063315	-	PUBCHEM	58977541	C29H27F3N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIUUZBXRQNCUIL-GGAORHGYSA-N
29499	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9477	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)-1,3-oxazol-2-yl]pyrrolidine-3-carboxylic acid	BDBM50063313	-	PUBCHEM	58977463	C28H26F3N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMYUDUHXSWKCSZ-IRLDBZIGSA-N
29500	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9478	(3R,4S)-4-[[3-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-phenylpyrrolidine-3-carboxylic acid	BDBM50063311	-	PUBCHEM	58977846	C30H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WWXVNRULVDGHSD-SQHAQQRYSA-N
29501	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9479	(3R,4S)-4-[2-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]ethyl]-1-phenoxycarbonylpyrrolidine-3-carboxylic acid	BDBM50063099	-	PUBCHEM	10370056	C32H32N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JHPSLFHGWGTITM-NAKRPHOHSA-N
29502	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9480	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-phenoxycarbonylpyrrolidine-3-carboxylic acid	BDBM50063089	-	PUBCHEM	10346786	C31H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IAXWLNXPJOTFTP-SQHAQQRYSA-N
29517	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9494	(2S)-N'-Hydroxy-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]-N-phenyloctanediamide	BDBM50042849	-	PUBCHEM	72947043	C18H24N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GHCWLYKERZOPPW-KBPBESRZSA-N
29518	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9495	(2S)-N'-Hydroxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyloctanediamide	ST8086AA1|(2S)-N-[(1S)-7-(HYDROXYAMINO)-7-OXO-1-(PHENYLCARBAMOYL)HEPTYL]-5-OXO-PYRROLIDINE-2-CARBOXAMIDE|BDBM50042848	-	PUBCHEM	72946833	C19H26N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QMGDCUHFYVMSBA-GJZGRUSLSA-N
29519	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9496	(2S)-N'-Hydroxy-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-N-[3-(trifluoromethyl)phenyl]octanediamide	ST-8078-AA1|(2R)-N-[(1S)-7-(HYDROXYAMINO)-7-OXO-1-[[3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL]HEPTYL]-5-OXO-PYRROLIDINE-2-CARBOXAMIDE|ST8078AA1|SB19290|1528755-83-0|BDBM50042847	-	PUBCHEM	72710871	C20H25F3N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XVGBJXUAVWXLJX-LSDHHAIUSA-N
29520	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9497	(2S)-N'-Hydroxy-N-(3-methylphenyl)-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]octanediamide	(2R)-N-[(1S)-7-(HYDROXYAMINO)-1-(M-TOLYLCARBAMOYL)-7-OXO-HEPTYL]-5-OXO-PYRROLIDINE-2-CARBOXAMIDE|ST8074AA1|BDBM50042846	-	PUBCHEM	72947044	C20H28N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DAGWCJGDWGPDPA-JKSUJKDBSA-N
29521	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9498	(2R)-N-[(2S)-1-Anilino-1-oxo-7-sulfanylheptan-2-yl]-5-oxopyrrolidine-2-carboxamide	BDBM50042845	-	PUBCHEM	91884636	C18H25N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YYSCXBPFYMVUDP-LSDHHAIUSA-N
29522	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9499	(2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamide	BDBM50027520	-	PUBCHEM	118719817	C19H24F3N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CXRLQBYGPWEWJP-LSDHHAIUSA-N
29523	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29535	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2015)	25462271	224855	9511	N-[(2S)-1-[3-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]phenoxy]-3-(1H-indol-3-yl)propan-2-yl]-4-methoxybenzamide	BDBM50038747	-	PUBCHEM	118720522	C28H27N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UXMMCAXDMKCFRK-UNJYKCMZSA-N
29536	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2015)	25462271	224855	9512	N-[(2S)-1-[3-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]phenoxy]-3-(1H-indol-3-yl)propan-2-yl]-2-methoxybenzamide	BDBM50038729	-	PUBCHEM	118720529	C28H27N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSRRZSNVPQPAFD-ARKBFRDHSA-N
29537	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2015)	25462271	224855	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29538	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Zwick V (2014)	25455492	224856	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29539	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9513	N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide	1454308-22-5|DB-096476|BDBM50440912	-	PUBCHEM	73333311	C14H15N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FOBBYTXDJVRRLB-UHFFFAOYSA-N
29540	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9514	N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide	ZINC68248700|N-HYDROXY-2-(1-METHYLPYRROLE-2-CARBONYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-6-CARBOXAMIDE|EX-A1852|BCP29593|SYN1218|CS-0064770|N-HYDROXY-2-(1-METHYL-1H-PYRROLE-2-CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBOXAMIDE|MPI 5A;MPI5A;HDAC6 INHIBITOR;HISTONE DEACETYLASE 6|1259296-46-2|MPI_5A|MPI-5A|DB-092801|HY-113957|1,2,3,4-TETRAHYDRO-N-HYDROXY-2-[(1-METHYL-1H-PYRROL-2-YL)CARBONYL]-6-ISOQUINOLINECARBOXAMIDE|BDBM50440907	-	PUBCHEM	49831258	C16H17N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NNQAQGDSGCGFER-UHFFFAOYSA-N
29541	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29542	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9515	N-Hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide	N-HYDROXY-7-(4-PHENYLBENZOYL)-6,8-DIHYDRO-5H-IMIDAZO[1,2-A]PYRAZINE-2-CARBOXAMIDE|BDBM50036305	-	PUBCHEM	53390842	C20H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OGQGBQMGXFYPBR-UHFFFAOYSA-N
29543	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9516	7-(1-Benzothiophene-2-carbonyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide	7-(1-BENZOTHIOPHENE-2-CARBONYL)-N-HYDROXY-6,8-DIHYDRO-5H-IMIDAZO[1,2-A]PYRAZINE-2-CARBOXAMIDE|BDBM50036304	-	PUBCHEM	58465842	C16H14N4O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GBJSJGWUCWJYTR-UHFFFAOYSA-N
29544	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9517	2-(4,5-Dichloro-1-methylpyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	2-(4,5-DICHLORO-1-METHYLPYRROLE-2-CARBONYL)-N-HYDROXY-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036303	-	PUBCHEM	58465719	C14H14Cl2N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GPVDZHZKWSWTAW-UHFFFAOYSA-N
29545	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9518	2-(1-Benzothiophene-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	BDBM50036301	-	PUBCHEM	118719410	C17H15N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PKOFMNJPOQAOMK-UHFFFAOYSA-N
29546	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9519	N-Hydroxy-2-(4-methoxybenzoyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(4-METHOXYBENZOYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036300	-	PUBCHEM	87400677	C16H17N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBYDKMSHGGWYID-UHFFFAOYSA-N
29547	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9520	2-(Cyclohexanecarbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	2-(CYCLOHEXANECARBONYL)-N-HYDROXY-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036299	-	PUBCHEM	58465664	C15H21N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IRYNPILZVVOIKV-UHFFFAOYSA-N
29548	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9521	N-Hydroxy-2-(1-methylindole-5-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(1-METHYLINDOLE-5-CARBONYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036296	-	PUBCHEM	58465755	C18H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZVYGMGIDIFWWGW-UHFFFAOYSA-N
29549	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9522	N-Hydroxy-2-(4-phenylbenzoyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(4-PHENYLBENZOYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036295	-	PUBCHEM	58465681	C21H19N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSAEIUYNAKOEW-UHFFFAOYSA-N
29550	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9523	N-Hydroxy-5-(1-methylindole-2-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide	N-HYDROXY-5-(1-METHYLINDOLE-2-CARBONYL)-6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE-2-CARBOXAMIDE|BDBM50036291	-	PUBCHEM	58465705	C17H17N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ODOAGJBJOFXVAD-UHFFFAOYSA-N
29551	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9524	N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(1-METHYLPYRROLE-2-CARBONYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036285	-	PUBCHEM	58465708	C14H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HXYDFXUSMZJLIU-UHFFFAOYSA-N
29552	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9525	Tubacin	AC-28328|DIOX-H_003551|Q27089032|AC1O7Y2P|TUBACIN (BML-GR362)|CTK8E6516|S2239|A10954|EX-A2172|1350555-93-9|HY-13428|CCG-270408|ZINC27551136|TUBACIN, >=98% (HPLC)|GTPL7374|537049-40-4|NCGC00346840-01|SW219084-1|BRD-K98426715-001-01-9|Y6280|N1-(4-((2R,4R,6S)-4-(((4,5-DIPHENYLOXAZOL-2-YL)THIO)METHYL)-6-(4-(HYDROXYMETHYL)PHENYL)-1,3-DIOXAN-2-YL)PHENYL)-N8-HYDROXYOCTANEDIAMIDE|N-[4-[(2R,4R,6S)-4-[[(4,5-DIPHENYL-2-OXAZOLYL)THIO]METHYL]-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL]PHENYL]-N'-HYDROXYOCTANEDIAMIDE|C41H43N3O7S|OCTANEDIAMIDE, N1-(4-((2R,4R,6S)-4-(((4,5-DIPHENYL-2-OXAZOLYL)THIO)METHYL)-6-(4-(HYDROXYMETHYL)PHENYL)-1,3-DIOXAN-2-YL)PHENYL)-N8-HYDROXY-, REL-|UNII-02C2G1D30D COMPONENT BHUZLJOUHMBZQY-YXQOSMAKSA-N|NCGC00346840-03|CS-5738|N-[4-[(2R,4R,6S)-4-[[4,5-DI(PHENYL)-1,3-OXAZOL-2-YL]SULFANYLMETHYL]-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL]PHENYL]-N'-HYDROXYOCTANEDIAMIDE|N-[4-[(2R,4R,6S)-4-[(4,5-DIPHENYL-1,3-OXAZOL-2-YL)SULFANYLMETHYL]-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL]PHENYL]-N'-HYDROXYOCTANEDIAMIDE|N-(4-{(2R,4R,6S)-4-{[(4,5-DIPHENYL-1,3-OXAZOL-2-YL)SULFANYL]METHYL}-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL}PHENYL)-N -HYDROXYOCTANEDIAMIDE|AKOS024457607|TUBACIN|KS-0000185J|BDBM22449	-	PUBCHEM	6675804	C41H43N3O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BHUZLJOUHMBZQY-YXQOSMAKSA-N
29553	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29554	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang G (2014)	25238284	224858	9526	N-Hydroxy-2-[[5-(3-nitrophenyl)furan-2-yl]methyl]-3,4-dihydro-1H-isoquinoline-7-carboxamide	2-[5-(3-NITROPHENYL)FURFURYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOHYDROXIMIC ACID|BDBM50027664	-	PUBCHEM	101882265	C21H19N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PMFDRULHDRRWFP-UHFFFAOYSA-N
29555	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang G (2014)	25238284	224858	9466	(7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide	(R)-7BETA-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOHYDROXIMIC ACID|BDBM50027662	-	PUBCHEM	92045024	C20H19N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWLFQRZKKHIDTM-QGZVFWFLSA-N
29556	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang G (2014)	25238284	224858	9527	(7S)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide	BDBM50027661	-	PUBCHEM	118715268	C20H19N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWLFQRZKKHIDTM-KRWDZBQOSA-N
29557	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	9528	N-Hydroxy-5-[1-[(4-phenylphenyl)methyl]pyrazol-3-yl]pentanamide	BDBM50026431	-	PUBCHEM	118714377	C21H23N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIMAODGURWKHJY-UHFFFAOYSA-N
29558	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	9529	N-Hydroxy-5-(1-phenylpyrazol-3-yl)pentanamide	BDBM50026430	-	PUBCHEM	118714371	C14H17N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SRBLEOJYOQUWOH-UHFFFAOYSA-N
29559	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	9530	5-[1-[(4-Anilinophenyl)methyl]pyrazol-3-yl]-N-hydroxypentanamide	BDBM50026429	-	PUBCHEM	118714376	C21H24N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XXOUJCCBKBTDDB-UHFFFAOYSA-N
29560	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29561	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Salvador LA (2014)	25147612	224860	9531	(5R,8S,11S)-5-Methyl-11-[(E)-4-[[(E)-4-[(5R,8S,11S)-5-methyl-6,9,13-trioxo-8-propan-2-yl-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-trien-11-yl]but-3-enyl]disulfanyl]but-1-enyl]-8-propan-2-yl-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione	BDBM50101331	-	PUBCHEM	118712502	C42H54N8O8S6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VXQMEGLYMWVBHB-UOLLFOIHSA-N
29562	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Salvador LA (2014)	25147612	224860	9532	Largazole Thiol	LARGAZOLE THIOL|BDBM50020912	-	PUBCHEM	56663191	C21H28N4O4S3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VEDPEVJAYWVUSJ-FJNFOTEGSA-N
29566	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9536	(2r)-2-Benzyl-3-[3-({[4-(Piperidin-1-Yl)benzoyl]amino}methyl)-4-Propoxyphenyl]propanoic Acid	Q27459965|(2R)-2-BENZYL-3-[3-({[4-(PIPERIDIN-1-YL)BENZOYL]AMINO}METHYL)-4-PROPOXYPHENYL]PROPANOIC ACID|(2R)-2-BENZYL-3-[3-[[(4-PIPERIDIN-1-YLBENZOYL)AMINO]METHYL]-4-PROPOXYPHENYL]PROPANOIC ACID|MEKT-28|EK8|BDBM50050557	-	PUBCHEM	56929502	C32H38N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ISYAJDFASPMBOB-HHHXNRCGSA-N
29567	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9537	(2R)-2-[[3-[[[4-(Azocan-1-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	(R)-2-[3-[[[4-(OCTAHYDROAZOCINE-1-YL)BENZOYL]AMINO]METHYL]-4-(PROPYLOXY)BENZYL]-3-PHENYLPROPANOIC ACID|BDBM50050556	-	PUBCHEM	102313443	C34H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NLXAFEDDAOLUIF-GDLZYMKVSA-N
29568	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9538	(2R)-2-[[3-[[[4-(Azonan-1-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050555	-	PUBCHEM	118708437	C35H44N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LEXLSPDBTSINAM-SSEXGKCCSA-N
29569	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9539	(2R)-2-Benzyl-3-[4-propoxy-3-[[[4-(3,3,5,5-tetramethylpiperidin-1-yl)benzoyl]amino]methyl]phenyl]propanoic acid	BDBM50050554	-	PUBCHEM	118708440	C36H46N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CTTGJGHAKDHCCV-GDLZYMKVSA-N
29570	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9540	(2R)-2-[[3-[[[4-(8-Azabicyclo[3.2.1]octan-8-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	(R)-2-[3-[[[4-(8-AZABICYCLO[3.2.1]OCTANE-8-YL)BENZOYL]AMINO]METHYL]-4-(PROPYLOXY)BENZYL]-3-PHENYLPROPANOIC ACID|BDBM50050553	-	PUBCHEM	102313442	C34H40N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JRGNQRQWJGAPES-WWUHRCHBSA-N
29571	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9541	(2R)-2-[[3-[[[4-(9-Azabicyclo[3.3.1]nonan-9-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050552	-	PUBCHEM	118708441	C35H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HTWMBKHFCRGFJX-WHIWCKBPSA-N
29572	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9542	(2R)-2-[[3-[[[4-(3-Azabicyclo[3.2.1]octan-3-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050551	-	PUBCHEM	118708442	C34H40N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SOCVTCXYXPQYPF-VMJMFXBVSA-N
29573	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9543	(2R)-2-[[3-[[[4-(2-Azatricyclo[3.3.1.13,7]decan-2-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050550	-	PUBCHEM	118708443	C36H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GRIHSHBOOIEZBN-YQNGJPPUSA-N
29574	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	9544	(E)-N-Hydroxy-3-[4-[[5-(naphthalen-1-ylmethyl)-1,3,4-oxadiazol-2-yl]methyl]phenyl]prop-2-enamide	N-HYDROXY-3-[4-[5-(1-NAPHTHYLMETHYL)-1,3,4-OXADIAZOLE-2-YLMETHYL]PHENYL]PROPENEAMIDE|BDBM50047967	-	PUBCHEM	102366363	C23H19N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DQHBWINPWGGELF-OUKQBFOZSA-N
29575	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	9545	(E)-N-Hydroxy-3-[4-[5-(1H-indol-3-ylmethyl)-1,3,4-oxadiazol-2-yl]phenyl]prop-2-enamide	BDBM50047966	-	PUBCHEM	118707836	C20H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MTSNUBCDRYSBCQ-JXMROGBWSA-N
29576	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	9546	(E)-N-Hydroxy-3-[4-[5-(naphthalen-1-ylmethyl)-1,3,4-oxadiazol-2-yl]phenyl]prop-2-enamide	BDBM50047965	-	PUBCHEM	118707835	C22H17N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LBRVMWDZJHBLGD-JLHYYAGUSA-N
29577	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29578	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Chen F (2014)	24944733	224865	9532	Largazole Thiol	LARGAZOLE THIOL|BDBM50020912	-	PUBCHEM	56663191	C21H28N4O4S3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VEDPEVJAYWVUSJ-FJNFOTEGSA-N
29586	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9553	N-[7-(Hydroxyamino)-7-oxoheptyl]-2-methoxyquinoline-6-carboxamide	BDBM50044648	-	PUBCHEM	117829456	C18H23N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VVZXDYPDBYYVAY-UHFFFAOYSA-N
29587	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9554	N-[7-(Hydroxyamino)-7-oxoheptyl]-1-methyl-2-oxoquinoline-6-carboxamide	BDBM50044646	-	PUBCHEM	117829462	C18H23N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FVXNWIVUIWQBNB-UHFFFAOYSA-N
29588	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9555	N-[7-(Hydroxyamino)-7-oxoheptyl]-4,4-dimethyl-2-oxo-1,3-dihydroquinoline-6-carboxamide	BDBM50044645	-	PUBCHEM	86581005	C19H27N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OEQQELYWLWKXKU-UHFFFAOYSA-N
29589	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9556	N'-Hydroxy-N-(2-oxo-1H-quinolin-6-yl)octanediamide	BDBM50044640	-	PUBCHEM	117829479	C17H21N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMKXBBIZQUFLCC-UHFFFAOYSA-N
29590	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9557	BDBM50033636	-	-	CHEMBL	CHEMBL3309297	C22H29N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RIHKXPFNMAZMOA-KTRQRASZSA-N
29596	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee HY (2014)	24766560	224871	9393	Ricolinostat	SW219836-1|ZINC89630354|W-5979|AS-73344|D10661|ROCILINOSTAT (ACY-1215)|GTPL7010|ROCILINOSTAT|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]PYRIMIDINE-5-CARBOXAMIDE|ACY-63|DTXSID40157148|RICOLINOSTAT (USAN/INN)|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)-|CCG-269054|AK151416|7-{[2-(DIPHENYLAMINO)PYRIMIDIN-5-YL]FORMAMIDO}-N-HYDROXYHEPTANAMIDE|SMR004702950|EX-A139|UNII-WKT909C62B|ACN-030031|S8001|AH4|CS-0965|DB12376|Q27088553|NS00073045|ACY-1215|1316214-52-4|SB17054|CC-661|HMS3426C09|US8609678, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE [26]|AB0032517|BCP06028|A11940|X5832|AC-30258|2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE|MLS006011181|N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-2-(N-PHENYLANILINO)PYRIMIDINE-5-CARBOXAMIDE|HY-16026|WKT909C62B|NCGC00345802-05|J-690127|ACY1215|AX8288032|AKOS024259260|RICOLINOSTAT (ACY-1215)|RICOLINOSTAT [USAN:INN]|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-5-PYRIMIDINECARBOXAMIDE|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-|NCGC00345802-01|RICOLINOSTAT|HMS3653F17|KS-00000SAV|BDBM50439674	-	PUBCHEM	53340666	C24H27N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QGZYDVAGYRLSKP-UHFFFAOYSA-N
29597	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee HY (2014)	24766560	224871	9561	(E)-N-Hydroxy-3-(3-pyrrolo[2,3-b]pyridin-1-ylsulfonylphenyl)prop-2-enamide	N-HYDROXY-3-[3-(1H-PYRROLO[2,3-B]PYRIDINE-1-YLSULFONYL)PHENYL]PROPENEAMIDE|(E)-N-HYDROXY-3-(3-PYRROLO[2,3-B]PYRIDIN-1-YLSULFONYLPHENYL)PROP-2-ENAMIDE|BDBM50015233	-	PUBCHEM	86765212	C16H13N3O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OXPJGPURVBXIAP-VOTSOKGWSA-N
29598	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee HY (2014)	24766560	224871	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29601	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	9562	(E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide	(E)-N-HYDROXY-3-[4-(4-METHOXYPHENYL)PHENYL]PROP-2-ENAMIDE|N-HYDROXY-E-3-(4''-METHOXYBIPHENYL-4-YL)-ACRYLAMIDE|BDBM50293361	-	PUBCHEM	15986509	C16H15NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WKQPXLKFQLGQSM-NYYWCZLTSA-N
29602	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	9563	(E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide	N-HYDROXY-E-3-(4''-HYDROXYBIPHENYL-4-YL)-ACRYLAMIDE|(E)-N-HYDROXY-3-[4-(4-HYDROXYPHENYL)PHENYL]PROP-2-ENAMIDE|BDBM50293358	-	PUBCHEM	15986418	C15H13NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MGGQEULGVBEMAL-XCVCLJGOSA-N
29603	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29604	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29605	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2014)	24694055	224874	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29606	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Taddei M (2014)	24588105	224875	9564	1-(2,4-Dihydroxy-5-propan-2-ylphenyl)-N-[7-(hydroxyamino)-7-oxoheptyl]-5-[4-(morpholin-4-ylmethyl)phenyl]triazole-4-carboxamide	BDBM50008222	-	PUBCHEM	90655296	C30H40N6O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IBHAGSBJXPUIFA-UHFFFAOYSA-N
29607	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Taddei M (2014)	24588105	224875	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29608	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Baruchello R (2014)	24565573	224876	9565	5-(2,4-Dihydroxy-5-propan-2-ylbenzoyl)-N-[7-(hydroxyamino)-7-oxoheptyl]-6,7-dihydro-4H-[1,2]oxazolo[4,5-c]pyridine-3-carboxamide	BDBM50007730	-	PUBCHEM	86302594	C24H32N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MSHYQCFSRGHYAU-UHFFFAOYSA-N
29609	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Baruchello R (2014)	24565573	224876	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29613	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18440229	224878	9568	1-[5-(2,3-Dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2-difluoroethan-1-one	THIOPHENE DERIVATIVE, 15H|1-[5-(2,3-DIHYDRO-1H-INDOL-1-YLCARBONYL)THIOPHEN-2-YL]-2,2-DIFLUOROETHAN-1-ONE|BDBM25172	-	PUBCHEM	25023808	C15H11F2NO2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WZGNPOPOCGTSMZ-UHFFFAOYSA-N
29614	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18440229	224878	9569	CID 24857909	THIOPHENE DERIVATIVE, 3I|N-METHYL-N-(QUINOXALIN-6-YLMETHYL)-5-(2,2,2-TRIFLUOROACETYL)THIOPHENE-2-CARBOXAMIDE|BDBM25163	-	PUBCHEM	24857909	C17H12F3N3O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RLNCISDDCDFAHS-UHFFFAOYSA-N
29615	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	9570	4-[[1-(3-Aminopropyl)triazol-4-yl]methylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide	BDBM50377688	-	PUBCHEM	44449588	C20H31N7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VYBKJKUFXIAVJM-UHFFFAOYSA-N
29616	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	9571	5-[3-[4-[[4-[[7-(Hydroxyamino)-7-oxoheptyl]carbamoyl]anilino]methyl]triazol-1-yl]propylcarbamothioylamino]-2-(3-oxoxanthen-9-yl)benzoic acid	BDBM50377687	-	PUBCHEM	44448637	C41H42N8O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SIKVCWVCYQGEQT-UHFFFAOYSA-N
29617	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29618	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29619	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Nakao Y (2008)	18397826	224880	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29620	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Casimiro-Garcia A (2008)	18394907	224881	9572	(S)-3-{4-[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-pyrrol-1-yl-propionic acid	(S)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PYRROL-1-YL-PROPIONIC ACID|(S)-3-[4-[2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY]PHENYL]-2-PYRROL-1-YL-PROPIONIC ACID|(2S)-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PYRROL-1-YLPROPANOIC ACID|(ALPHAS)-ALPHA-(1H-PYRROLE-1-YL)-4-[2-(2-PHENYL-5-METHYL-4-OXAZOLYL)ETHOXY]BENZENEPROPIONIC ACID|PHENYLPROPANOIC ACID DERIVATIVE, 7|BDBM34017	-	PUBCHEM	9866595	C25H24N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OCWDFPOKWYMLGH-QHCPKHFHSA-N
29624	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18370373	224883	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29625	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18308563	224884	4802	Belinostat	UNII-F4H96P17NZ|NSC-726630|ZINC3818726|ABP000140|866323-14-0|SC-71101|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|SW219445-1|NSC726630|BELEODAQ|BCPP000351|EX-A180|PX 105684|QCR-181|BCP01741|BRD-K17743125-001-01-9|GTPL7496|(E)-N-HYDROXY-3-(3-(N-PHENYLSULFAMOYL)PHENYL)ACRYLAMIDE|BELINOSTAT - PXD101|SB16466|CC-489|AOB87787|BELINOSTAT|AX8144528|MLS006011091|AC-25046|AB0007889|BELINOSTAT (PXD101)|BELINOSTAT,PXD101, PX105684|W-5363|(E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|414864-00-9|D08870|(E)-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENEHYDROXAMIC ACID|BELINOSTAT [USAN:INN]|SMR004702879|Q4882925|E-BELINOSTAT|BELINOSTAT (PXD101)|PXD101|PXD 101|N-HYDROXY-3-(3-PHENYLSULPHAMOYLPHENYL)ACRYLAMIDE|API0003555|BELINOSTAT (USAN/INN)|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]ACRYLAMIDE|BELEODAQ (TN)|PUBCHEM22405|NCGC00263155-05|(E)-N-HYDROXY-3-(3-PHENYLSULFAMOYL-PHENYL)-ACRYLAMIDE|PXD-101|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PR|S1085|LS41098|PX-105684|BELINOSTAT PH3|N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE|EC-000.2286|BELINOSTAT/PXD101,PX105684/|5OG|DTXSID60194378|2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-, (2E)-|BCP9000386|PX105684|F4H96P17NZ|N-HYDROXY-3-[(PHENYLAMINO)SULFONYL]-TRANS-CINNAMAMIDE|AS-17068|BELINOSTAT(RANDOM CONFIGURATION)|A25012|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE|AKOS025401741|N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE|CCG-208758|2-PROPENAMIDE, N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-, (2E)-|DB05015|J-523584|BDBM25150	beleodaq	DRUGBANK	DB05015	C15H14N2O4S	small molecule	L01XX49	866323-14-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NCNRHFGMJRPRSK-MDZDMXLPSA-N
29626	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18308563	224884	9576	Dacinostat	AS-74728|(2E)-N-HYDROXY-3-(4-{[(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL}PHENYL)PROP-2-ENAMIDE|S1095|ABP000476|AOB87324|SB19288|404951-53-7|Z-3310|(2E)-N-HYDROXY-3-[4-({(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]AMINO}METHYL)PHENYL]PROP-2-ENAMIDE|MLS006011098|(E)-N-HYDROXY-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2-PROPENAMIDE|LAQ824 (NVP-LAQ824,DACINOSTAT)|AK174336|139303-EP2292617A1|EX-A2226|LAQ824; DACINOSTAT; NVP-LAQ824|ZINC1494627|Q27076972|DACINOSTAT (NVP-LAQ824, LAQ824)|V10P524501|BCP9000839|UNII-V10P524501|2-PROPENAMIDE, N-HYDROXY-3-[4-[[(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-, (2E)-|A825135|LAQ824 (DACINOSTAT)|139303-EP2270008A1|X7607|BRD-K56957086-001-02-2|DACINOSTAT [INN]|LAQ824/|CS-1974|X7530|LS-192513|NVP-LAQ824|(2E)-N-HYDROXY-3-(4-({(2-HYDROXYETHYL)(2-(1H-INDOL-3-YL)ETHYL)AMINO}METHYL)PHENYL)PROPENAMIDE|HY-13606|DTXSID1041055|EC-000.2469|(E)-N-HYDROXY-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METH YL]PHENYL]PROP-2-ENAMIDE|NVP-LAQ 824|GTPL7497|2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-HYDROXYETHYL)(2-(1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)-, (2E)-|LAQ824,NVP-LAQ824|LAQ-824|CCG-208761|LAQ824|SMR004701446|N-HYDROXY-3-[4-[[(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]-AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE|SW219385-1|SMR004702886|BCP01747|(E)-N-HYDROXY-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]PROP-2-ENAMIDE|AKOS015899788|DACINOSTAT|MLS006010418|(E)-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-N-OXIDANYL-PROP-2-ENAMIDE|BDBM19428	-	PUBCHEM	6445533	C22H25N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWDQBBCUWLSASG-MDZDMXLPSA-N
29627	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18308563	224884	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29628	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9577	(2S,3S)-1-(4-Tert-butylphenyl)-3-[[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	BDBM50372118	-	PUBCHEM	10369999	C33H34N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XRVNSFDHOMAYDC-YTMVLYRLSA-N
29629	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9578	(2S,3S)-1-(4-Methoxyphenyl)-3-[[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	Q27465016|(2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2-CARBOXYLIC ACID|REW|(2S,3S)-1-(4-METHOXYPHENYL)-3-{3-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]BENZYL}-4-OXOAZETIDINE-2-CARBOXYLIC ACID|BDBM50372107	-	PUBCHEM	10391684	C30H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DKIUFVFEAUCDLY-BDYUSTAISA-N
29630	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9579	(2S,3S)-1-(4-Methoxyphenyl)-3-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	BDBM50372105	-	PUBCHEM	9983904	C30H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WTRWFOXPPRLKFP-BDYUSTAISA-N
29631	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29632	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Paris M (2008)	18247554	224886	9580	2-Propenamide, N-hydroxy-3-(4-(((2-hydroxyethyl)(2-(1H-indol-2-yl)ethyl)amino)methyl)phenyl)-	591207-53-3|LAQ 824|2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-HYDROXYETHYL)(2-(1H-INDOL-2-YL)ETHYL)AMINO)METHYL)PHENYL)BDBM50372470	-	PUBCHEM	44456564	C22H25N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FGJCGXHQLHHNFO-MDZDMXLPSA-N
29633	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Paris M (2008)	18247554	224886	9581	(2S)-2-[(1-Methylpiperidin-2-yl)amino]-8-oxo-N-(4-phenyl-1,3-thiazol-2-yl)nonanamide	BDBM50372446	-	PUBCHEM	44456965	C24H34N4O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KQYOQEZNUIXORM-AIBWNMTMSA-N
29634	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Paris M (2008)	18247554	224886	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29635	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Witter DJ (2008)	18060775	114009	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29636	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Schaefer S (2008)	18054239	123981	9582	6-[(3S,9S,12R)-3-Benzyl-6,6-dimethyl-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]-N-hydroxyhexanamide	6-((5S,11S,13AR)-5-BENZYL-8,8-DIMETHYL-4,7,10,13-TETRAOXO-TETRADECAHYDRO-3A,6,9,12-TETRAAZA-CYCLOPENTACYCLODODECEN-11-YL)-HEXANOIC ACID HYDROXYAMIDE|6-((9S,13AR)-5-(S)-1-BENZYL-8,8-DIMETHYL-4,7,10,13-TETRAOXO-TETRADECAHYDRO-3A,6,9,12-TETRAAZA-CYCLOPENTACYCLODODECEN-11-YL)-HEXANOIC ACID HYDROXYAMIDE|BDBM50154337	-	PUBCHEM	9806551	C26H37N5O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XWZYWFHHLWISBR-SLFFLAALSA-N
29637	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Potterat O (2007)	18044841	224887	9583	Chlorocyclinone B	METHYL 9-[1-(ACETYLOXYETHYL)]-2-CHLORO-6,8-DIHYDROXY-1-METHOXY-3-METHYL-7,12-DIOXO-7,12-DIHYDROTETRAPHENE-10-CARBOXYLATE|CHLOROCYCLINONE B|BDBM50228360	-	PUBCHEM	24762580	C26H21ClO9	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MFLXCCWOEBQIHW-UHFFFAOYSA-N
29638	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Potterat O (2007)	18044841	224887	9584	Chlorocyclinone C	METHYL 2-CHLORO-6,8-DIHYDROXY-9-{1-[(HYDROXYACETYL)OXY]ETHYL}-1-METHOXY-3-METHYL-7,12-DIOXO-7,12-DIHYDROTETRAPHENE-10-CARBOXYLATE|CHLOROCYCLINONE C|BDBM50228359	-	PUBCHEM	24180661	C26H21ClO10	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMNHPKWXMIGBEL-UHFFFAOYSA-N
29639	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Bain J (2007)	17850214	224888	6832	Su6656	330161-87-0|NCGC00094279-01|B5839|HMS3648O08|NCGC00015981-09|N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|2,3-DIHYDRO-N,N-DIMETHYL-2-OXO-3-[(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE]-1H-INDOLE-5-SULFONAMIDE|EX-A584|4071AH|AKOS015994571|MLS002153475|HMS2232C04|INSOLUTION&TRADE; SU6656|LOPAC0_000979|EU-0100979|NCGC00261664-01|S7774|Q7394936|NCGC00015981-03|1240328-42-0|SU 6656|SR-01000076237-6|HMS3263C19|(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE|CCG-205059|SU-6656|SU6656|ES-0024|SU 6656, >=98% (HPLC)|SDCCGSBI-0050952.P003|NCGC00015981-04|NCGC00094279-02|LOPAC-S-9692|NCGC00015981-02|HSCI1_000124|SR-01000076237-1|HMS3229I04|SR-01000076237|CS-3943|GTPL6044|TOX21_500979|DB08039|(Z)-N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|MFCD10565928|NCGC00015981-05|NCGC00015981-01|NCGC00015981-06|ZINC3875028|2-OXO-3-[1-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)-METH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOLE-5-SULFONIC ACID DIMETHYLAMIDE|SMR001230828|S 9692|LP00979|BRD-K97354755-001-01-5|HY-B0789|BDBM50307127	-	DRUGBANK	DB08039	C19H21N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LOGJQOUIVKBFGH-YBEGLDIGSA-N
29640	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee S (2007)	17588744	224889	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29641	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9585	N-[4-[2-[[(2S)-2-Amino-3-phenylpropanoyl]amino]phenyl]phenyl]-N'-hydroxyoctanediamide	OCTANEDIOIC ACID [2''-(2-AMINO-3-PHENYLPROPIONYLAMINO)-BIPHENYL-4-YL]AMIDE HYDROXYAMIDE|BDBM50214441	-	PUBCHEM	16733294	C29H34N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SZYFHRXJYNBDKS-VWLOTQADSA-N
29642	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9586	N-[4-[2-[[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]phenyl]phenyl]-N'-hydroxyoctanediamide	OCTANEDIOIC ACID {2''-[2-AMINO-3-(4-HYDROXY-PHENYL)PROPIONYLAMINO]BIPHENYL-4-YL}AMIDE HYDROXYAMIDE|BDBM50214439	-	PUBCHEM	16733417	C29H34N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BKQJCMOVBFAIQR-VWLOTQADSA-N
29643	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9587	N-[4-[2-[[(2S)-2-Amino-3-(1H-indol-3-yl)propanoyl]amino]phenyl]phenyl]-N'-hydroxyoctanediamide	OCTANEDIOIC ACID {2''-[2-AMINO-3-(1H-INDOL-3-YL)PROPIONYLAMINO]BIPHENYL-4-YL}AMIDE HYDROXYAMIDE|BDBM50214436	-	PUBCHEM	16733410	C31H35N5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ACGVFMBQNSCSQI-SANMLTNESA-N
29644	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9588	1-(4-(Dimethylamino)phenyl)-3-(7-(hydroxyamino)-7-oxoheptyl)urea	7-[[4-(DIMETHYLAMINO)PHENYL]CARBAMOYLAMINO]-N-HYDROXYHEPTANAMIDE|1-(4-(DIMETHYLAMINO)PHENYL)-3-(7-(HYDROXYAMINO)-7-OXOHEPTYL)UREA|7-[3-(4-DIMETHYLAMINO-PHENYL)-UREIDO]-HEPTANOIC ACID HYDROXYAMIDE|7-[3-(4-DIMETHYLAMINOPHENYL)-UREIDO]HEPTANOIC ACID HYDROXYAMIDE|BDBM50214433	-	PUBCHEM	11558827	C16H26N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZYOHRYKXMFPCNU-UHFFFAOYSA-N
29645	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9589	N'-Hydroxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]octanediamide	OCTANEDIOIC ACID HYDROXYAMIDE [4-(3-NITRO-PHENYL)THIAZOL-2-YL]AMIDE|N'-HYDROXY-N-[4-(3-NITROPHENYL)-1,3-THIAZOL-2-YL]OCTANEDIAMIDE|BDBM50214432	-	PUBCHEM	16733411	C17H20N4O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LJFNWCGSOPRFNA-UHFFFAOYSA-N
29646	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9590	3-[[4-(Dimethylamino)phenyl]methylcarbamoylamino]-N-hydroxypropanamide	8-[3-(4-DIMETHYLAMINOBENZYL)UREIDO]OCTANOIC ACID HYDROXYAMIDE|BDBM50214431	-	PUBCHEM	16733415	C13H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FJIZCQBWUCHHAR-UHFFFAOYSA-N
29647	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9591	N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide	828920-13-4|6-(2-MERCAPTOACETYLAMINO)-HEXANOIC ACID QUINOLIN-8-YLAMIDE|N-(8-QUINOLYL)-6-[(MERCAPTOACETYL)AMINO]HEXANAMIDE|N-(QUINOLIN-8-YL)-6-(2-SULFANYLACETAMIDO)HEXANAMIDE|N-QUINOLIN-8-YL-6-[(2-SULFANYLACETYL)AMINO]HEXANAMIDE|HEXANAMIDE, 6-[(MERCAPTOACETYL)AMINO]-N-8-QUINOLINYL-|CTK3D5606|6-(2-MERCAPTO-ACETYLAMINO)-HEXANOIC ACID QUINOLIN-8-YLAMIDE|DTXSID10587453|6-(2-MERCAPTOACETAMIDO)-N-(QUINOLIN-8-YL)HEXANAMIDE|BDBM50161470	-	PUBCHEM	16733414	C17H21N3O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KQBNGYXGCIUPHR-UHFFFAOYSA-N
29653	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Pochetti G (2007)	17403688	224891	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29655	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Devasthale PV (2007)	17292606	224893	9596	2-((3-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)(naphthalen-1-ylmethyl)amino)acetic acid	2-((3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)(NAPHTHALEN-1-YLMETHYL)AMINO)ACETIC ACID|BDBM50205086	-	PUBCHEM	22087541	C32H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NICLRQUMPVQLFM-UHFFFAOYSA-N
29671	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9612	3-[4-[(3R)-3-(4-Ethyl-2-pyridin-3-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-ETHYL-2-(PYRIDIN-3-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199783	-	PUBCHEM	44439626	C27H31NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QNTSQSFJMIOVQR-HXUWFJFHSA-N
29672	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9613	3-[2-Ethyl-4-[(3R)-3-[2-pyridin-2-yl-4-(trifluoromethyl)phenoxy]butoxy]phenyl]propanoic acid	3-(2-ETHYL-4-((R)-3-(2-(PYRIDIN-2-YL)-4-(TRIFLUOROMETHYL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199781	-	PUBCHEM	11409173	C27H28F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JUWZDSPINIDMLW-GOSISDBHSA-N
29673	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9614	3-[4-[(3R)-3-(4-Ethyl-2-pyridin-2-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-ETHYL-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199779	-	PUBCHEM	11178006	C27H31NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KZAXXZUCCUNGNL-HXUWFJFHSA-N
29674	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9615	3-[2-Methyl-4-[(3R)-3-[2-pyridin-2-yl-4-(trifluoromethyl)phenoxy]butoxy]phenyl]propanoic acid	3-(2-METHYL-4-((R)-3-(2-(PYRIDIN-2-YL)-4-(TRIFLUOROMETHYL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199777	-	PUBCHEM	44439633	C26H26F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AIUXBXGPPYWHFP-GOSISDBHSA-N
29675	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9616	3-[2-Ethyl-4-[(3R)-3-(4-ethyl-2-pyridin-2-ylphenoxy)butoxy]phenyl]propanoic acid	3-(2-ETHYL-4-((R)-3-(4-ETHYL-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199776	-	PUBCHEM	11155087	C28H33NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYZNATQOXOBZSD-HXUWFJFHSA-N
29676	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9617	3-[4-[(3R)-3-(4-Chloro-2-pyridin-2-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-CHLORO-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199773	-	PUBCHEM	11247654	C25H26ClNO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PHVHNSMKCROBSA-GOSISDBHSA-N
29677	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9618	(R)-3-(4-(3-(2-Benzoyl-4-ethylphenoxy)butoxy)-2-methylphenyl)propanoic acid	(R)-3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|(R)-3-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50194627	-	PUBCHEM	11431103	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-OAQYLSRUSA-N
29678	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29682	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9622	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(pyrazin-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-{4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-[(PYRAZIN-2-YLOXYCARBONYLAMINO)-METHYL]-PHENYL}-PROPIONIC ACID|BDBM50195716	-	PUBCHEM	44420485	C33H30N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VATCVNIKAWMLQK-UHFFFAOYSA-N
29683	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9623	3-[4-[2-[5-Methyl-2-(4-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENOXYPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-(4-PHENOXYPHENYL)OXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|BDBM50195715	-	PUBCHEM	10144243	C32H34N2O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MAINKGNWZLMMRF-UHFFFAOYSA-N
29684	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9624	3-(2-((Isopropoxycarbonyl)methyl)-4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|BDBM50195714	-	PUBCHEM	10205220	C26H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QDTHAXJGRDPCSZ-UHFFFAOYSA-N
29685	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9625	3-[4-[2-[5-Methyl-2-(4-pyrimidin-2-ylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-(4-(PYRIMIDIN-2-YL)PHENYL)OXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-[5-METHYL-2-(4-PYRIMIDIN-2-YLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|BDBM50195713	-	PUBCHEM	10119824	C30H32N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NTXHMSZOGJFPTJ-UHFFFAOYSA-N
29686	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9626	3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-[(pyrazin-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-(((PYRAZIN-2-YLOXY)CARBONYL)METHYL)PHENYL)PROPANOIC ACID|BDBM50195711	-	PUBCHEM	44420506	C27H26N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CASKZOPCCIBBBW-UHFFFAOYSA-N
29687	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9627	3-(2-((Benzyloxycarbonyl)methyl)-4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid	3-(2-((BENZYLOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-(PHENYLMETHOXYCARBONYLAMINOMETHYL)PHENYL]PROPANOIC ACID|BDBM50195710	-	PUBCHEM	17984540	C30H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FUTRFISBYXLQDO-UHFFFAOYSA-N
29688	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9628	3-[4-[2-(5-Methyl-2-morpholin-4-yl-1,3-thiazol-4-yl)ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-MORPHOLINOTHIAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-MORPHOLIN-4-YL-1,3-THIAZOL-4-YL)ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-{2-(ISOPROPOXYCARBONYLAMINOMETHYL)-4-[2-(5-METHYL-2-MORPHOLIN-4-YL-THIAZOL-4-YL)ETHOXY]-PHENYL}PROPIONIC ACID|BDBM50195708	-	PUBCHEM	9805639	C24H33N3O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IACIAFCVQNZHDL-UHFFFAOYSA-N
29689	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9629	3-[2-[(Benzylsulfonylamino)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid	3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-((PHENYLMETHYLSULFONAMIDO)METHYL)PHENYL)PROPANOIC ACID|BDBM50195707	-	PUBCHEM	44420484	C29H30N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AFMUUVLVLJLAEP-UHFFFAOYSA-N
29690	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9630	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-[4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-(ISOPROPOXYCARBONYLAMINO-METHYL)-PHENYL]-PROPIONIC ACID|BDBM50195702	-	PUBCHEM	10143678	C32H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLZAMMQCUXFOTM-UHFFFAOYSA-N
29691	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29692	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9631	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-PROPOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|3-(5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-(PROPOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|BDBM50195706	-	PUBCHEM	11317867	C28H32N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WVKGGZXCUUYLIT-UHFFFAOYSA-N
29693	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9632	3-[2-(2,2-Dimethylpropoxycarbonyl)-5-[2-[5-methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-[2-(2,2-DIMETHYLPROPOXYCARBONYL)-5-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|5-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-8-(2-CARBOXY-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID 2,2-DIMETHYL-PROPYL ESTER|BDBM50195705	-	PUBCHEM	44420402	C36H40N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JYMSZNJYYIGFPC-UHFFFAOYSA-N
29694	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9633	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-methylpropoxycarbonyl)-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-(2-(ISOBUTOXYCARBONYL)-5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-(2-METHYLPROPOXYCARBONYL)-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195704	-	PUBCHEM	44420566	C29H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZGYKSGFEFIEJCW-UHFFFAOYSA-N
29695	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9634	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-prop-2-ynoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-(5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-((PROP-2-YNYLOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-PROP-2-YNOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195703	-	PUBCHEM	44420565	C28H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KZTWWKBUXGHLOG-UHFFFAOYSA-N
29696	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9630	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-[4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-(ISOPROPOXYCARBONYLAMINO-METHYL)-PHENYL]-PROPIONIC ACID|BDBM50195702	-	PUBCHEM	10143678	C32H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLZAMMQCUXFOTM-UHFFFAOYSA-N
29697	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9635	3-[5-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-propoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	5-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-8-(2-CARBOXY-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID PROPYL ESTER|3-[5-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-PROPOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195699	-	PUBCHEM	11421714	C34H36N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LLUZQFNWHGWRKI-UHFFFAOYSA-N
29698	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9636	Farglitazar	GTPL2672|O-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHYL]-N-[2-(PHENYLCARBONYL)PHENYL]-L-TYROSINE|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID(GI 262570)|(S)-2-(2-BENZOYLPHENYLAMINO)-3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|GI262570; FARGLITAZAR|FARGLITAZAR (USAN/INN)|KBIOSS_002350|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)|KBIOGR_002347|3433GY7132|DSSTOX_CID_27310|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-|D04132|KBIO2_007483|1FM9|DTXSID1047310|UNII-3433GY7132|NCGC00254050-01|FARGLITAZAR [USAN]|DSSTOX_GSID_47310|TOX21_300218|NCGC00247940-01|(S)-2-((2-BENZOYLPHENYL)AMINO)-3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|LS-184758|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|GI262570X|GI-262570|FARGLITAZAR|GI-262570X|FARGLITAZAR [USAN:INN]|196808-45-4|DSSTOX_RID_82260|CMAP_000025|2(S)-(2-BENZOYLPHENYLAMINO)-3-[4-[2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY]PHENYL]PROPIONIC ACID|(2S)-2-[[2-(BENZOYL)PHENYL]AMINO]-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]PROPANOIC ACID|Q5435087|G1-262570|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL]- (9CI)|GI262570|GI 262570|KBIO2_002347|(S)-2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL]-|GI 262570X|ZINC49639808|N-(O-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-L-TYROSINE|KBIO2_004915|BDBM50085044	-	PUBCHEM	170364	C34H30N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZZCHHVUQYRMYLW-HKBQPEDESA-N
29699	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29700	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2006)	16987657	224901	9637	(2S)-N'-Hydroxy-2-[[2-(5-methoxy-2-methyl-1H-indol-3-yl)acetyl]amino]-N-[2-(2-phenyl-1H-indol-3-yl)ethyl]octanediamide	(S)-N8-HYDROXY-2-(2-(5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETAMIDO)-N1-(2-(2-PHENYL-1H-INDOL-3-YL)ETHYL)OCTANEDIAMIDE|(2S)-N'-HYDROXY-2-[[2-(5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETYL]AMINO]-N-[2-(2-PHENYL-1H-INDOL-3-YL)ETHYL]OCTANEDIAMIDE|BDBM50195108	-	PUBCHEM	11664499	C36H41N5O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VBWCMILVHANAGG-YTTGMZPUSA-N
29701	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2006)	16987657	224901	9638	N-[(2S)-1,8-Dioxo-1-[(4-phenyl-1,3-thiazol-2-yl)amino]nonan-2-yl]-1-methylpiperidine-2-carboxamide	(2S)-2-[(1-METHYLPIPERIDIN-2-YL)FORMAMIDO]-8-OXO-N-(4-PHENYL-1,3-THIAZOL-2-YL)NONANAMIDE|N-[(2S)-1,8-DIOXO-1-[(4-PHENYL-1,3-THIAZOL-2-YL)AMINO]NONAN-2-YL]-1-METHYLPIPERIDINE-2-CARBOXAMIDE|BIS-AMIDE INHIBITOR, 15|BDBM25144	-	PUBCHEM	16036765	C25H34N4O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVGAXXKEFDOLGL-AIBWNMTMSA-N
29702	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9639	3-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-pentyloxy]-2-methyl-phenyl}-propionic acid	3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-PENTYLOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)PENTOXY]-2-METHYLPHENYL]PROPANOIC ACID|BDBM50194638	-	PUBCHEM	16085984	C30H34O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KEUWMDZMXVQKJB-UHFFFAOYSA-N
29703	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9640	(r)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-fluoro-phenyl}-propionic acid	3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-FLUOROPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-FLUORO-PHENYL}-PROPIONIC ACID|BDBM50194637	-	PUBCHEM	16085987	C25H24ClFO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WXCQOBJBCVSXBR-QGZVFWFLSA-N
29704	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9641	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|BDBM50194635	-	PUBCHEM	16085985	C26H27ClO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZARBOTMPCCXOHE-LJQANCHMSA-N
29705	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9642	3-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	LS-193043|3-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|BDBM50194634	-	PUBCHEM	11305717	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-UHFFFAOYSA-N
29706	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9643	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-trifluoromethyl-phenyl}-propionic acid	3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-(TRIFLUOROMETHYL)PHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-TRIFLUOROMETHYL-PHENYL}-PROPIONIC ACID|BDBM50194633	-	PUBCHEM	16085982	C26H24ClF3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIOGFQCBUGMDNX-QGZVFWFLSA-N
29707	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9644	(R)-3-{4-[3-(4-Ethyl-2-phenoxy-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	3-[4-[(3R)-3-(4-ETHYL-2-PHENOXYPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-ETHYL-2-PHENOXY-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|BDBM50194631	-	PUBCHEM	16085980	C28H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VWGFBGMULZAECR-OAQYLSRUSA-N
29708	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9645	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-ethyl-phenyl}-propionic acid	LS-193041|3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-ETHYLPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-ETHYL-PHENYL}-PROPIONIC ACID|BDBM50194630	-	PUBCHEM	16085988	C27H29ClO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIPGEDLLCCHFDI-LJQANCHMSA-N
29709	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9646	2-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-butoxy]-phenoxy}-2-methyl-propionic acid	2-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY]PHENOXY]-2-METHYLPROPANOIC ACID|2-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50194629	-	PUBCHEM	11340513	C29H32O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ILHLGCBMPLPUEJ-UHFFFAOYSA-N
29710	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9647	(R)-3-{2-Methyl-4-[3-(2-phenoxy-4-trifluoromethyl-phenoxy)-butoxy]-phenyl}-propionic acid	3-[2-METHYL-4-[(3R)-3-[2-PHENOXY-4-(TRIFLUOROMETHYL)PHENOXY]BUTOXY]PHENYL]PROPANOIC ACID|(R)-3-{2-METHYL-4-[3-(2-PHENOXY-4-TRIFLUOROMETHYL-PHENOXY)-BUTOXY]-PHENYL}-PROPIONIC ACID|BDBM50194628	-	PUBCHEM	16085986	C27H27F3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CDXOSGNAXOTFBO-LJQANCHMSA-N
29711	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9618	(R)-3-(4-(3-(2-Benzoyl-4-ethylphenoxy)butoxy)-2-methylphenyl)propanoic acid	(R)-3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|(R)-3-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50194627	-	PUBCHEM	11431103	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-OAQYLSRUSA-N
29712	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9648	2-(4-(3-(2-Benzoyl-4-ethylphenoxy)propoxy)phenoxy)-2-methylpropanoic acid	2-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)PROPOXY)PHENOXY)-2-METHYLPROPANOIC ACID|BDBM50194626	-	PUBCHEM	16085983	C28H30O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AFQIAKAIRKBLKC-UHFFFAOYSA-N
29713	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9649	(R)-3-{2-Methyl-4-[3-(2-phenoxy-4-trifluoromethoxy-phenoxy)-butoxy]-phenyl}-propionic acid	(R)-3-{2-METHYL-4-[3-(2-PHENOXY-4-TRIFLUOROMETHOXY-PHENOXY)-BUTOXY]-PHENYL}-PROPIONIC ACID|3-[2-METHYL-4-[(3R)-3-[2-PHENOXY-4-(TRIFLUOROMETHOXY)PHENOXY]BUTOXY]PHENYL]PROPANOIC ACID|BDBM50194625	-	PUBCHEM	16085981	C27H27F3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CQHWVRVOKKOIJC-LJQANCHMSA-N
29714	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9650	3-{4-[3-(2-Benzyl-4-ethyl-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	3-[4-[3-(2-BENZYL-4-ETHYLPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|3-{4-[3-(2-BENZYL-4-ETHYL-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|BDBM50194624	-	PUBCHEM	11316788	C29H34O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QRUJOOQWHBDHME-UHFFFAOYSA-N
29715	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29721	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9656	1-(3-(Trifluoromethyl)benzyl)-N-(naphthalen-2-ylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(NAPHTHALEN-2-YLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193752	-	PUBCHEM	44419355	C27H19F3N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RSDUQVSYQVYCFK-UHFFFAOYSA-N
29722	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9657	3-(4-Methoxyphenyl)-N-(2-methylphenyl)sulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(O-TOLYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193751	-	PUBCHEM	44419391	C31H25F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIJPWVGTDPKGSQ-UHFFFAOYSA-N
29723	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9658	1-(3-(Trifluoromethyl)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193750	-	PUBCHEM	44419352	C24H16F6N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BNRJBWWXERRJDS-UHFFFAOYSA-N
29724	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9659	3-(4-Methoxyphenyl)-N-(Phenylsulfonyl)-1-[3-(Trifluoromethyl)benzyl]-1h-Indole-2-Carboxamide	76023-EP2308860A1|3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)-1-[3-(TRIFLUOROMETHYL)BENZYL]-1H-INDOLE-2-CARBOXAMIDE|N-(BENZENESULFONYL)-3-(4-METHOXYPHENYL)-1-[[3-(TRIFLUOROMETHYL)PHENYL]METHYL]INDOLE-2-CARBOXAMIDE|2HFP|1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|Q27463924|(3-(4-METHOXYPHENYL)-1-{[3-(TRIFLUOROMETHYL)PHENYL]METHYL}INDOL-2-YL)-N-(PHENYLSULFONYL) CARBOXAMIDE|NSI|BDBM50193748	-	PUBCHEM	9549238	C30H23F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCPFCXDCWUXOGT-UHFFFAOYSA-N
29725	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9660	N-(4-Fluorophenyl)sulfonyl-3-(4-methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(4-FLUOROPHENYLSULFONYL)-3-(4-METHOXYPHENYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193744	-	PUBCHEM	44419390	C30H22F4N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AOVDRHLXGSLJQB-UHFFFAOYSA-N
29726	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9661	1-(3-(Trifluoromethyl)benzyl)-N-(2-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(2-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193742	-	PUBCHEM	44419356	C24H16F6N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RYZBTWSMNGDKFD-UHFFFAOYSA-N
29727	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9662	1-(3-(Trifluoromethoxy)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHOXY)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193741	-	PUBCHEM	44419366	C24H16F6N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVMATXNFISADDB-UHFFFAOYSA-N
29728	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9663	N-(5-Chlorothiophen-2-yl)sulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(5-CHLOROTHIOPHEN-2-YLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193739	-	PUBCHEM	44419357	C21H14ClF3N2O3S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZRPUUOXOGLOCQT-UHFFFAOYSA-N
29729	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9664	3-(4-Methoxyphenyl)-N-methylsulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(METHYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193736	-	PUBCHEM	44419392	C25H21F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RUSDVKUNFXBCHZ-UHFFFAOYSA-N
29730	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9665	Methyl 2-[[3-(4-methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carbonyl]sulfamoyl]benzoate	2-{[3-(4-METHOXY-PHENYL)-1-(3-TRIFLUOROMETHYL-BENZYL)-1H-INDOLE-2-CARBONYL]-SULFAMOYL}-BENZOIC ACID METHYL ESTER|BDBM50193734	-	PUBCHEM	44419255	C32H25F3N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RRLTYQDNNRNQPH-UHFFFAOYSA-N
29731	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9666	1-(3-(Benzyloxy)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(BENZYLOXY)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193733	-	PUBCHEM	44419381	C30H23F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NZNRDAXVBYSQEB-UHFFFAOYSA-N
29732	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9667	3-(4-Methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]-N-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193729	-	PUBCHEM	44419253	C31H22F6N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LINUGMFIDAUGBH-UHFFFAOYSA-N
29733	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29734	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	9668	Tert-butyl N-[(2S)-1-(cycloheptylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate	TERT-BUTYL N-[(1S)-1-(CYCLOHEPTYLCARBAMOYL)-6-SULFANYLHEXYL]CARBAMATE|TERT-BUTYL N-[(2S)-1-(CYCLOHEPTYLAMINO)-1-OXO-7-SULFANYLHEPTAN-2-YL]CARBAMATE|THIOLATE ANALOGUE, 18A|BDBM19136	-	PUBCHEM	11844893	C19H36N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTVMPAGMFUPGRI-INIZCTEOSA-N
29735	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	9669	Tert-butyl N-[(2S)-1-(cyclohexylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate	TERT-BUTYL N-[(1S)-1-(CYCLOHEXYLCARBAMOYL)-6-SULFANYLHEXYL]CARBAMATE|THIOLATE ANALOGUE, 17A|TERT-BUTYL N-[(2S)-1-(CYCLOHEXYLAMINO)-1-OXO-7-SULFANYLHEPTAN-2-YL]CARBAMATE|BDBM19135	-	PUBCHEM	11844892	C18H34N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NREURQUIJSGJMZ-HNNXBMFYSA-N
29736	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	9670	Tert-butyl N-[(2S)-1-(cyclopentylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate	TERT-BUTYL N-[(1S)-1-(CYCLOPENTYLCARBAMOYL)-6-SULFANYLHEXYL]CARBAMATE|TERT-BUTYL N-[(2S)-1-(CYCLOPENTYLAMINO)-1-OXO-7-SULFANYLHEPTAN-2-YL]CARBAMATE|THIOLATE ANALOGUE, 16A|BDBM19134	-	PUBCHEM	11844891	C17H32N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IKSFNOMXHPMYIQ-AWEZNQCLSA-N
29737	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29738	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9671	3-(1-((2-(3,5-Dimethylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DIMETHYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DIMETHYL-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DIMETHYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188038	-	PUBCHEM	10455511	C26H28N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DSKLBNZCCNQVBC-UHFFFAOYSA-N
29739	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9672	3-(1-((2-(3,5-Dichlorophenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DICHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DICHLORO-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DICHLOROPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188037	-	PUBCHEM	10344769	C24H22Cl2N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RQMKNZHMAWCBJL-UHFFFAOYSA-N
29740	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9673	3-(1-((2-(3-Chlorophenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-(1-((2-(3-CHLOROPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|3-[1-[[2-(3-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3-CHLORO-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|BDBM50188035	-	PUBCHEM	9980586	C24H23ClN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HMMQETYZLNQVSF-UHFFFAOYSA-N
29741	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9674	3-(1-((2-(3,5-Dimethoxyphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DIMETHOXYPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DIMETHOXY-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DIMETHOXYPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188025	-	PUBCHEM	10412116	C26H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PMZZWDLQGMUYFU-UHFFFAOYSA-N
29742	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9675	3-(1-((2-(4-Tert-butylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-(1-((2-(4-TERT-BUTYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|3-[1-[[2-(4-TERT-BUTYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|BDBM50188024	-	PUBCHEM	10072967	C28H32N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FVPCEABQEUPZJE-UHFFFAOYSA-N
29743	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9676	2-Ethoxy-3-(1-((2-(4-isopropylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)propanoic acid	2-ETHOXY-3-[1-[[5-METHYL-2-(4-PROPAN-2-YLPHENYL)-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]PROPANOIC ACID|2-ETHOXY-3-(1-((2-(4-ISOPROPYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)PROPANOIC ACID|BDBM50188023	-	PUBCHEM	10343538	C27H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UDXHXODNGSKQKU-UHFFFAOYSA-N
29744	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9677	2-Ethoxy-3-(1-((2-(4-ethylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)propanoic acid	RAC-2-ETHOXY-3-{1-[2-(4-ETHYL-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-PROPIONIC ACID|2-ETHOXY-3-[1-[[2-(4-ETHYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]PROPANOIC ACID|2-ETHOXY-3-(1-((2-(4-ETHYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)PROPANOIC ACID|BDBM50188022	-	PUBCHEM	10342769	C26H28N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTXIDZKNOYTSIW-UHFFFAOYSA-N
29745	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Lu IL (2006)	16640330	171129	9678	N-[1-(4-Fluorophenyl)-3-(2-thienyl)-1H-pyrazol-5-YL]-3,5-bis(trifluoromethyl)benzenesulfonamide	N-(1-(4-FLUOROPHENYL)-3-(THIOPHEN-2-YL)-1H-PYRAZOL-5-YL)-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|MCULE-9080417768|Q27465446|N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|N-[1-(4-FLUOROPHENYL)-3-THIOPHEN-2-YL-1H-PYRAZOL-5-YL]-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|ZINC24800189|2G0H|BDBM50185944	-	PUBCHEM	2742759	C21H12F7N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BQSKQGGQDUBLNS-UHFFFAOYSA-N
29750	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2006)	16451087	171122	4493	2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	CAY10573|(5-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID|5-[3-(6-BENZOYL-1-PROPYL-2-NAPHTHYLOXY)PROPOXY]-1H-INDOLE-1-ACETIC ACID|Q27095435|1444AH|853652-40-1|5-[3-[(6-BENZOYL-1-PROPYL-2-NAPHTHALENYL)OXY]PROPOXY]-1H-INDOLE-1-ACETIC ACID|2F4B|2-(5-{3-[(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID|ZINC12504466|2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID|DB04689|2-(5-(3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY)-1H-INDOL-1-YL)ACETIC ACID|[5-(3-{[6-(PHENYLCARBONYL)-1-PROPYLNAPHTHALEN-2-YL]OXY}PROPOXY)-1H-INDOL-1-YL]ACETIC ACID|NS00070789|BDBM50181911	-	DRUGBANK	DB04689	C33H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZXWVCCFKIRBLDP-UHFFFAOYSA-N
29751	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2006)	16451087	171122	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29752	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2005)	16366601	224907	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29754	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Morphy R (2005)	16220969	224908	9684	2-Methyl-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid	2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145712	-	PUBCHEM	10139247	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-UHFFFAOYSA-N
29755	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Shinji C (2005)	16137884	224909	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29756	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9685	(2S)-2-[(2-Oxo-3,5,7-tripropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	I(S)-(4-ISOPROPYL-PHENYL)-(2-OXO-3,5,7-TRIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-ACETIC ACID|BDBM50169254	-	PUBCHEM	11247998	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGNJRUSCVGOQDZ-DEOSSOPVSA-N
29757	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9686	(S)-(4-Isopropyl-phenyl)-(4-propionyl-2,6-dipropyl-phenoxy)-acetic acid	(S)-(4-ISOPROPYL-PHENYL)-(4-PROPIONYL-2,6-DIPROPYL-PHENOXY)-ACETIC ACID|BDBM50169253	-	PUBCHEM	11223613	C26H34O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BLBKQSCECDPYAW-VWLOTQADSA-N
29758	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9687	(2S)-2-[(2-Oxo-3-propan-2-yl-5,7-dipropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	(S)-(3-ISOPROPYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-(4-ISOPROPYL-PHENYL)-ACETIC ACID|BDBM50169245	-	PUBCHEM	11339979	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CMBADTBQKXKEOM-DEOSSOPVSA-N
29759	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9688	(2S)-2-[(3-Methyl-2-oxo-5,7-dipropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	(S)-(4-ISOPROPYL-PHENYL)-(3-METHYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-ACETIC ACID|BDBM50169233	-	PUBCHEM	11189474	C25H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSBAWOCZJWUIIT-QFIPXVFZSA-N
29760	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9689	(S)-(3-Ethyl-2-oxo-5,7-dipropyl-2,3-dihydro-benzooxazol-6-yloxy)-(4-isopropyl-phenyl)-acetic acid	(S)-(3-ETHYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-(4-ISOPROPYL-PHENYL)-ACETIC ACID|BDBM50169227	-	PUBCHEM	11178156	C26H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WEQANHSKIULRFP-QHCPKHFHSA-N
29761	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9690	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]acetonitrile	{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-ACETONITRILE|BDBM50166303	-	PUBCHEM	44400131	C27H21F3N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZAJIYHJMAFTGB-UHFFFAOYSA-N
29762	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9691	(2S)-2-[5-[1-(6-Chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxy-2-propylphenoxy]propanoic acid	(S)-2-{5-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-2-PROPYL-PHENOXY}-PROPIONIC ACID|BDBM50166302	-	PUBCHEM	44399972	C29H24ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NKVXQMXXQRJUBJ-INIZCTEOSA-N
29763	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9692	(4-Methoxyphenyl)-[2-methyl-3-[(3-prop-2-ynoxyphenyl)methyl]-5-(trifluoromethoxy)indol-1-yl]methanone	(4-METHOXY-PHENYL)-[2-METHYL-3-(3-PROP-2-YNYLOXY-BENZYL)-5-TRIFLUOROMETHOXY-INDOL-1-YL]-METHANONE|BDBM50166301	-	PUBCHEM	44399967	C28H22F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HEMWJRLDDQKGLA-UHFFFAOYSA-N
29764	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9693	(2S)-2-[2-Chloro-5-[1-(6-chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(2S)-2-[2-CHLORO-5-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|(S)-2-{2-CHLORO-5-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166300	-	PUBCHEM	10371027	C26H17Cl2F3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PESUMSRASMUYKX-ZDUSSCGKSA-N
29765	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9694	(2S)-2-[4-Chloro-3-[1-(6-chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(S)-2-{4-CHLORO-3-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-(4-CHLORO-3-(1-(6-CHLOROBENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YLOXY)PHENOXY)PROPANOIC ACID|(2S)-2-[4-CHLORO-3-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|BDBM50166298	-	PUBCHEM	10438226	C26H17Cl2F3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NOWYXMPKECMLMR-ZDUSSCGKSA-N
29766	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9695	(2S)-2-[3-[[1-(6-Methoxyquinolin-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(S)-2-{3-[1-(6-METHOXY-QUINOLIN-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166296	-	PUBCHEM	44399773	C30H25F3N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VBLJJBHFZCXXCW-SFHVURJKSA-N
29767	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9696	(2R)-2-[4-Chloro-3-[[1-(6-methoxy-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(R)-2-{4-CHLORO-3-[1-(6-METHOXY-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166295	-	PUBCHEM	44399983	C28H22ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QRGIUBNDZNAVAU-OAHLLOKOSA-N
29768	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9697	(2S)-2-[3-[1-(6-Chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(2S)-2-[3-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|(S)-2-{3-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166293	-	PUBCHEM	10437965	C26H18ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGORCQXXKHIAFG-AWEZNQCLSA-N
29769	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9698	(2S)-2-[3-[[1-(4-Methoxyphenyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(S)-2-{3-[1-(4-METHOXY-PHENYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166292	-	PUBCHEM	44399778	C27H24F3NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WASROFIOUZGJFW-KRWDZBQOSA-N
29770	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9699	(2S)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3- YL]METHYL]PHENOXY]PROPANOIC ACID|Q27087738|(S)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|MRL24|(2S)-2-[3-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|GTPL6743|(S)-2-(3-((1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL)METHYL)PHENOXY)PROPANOIC ACID|NCGC00390369-01|(2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL 24|BDBM50157917	-	PUBCHEM	9958543	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-KRWDZBQOSA-N
29771	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Fabian MA (2005)	15711537	224911	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29773	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9700	{4-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-acetic acid	2-[4-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]ACETIC ACID|{4-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-ACETIC ACID|BDBM50157938	-	PUBCHEM	10226701	C26H22ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YAGQPGVXBAGTLQ-UHFFFAOYSA-N
29774	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9701	CID 10143056	Q27087737|(2S)-2-(2-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL20|(2S)-2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|GTPL6742|(2S)-2-[2-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|(S)-2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157936	-	PUBCHEM	10143056	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-KRWDZBQOSA-N
29775	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9702	2-{3-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{3-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[3-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157934	-	PUBCHEM	10184159	C27H24ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UZJIHIMYKLEBBQ-UHFFFAOYSA-N
29776	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9703	2-{2-[1-(4-Methoxy-benzoyl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157933	-	PUBCHEM	10208548	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-UHFFFAOYSA-N
29777	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9704	(2R)-2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2R)-2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|(R)-2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157932	-	PUBCHEM	10119125	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-QGZVFWFLSA-N
29778	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9705	2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50157931	-	PUBCHEM	10230642	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SGUDWIZALUVLKT-UHFFFAOYSA-N
29779	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9706	2-{2-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-[2-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|2-{2-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157930	-	PUBCHEM	10277333	C27H24ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XICCHOADKSBRIM-UHFFFAOYSA-N
29780	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9707	(2R)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2R)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|(R)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157927	-	PUBCHEM	44388966	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-QGZVFWFLSA-N
29781	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9708	2-{3-[1-(4-Methoxy-benzoyl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157926	-	PUBCHEM	10279905	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-UHFFFAOYSA-N
29782	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9709	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]butanoic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-BUTYRIC ACID|BDBM50157925	-	PUBCHEM	44389085	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XTHHGKZVXMNJNA-UHFFFAOYSA-N
29783	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9710	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]pentanoic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PENTANOIC ACID|BDBM50157921	-	PUBCHEM	44389098	C30H28F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UNNWWBCMUJHNAH-UHFFFAOYSA-N
29784	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9711	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50157920	-	PUBCHEM	10280496	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WTIUDROYDYCRCV-UHFFFAOYSA-N
29785	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9712	2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]butanoic acid	2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-BUTYRIC ACID|BDBM50157919	-	PUBCHEM	44388998	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CHGUIFODGMMMKV-UHFFFAOYSA-N
29786	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9713	2-[2-[[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-{2-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|2-[2-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|BDBM50157918	-	PUBCHEM	10184971	C28H26ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIPJZUFYVANNKA-UHFFFAOYSA-N
29787	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9699	(2S)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3- YL]METHYL]PHENOXY]PROPANOIC ACID|Q27087738|(S)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|MRL24|(2S)-2-[3-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|GTPL6743|(S)-2-(3-((1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL)METHYL)PHENOXY)PROPANOIC ACID|NCGC00390369-01|(2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL 24|BDBM50157917	-	PUBCHEM	9958543	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-KRWDZBQOSA-N
29788	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9714	2-[3-[[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-{3-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|2-[3-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|BDBM50157916	-	PUBCHEM	10228304	C28H26ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NJQKVYQTUIWJEQ-UHFFFAOYSA-N
29789	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9715	(S)-3-{4-[3-(Biphenyl-4-yloxy)-propoxy]-phenyl}-2-methoxy-propionic acid	(2S)-2-METHOXY-3-[4-[3-(4-PHENYLPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|(S)-3-{4-[3-(BIPHENYL-4-YLOXY)-PROPOXY]-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157061	-	PUBCHEM	10223023	C25H26O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CFJFKSKRLAYDHM-DEOSSOPVSA-N
29790	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9716	(S)-2-Methoxy-3-{4-[4-(4-phenoxy-phenoxy)-but-1-ynyl]-phenyl}-propionic acid	(S)-2-METHOXY-3-{4-[4-(4-PHENOXY-PHENOXY)-BUT-1-YNYL]-PHENYL}-PROPIONIC ACID|(2S)-2-METHOXY-3-[4-[4-(4-PHENOXYPHENOXY)BUT-1-YNYL]PHENYL]PROPANOIC ACID|(2S)-2-METHOXY-3-{4-[4-(4-PHENOXY-PHENOXY)-BUT-1-YNYL]-PHENYL}-PROPIONIC ACID|BDBM50157060	-	PUBCHEM	10136660	C26H24O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PXPYSVWYMMGIEN-VWLOTQADSA-N
29791	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9717	(S)-3-{4-[3-(4-Benzoyl-phenoxy)-propoxy]-phenyl}-2-methoxy-propionic acid	(2S)-3-[4-[3-(4-BENZOYLPHENOXY)PROPOXY]PHENYL]-2-METHOXYPROPANOIC ACID|(S)-3-{4-[3-(4-BENZOYL-PHENOXY)-PROPOXY]-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157059	-	PUBCHEM	10226233	C26H26O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONPSUOOPYWPISK-DEOSSOPVSA-N
29792	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9718	(S)-2-Methoxy-3-{3-methoxy-4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid	(2S)-2-METHOXY-3-[3-METHOXY-4-[3-(4-PHENOXYPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|(S)-2-METHOXY-3-{3-METHOXY-4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|BDBM50157058	-	PUBCHEM	10297760	C26H28O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IUORCUOWVWRBDQ-VWLOTQADSA-N
29793	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9719	(S)-2-Methoxy-3-{4-[5-(4-phenoxy-phenoxy)-pent-1-ynyl]-phenyl}-propionic acid	(2S)-2-METHOXY-3-[4-[5-(4-PHENOXYPHENOXY)PENT-1-YNYL]PHENYL]PROPANOIC ACID|(S)-2-METHOXY-3-{4-[5-(4-PHENOXY-PHENOXY)-PENT-1-YNYL]-PHENYL}-PROPIONIC ACID|(2S)-2-METHOXY-3-{4-[5-(4-PHENOXY-PHENOXY)-PENT-1-YNYL]-PHENYL}-PROPIONIC ACID|BDBM50157057	-	PUBCHEM	10113515	C27H26O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KNNHPJKYTMZLEP-SANMLTNESA-N
29794	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9720	Naveglitazar	UNII-Y995M7GM0G|LY 519818|476436-68-7|LY-519818|HY-U00036A|(2S)-2-METHOXY-3-(4-(3-(4-PHENOXYPHENOXY)PROPOXY)PHENYL)PROPANOIC ACID|D08949|BENZENEPROPANOIC ACID, ALPHA-METHOXY-4-(3-(4-PHENOXYPHENOXY)PROPOXY)-, (ALPHAS)-|LY-818|ZINC3950327|CCRIS 9448|LY519818|(S)-2-METHOXY-3-{4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|Q27294403|NAVEGLITAZAR (USAN/INN)|(2S)-2-METHOXY-3-[4-[3-(4-PHENOXYPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|NAVEGLITAZAR [USAN:INN]|LY-9818|LY9818|LY 9818|CS-0021934|DB12662|NAVEGLITAZAR|Y995M7GM0G|BDBM50157056	-	PUBCHEM	9888484	C25H26O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OKJHGOPITGTTIM-DEOSSOPVSA-N
29795	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9721	(S)-3-{4-[3-(4-Benzoyl-phenoxy)-propoxy]-3-chloro-phenyl}-2-methoxy-propionic acid	(2S)-3-[4-[3-(4-BENZOYLPHENOXY)PROPOXY]-3-CHLOROPHENYL]-2-METHOXYPROPANOIC ACID|(S)-3-{4-[3-(4-BENZOYL-PHENOXY)-PROPOXY]-3-CHLORO-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157055	-	PUBCHEM	44392315	C26H25ClO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XCVUGMYZFJHTQE-DEOSSOPVSA-N
29796	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9722	(S)-2-Ethoxy-3-{4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid	NAVAGLITAZAR|(S)-2-ETHOXY-3-{4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|BDBM50157054	-	PUBCHEM	10115344	C26H28O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QTVFGQWILVTOFS-VWLOTQADSA-N
29797	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29798	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jose B (2004)	15454224	224914	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29799	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9723	3-{4-[2-(2-Biphenyl-3-yl-5-methyl-oxazol-4-yl)ethoxy]-phenyl}-2-methyl-2-phenoxypropionic acid	3-{4-[2-(2-BIPHENYL-3-YL-5-METHYL-OXAZOL-4-YL)ETHOXY]-PHENYL}-2-METHYL-2-PHENOXYPROPIONIC ACID|3-{4-[2-(2-BIPHENYL-3-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-[5-METHYL-2-(3-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145723	-	PUBCHEM	10119393	C34H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QUFDAJDYOPXGGD-UHFFFAOYSA-N
29800	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9724	(2S)-2-Methyl-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|(S)-2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|BDBM50145722	-	PUBCHEM	10004270	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-NDEPHWFRSA-N
29801	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9725	(2S)-2-Methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	Q27083197|(S)-2-METHYL-3-{4-[2-(5-METHYL-2-THIOPHEN-2-YL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|LY-510929|(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|LY-929|(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-(PHENOXY)PROPANOIC ACID|LY 510929|GTPL2657|BDBM50145721	-	PUBCHEM	9890585	C26H25NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSPYUOBNIMILB-SANMLTNESA-N
29802	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9726	(2S)-3-[4-[2-(2-Cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-methyl-2-phenoxypropanoic acid	(S)-3-{4-[2-(2-CYCLOHEXYL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|BDBM50145719	-	PUBCHEM	11178750	C28H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OYRNUVYEOVJEPD-NDEPHWFRSA-N
29803	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9727	3-{4-[2-(2-Cyclohexyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid	3-{4-[2-(2-CYCLOHEXYL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|3-[4-[2-(2-CYCLOHEXYL-5-METHYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-METHYL-2-PHENOXYPROPANOIC ACID|BDBM50145718	-	PUBCHEM	11374677	C28H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OYRNUVYEOVJEPD-UHFFFAOYSA-N
29804	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9684	2-Methyl-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid	2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145712	-	PUBCHEM	10139247	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-UHFFFAOYSA-N
29805	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9728	2-Methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|2-METHYL-3-{4-[2-(5-METHYL-2-THIOPHEN-2-YL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|BDBM50145710	-	PUBCHEM	10276539	C26H25NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSPYUOBNIMILB-UHFFFAOYSA-N
29807	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wu TY (2004)	14698179	224917	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29808	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9730	5-[3-[3-(4-Cycloheptyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133669	-	PUBCHEM	44345278	C28H35NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSCDIBRPSQPEET-UHFFFAOYSA-N
29809	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9731	5-[3-[3-(4-Cyclopentyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133667	-	PUBCHEM	44345252	C26H31NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BZLTUCWBZRKZHF-UHFFFAOYSA-N
29810	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9732	5-[3-[3-[2-Propyl-4-(cyclohexylmethyl)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(CYCLOHEXYLMETHYL)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50133666	-	PUBCHEM	44345031	C28H35NO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UJHOOSFHNXHHKX-UHFFFAOYSA-N
29811	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9733	(5S)-5-[3-[3-(4-Benzoyl-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133663	-	PUBCHEM	70694429	C28H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OZZBRLWUSGYQBE-SANMLTNESA-N
29812	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9734	(5R)-5-[3-[3-[4-(1,2-Benzoxazol-3-yl)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133661	-	PUBCHEM	54583265	C28H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLAXJZRUAXLLMT-AREMUKBSSA-N
29813	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9735	5-[3-[3-(4-Cyclohexyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133658	-	PUBCHEM	44345458	C27H33NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYMUSJRQCDBZCQ-UHFFFAOYSA-N
29814	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9736	5-[3-[3-[2-Propyl-4-(cyclohexylcarbonyl)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(CYCLOHEXYLCARBONYL)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50133654	-	PUBCHEM	44344982	C28H33NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DSILKMLNLQMKEG-UHFFFAOYSA-N
29815	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9737	(5S)-5-[3-[3-(4-Phenoxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131503	-	PUBCHEM	54583268	C27H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZNLPWBJCSSSCCR-VWLOTQADSA-N
29816	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	unknown	target	Berger D (2003)	12941327	224919	9738	4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile	3-CYANOQUINOLINE, 8|4-[3-CHLORO-4-(1-METHYL-1H-IMIDAZOLE-2-YLTHIO)PHENYLAMINO]-6-METHOXY-7-(3-MORPHOLINOPROPOXY)QUINOLINE-3-CARBONITRILE|4-[3-CHLORO-4-(1-METHYLIMIDAZOL-2-YL)SULFANYLANILINO]-6-METHOXY-7-(3-MORPHOLIN-4-YLPROPOXY)QUINOLINE-3-CARBONITRILE|4-({3-CHLORO-4-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]PHENYL}AMINO)-6-METHOXY-7-[3-(MORPHOLIN-4-YL)PROPOXY]QUINOLINE-3-CARBONITRILE|BDBM28123	-	PUBCHEM	10303277	C28H29ClN6O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QSENMPAGYMUVDE-UHFFFAOYSA-N
29817	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9739	(5R)-5-[3-[3-[4-(4-Hydroxyphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131514	-	PUBCHEM	54587161	C27H27NO6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMCOHKMLPVPQBF-RUZDIDTESA-N
29818	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9740	(5S)-5-[3-[3-[4-(4-Chloro-3-methylphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131512	-	PUBCHEM	54580272	C28H28ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RHXBMPROSWDTQC-SANMLTNESA-N
29819	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9741	5-[3-[3-[2-Propyl-4-(3,4-dichlorophenoxy)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(3,4-DICHLOROPHENOXY)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50131511	-	PUBCHEM	44327417	C27H25Cl2NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SXOUCNMFIUAZNE-UHFFFAOYSA-N
29820	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9742	(5S)-5-[3-[3-[4-(4-Fluorophenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131506	-	PUBCHEM	54584231	C27H26FNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BEESZPXMMFEPAP-VWLOTQADSA-N
29821	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9743	(5R)-5-[3-[3-[4-(4-Fluoro-3-methylphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131505	-	PUBCHEM	54585196	C28H28FNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TVEAXARFLUXLEB-AREMUKBSSA-N
29822	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9744	(5R)-5-[3-[3-[4-(4-Chlorophenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131504	-	PUBCHEM	54585195	C27H26ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BSYLKYWBLKSLBJ-RUZDIDTESA-N
29823	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9737	(5S)-5-[3-[3-(4-Phenoxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131503	-	PUBCHEM	54583268	C27H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZNLPWBJCSSSCCR-VWLOTQADSA-N
29824	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9745	(5S)-5-[3-[3-(4-Phenoxyphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131502	-	PUBCHEM	54581270	C24H21NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BTMVNTBNPIYHBM-QFIPXVFZSA-N
29825	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Ebdrup S (2003)	12672231	170525	6481	Ragaglitazar	NN-622|(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID(-) DRF 2725|Q27088511|DRF-2725|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|NNC-61-0029|(2S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YLETHOXY)PHENYL]PROPANOIC ACID|1NYX|DRF|(-)-DRF-2725|DRF2725|(S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|DB07675|RAGAGLITAZAR|GTPL2664|BDBM50109551	-	DRUGBANK	DB07675	C25H25NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WMUIIGVAWPWQAW-DEOSSOPVSA-N
29826	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Santini C (2003)	12657263	224921	9746	2-[3-Chloro-4-[3-[4-[(Z)-C-ethyl-N-hydroxycarbonimidoyl]-3-hydroxy-2-propylphenoxy]propylsulfanyl]phenyl]acetic acid	3-CHLORO-4-[3-[2-PROPYL-3-HYDROXY-4-[1-(HYDROXYIMINO)PROPYL]PHENOXY]PROPYLTHIO]BENZENEACETIC ACID|BDBM50126019	-	PUBCHEM	136088972	C23H28ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLVVAYSKHQLKES-PLRJNAJWSA-N
29827	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Santini C (2003)	12657263	224921	9747	Benzeneacetic acid, 3-chloro-4-((3-((3-phenyl-7-propyl-6-benzofuranyl)oxy)propyl)thio)-	UNII-O937X0Z5EM|{3-CHLORO-4-[3-(3-PHENYL-7-PROPYL-BENZOFURAN-6-YLOXY)-PROPYLSULFANYL]-PHENYL}-ACETIC ACID|BENZENEACETIC ACID, 3-CHLORO-4-((3-((3-PHENYL-7-PROPYL-6-BENZOFURANYL)OXY)PROPYL)THIO)-|3-CHLORO-4-(3-(3-PHENYL-7-PROPYLBENZOFURAN-6-YLOXY)PROPYLTHIO)-PHENYLACETIC ACID|L-796,449|L796449|O937X0Z5EM|2-[3-CHLORO-4-[3-[(3-PHENYL-7-PROPYL-1-BENZOFURAN-6-YL)OXY]PROPYLSULFANYL]PHENYL]ACETIC ACID|L-796449|L 796449|Q27078434|{3-CHLORO-4-[3-(3-PHENYL-7-PROPYL-BENZOFURAN-6-YLOXY)-PROPYLSULFANYL]-PHENYL}-ACETIC ACID(L-796449)|GTPL2689|194608-80-5|BDBM50085040	-	PUBCHEM	9891946	C28H27ClO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KAPDPGZDHUCILF-UHFFFAOYSA-N
29828	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Brooks DA (2001)	11405642	224922	9748	5-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	AD 5061|AD-5061|BM-131246|AD 7057|AD5061|5-{4-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHOXY]BENZYL}-2,4-THIAZOLIDINEDIONE|GTPL2663|5-({4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}METHYL)-1,3-THIAZOLIDINE-2,4-DIONE|Q27074311|HY-101758|AD-7057|CS-6704|5-[[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]METHYL]-1,3-THIAZOLIDINE-2,4-DIONE|AD7057|BDBM50064451	-	PUBCHEM	9953271	C22H20N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GUTCYOKMCPFRGH-UHFFFAOYSA-N
29829	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Brooks DA (2001)	11405642	224922	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29832	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henke BR (1999)	10612594	224924	9750	2-Phenyl-3-(4-methoxyphenethyl)-1H-indole-5-acetic acid	{3-[2-(4-METHOXY-PHENYL)-ETHYL]-2-PHENYL-1H-INDOL-5-YL}-ACETIC ACID(GW 0207)|2-PHENYL-3-(4-METHOXYPHENETHYL)-1H-INDOLE-5-ACETIC ACID|258345-12-9|2-(3-(4-METHOXYPHENETHYL)-2-PHENYL-1H-INDOL-5-YL)ACETIC ACID|2-[3-[2-(4-METHOXYPHENYL)ETHYL]-2-PHENYL-1H-INDOL-5-YL]ACETIC ACID|{3-[2-(4-METHOXY-PHENYL)-ETHYL]-2-PHENYL-1H-INDOL-5-YL}-ACETIC ACID|GW0207|BDBM50083625	-	PUBCHEM	10068664	C25H23NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YZLHLVJLTOPOHC-UHFFFAOYSA-N
29833	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Parks DJ (1998)	9934490	224925	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29848	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	Yoshimura C (2019)	31092565	228648	9877	TAS4464	7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-[5-[(aminosulfonyl)amino]-5-deoxy-beta-D-ribofuranosyl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]-|7-[5-Deoxy-5-(sulfamoylamino)-beta-D-ribofuranosyl]-5-[(2-ethoxy-6-fluorophenyl)ethynyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	CHEMSPIDER	75533883	C21H23FN6O6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TZTRUHFXPVXWRD-QTQZEZTPSA-N
29937	113041	7189	-	TRAF6	MGC:3310|RNF85	9606	Homo sapiens	inhibitor	target	Brenke JK (2018)	29950522	216477	9880	C25-140	1-Propanone, 3-[3,5-dimethyl-1-(3-methyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-1H-pyrazol-4-yl]-1-[4-(phenylmethyl)-1-piperidinyl]-|1-(4-Benzyl-1-piperidinyl)-3-[3,5-dimethyl-1-(3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-1H-pyrazol-4-yl]-1-propanone	-	CHEMSPIDER	29053655	C26H31N7O	small molecule	-	1358099-18-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HFKVRXVHZGBRKF-UHFFFAOYSA-N
29939	124085	84447	-	SYVN1	DER3|HRD1	9606	Homo sapiens	inhibitor	target	Fujita H (2018)	30365055	218199	9844	LS-102	1,3,5-Triazine-2,4,6-triamine, N~4~-6-benzoxazolyl-N~6~-[(1S)-1-cyclohexylethyl]-N~2~-ethyl-N~2~-[2-(ethylamino)ethyl]-|N~4~-(1,3-Benzoxazol-6-yl)-N~6~-[(1S)-1-cyclohexylethyl]-N~2~-ethyl-N~2~-[2-(ethylamino)ethyl]-1,3,5-triazine-2,4,6-triamine	-	CHEMSPIDER	92169543	C24H36N8O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DEDHMXBDEJSZFE-KRWDZBQOSA-N
29986	112372	6477	-	SIAH1	SIAH1A	9606	Homo sapiens	inhibitor	target	Zhang Q (2017)	27776223	199360	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
30025	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Reynders M (2020)	32128406	228703	9768	Bivalent ligand 177	PHOTAC-II-6|Bivalent_ligand_177	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PHOTAC-II-6 (CRBN:thalidomide --- FKBP12:SLF)	-
30039	111589	5603	RP1-179N16.4	MAPK13	MAPK 13|MAPK-13|PRKM13|SAPK4|p38delta	9606	Homo sapiens	degradation	target	Smith BE (2019)	30631068	219514	9803	Bivalent ligand 183	SJFDelta|Bivalent_ligand_183	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJF (VHL:ligand 7 ---MAPK13:Foretinib)	-
30041	111589	5603	RP1-179N16.4	MAPK13	MAPK 13|MAPK-13|PRKM13|SAPK4|p38delta	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC2 (CRBN:CRBN ligand --- MAPK13:foretinib)|Standardized BVL Name: PROTAC2 (CRBN:CRBN ligand --- MERTK:foretinib)	-
30045	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	An Z (2019)	30603959	228709	9798	Bivalent ligand 186	PROTAC NP8|Bivalent_ligand_186	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC NP8 (CRBN:pomalidomide --- HDAC6:Nexturastat A (Nex A))	-
30047	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Wu H (2019)	31271281	228479	9797	Bivalent ligand 185	PROTAC 12d|Bivalent_ligand_185	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC 12d (CRBN:pomalidomide --- HDAC6:Nexturastat A (Nex A))	-
30061	108918	2648	-	KAT2A	GCN5|GCN5L2|PCAF-b|hGCN5	9606	Homo sapiens	degradation	target	Bassi ZI (2018)	30200762	228710	9799	Bivalent ligand 187	GSK699|Bivalent_ligand_187	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: GSK699 (CRBN:thalidomide --- KAT2A:GSK4027)	-
30069	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- RPS6KA1:TAE684)	-
30079	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- RPS6KA1:ceritinib)	-
30111	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Kargbo RB (2020)	32550983	228713	9762	Bivalent ligand 198	compound 1|Bivalent_ligand_198	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 1 (VHL:VHL-1 --- SNCA:BTA-1)	-
30113	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Kargbo RB (2020)	32550983	228713	9761	Bivalent ligand 199	compound 4|Bivalent_ligand_199	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 4 (VHL:VHL-1 --- SNCA:BTA-1)	-
30115	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Kargbo RB (2020)	32550983	228713	9787	Bivalent ligand 200	compound 5|Bivalent_ligand_200	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 5 (VHL:VHL-1 --- SNCA:BTA-1)	-
30117	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Kargbo RB (2020)	32550983	228713	9786	Bivalent ligand 201	compound 7|Bivalent_ligand_201	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 7 (VHL:VHL-1 --- SNCA:SNCA ligand)	-
30119	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Kargbo RB (2020)	32550983	228713	9785	Bivalent ligand 202	compound 34|Bivalent_ligand_202	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 34 (VHL:VHL-1 --- SNCA:SNCA ligand)	-
30121	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Kargbo RB (2020)	32550983	228713	9784	Bivalent ligand 203	compound 30|Bivalent_ligand_203	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 30 (CRBN:thalidomide --- SNCA:SNCA ligand)	-
30137	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Shah RR (2020)	32001089	227145	9782	Bivalent ligand 205	JP1|Bivalent_ligand_205	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JP1 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30139	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Shah RR (2020)	32001089	227145	9781	Bivalent ligand 206	JP2|Bivalent_ligand_206	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JP2 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30141	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Shah RR (2020)	32001089	227145	9780	Bivalent ligand 207	JP3|Bivalent_ligand_207	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JP3 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30143	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Shah RR (2020)	32001089	227145	9795	Bivalent ligand 208	JP4|Bivalent_ligand_208	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JP4 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30145	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Shah RR (2020)	32001089	227145	9794	Bivalent ligand 209	JP5|Bivalent_ligand_209	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JP5 (XIAP:Boc-IAP --- JAK2:quinoxaline)	-
30147	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Shah RR (2020)	32001089	227145	9824	Bivalent ligand 210	JP6|Bivalent_ligand_210	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JP6 (XIAP:Boc-IAP --- JAK2:quinoxaline)	-
30161	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	You I (2020)	31859249	224930	9827	Bivalent ligand 213	INY-03-041|Bivalent_ligand_213	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: INY-03-041 (CRBN:lenalidomide --- AKT1:GDC-0068)	-
30179	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	degradation	target	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- MYC-FKBP12F36V:AP1867)	-
30181	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	degradation	target	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- MYC-FKBP12F36V:AP1867)	-
30233	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	degradation	target	Manda S (2020)	32340152	228719	9818	Bivalent ligand 256	CPR3|Bivalent_ligand_256	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CPR3 (CRBN:pomalidomide --- IGF1R:RBx10080307)	-
30235	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	degradation	target	Manda S (2020)	32340152	228719	9831	Bivalent ligand 226	CPR4|Bivalent_ligand_226	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CPR4 (CRBN:pomalidomide --- IGF1R:RBx10080307)	-
30237	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Manda S (2020)	32340152	228719	9818	Bivalent ligand 256	CPR3|Bivalent_ligand_256	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CPR3 (CRBN:pomalidomide --- Src:RBx10080307)	-
30239	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Manda S (2020)	32340152	228719	9831	Bivalent ligand 226	CPR4|Bivalent_ligand_226	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CPR4 (CRBN:pomalidomide --- Src:RBx10080307)	-
30272	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9772	Bivalent ligand 243	vhhGFP4-CHIP|Bivalent_ligand_243	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-CHIP (CHIP:vhhGFP4 --- H2B:GFP)	-
30278	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9772	Bivalent ligand 243	vhhGFP4-CHIP|Bivalent_ligand_243	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-CHIP (CHIP:vhhGFP4 --- PCNA:GFP)	-
30295	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	degradation	target	Vannam R (2021)	33400925	228723	9778	Bivalent ligand 245	dCBP-1|Bivalent_ligand_245	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dCBP-1 (CRBN:lenalidomide --- EP300:GNE-781)	-
30297	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	degradation	target	Vannam R (2021)	33400925	228723	9778	Bivalent ligand 245	dCBP-1|Bivalent_ligand_245	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dCBP-1 (CRBN:lenalidomide --- CREBBP:GNE-781)	-
30307	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	degradation	target	Petzold G (2016)	26909574	193065	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: (CRBN:lenalidomide --- CSNK1A1:lenalidomide)	-
30325	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Wu H (2019)	31271281	228479	9817	Bivalent ligand 255	Bivalent_ligand_255	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: (CRBN:pomalidomide  ---HDAC6:Nexturastat A)	-
30367	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Jin YH (2020)	32153174	223638	8521	Bivalent ligand 133	Azo-PROTAC-4C|Bivalent_ligand_133	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Azo-PROTAC-4C (CRBN:lenalidomide --- BCR-ABL:dasatinib)	-
30378	116183	10987	-	COPS5	CSN5|JAB1|MOV-34|SGN5	9606	Homo sapiens	inhibitor	target	Liu Y (2020)	33354502	229845	3947	Berberine	-	-	DRUGBANK	DB04115	C20H18NO4	small molecule	-	2086-83-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YBHILYKTIRIUTE-UHFFFAOYSA-N
30504	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Yokoo H (2020)	32631565	229142	10155	Bivalent ligand 257	POM-PERM3-R7|Bivalent_ligand_257	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: POM-PERM3-R7 (CRBN:pomalidomide ---ESR1:PERM3-R7)	-
30508	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Yokoo H (2020)	32631565	229142	10144	Bivalent ligand 258	VH032-PERM3-R7|Bivalent_ligand_258	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: VH032-PERM3-R7 (VHL:VH032 ---ESR1:PERM3-R7)	-
30512	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Yokoo H (2020)	32631565	229142	10145	Bivalent ligand 259	MV1-PERM3-R7|Bivalent_ligand_259	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MV1-PERM3-R7 (XIAP:MV1 ---ESR1:PERM3-R7)	-
30516	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Yokoo H (2020)	32631565	229142	10145	Bivalent ligand 259	MV1-PERM3-R7|Bivalent_ligand_259	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MV1-PERM3-R7 (BIRC2:MV1 ---ESR1:PERM3-R7)	-
30520	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Yokoo H (2020)	32631565	229142	10002	Bivalent ligand 260	LCL-PERM3-R7|Bivalent_ligand_260	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LCL-PERM3-R7 (XIAP:LCL161 ---AR:PERM3-R7)	-
30524	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Yokoo H (2020)	32631565	229142	10002	Bivalent ligand 260	LCL-PERM3-R7|Bivalent_ligand_260	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LCL-PERM3-R7 (BIRC2:LCL161 ---ESR1:PERM3-R7)	-
30528	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Takahashi D (2019)	31606272	239579	10004	Bivalent ligand 262	AUTAC2|Bivalent_ligand_262	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 autophagosome recruiting moiety--linker--target binding moiety; target degraded via autophagic degradation	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	autophagy-targeting protein	Standardized BVL Name: AUTAC2 (S-guanylation --- FKBP12:SLF)	-
30534	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ABL1:TAE684)	-
30536	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ABL2:TAE684)	-
30546	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BCKDK:TAE684)	-
30570	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK17:TAE684)	-
30572	111156	5129	RP11-288G13.1	CDK18	PCTAIRE|PCTAIRE3|PCTK3	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK18:TAE684)	-
30574	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK2:TAE684)	-
30578	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK5:TAE684)	-
30588	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CSNK1D:TAE684)	-
30590	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- EPHB2:TAE684)	-
30596	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- FYN:TAE684)	-
30606	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LCK:TAE684)	-
30612	125700	120892	-	LRRK2	AURA17|DARDARIN|PARK8|RIPK7|ROCO2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LRRK2:TAE684)	-
30614	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP3K1:TAE684)	-
30630	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MARK2:TAE684)	-
30632	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MARK4:TAE684)	-
30648	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PRKAA1:TAE684)	-
30650	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PRKAA2:TAE684)	-
30654	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PTK2B:TAE684)	-
30660	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RPS6KA1:TAE684)	-
30664	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RPS6KB1:TAE684)	-
30672	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- SRC:TAE684)	-
30718	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- ABL1:TAE684)	-
30738	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK17:TAE684)	-
30740	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK2:TAE684)	-
30744	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK5:TAE684)	-
30756	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CSNK1D:TAE684)	-
30758	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CSNK1E:TAE684)	-
30760	118953	29904	-	EEF2K	HSU93850|eEF-2K	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- EEF2K:TAE684)	-
30774	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- LCK:TAE684)	-
30792	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MARK2:TAE684)	-
30794	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MARK4:TAE684)	-
30806	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PRKAA1:TAE684)	-
30808	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PTK2B:TAE684)	-
30812	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- RPS6KA1:TAE684)	-
30816	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- SRC:TAE684)	-
30836	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide---ABL2:GNF-7)	-
30852	110975	4921	RP11-572K18.1	DDR2	MIG20a|NTRKR3|TKT|TYRO10	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- DDR2:GNF-7)	-
30862	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- FYN:GNF-7)	-
30868	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LCK:GNF-7)	-
30874	125700	120892	-	LRRK2	AURA17|DARDARIN|PARK8|RIPK7|ROCO2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LRRK2:GNF-7)	-
30878	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP3K1:GNF-7)	-
30890	111586	5600	-	MAPK11	P38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK11:GNF-7)	-
30892	112207	6300	-	MAPK12	ERK-6|ERK3|ERK6|MAPK 12|P38GAMMA|PRKM12|SAPK-3|SAPK3	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK12:GNF-7)	-
30894	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK14:GNF-7)	-
30896	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK8:GNF-7)	-
30898	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK9:GNF-7)	-
30910	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- PTK2B:GNF-7)	-
30916	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- RPS6KA3:GNF-7)	-
30920	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- SRC:GNF-7)	-
30922	114750	9344	UNQ2971/PRO7431	TAOK2	MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide---TAOK2:GNF-7)	-
30940	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- ABL2:TAE)	-
30950	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK1:TAE)	-
30956	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK2:TAE)	-
30966	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CHEK1:TAE)	-
30968	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CSNK1D:TAE)	-
30992	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MARK4:TAE)	-
30994	115171	9833	RP11-8N6.1	MELK	HPK38	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MELK:TAE)	-
31000	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PRKAA1:TAE)	-
31026	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
31032	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK17:Ceritinib)	-
31034	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK2:Ceritinib)	-
31036	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK5:Ceritinib)	-
31046	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- GSK3A:Ceritinib)	-
31048	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- GSK3B:Ceritinib)	-
31054	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- MAPK8:Ceritinib)	-
31056	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
31066	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- NUAK1:Ceritinib)	-
31068	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PRKAA1:Ceritinib)	-
31070	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PRKAA2:Ceritinib)	-
31074	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PTK2B:Ceritinib)	-
31076	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- RPS6KA1:Ceritinib)	-
31078	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- RPS6KA3:Ceritinib)	-
31096	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide---ABL1:GNF-7)	-
31098	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- ABL2:GNF-7)	-
31114	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- FYN:GNF-7)	-
31118	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- LCK:GNF-7)	-
31122	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAP3K1:GNF-7)	-
31130	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK14:GNF-7)	-
31132	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK8:GNF-7)	-
31134	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK9:GNF-7)	-
31144	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- PTK2B:GNF-7)	-
31146	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- RPS6KA1:GNF-7)	-
31148	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- RPS6KA3:GNF-7)	-
31152	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- SRC:GNF-7)	-
31164	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- ABL2:Rebastinib)	-
31176	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK17:Rebastinib)	-
31178	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK2:Rebastinib)	-
31182	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK5:Rebastinib)	-
31194	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- LCK:Rebastinib)	-
31202	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- MARK4:Rebastinib)	-
31206	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- PRKAA1:Rebastinib)	-
31208	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- RPS6KA1:Rebastinib)	-
31210	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- SRC:Rebastinib)	-
31226	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide---ABL1:Ponatinib)	-
31228	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- ABL2:Ponatinib)	-
31234	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- CDK17:Ponatinib)	-
31236	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- CDK5:Ponatinib)	-
31248	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- FYN:Ponatinib)	-
31254	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- LCK:Ponatinib)	-
31258	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAP3K1:Ponatinib)	-
31268	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAPK14:Ponatinib)	-
31280	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- SRC:Ponatinib)	-
31288	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1---ABL1:GNF-7)	-
31290	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- ABL2:GNF-7)	-
31308	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1---a LCK:GNF-7)	-
31322	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPK14:GNF-7)	-
31326	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPK9:GNF-7)	-
31334	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- PTK2B:GNF-7)	-
31338	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- RPS6KA1:GNF-7)	-
31344	114750	9344	UNQ2971/PRO7431	TAOK2	MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- TAOK2:GNF-7)	-
31350	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1---ABL1:GNF-7)	-
31352	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- ABL2:GNF-7)	-
31380	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK14:GNF-7)	-
31384	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK8:GNF-7)	-
31386	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK9:GNF-7)	-
31396	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- PTK2B:GNF-7)	-
31400	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- RPS6KA1:GNF-7)	-
31402	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- RPS6KA3:GNF-7)	-
31420	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
31426	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK17:Ceritinib)	-
31428	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK2:Ceritinib)	-
31430	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK5:Ceritinib)	-
31440	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- GSK3A:Ceritinib)	-
31442	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- GSK3B:Ceritinib)	-
31448	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- MAPK8:Ceritinib)	-
31450	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
31452	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- NUAK1:Ceritinib)	-
31454	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- PRKAA1:Ceritinib)	-
31456	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- PRKAA2:Ceritinib)	-
31458	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- PTK2B:Ceritinib)	-
31460	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- RPS6KA1:Ceritinib)	-
31462	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- RPS6KA3:Ceritinib)	-
31480	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK17:AT7519)	-
31486	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CHEK1:AT7519)	-
31490	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CSNK1A1:AT7519)	-
31492	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CSNK1D:AT7519)	-
31494	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- DAPK1:AT7519)	-
31498	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- GSK3A:AT7519)	-
31500	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- GSK3B:AT7519)	-
31502	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- MAP3K1:AT7519)	-
31504	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- NUAK1:AT7519)	-
31526	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK1:Thienopyrimidines)	-
31530	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK2:Thienopyrimidines)	-
31548	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MARK2:Thienopyrimidines)	-
31550	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MARK4:Thienopyrimidines)	-
31556	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- RPS6KB1:Thienopyrimidines)	-
31572	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- ABL2:TAE684)	-
31584	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK17:TAE684)	-
31586	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK2:TAE684)	-
31590	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK5:TAE684)	-
31604	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- LCK:TAE684)	-
31608	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- PRKAA1:TAE684)	-
31610	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- PTK2B:TAE684)	-
31612	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- RPS6KA1:TAE684)	-
31614	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- SRC:TAE684)	-
31632	111596	5610	-	EIF2AK2	EIF2AK1|PKR|PPP1R83|PRKR	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- EIF2AK2:Thienopyrimidines)	-
31638	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- LCK:Thienopyrimidines)	-
31644	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- MAPK8:Thienopyrimidines)	-
31646	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- MAPK9:Thienopyrimidines)	-
31652	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- PTK2B:Thienopyrimidines)	-
31666	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10070	Bivalent Ligand 280	DD-02-198|Bivalent_Ligand_280	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-02-198 (VHL:VH032---MAPK14:AZ628)	-
31688	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK5:TAE684)	-
31690	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK2:TAE684)	-
31694	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK17:TAE684)	-
31696	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- LCK:TAE684)	-
31698	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- PTK2B:TAE684)	-
31706	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- PRKAA1:TAE684)	-
31716	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- BCKDK:Dabrafenib)	-
31718	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK1:Dabrafenib)	-
31722	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK17:Dabrafenib)	-
31724	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK2:Dabrafenib)	-
31738	111596	5610	-	EIF2AK2	EIF2AK1|PKR|PPP1R83|PRKR	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- EIF2AK2:Dabrafenib)	-
31756	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide---ABL1:PP58 (kinobeads) 212391-57-6)	-
31758	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- ABL2:PP58 (kinobeads) 212391-57-6)	-
31770	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- FYN:PP58 (kinobeads) 212391-57-6)	-
31774	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- LCK:PP58 (kinobeads) 212391-57-6)	-
31778	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- MAPK14:PP58 (kinobeads) 212391-57-6)	-
31788	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- SRC:PP58 (kinobeads) 212391-57-6)	-
31804	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK17:TAE684)	-
31806	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK2:TAE684)	-
31810	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK5:TAE684)	-
31822	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- LCK:TAE684)	-
31826	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- PTK2B:TAE684)	-
31846	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- LCK:GNF-7)	-
31848	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- PTK2B:GNF-7)	-
31850	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- SRC:GNF-7)	-
31852	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- ABL2:GNF-7)	-
31854	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- MAPK14:GNF-7)	-
31856	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide---a MAPK9:GNF-7)	-
31876	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- LCK:GNF-7)	-
31880	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- MAPK8:GNF-7)	-
31882	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- MAPK9:GNF-7)	-
31888	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- PTK2B:GNF-7)	-
31892	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- SRC:GNF-7)	-
31914	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK2:MRT68921)	-
31916	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK3:MRT68921)	-
31918	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK4:MRT68921)	-
31934	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK1:Ceritinib)	-
31940	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK17:Ceritinib)	-
31942	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK2:Ceritinib)	-
31946	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK5:Ceritinib)	-
31954	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK10:Ceritinib)	-
31956	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK8:Ceritinib)	-
31958	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK9:Ceritinib)	-
31960	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- RPS6KA1:Ceritinib)	-
31970	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK17:TAE684)	-
31972	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK2:TAE684)	-
31974	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK5:TAE684)	-
31984	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- LCK:TAE684)	-
31988	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- PTK2B:TAE684)	-
32006	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- MAP3K1:Dinaciclib)	-
32012	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- NUAK1:Dinaciclib)	-
32016	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- CSNK1A1:Dinaciclib)	-
32028	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- EPHB2:APY-24)	-
32030	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- GSK3B:APY-24)	-
32048	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- CSNK1A1:not specified)	-
32050	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- CSNK1D:not specified)	-
32052	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- CSNK1E:not specified)	-
32054	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- GSK3A:not specified)	-
32056	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- GSK3B:not specified)	-
32060	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- MAP3K1:not specified)	-
32064	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- NUAK1:not specified)	-
32092	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- PTK2B:Thienopyrimidines)	-
32108	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK2:MRT68921)	-
32110	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK3:MRT68921)	-
32112	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK4:MRT68921)	-
32114	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- RPS6KB1:MRT68921)	-
32134	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
32136	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK2:Ceritinib)	-
32138	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK5:Ceritinib)	-
32140	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- MAPK8:Ceritinib)	-
32142	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
32146	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- RPS6KA1:Ceritinib)	-
32148	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- RPS6KA3:Ceritinib)	-
32154	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide---ABL1:TX1-85-1)	-
32156	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- ABL2:TX1-85-1)	-
32164	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- CSNK1E:TX1-85-1)	-
32166	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- FYN:TX1-85-1)	-
32170	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- LCK:TX1-85-1)	-
32176	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- SRC:TX1-85-1)	-
32186	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-123 (VHL:VHL-1--- MARK4:TG101209)	-
32190	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-123 (VHL:VHL-1--- RPS6KB1:TG101209)	-
32202	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide---ABL1:TX1-85-1)	-
32204	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- ABL2:TX1-85-1)	-
32208	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- CSNK1E:TX1-85-1)	-
32212	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- FYN:TX1-85-1)	-
32216	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- LCK:TX1-85-1)	-
32222	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- SRC:TX1-85-1)	-
32226	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- CDK5:Quizartinib)	-
32234	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- LCK:Quizartinib)	-
32238	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- MAPK14:Quizartinib)	-
32242	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- SRC :Quizartinib)	-
32246	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- CSNK1D:not specified)	-
32248	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- GSK3A:not specified)	-
32250	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- GSK3B:not specified)	-
32252	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- NUAK1:not specified)	-
32274	111570	5584	-	PRKCI	DXS1179E|PKCI|nPKC-iota	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PRKCI:Adavosertib)	-
32306	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- PTK2B:PND-1186)	-
32308	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- RPS6KA1:PND-1186)	-
32310	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- RPS6KA3:PND-1186)	-
32316	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide---BCKDK:Palbociclib)	-
32354	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- GSK3A:AT7519)	-
32356	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- GSK3B:AT7519)	-
32364	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- NUAK1:PND-1186)	-
32366	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- PTK2B:PND-1186)	-
32368	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- RPS6KA1:PND-1186)	-
32370	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- RPS6KA3:PND-1186)	-
32376	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide---BCKDK:Ribociclib)	-
32390	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide---ABL2:Ibrutinib)	-
32396	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- FYN:Ibrutinib)	-
32398	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- LCK:Ibrutinib)	-
32400	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- SRC:Ibrutinib)	-
32408	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- LCK:Vemurafenib)	-
32416	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide---AKT1:Ipatasertib)	-
32434	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9991	Bivalent Ligand 313	TL13-178|Bivalent_Ligand_313	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-178 (CRBN:pomalidomide--- MAPK14:Ponatininb)	-
32444	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide---BCKDK:Dabrafenib)	-
32456	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9996	Bivalent Ligand 316	INY-02-164|Bivalent_Ligand_316	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: INY-02-164 (CRBN:Thalidomide---AKT1:Ipatasertib)	-
32462	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9996	Bivalent Ligand 316	INY-02-164|Bivalent_Ligand_316	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: INY-02-164 (CRBN:Thalidomide--- BCKDK:Ipatasertib)	-
32478	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide--- GSK3A:APY-24)	-
32488	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10138	Bivalent Ligand 320	DB-3-291|Bivalent_Ligand_320	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB-3-291 (CRBN:thalidomide---ABL2:dasatinib)	-
32496	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10139	Bivalent Ligand 321	JWG-148|Bivalent_Ligand_321	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-148 (VHL:VHL-1---ABL2:not specified)	-
32498	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10139	Bivalent Ligand 321	JWG-148|Bivalent_Ligand_321	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-148 (VHL:VHL-1--- EPHB2:not specified)	-
32504	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10140	Bivalent Ligand 322	DD-03-156|Bivalent_Ligand_322	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-156 (VHL:VHL-1--- CDK17:Dabrafenib)	-
32548	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10117	Bivalent Ligand 330	TL13-112|Bivalent_Ligand_330	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-112 (CRBN:pomalidomide---RPS6KA1:TAE684)	-
32568	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Zhang X (2021)	33783207	232094	10121	Bivalent Ligand 338	21-SLF|Bivalent_Ligand_338	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123251	80344	GL014	DCAF11	PRO2389|WDR23	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 21-SLF (DCAF11:not specified---FKBP12:SLF)	-
32582	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	degradation	target	Zhang C (2021)	34927316	232727	10096	Bivalent Ligand 342	SPNCOX|Bivalent_Ligand_342	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SPNCOX (VHL:GSGSALAPYIP---PTGS2:indomethacin)	-
32586	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Lu Y (2021)	34885822	232750	10102	Bivalent Ligand 344	21a|Bivalent_Ligand_344	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 21a(CRBN:lenalidomide---HDAC6:benzamide)	-
32588	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Hahn F (2021)	34884662	232751	10103	Bivalent Ligand 345	THAL-SNS032|Bivalent_Ligand_345	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: THAL-SNS032(CRBN:thalidomide---CDK2:SNS032; Coronavirus Project)	-
32594	111902	5970	-	RELA	NFKB3|p65	9606	Homo sapiens	degradation	target	Liu J (2021)	34100597	232747	10100	Bivalent Ligand 346	Bivalent_Ligand_346	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NF-kB-PROTAC (dNF-kB)(VHL:VHLL-X-BCN---RELA:N3-ODN)	-
32596	108201	1869	-	E2F1	E2F-1|RBAP1|RBBP3|RBP3	9606	Homo sapiens	degradation	target	Liu J (2021)	34100597	232747	10101	Bivalent Ligand 347	Bivalent_Ligand_347	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: E2F-PROTAC (dE2F) (VHL:VHLL-X-BCN---E2F1:N3-ODN)	-
32598	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Cao Z (2021)	34860497	239580	10105	Bivalent Ligand 348	14a|Bivalent_Ligand_348	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 14a (CRBN:pomalidomide---HDAC6:indirubin)	-
32600	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	Yu X (2021)	34855399	232882	10106	Bivalent Ligand 349	MS98|Bivalent_Ligand_349	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MS98 (VHL:VHL-2---AKT1:GDC-0068)	-
32606	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	Yu X (2021)	34855399	232882	10078	Bivalent Ligand 350	MS170|Bivalent_Ligand_350	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MS170 (CRBN:pomalidomide---AKT1:GDC-0068)	-
32611	114397	8878	-	SQSTM1	A170|OSIL|PDB3|ZIP3|p60|p62|p62B	9606	Homo sapiens	degradation	lysosome-targeting protein	Zheng ZG (2021)	32432943	233272	10077	Bivalent Ligand 351	lycorine|Bivalent_Ligand_351	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	116596	22937	PSEC0227	SCAP	-	9606	Homo sapiens	target	Standardized BVL Name: lycorine (SQSTM1:lycorine---SCAP:lycorine)	-
32622	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Liu H (2021)	34217059	233625	10076	Bivalent Ligand 356	SIAIS056|Bivalent_Ligand_356	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SIAIS056 (CRBN:pomalidomide---BCR-ABL:dasatinib)	-
32626	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation	target	Lv D (2021)	34824248	234973	10072	Bivalent Ligand 358	753b|Bivalent_Ligand_358	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 753b (VHL:VHL ligand---BCL2L1:ABT263)	-
32636	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Roberts BL (2020)	32255606	235043	10048	Bivalent Ligand 362	AM-A3|Bivalent_Ligand_362	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: AM-A3 (VHL:VHL ligand---ER:raloxifene)	-
32642	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Lin X (2020)	32829249	223472	10051	Bivalent Ligand 365	ARV-471|Bivalent_Ligand_365	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ARV-471(CRBN:lenalidomide---ESR1:Lasofoxifene)	-
32670	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	degradation	target	Liu Q (2022)	34864330	235159	10030	Bivalent Ligand 376	BP3|Bivalent_Ligand_376	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BP3 (CRBN:pomalidomide---HSP90AA1:BIIB021)	-
32672	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 5 (CRBN:pomalidomide---JAK2:ruxolitinib)	-
32674	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 6 (CRBN:pomalidomide---JAK2:baricitinib)	-
32676	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 7 (CRBN:pomalidomide---JAK2:ruxolitinib N-propyl analog)	-
32678	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Chang Y (2021)	34110416	235255	10007	Bivalent Ligand 380	compound 8|Bivalent_Ligand_380	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 8 (CRBN:thalidomide---JAK2:baricitinib)	-
32716	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Hu J (2019)	30990042	235710	10133	Bivalent Ligand 383	ERD-308|Bivalent_Ligand_383	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ERD-308 (VHL:compound 11---ESR1:raloxifene)	-
32718	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK1:TL13-87)	-
32720	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK2:TL13-87)	-
32724	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK5:TL13-87)	-
32746	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK17:TL13-87)	-
32748	111156	5129	RP11-288G13.1	CDK18	PCTAIRE|PCTAIRE3|PCTK3	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK18:TL13-87)	-
32758	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	degradation	target	Durbin AD (2022)	34772733	236045	9997	Bivalent ligand 386	JQAD1|Bivalent_ligand_386	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JQAD1 (CRBN:pomalidomide --- EP300:A485)	-
32768	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	degradation	target	Yamanaka S (2022)	35013300	235958	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CC-885 (CRBN:CC-885 --- CSNK1A1:CC-885)	-
32814	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Nalawansha DA (2022)	35311258	239583	10130	Bivalent ligand 409	KL-4|Bivalent_ligand_409	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114343	8816	-	DCAF5	BCRG2|BCRP2|D14S1461E|WDR22	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: KL-4 (DCAF5:L3MBTL3-UNC1215 --- FKBP1A:SLF)	-
32822	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	degradation	target	Alcock LJ (2022)	35300081	239585	10107	Bivalent ligand 413	PROTAC11/SJ10542|Bivalent_ligand_413	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC11/SJ10542 (CRBN:phenyl glutarimide --- JAK2:baricitinib)	-
32832	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	Yu X (2022)	35119851	239588	10043	Bivalent ligand 417	compound 20|Bivalent_ligand_417	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 20 (VHL:VHL-1 --- AKT:AZD5363)	-
32834	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	degradation	target	Yu X (2022)	35119851	239588	10154	Bivalent ligand 418	compound 35|Bivalent_ligand_418	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 35 (CRBN:pomalidomide --- AKT:AZD5363)	-
32869	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Tao Y (2022)	36170674	241674	10355	Bivalent ligand 428	YT41R|Bivalent_ligand_428	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: YT41R (DCAF1:MY-1B --- FKBP12:SLF)	-
32871	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Tao Y (2022)	36170674	241674	10353	Bivalent ligand 429	YT47R|Bivalent_ligand_429	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: YT47R (DCAF1:MY-1B --- FKBP12:SLF)	-
32877	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Henning NJ (2022)	34994556	235307	10372	Bivalent ligand 432	NJH-2-142|Bivalent_ligand_432	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115421	10116	-	FEM1B	F1A-ALPHA|F1AA|FEM1-beta	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NJH-2-142 (FEM1B:EN106 ---ABL1:dasatinib)	-
32879	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	degradation	target	Lier S (2022)	34838332	242581	10373	Bivalent ligand 433	MDEG-541|Bivalent_ligand_433	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MDEG-541  (CRBN:thalidomide --- MYC:10058-F4)	-
32890	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10362	Bivalent ligand 438	iDAb RAS-UBOX|Bivalent_ligand_438	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: iDAb RAS-UBOX (CHIP --- KRAS:iDAB RAS)	-
32892	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10362	Bivalent ligand 438	iDAb RAS-UBOX|Bivalent_ligand_438	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: iDAb RAS-UBOX (CHIP --- HRAS:iDAB RAS)	-
32894	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10362	Bivalent ligand 438	iDAb RAS-UBOX|Bivalent_ligand_438	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110952	4893	RP5-1000E10.2	NRAS	ALPS4|CMNS|N-ras|NCMS|NRAS1|NS6	9606	Homo sapiens	target	Standardized BVL Name: iDAb RAS-UBOX (CHIP --- NRAS:iDAB RAS)	-
32896	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10363	Bivalent ligand 439	UBOX-iDAb RAS|Bivalent_ligand_439	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: UBOX-iDAb RAS (CHIP --- KRAS:iDAB RAS)	-
32898	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10363	Bivalent ligand 439	UBOX-iDAb RAS|Bivalent_ligand_439	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: UBOX-iDAb RAS (CHIP --- HRAS:iDAB RAS)	-
32900	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10363	Bivalent ligand 439	UBOX-iDAb RAS|Bivalent_ligand_439	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110952	4893	RP5-1000E10.2	NRAS	ALPS4|CMNS|N-ras|NCMS|NRAS1|NS6	9606	Homo sapiens	target	Standardized BVL Name: UBOX-iDAb RAS (CHIP --- NRAS:iDAB RAS)	-
32918	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10399	Bivalent ligand 447	CHIP-vhhGFP4|Bivalent_ligand_447	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: CHIP-vhhGFP4 (STUB1:vhhGFP4 --- KRAS:GFP)	-
32951	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation	target	Zhang L (2023)	35015337	246241	10380	Bivalent ligand 504	PZ15227|Bivalent_ligand_504	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PZ15227 (CRBN:pomalidomide --- BCL2L1:ABT263)	-
32953	109186	2931	-	GSK3A	-	9606	Homo sapiens	degradation	target	Qu L (2021)	34649182	243029	10381	Bivalent ligand 505	PT-65|Bivalent_ligand_505	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PT-65 (CRBN:pomalidomide --- GSK3A:AZD2858)	-
32955	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Qu L (2021)	34649182	243029	10381	Bivalent ligand 505	PT-65|Bivalent_ligand_505	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PT-65 (CRBN:pomalidomide --- GSK3B:AZD2858)	-
33003	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	degradation	target	Fuchs O (2023)	35933246	246246	10429	Bivalent ligand 466	CC-91633|Bivalent_ligand_466	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CC-91633 (BMS-986397) (CRBN:CC-91633 (BMS-986397) --- CSNK1A1:CC-91633 (BMS-986397))	-
33012	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Henning NJ (2022)	35210618	236326	10406	Bivalent ligand 469	NJH-2-057|Bivalent_ligand_469	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	target	Standardized BVL Name: NJH-2-057 (OTUB1:EN523 --- deltaF508-CFTR:lumacaftor)	-
33014	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Henning NJ (2022)	35210618	236326	10358	Bivalent ligand 470	LEB-03-144|Bivalent_ligand_470	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: LEB-03-144 (OTUB1:EN523 --- WEE1:AZD1775)	-
33016	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Henning NJ (2022)	35210618	236326	10375	Bivalent ligand 471	LEB-03-146|Bivalent_ligand_471	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: LEB-03-146 (OTUB1:EN523 --- WEE1:AZD1775)	-
33018	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10394	Bivalent ligand 472	FOXO-DUBTAC #6|Bivalent_ligand_472	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	108598	2309	-	FOXO3	AF6q21|FKHRL1|FKHRL1P2|FOXO2|FOXO3A	9606	Homo sapiens	target	Standardized BVL Name: FOXO-DUBTAC #6 (OTUB1:DUBL-X-BCN --- FOXO3A:N3-ODN)	-
33020	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10410	Bivalent ligand 473	p53-DUBTACs #6|Bivalent_ligand_473	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	target	Standardized BVL Name: p53-DUBTACs #6 (OTUB1:DUBL-X-BCN --- TP53:p53-ODN)	-
33022	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10428	Bivalent ligand 474	p53-DUBTACs #7|Bivalent_ligand_474	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	target	Standardized BVL Name: p53-DUBTACs #7 (OTUB1:DUBL-X-BCN --- TP53:p53-ODN)	-
33024	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10417	Bivalent ligand 475	IRF-DUBTAC #7|Bivalent_ligand_475	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	109869	3661	-	IRF3	-	9606	Homo sapiens	target	Standardized BVL Name: IRF-DUBTAC #7 (OTUB1:DUBL-X-BCN --- IRF3:N3-IRF3-ODN)	-
33077	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation 	target	Zhang X (2020)	32145645	246255	10395	Bivalent ligand 498	XZ739|Bivalent_ligand_498	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: XZ739 (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33079	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation 	target	Zhang X (2020)	32145645	246255	10421	Bivalent ligand 499	12c|Bivalent_ligand_499	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 12c (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33081	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation 	target	Zhang X (2020)	32145645	246255	10416	Bivalent ligand 500	15a|Bivalent_ligand_500	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 15a (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33083	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation 	target	Zhang X (2020)	32145645	246255	10354	Bivalent ligand 501	16a|Bivalent_ligand_501	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 16a (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33085	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation 	target	Zhang X (2020)	32145645	246255	10378	Bivalent ligand 502	6c|Bivalent_ligand_502	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 6c (VHL:VHL ligand ---BCL-XL:ABT-263)	-
33110	114840	9451	-	EIF2AK3	PEK|PERK|WRS	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Patten JJ (2022)	35992305	239003	9956	GSK2606414	1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]ethanone|Ethanone, 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]-|GSK2606414|GSK 2606414|7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	CHEMSPIDER	28643060	C24H20F3N5O	small molecule	-	1337531-36-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: EIF2AK3 inhibitor; Prevented ]80% SARS-CoV-2 infection in primary intestinal epithelial cell cultures.	SIXVRXARNAVBTC-UHFFFAOYSA-N
33161	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Raymonda MH (2022)	34871905	239614	2916	Doramapimod	DSSTOX_RID_83151|KINOME_2137|CCG-264915|1-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|ZINC24044436|DORAMAPIMOD1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|NSC785337|AKOS005256489|S1574|ALBB-035131|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|MLS006010153|NCGC00241104-07|BIRB 0796|NSC-785337|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|1-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-3-(4-(2-(MORPHOLIN-4-YL)ETHOXY)NAPHTHALEN-1-YL)UREA|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA.|CS-0219|BIRB796|1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|BIRB 796BS|MFCD09752957|BIRB 796 (DORAMAPIMOD)|UNII-HO1A8B3YVV|SR-00000002531|Q-101419|B96|EX-A4530|DB03044|D03736|TOX21_113386_1|AS-19375|BIRB 796 BS|SW219700-1|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-PYRAZOLYL]-3-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|285983-48-4|UREA, N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-(2-(4-MORPHOLINYL)ETHOXY)-1-NAPHTHALENYL)-|UREA, N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-|BIRB-796 BS|DORAMAPIMOD (BIRB-796)|BIRB-796, 3|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3(4-(2-MORPHOLIN-4-YL-ETHOXY)NAPHTHALEN-1-YL)UREA|BIRB-796|FT-0667779|DSSTOX_GSID_48957|NCGC00241104-01|BIRB 796|BCPP000333|DORAMAPIMOD|BCP01896|1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|CID_156422|BRD-K74065929-001-01-5|N-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA|TOX21_113386|GTPL5668|SMR004458704|1KV2|P38 MAP KINASE INHIBITOR X, BIRB 796 - CAS 285983-48-4|1-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]- N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-UREA|NCGC00241104-02|DSSTOX_CID_28883|DORAMAPIMOD [INN]|BIRB 796,DORAMAPIMOD|DORAMAPIMOD [USAN]|HMS3295M15|DORAMAPIMOD (USAN/INN)|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|DTXSID2048957|DIARYL UREA COMPOUND 10|HMS3747G11|HO1A8B3YVV|DORAMAPIMOD (BIRB 796)|SR-00000002531-1|DORAMAPIMOD [WHO-DD]|BCP9000416|US8933228, BIRB 796|HY-10320|BIBR-796|AC-24379|HMS3655C07|DORAMAPIMOD [USAN:INN]|A819503|SB16634|Q27077098|BIRB-0796|3-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-1-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|3-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-1-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA	-	DRUGBANK	DB03044	C31H37N5O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: p38 MAPK inhibitor; viral inhibition mechanism undetermined	MVCOAUNKQVWQHZ-UHFFFAOYSA-N
33162	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Raymonda MH (2022)	34871905	239614	9964	17-AAG	Tanespimycin|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|2-azabicyclo[16.3.1]docosa-2,4,6,10,18,21-hexaene-20,22-dione, 3,13-dihydroxy-9-(hydroxyiminomethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (2E,4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|17-demethoxygeldanamycin|MFCD04973892|Geldanamycin,17-demethoxy-17-(2-propenylamino)-|4GY0AVT3L4	-	CHEMSPIDER	21106220	C31H43N3O8	small molecule	-	75747-14-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: HSP90 inhibitor; viral inhibition mechanism undetermined	AYUNIORJHRXIBJ-TXHRRWQRSA-N
33163	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	inhibitor/sars-cov inhibitor	target	Li C (2020)	33179566	239615	9964	17-AAG	Tanespimycin|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|2-azabicyclo[16.3.1]docosa-2,4,6,10,18,21-hexaene-20,22-dione, 3,13-dihydroxy-9-(hydroxyiminomethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (2E,4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|17-demethoxygeldanamycin|MFCD04973892|Geldanamycin,17-demethoxy-17-(2-propenylamino)-|4GY0AVT3L4	-	CHEMSPIDER	21106220	C31H43N3O8	small molecule	-	75747-14-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV indirect chemical interaction: HSP90 inhibitor; viral inhibition mechanism undetermined	AYUNIORJHRXIBJ-TXHRRWQRSA-N
33164	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	inhibitor/mers-cov inhibitor	target	Li C (2020)	33179566	239615	9964	17-AAG	Tanespimycin|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|2-azabicyclo[16.3.1]docosa-2,4,6,10,18,21-hexaene-20,22-dione, 3,13-dihydroxy-9-(hydroxyiminomethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (2E,4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|17-demethoxygeldanamycin|MFCD04973892|Geldanamycin,17-demethoxy-17-(2-propenylamino)-|4GY0AVT3L4	-	CHEMSPIDER	21106220	C31H43N3O8	small molecule	-	75747-14-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV indirect chemical interaction: HSP90 inhibitor; viral inhibition mechanism undetermined	AYUNIORJHRXIBJ-TXHRRWQRSA-N
33197	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10202	Torin 2	Torin 2|9-(6-AMINOPYRIDIN-3-YL)-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H,2H-BENZO[H]1,6-NAPHTHYRIDIN-2-ONE|Benzo[h][1,6]naphthyridin-2(1H)-one, 9-(6-amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]-|9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2(1H)-one	-	CHEMSPIDER	26232176	C24H15F3N4O	small molecule	-	1223001-51-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: mTOR inhibitor (PMID: 26239364); viral inhibition mechanism undetermined	GUXXEUUYCAYESJ-UHFFFAOYSA-N
33198	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10207	vistusertib	AZD-2014|AZD 2014|vistusertib	-	CHEMSPIDER	28294977	C25H30N6O3	small molecule	-	1009298-59-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: mTOR inhibitor (PMID: 27031247); viral inhibition mechanism undetermined	JUSFANSTBFGBAF-IRXDYDNUSA-N
33199	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10258	dactolisib	BEZ-235|2-Methyl-2-{4-[3-methyl-2-oxo-8-(3-quinolinyl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile|Benzeneacetonitrile, 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-alpha,alpha-dimethyl-|NVP-BEZ 235|NVP-BEZ235|BEZ 235|NVP-BEZ235-NX|BEZ235|Dactolisib|NVPBEZ235|NVP BEZ235	-	CHEMSPIDER	10151099	C30H23N5O	small molecule	-	915019-65-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: mTOR inhibitor; viral inhibition mechanism undetermined	JOGKUKXHTYWRGZ-UHFFFAOYSA-N
33240	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	activator/sars-cov-2 inhibitor	target	Mann BJ (2022)	888800000889	240918	4796	Apadenoson	-	-	DRUGBANK	DB05009	C23H30N6O6	small molecule	-	250386-15-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: A2A receptor (A2AR) agonist; viral inhibition mechanism undetermined	FLEVIENZILQUKB-XTWQNQIISA-N
33282	106616	102	-	ADAM10	AD10|AD18|CD156c|HsT18717|MADM|RAK|kuz	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yamamoto M (2021)	888800000485	232833	10255	GW280264X	N~6~-[(Benzyloxy)carbonyl]-N~2~-{(2R,3S)-3-[formyl(hydroxy)amino]-2-isobutylhexanoyl}-N-1,3-thiazol-2-yl-L-lysinamide|benzyl N-[(5S)-5-[(2R,3S)-3-(N-hydroxyformamido)-2-(2-methylpropyl)hexanamido]-5-[(1,3-thiazol-2-yl)carbamoyl]pentyl]carbamate|Carbamic acid, N-[(5S)-5-[[(2R,3S)-3-(formylhydroxyamino)-2-(2-methylpropyl)-1-oxohexyl]amino]-6-oxo-6-(2-thiazolylamino)hexyl]-, phenylmethyl ester	-	CHEMSPIDER	43055104	C28H41N5O6S	small molecule	-	866924-39-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:ADAM10 inhibitor; exact viral inhibition mechanism undetermined but authors show disruption of the metalloproteinase pathway ans specifically ADAM10 is involved	SKJLITFHSZNZMQ-SGNDLWITSA-N
33283	106616	102	-	ADAM10	AD10|AD18|CD156c|HsT18717|MADM|RAK|kuz	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yamamoto M (2021)	888800000485	232833	10349	GI254023X	N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide|N(2)-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE|GHVMTHKJUAOZJP-CGTJXYLNSA-N|(2R,3S)-3-(FORMYL-HYDROXYAMINO)-2-(3-PHENYL-1-PROPYL)BUTANOIC ACID [(1S)-2,2-DIMETHYL-1-METHYLCARBAMOYL-1-PROPYL]AMIDE|N^2^-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE|AC-27562|S8660|(R)-N-((S)-3,3-DIMETHYL-1-(METHYLAMINO)-1-OXOBUTAN-2-YL)-2-((S)-1-(NHYDROXYFORMAMIDO)|GI254023X|EX-A4990|A818145|Q27449782|GI254023X, >=98% (HPLC)|DTXSID20433275|(2R,3S)-3-(FORMYLHYDROXYAMINO)-2-(3-PHENYL-1-PROPYL)BUTANOIC ACID [(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)-1-PROPYL]AMIDE|N~2~-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE|CCG-268545|GI4023;SRI028594|(2R)-N-[(1S)-2,2-DIMETHYL-1-[(METHYLAMINO)CARBONYL]-PROPYL]-2-[(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL]-5-PHENYLPENTANAMIDE|GI 254023X|GI4023|GI-254023X|(2R)-N-[(1S)-2,2-DIMETHYL-1-[(METHYLAMINO)CARBONYL]PROPYL]-2-[(1S)-1-(N-HYDROXYFORMAMIDO)ETHYL]-5-PHENYLPENTANAMIDE|GTPL9687|(R)-N-((S)-3,3-DIMETHYL-1-(METHYLAMINO)-1-OXOBUTAN-2-YL)-2-((S)-1-(N-HYDROXYFORMAMIDO)ETHYL)-5-PHENYLPENTANAMIDE|CS-7675|BIDD:PXR0042|260264-93-5|NCGC00370683-05|AS-16438|HY-19956|AKOS024457920|(2R)-N-[(2S)-3,3-DIMETHYL-1-(METHYLAMINO)-1-OXOBUTAN-2-YL]-2-[(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL]-5-PHENYLPENTANAMIDE|BENZENEPENTANAMIDE, N-[(1S)-2,2-DIMETHYL-1-[(METHYLAMINO)CARBONYL]PROPYL]-ALPHA-[(1S)-1-(FORMYLHYDROXYAMINO)ETHYL]-, (ALPHAR)-|MFCD19381832|(2R)-N-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-2-[(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL]-5-PHENYL-PENTANAMIDE|GI-4023|J-016226	-	PUBCHEM	9952396	C21H33N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:ADAM10 inhibitor; exact viral inhibition mechanism undetermined but authors show disruption of the metalloproteinase pathway ans specifically ADAM10 is involved	GHVMTHKJUAOZJP-CGTJXYLNSA-N
33284	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yang X (2022)	35723434	232852	10245	SGC-CK2-1	Propanamide, N-[5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-methylphenyl]-|N-(5-{[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}-2-methylphenyl)propanamide	-	CHEMSPIDER	98644473	C20H21N7O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:CSNK2A inhibitor; exact viral inhibition mechanism undetermined	YKDZIFFKQUNVHH-UHFFFAOYSA-N
33294	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator/sars-cov-2 inhibitor	target	Parthasarathy H (2023)	36417940	246230	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:AMPK activator; viral inhibition mechanism undetermined	XZWYZXLIPXDOLR-UHFFFAOYSA-N
33323	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Dowey R (2022)	35382002	246231	10159	Ruboxistaurin	Ruboxistaurin|Arxxant|(18S)-18-[(Dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1~7,14~.0~2,6~.0~8,13~.0~22,27~]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione|9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, 9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-, (9S)-|721809WQCP	-	CHEMSPIDER	135727	C28H28N4O3	small molecule	-	169939-94-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PKC inhibitor, reduces neutrophil extracellular trap (NET) formation in patients with COVID-19, possibly reducing proinflammatory and tissue-damaging consequences of neutrophils during diseas	ZCBUQCWBWNUWSU-SFHVURJKSA-N
33329	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	6367	ALLN	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|Calpain Inhibitor I|110044-82-1|MG-101|Acetylleucyl-Leucyl-Norleucinal|Calpain Inhibitor I	-	DRUGBANK	DB07558	C20H37N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	FMYKJLXRRQTBOR-BZSNNMDCSA-N
33330	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	10232	Calpain Inhibitor III	Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]amino}butan-2-yl]carbamate|Carbamic acid, N-[(1S)-1-[[[(1S)-1-formyl-2-phenylethyl]amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester|Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenyl-2-propanyl]amino}-2-butanyl]carbamate|Z-Val-Phe-H	-	CHEMSPIDER	65358	C22H26N2O4	small molecule	-	88191-84-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	NGBKFLTYGSREKK-PMACEKPBSA-N
33331	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	10192	Calpeptin	MFCD00155623|N-Benzyloxycarbonyl-L-leucylnorieucinal|Z-Leu-Nle-CHO|Carbamic acid, N-[(1S)-1-[[[(1S)-1-formylpentyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester|N~2~-[(benzyloxy)carbonyl]-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide|Calpeptin|N~2~-[(Benzyloxy)carbonyl]-N-[(2S)-1-oxo-2-hexanyl]-L-leucinamide	-	CHEMSPIDER	66091	C20H30N2O4	small molecule	-	117591-20-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	PGGUOGKHUUUWAF-ROUUACIJSA-N
33332	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	10246	E-64d	Loxistatin|EST|(2S-(2a,3b(R*)))-3-(((3-Methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)oxiranecarboxylic Acid Ethyl Ester|(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester|E-64d|Ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxo-2-pentanyl}carbamoyl)-2-oxiranecarboxylate|RR0404300|MFCD00132883|L5W337AOUR|2-Oxiranecarboxylic acid, 3-[(Z)-hydroxy[[(1S)-1-[(Z)-hydroxy[(3-methylbutyl)imino]methyl]-3-methylbutyl]imino]methyl]-, ethyl ester, (2S,3S)-|(2S,3S)-3-(Ethoxycarbonyl)-N-{(1Z,2S)-1-hydroxy-4-methyl-1-[(3-methylbutyl)imino]-2-pentanyl}-2-oxiranecarboximidic acid|2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)-|Ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate|aloxistatin	-	CHEMSPIDER	59098	C17H30N2O5	small molecule	-	88321-09-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	SRVFFFJZQVENJC-IHRRRGAJSA-N
33342	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10175	NH125	3-Benzyl-1-hexadecyl-2-methyl-1H-imidazol-3-ium|1H-Imidazolium, 1-hexadecyl-2-methyl-3-(phenylmethyl)-	-	CHEMSPIDER	8612264	C27H45N2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CaMK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	ZZXUNAFAKNKXFW-UHFFFAOYSA-N
33347	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10209	Azaindole 1	TC-S 7001|6-Chloro-N~4~-{3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl}-2,4-pyrimidinediamine|2,4-Pyrimidinediamine, 6-chloro-N~4~-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-|(6-chloro-N4-(3,5-difluoro-4-((3-methyl-1H-pyrrolo(2,3-b)pyridin-4-yl)oxy)-phenyl)pyrimidine-2,4-diamine)	-	CHEMSPIDER	9698986	C18H13ClF2N6O	small molecule	-	867017-68-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	NRSGWEVTVGZDFC-UHFFFAOYSA-N
33348	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10197	GSK269962A	GSK269962A|GSK269962|GSK 269962	-	CHEMSPIDER	17253632	C29H30N8O5	small molecule	-	850664-21-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	YOVNFNXUCOWYSG-UHFFFAOYSA-N
33349	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10212	ZINC00881524	N-(4,5-Dihydronaphtho[1,2-d][1,3]thiazol-2-yl)-2-(3,4-dimethoxyphenyl)acetamide|Benzeneacetamide, N-(4,5-dihydronaphtho[1,2-d]thiazol-2-yl)-3,4-dimethoxy-	-	CHEMSPIDER	968152	C21H20N2O3S	small molecule	-	557782-81-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	DQNMDJGZWFZNHS-UHFFFAOYSA-N
33350	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10158	WAY-658513	2-(2-Chloro-6-fluorophenyl)-N-[4-(4-pyridinyl)-1,3-thiazol-2-yl]acetamide|Benzeneacetamide, 2-chloro-6-fluoro-N-[4-(4-pyridinyl)-2-thiazolyl]-	-	CHEMSPIDER	4012517	C16H11ClFN3OS	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	BPGUVXHQHDKSTA-UHFFFAOYSA-N
33351	111095	5058	-	PAK1	PAKalpha	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10203	LCH-7749944	2,4-Quinazolinediamine, N~2~-(3-methoxyphenyl)-N~4~-[(tetrahydro-2-furanyl)methyl]-|N~2~-(3-Methoxyphenyl)-N~4~-(tetrahydro-2-furanylmethyl)-2,4-quinazolinediamine|N-[2-(3-methoxyanilino)-4-quinazolinyl]-N-(tetrahydro-2-furanylmethyl)amine	-	CHEMSPIDER	2224829	C20H22N4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PAK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	FBWZAFQEOKNGQL-UHFFFAOYSA-N
33357	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10267	Indirubin-3'-Oxime	[2,3'-Bi-1H-indol]-2'-ol, 3-nitroso-|3-Nitroso-1H,1'H-2,3'-biindol-2'-ol	-	CHEMSPIDER	23207173	C16H11N3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CDK5 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	FQCPPVRJPILDIK-UHFFFAOYSA-N
33360	112550	6667	-	SP1	-	9606	Homo sapiens	sars-cov-2 inhibitor	target	Han H (2024)	38375778	241442	5643	Plicamycin	Mithramycine|Mithracin|Mithramycinum|Plicamycine|Plicamycin|Plicamycinum|Mithramycin|Aureolic acid	-	DRUGBANK	DB06810	C52H76O24	small molecule	L01DC02	18378-89-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: SP1 inhibitor, mechanism undetermined; antiviral activity in cells and hamsters	CFCUWKMKBJTWLW-BKHRDMLASA-N
33362	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	sars-cov-2 inhibitor	target	Kelch MA (2023)	37342561	241452	10275	PRI-724	PRI-724|N-Benzyl-6-(4-hydroxybenzyl)-8-(1-naphthylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide|2H-Pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide, hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-	-	CHEMSPIDER	19546236	C33H32N4O4	small molecule	-	847591-62-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CBP-CTNNB1 interaction inhibitor; CBP interactor; antiviral activity against SARS-CoV-2 Wuhan-Hu-1, Zeta, Epsilon, Kappa, Alpha, Beta, Delta, and Omicron variants, SARS-CoV and MERS	HQWTUOLCGKIECB-UHFFFAOYSA-N
33396	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yao Y (2023)	37467664	243884	10162	Lysergol	Lysergol|Ergoline-8-methanol, 9,10-didehydro-6-methyl-, (8.beta.)-|9,10-Didehydro-6-methylergoline-8beta-methanol|9,10-Didehydro-6-methylergoline-8b-methanol|Methanol, 1-[(8beta)-9,10-didehydro-6-methylergolin-8-yl]-|[(8beta)-6-Methyl-9,10-didehydroergolin-8-yl]methanol|(+)-lysergol	-	CHEMSPIDER	14267	C16H18N2O	small molecule	-	602-85-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human GRP78 binding (computational); antiviral activity against SARS-CoV-2 in A549 cells	BIXJFIJYBLJTMK-MEBBXXQBSA-N
33397	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yao Y (2023)	37467664	243884	10218	Sophoridine	sophoridine|1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aR,13aR,13bR,13cS)-|(5beta)-Matridin-15-one|(7aR,13aR,13bR,13cS)-Dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one|Allomatrine|W5S1M800J7|(+)-Allomatrine|(-)-Sophoridine	-	CHEMSPIDER	145087	C15H24N2O	small molecule	-	6882-68-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human GRP78 binding (computational); antiviral activity against SARS-CoV-2 in A549 cells	ZSBXGIUJOOQZMP-BHPKHCPMSA-N
33417	111317	5300	-	PIN1	DOD|UBL5	9606	Homo sapiens	sars-cov-2 inhibitor	target	Aviner R (2023)	888800000985	244285	10191	Juglone	Juglone|Regianin|Nucin|5-Hydroxy-1,4-naphthoquinone|5-HNQ|5-Hydroxy-1,4-naphthalenedione|5-hydroxynaphthalene-1,4-dione|1,4-Naphthalenedione, 5-hydroxy-|5-Hydroxy-1,4-naphthochinone|1909764|5-hydroxy-1,4-dihydronaphthalene-1,4-dione	-	CHEMSPIDER	3674	C10H6O3	small molecule	-	481-13-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human PIN1 inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	KQPYUDDGWXQXHS-UHFFFAOYSA-N
33426	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10172	GSK-690693	GSK-690693|4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methyl-3-butyn-2-ol|3-Butyn-2-ol, 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-|MFCD14105605|4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol	-	CHEMSPIDER	20557532	C21H27N7O3	small molecule	-	937174-76-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AKT inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	KGPGFQWBCSZGEL-ZDUSSCGKSA-N
33429	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10248	Fostamatinib	2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-|Fostamatinib|SQ8A3S5101|TAVALISSE|[6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl}amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate	-	CHEMSPIDER	9846198	C23H26FN6O9P	small molecule	-	901119-35-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: SYK inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	GKDRMWXFWHEQQT-UHFFFAOYSA-N
33449	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10330	4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole	SW218141-2|4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-5-(4-PYRIDYL)-1H-IMIDAZOLE;SB-203580|SR-01000597367|J-008891|HMS3267B07|BCP01763|CDMGBJANTYXAIV-UHFFFAOYSA-N|RWJ-64809|US9187470, 104 (SB203580)|4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-5-(4-PYRIDYL)-1H-IMIDAZOLE|PYRIDINE, 4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-YL]- & Z-100|4-[5-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-3H-IMIDAZOL-4-YL]PYRIDINE|OU13V1EYWQ|SB 203580|AKOS015994568|HMS1792H05|AM81234|4-{4-(4-FLUOROPHENYL)-2-[4-(METHANESULFINYL)PHENYL]-1H-IMIDAZOL-5-YL}PYRIDINE|PB-203580|UNII-OU13V1EYWQ|HMS3403H05|RAC-4-(5-(4-FLUOROPHENYL)-2-(4-((R)- METHANESULFINYL)PHENYL)-1H-IMIDAZOL-4-YL)PYRIDINE|NCGC00025035-04|PB203580|HMS3676M17|CCG-206878|BIO1_000745|4-{4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-5-YL}PYRIDINE|HB1302|NCGC00025035-05|4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFONYL)PHENYL]-1H-IMIDAZOL-4-YL]PYRIDINE|4-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-5-(4-PYRIDYL)-1H-IMIDAZOLE|S1076|F0864|HMS3244I16|BIO1_000256|NCGC00025035-02|A15256|NCGC00025035-01|J-513573|RWJ 64809|K00038|PYRIDINE, 4-(4-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-5-YL)-|ES-0013|NSC-755772|PYRIDINE, 4-[4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-5-YL]-|TOCRIS-1402|4-(5-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-4-YL)PYRIDINE|4-[4-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-1H-IMIDAZOL-5-YL]PYRIDINE|PYRIDINE, 4-(5-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-4-YL)-|SB203580|4-[4-(4-FLUOROPHENYL)-2-(4-METHANESULFINYLPHENYL)-1H-IMIDAZOL-5-YL]PYRIDINE|BIRB-203580|4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-4-YL]PYRIDINE|HMS3295M11|NSC755772|BRD-A37704979-003-01-2|SB 203580, SOLID, >=98% (HPLC)|SB 203580 & Z-100|SR-01000597367-1|CBIOL_001970|ADEZMAPIMOD|NCGC00381704-12|PYRIDINE, 4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-YL]-|KINOME_2521|4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE|ADEZMAPIMOD [INN]|SMR004701767|1PME|TOCRIS-1202|SB16633|MLS006010840|HMS3244I15|4-(4-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)-PHENYL)-1H-IMIDAZOL-5-YL)PYRIDINE|AC-32046|BIO1_001234|4-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-5-(4-PYRIDYL)1H-IMIDAZOLE|EX-A134|GTPL5269|NCGC00025035-03|SB-203580|DTXSID2040577|CS-0140|152121-47-6|PB 203580|FT-0674525|BIRB203580|4-(4-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-5-YL)PYRIDINE|HMS3412M17|CID_176155|F17411|HMS3654M15|SB 203580 - CAS 152121-47-6|SB203580,RWJ 64809,PB 203580|BRD-A37704979-001-02-4|Q7389023|C21H16FN3OS|BCPP000074|RWJ64809|HMS3244J15|MFCD00922198|HMS1990H05|HY-10256|AKOS005145971|HMS3229O04|BSPBIO_001104	-	PUBCHEM	176155	C21H16FN3OS	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human p38 inhibitor;  antiviral activity against SARS-CoV-2 in ACE2-A549 cells	CDMGBJANTYXAIV-UHFFFAOYSA-N
33450	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10331	Silmitasertib	GTPL8126|J-516169|EX-8673|HMS3244N13|NSC-761193|AS-16253|EN300-6482034|5-[(3-CHLOROPHENYL)AMINO]PYRIDO[4,3-C]QUINOLINE-8-CARBOXYLIC ACID|SB17201|Q27076934|5-((3-CHLOROPHENYL)AMINO)BENZO-[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945|HMS3746E13|CX-4945 (SILMITASERTIB)|CCG-264955|BCP02399|HMS3244M14|SILMITASERTIB [INN]|HMS3244M13|1009820-21-6|CX-4945,CAS:1009820-21-6|5-(3-CHLOROPHENYLAMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)-BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|C19H12CLN3O2|5-[(3-CHLOROPHENYL)AMINO]-BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945 FREE ACID|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|DB15408|SILMITASERTIBUM|5-[(3-CHLOROPHENYL)AMINO]BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|FT-0723994|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CS-0563|NCGC00263192-02|NCGC00263192-09|AC-28426|W-204393|HY-50855|SILMITASERTIB|J-000296|5-((3-CHLOROPHENYL)AMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|BCP9000560|SILMITASERTIB; CX 4945|NSC-800885|CX-4945 (SILMITASERIB)|A25034|MFCD13184796|CX 4945 (SILMITASERTIB)|BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)-|SY069677|DTXCID9066093|AKOS005266722|CX4945 (SILMITASERTIB)|C6RWP0N0L2|SW218157-2|SILMITASERTIB (CX-4945)|HMS3655F16|BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-[(3-CHLOROPHENYL)AMINO]-|EX-A070|S2248|5-(3-CHLOROANILINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX4945|CX 4945|UNII-C6RWP0N0L2|DTXSID40143602|SILMITASERTIB [WHO-DD]|5-(3-CHLOROPHENYLAMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|NSC761193|3NG|NSC800885|NCGC00263192-01	-	PUBCHEM	24748573	C19H12ClN3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CSNK2A1 and CSNK2A2 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	MUOKSQABCJCOPU-UHFFFAOYSA-N
33453	111586	5600	-	MAPK11	P38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10333	Ralimetinib	5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL)-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO(4,5-B)PYRIDIN-2-YLAMINE|UNII-73I34XW4HD|SB16635|NCGC00346537-01|XPPBBJCBDOEXDN-UHFFFAOYSA-N|NSC-766820|LSN-2322600 FREE BASE|BCPP000180|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|RALIMETINIB [USAN]|Q27088512|862505-00-8|RALIMETINIB [INN]|LY 2228820|RALIMETINIB [USAN:INN]|LY2228820 FREE BASE|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|862505-00-8 (FREE BASE)|RALIMETINIB [WHO-DD]|NCGC00346537-05|LY22288220|DB11787|AKOS027282678|HMS3674E21|3H-IMIDAZO(4,5-B)PYRIDIN-2-AMINE, 5-(2-(1,1-DIMETHYLETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-|GTPL7959|3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE,5-[2-(1,1-DIMETHYLETHYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)-|CS-0008496|D10658|RALIMETINIB (USAN/INN)|(5P)-5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|DTXSID00235456|HY-13241A|BCP02033|LY-2228820|73I34XW4HD|RALIMETINIB ( LY2228820)|NSC766820|NCGC00346537-03|E98891|RALIMETINIB|YXT|5-(2-(TERT-BUTYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|LSN2322600 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-YLAMINE|LY-2228820 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUOROPHENYL)-3H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[5,4-B]PYRIDIN-2-AMINE|NSC785335|NSC-785335|BCP9000871|FT-0727743	-	PUBCHEM	11539025	C24H29FN6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK11/MAPK14 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	XPPBBJCBDOEXDN-UHFFFAOYSA-N
33454	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10333	Ralimetinib	5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL)-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO(4,5-B)PYRIDIN-2-YLAMINE|UNII-73I34XW4HD|SB16635|NCGC00346537-01|XPPBBJCBDOEXDN-UHFFFAOYSA-N|NSC-766820|LSN-2322600 FREE BASE|BCPP000180|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|RALIMETINIB [USAN]|Q27088512|862505-00-8|RALIMETINIB [INN]|LY 2228820|RALIMETINIB [USAN:INN]|LY2228820 FREE BASE|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|862505-00-8 (FREE BASE)|RALIMETINIB [WHO-DD]|NCGC00346537-05|LY22288220|DB11787|AKOS027282678|HMS3674E21|3H-IMIDAZO(4,5-B)PYRIDIN-2-AMINE, 5-(2-(1,1-DIMETHYLETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-|GTPL7959|3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE,5-[2-(1,1-DIMETHYLETHYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)-|CS-0008496|D10658|RALIMETINIB (USAN/INN)|(5P)-5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|DTXSID00235456|HY-13241A|BCP02033|LY-2228820|73I34XW4HD|RALIMETINIB ( LY2228820)|NSC766820|NCGC00346537-03|E98891|RALIMETINIB|YXT|5-(2-(TERT-BUTYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|LSN2322600 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-YLAMINE|LY-2228820 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUOROPHENYL)-3H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[5,4-B]PYRIDIN-2-AMINE|NSC785335|NSC-785335|BCP9000871|FT-0727743	-	PUBCHEM	11539025	C24H29FN6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK11/MAPK14 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	XPPBBJCBDOEXDN-UHFFFAOYSA-N
33455	111589	5603	RP1-179N16.4	MAPK13	MAPK 13|MAPK-13|PRKM13|SAPK4|p38delta	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10334	1-(3-Tert-Butyl-1-Methyl-1h-Pyrazol-5-Yl)-3-[4-(Pyridin-4-Yloxy)phenyl]urea	229002-10-2|Z1084765976|AKOS040733667|COMPOUND 61 [WO2014015056A2]|MAPK13 INHIBITOR COMPOUND 61|N-(3-TERT-BUTYL-1-METHYL-5-PYRAZOLYL)-N'-(4-(4-PYRIDINYLOXY)PHENYL)UREA|4EYJ|GTPL11096|MS-25838|1-(5-TERT-BUTYL-2-METHYLPYRAZOL-3-YL)-3-(4-PYRIDIN-4-YLOXYPHENYL)UREA|MHSLDASSAFCCDO-UHFFFAOYSA-N|1-(3-TERT-BUTYL-1-METHYL-1H-PYRAZOL-5-YL)-3-(4-(PYRIDIN-4-YLOXY)PHENYL)UREA|Q27463685|CS-0014526|N61|1-(3-TERT-BUTYL-1-METHYL-1H-PYRAZOL-5-YL)-3-[4-(PYRIDIN-4-YLOXY)PHENYL]UREA|HY-18850|MAPK13-IN-1	-	PUBCHEM	17941505	C20H23N5O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK13 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	MHSLDASSAFCCDO-UHFFFAOYSA-N
33456	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10335	p38alpha Inhibitor 1	5-(2,4-DIFLUOROPHENOXY)-N-(2-(DIMETHYLAMINO)ETHYL)-1-ISOBUTYL-1H-INDAZOLE-6-CARBOXAMIDE|ARRY-797|1034189-82-6|CS-0085271|P38?? INHIBITOR 1|EX-A3148|ARRY-371797|ARRY371797|1036404-17-7|COMPOUND 7 [PMID: 19950901]|ARRY797|P38A INHIBITOR 1|P38 ALPHA INHIBITOR 1|P38-ALPHA- INHIBITOR 1|-(2,4-DIFLUOROPHENOXY)-N-[2-(DIMETHYLAMINO)ETHYL]-1-(2-METHYLPROPYL)INDAZOLE-6-CARBOXAMIDE|P38ALPHA INHIBITOR 1|HY-114423|AKOS040733949|ARRY-797; ARRY-371797|P38|A INHIBITOR 1|MS-27245|5-(2,4-DIFLUOROPHENOXY)-N-[2-(DIMETHYLAMINO)ETHYL]-1-(2-METHYLPROPYL)INDAZOLE-6-CARBOXAMIDE|GTPL11095	-	PUBCHEM	46883775	C22H26F2N4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK14 inhibitor;  antiviral activity against SARS-CoV-2 in ACE2-A549 cells	IFGWYHGYNVGVRB-UHFFFAOYSA-N
33457	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10176	dinaciclib	Dinaciclib|SCH 727965|SCH727965|2-[(2S)-1-(3-Ethyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol|4V8ECV0NBQ|2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-, (2S)-	-	CHEMSPIDER	25027387	C21H28N6O2	small molecule	-	779353-01-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CDK2/5/9 inhibitor;  antiviral activity against SARS-CoV-2 in VERO-E6 and ACE2-A549 cells	PIMQWRZWLQKKBJ-SFHVURJKSA-N
33458	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10176	dinaciclib	Dinaciclib|SCH 727965|SCH727965|2-[(2S)-1-(3-Ethyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol|4V8ECV0NBQ|2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-, (2S)-	-	CHEMSPIDER	25027387	C21H28N6O2	small molecule	-	779353-01-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CDK2/5/9 inhibitor;  antiviral activity against SARS-CoV-2 in VERO-E6 and ACE2-A549 cells	PIMQWRZWLQKKBJ-SFHVURJKSA-N
33465	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	sars-cov-2 inhibitor	target	Kelch MA (2023)	37342561	241452	10338	Foscenvivint	2H-PYRAZINO(2,1-C)(1,2,4)TRIAZINE-1(6H)-CARBOXAMIDE, HEXAHYDRO-2,9-DIMETHYL-4,7-DIOXO-N-(PHENYLMETHYL)-6-((4-(PHOSPHONOOXY)PHENYL)METHYL)-8-(8-QUINOLINYLMETHYL)-, (6S,9S,9AS)-|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7- DIOXO-8-((QUINOLIN-8-YL)METHYL)OCTAHYDRO-2HPYRAZINO(2,1-C)(1,2,4)TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|1198780-38-9|43Y934BBZ6|UNII-43Y934BBZ6|PRI724|(S,S)-ICG-001|1422253-38-0 (PRI-724)|HY-112045|FOSCENVIVINT|EX-A3641|[4-[[(6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)-3,6,9,9A-TETRAHYDROPYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL]METHYL]PHENYL] DIHYDROGEN PHOSPHATE|DB15034|1422253-38-0|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)OCTAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|AC-31548||A-CATENIN/CBP-IN-1|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)OCTAHYDRO-1H-PYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|PRI-724|FOSCENVIVINT [INN]|CS-0042484|(6S,9S,9AS)-HEXAHYDRO-2,9-DIMETHYL-4,7-DIOXO-N-(PHENYLMETHYL)-6-[[4-(PHOSPHONOOXY)PHENYL]METHYL]-8-(8-QUINOLINYLMETHYL)-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE	-	PUBCHEM	71509318	C33H35N6O7P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: small-molecule inhibitor of the Beta-catenin/CBP interaction; shows anti-viral acitivity against multiple coronaviruses including SARS-CoV-2 variants (Ancestral variants: B (FFM5), B.1 (FFM7, D614G); variants of interest (VOI): P.2 (Zeta), B.1.429 (Epsilon), B.1.617.1 (Kappa); deescalated variants of concern (VOC): B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta); VOC: B.1.1.529 BA.1, BA.2, and BA.5 (Omicron), SARS-CoV-1, and Influenza A virus in A549-AT cells	VHOZWHQPEJGPCC-AZXNYEMZSA-N
33474	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ramsey JR (2024)	38134034	245509	9979	Calpain Inhibitor XII	Calpain Inhibitor XII|Carbamic acid, N-[1-[[[1-[1,2-dioxo-2-[(2-pyridinylmethyl)amino]ethyl]butyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester|N~2~-[(benzyloxy)carbonyl]-N-{1,2-dioxo-1-[(pyridin-2-ylmethyl)amino]hexan-3-yl}leucinamide|N~2~-[(Benzyloxy)carbonyl]-N-{1,2-dioxo-1-[(2-pyridinylmethyl)amino]-3-hexanyl}leucinamide	-	CHEMSPIDER	21396054	C26H34N4O5	small molecule	-	181769-57-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CTSL inhibitor; Calpain inhibitor XII (CI-XII), MG-101 and CatL inhibitor IV (CLI-IV) possess antiviral activity in the very low nanomolar IC50 range in Vero E6 cells	PLVWMBFPIAQRHK-UHFFFAOYSA-N
33475	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ramsey JR (2024)	38134034	245509	6367	ALLN	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|Calpain Inhibitor I|110044-82-1|MG-101|Acetylleucyl-Leucyl-Norleucinal|Calpain Inhibitor I	-	DRUGBANK	DB07558	C20H37N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CTSL inhibitor; Calpain inhibitor XII (CI-XII), MG-101 and CatL inhibitor IV (CLI-IV) possess antiviral activity in the very low nanomolar IC50 range in Vero E6 cells	FMYKJLXRRQTBOR-BZSNNMDCSA-N
33476	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ramsey JR (2024)	38134034	245509	10340	1-Naphthalenylsulfonyl-Ile-Trp-aldehyde	J-009852|N-(1NAPHTHALENYLSULFONYL)- IW-CHO|(2S,3S)-N-[(2S)-1-(1H-INDOL-3-YL)-3-OXOPROPAN-2-YL]-3-METHYL-2-(NAPHTHALEN-1-YLSULFONYLAMINO)PENTANAMIDE|(3S)-N-((S)-1-(1H-INDOL-3-YL)-3-OXOPROPAN-2-YL)-3-METHYL-2-(NAPHTHALENE-1-SULFONAMIDO)PENTANAMIDE|161709-56-4|1-NAPHTHALENYLSULFONYL-ILE-TRP-ALDEHYDE|CATHEPSIN L INHIBITOR IV|MFCD00932733|N-(1-NAPHTHALENYLSULFONYL)-ILE-TRP-ALDEHYDE	-	PUBCHEM	9957276	C27H29N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CTSL inhibitor; Calpain inhibitor XII (CI-XII), MG-101 and CatL inhibitor IV (CLI-IV) possess antiviral activity in the very low nanomolar IC50 range in Vero E6 cells	FFPHAWVFZQFOJA-JCWFFFCVSA-N
33496	110852	4780	-	NFE2L2	NRF2	9606	Homo sapiens	degradation	target	Ji J (2023)	36892138	247218	10736	Bivalent ligand 506	ARE-PROTAC C2|bivalent_ligand_506	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ARE-PROTAC C2 (CRBN:lenalidomide --- NFE2L2:5-TGAG/CNNNGC-3)	-
33498	110852	4780	-	NFE2L2	NRF2	9606	Homo sapiens	degradation	target	Rosenberg SC (2023)	36773603	247269	10737	Bivalent ligand 507	GNE-579|bivalent_ligand_507	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: GNE-579 (VHL:VH032 --- EGFRExon19/L858R:Compound A)	-
33596	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation	target	Zhang X (2019)	31754664	256622	10769	Bivalent ligand 540	XZ424|bivalent_ligand_540	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: XZ424 (CRBN:pomalidomide --- BCL2L1:compound 3 (A-1155463 derivative))	-
33630	125700	120892	-	LRRK2	AURA17|DARDARIN|PARK8|RIPK7|ROCO2	9606	Homo sapiens	degradation	target	Liu X (2022)	36007011	256627	10783	Bivalent ligand 554	XL01126|bivalent_ligand_554	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: XL01126 (VHL:VH101 --- LRRK2:HG-10-102-01)	-
33634	109314	3064	-	HTT	HD|IT15	9606	Homo sapiens	degradation	target	Mei L (2023)	37424101	254385	10785	Bivalent ligand 556	QBP-LIR|bivalent_ligand_556	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	autophagy-targeting protein	Standardized BVL Name: QBP-LIR (MAP1LC3B:LIR --- HTT65Q:QBP)	-
33636	109314	3064	-	HTT	HD|IT15	9606	Homo sapiens	degradation	target	Mei L (2023)	37424101	254385	10786	Bivalent ligand 557	QBP-ABP|bivalent_ligand_557	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	120375	55054	hCG_1817841	ATG16L1	APG16L|ATG16A|ATG16L|IBD10|WDR30	9606	Homo sapiens	autophagy-targeting protein	Standardized BVL Name: QBP-ABP (ATG16L1:ABP --- HTT65Q:QBP)	-
33644	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	degradation	target	Jiang L (2021)	34094836	254471	10790	Bivalent ligand 561	Compound 7o|bivalent_ligand_561	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 7o (CRBN:pomalidomide --- Bcr-Abl:GZD824)	-
33660	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	degradation	target	Xu H (2021)	34124002	254519	10798	Bivalent ligand 569	Compound 3|bivalent_ligand_569	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 3 (VHL:VH032 --- LXRB:GW3965)	-
33666	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	degradation	target	Gazorpak M (2023)	38071198	256631	10801	Bivalent ligand 572	KH-102|bivalent_ligand_572	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: KH-102 (CRBN:lenalidomide --- NR3C1:dexamethasone)	-
33668	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	degradation	target	Gazorpak M (2023)	38071198	256631	10802	Bivalent ligand 573	KH-103|bivalent_ligand_573	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: KH-103 (CRBN:lenalidomide --- NR3C1:dexamethasone)	-
33684	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Yang H (2019)	31769449	256639	10810	Bivalent ligand 581	NH2|bivalent_ligand_581	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NH2 (CRBN:pomalidomide --- HDAC6:Nexturastat A (Nex A))	-
33730	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Basu AA (2024)	38965383	254538	10823	Bivalent ligand 602	22-SLF|bivalent_ligand_602	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117649	26263	-	FBXO22	FBX22|FISTC1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 22-SLF (FBXO22:22 --- FKBP12:SLF)	-
33732	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Basu AA (2024)	38965383	254538	10824	Bivalent ligand 603	22a-SLF|bivalent_ligand_603	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117649	26263	-	FBXO22	FBX22|FISTC1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 22-SLF (FBXO22:22a --- FKBP12:SLF)	-
33738	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	degradation	target	Ko T (2023)	37712589	254591	10827	Bivalent ligand 606	CaMKIIa-PHOTAC|bivalent_ligand_606	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CaMKII-PHOTAC (CRBN:lenalidomide --- CAMK2A:bosutinib)	-
33748	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Chen Z (2023)	37647546	254601	10832	Bivalent ligand 611	ERD-3111|bivalent_ligand_611	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ERD-3111 (CRBN:TX-16 --- ESRA:lasofoxifene)	-
33778	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Kumarasamy V (2023)	37626264	254608	10846	Bivalent ligand 625	FN-POM|bivalent_ligand_625	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FN-POM (CRBN:pomalidomide --- CDK2:N-1501)	-
33780	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	degradation	target	Jiang Q (2023)	37619298	254609	10847	Bivalent ligand 626	X10g|bivalent_ligand_626	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: X10g (CRBN:pomalidomide --- HSP90AA1:AT13387 analogue X1)	-
33812	128244	197259	-	MLKL	hMLKL	9606	Homo sapiens	degradation	target	Rathje OH (2023)	37535857	254770	10859	Bivalent ligand 638	Compound 36|bivalent_ligand_638	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 36 (CRBN:Lenalidomide --- MLKL:Ligand 1)	-
33830	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Bockstiegel J (2023)	37481141	254804	10866	Bivalent ligand 645	A6|bivalent_ligand_645	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: A6 (CRBN:thalidomide --- HDAC6:pan-HDAC inhibitor SAHA)	-
33840	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	degradation	target	Wurnig S (2023)	37448856	254811	10871	Bivalent ligand 650	3a|bivalent_ligand_650	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 3a (CRBN:pomalidomide --- HSP90AA1:geldanamycin)	-
33842	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	degradation	target	Wurnig S (2023)	37448856	254811	10871	Bivalent ligand 650	3a|bivalent_ligand_650	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 3a (CRBN:pomalidomide --- HSP90AB1:geldanamycin)	-
33912	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Sinatra L (2020)	32780485	256645	10903	Bivalent ligand 682	HDAC PROTAC 4|bivalent_ligand_682	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: HDAC PROTAC 4 (CRBN:thalidomide-based ligand ---HDAC1:HAIR D)	-
33914	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Sinatra L (2022)	36473103	256646	10904	Bivalent ligand 683	A6|bivalent_ligand_683	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: A6 (CRBN:thalidomide --- HDAC6:vorinostat-like HDAC ligand)	-
33918	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	degradation	target	Sinatra L (2022)	36473103	256646	10905	Bivalent ligand 684	B4|bivalent_ligand_684	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: B4 (CRBN:thalidomide --- HDAC6:benzimidazole-based HDAC6 ligand)	-
33926	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Wang L (2021)	33664520	256648	10909	Bivalent ligand 688	CPS2|bivalent_ligand_688	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CPS2 (CRBN:pomalidomide --- CDK2:J2)	-
33982	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	degradation	target	Hati S (2021)	34560429	255476	10936	Bivalent ligand 715	PROTAC-8|bivalent_ligand_715	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC-8 (VHL:VH032 --- CDK2:AZD5438)	-
34050	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Reynders M (2021)	34432252	256663	10959	Bivalent ligand 738	PHOTAC-II-5|bivalent_ligand_738	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PHOTAC-II-5 (CRBN:glutarimide --- FKBP12:SLF)	-
34052	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Reynders M (2021)	34432252	256663	10960	Bivalent ligand 739	PHOTAC-II-6|bivalent_ligand_739	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PHOTAC-II-6 (CRBN:glutarimide --- FKBP12:SLF)	-
34102	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	degradation	target	Sun X (2019)	30729032	256670	10975	Bivalent ligand 754	RC32|bivalent_ligand_754	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RC32 (CRBN:pomalidomide --- FKBP1A:rapamycin)	-
34126	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Wen T (2023)	37298935	256429	10979	Bivalent ligand 758	Compound 5|bivalent_ligand_758	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 5 (cIAP1 :bestatin --- SNCA:sery384)	-
34136	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	degradation	target	Tong Y (2023)	37267712	256432	10983	Bivalent ligand 762	Compound 2b|bivalent_ligand_762	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 2b (CRBN:pomalidomide --- SNCA:sery308)	-
34148	109187	2932	-	GSK3B	-	9606	Homo sapiens	degradation	target	Guardigni M (2023)	37218653	256440	10988	Bivalent ligand 767	Compound 1|bivalent_ligand_767	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 1 (CRBN:pomalidomide --- GSK3B:SB-216763)	-
34176	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Xie B (2023)	37163809	256447	10997	Bivalent ligand 776	PROTAC 8a|bivalent_ligand_776	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC 8a (VHL:VHL ligand --- ESR1:OBHSA)	-
34178	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Xie B (2023)	37161783	256448	10998	Bivalent ligand 777	ZD12|bivalent_ligand_777	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZD12 (VHL:VHL ligand --- ESR1:OBHSA)	-
34180	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Xie B (2023)	37161783	256448	10999	Bivalent ligand 778	ZD11|bivalent_ligand_778	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZD11 (VHL:VHL ligand --- ESR1:OBHSA)	-
34182	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Xie B (2023)	37161783	256448	11000	Bivalent ligand 779	ZD8|bivalent_ligand_779	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZD8 (VHL:VHL ligand --- ESR1:OBHSA)	-
34184	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	degradation	target	Xie B (2023)	37161783	256448	11001	Bivalent ligand 780	ZD2|bivalent_ligand_780	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZD2 (VHL:VHL ligand --- ESR1:OBHSA)	-
34224	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	degradation	target	Dong J (2023)	36973833	256473	11016	Bivalent ligand 795	DU-14|bivalent_ligand_795	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DU-14 (VHL:(S,R,S)-AHPC-Me --- PTP1B:DI-03)	-
34228	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Son SH (2023)	36968534	256474	11017	Bivalent ligand 796	PRZ-18002|bivalent_ligand_796	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PRZ-18002 (CRBN:pomalidomide --- MAPK14:p-p38 ligand)	-
34238	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	degradation	target	Chang M (2022)	36910255	256500	11022	Bivalent ligand 800	BMM4|bivalent_ligand_800	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BMM4 (MDM2:Nutlin-3 --- BCL-XL:ABT-263)	-
34248	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11027	Bivalent ligand 805	SJ34739/PD-PROTAC 2|bivalent_ligand_805	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ34739/PD-PROTAC 2 (CRBN:phenyl dihydrouracil (PD) --- LCK:dasatinib)	-
34250	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11028	Bivalent ligand 806	SJ42176/thal-PROTAC 3|bivalent_ligand_806	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ42176/thal-PROTAC 3 (CRBN:thalidamide) --- LCK:dasatinib)	-
34252	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11029	Bivalent ligand 807	SJ34769/PG-PROTAC 4|bivalent_ligand_807	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ34769/PG-PROTAC 4 (CRBN:phenyl glutarimide (PG) --- LCK:dasatinib)	-
34254	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11030	Bivalent ligand 808	SJ43489/PD-PROTAC 5|bivalent_ligand_808	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ43489/PD-PROTAC 5 (CRBN:phenyl dihydrouracil (PD) --- LCK:dasatinib)	-
34256	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Hu J (2022)	36001679	256518	11031	Bivalent ligand 809	SJ11646|bivalent_ligand_809	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ11646 (CRBN:phenyl glutarimide (PG) --- LCK:dasatinib)	-
34260	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	degradation	target	Hu J (2022)	36001679	256518	11031	Bivalent ligand 809	SJ11646|bivalent_ligand_809	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ11646 (CRBN:phenyl glutarimide (PG) --- SRC:dasatinib)	-
34262	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	degradation	target	Cubillos-Rojas M (2023)	36765568	256520	11032	Bivalent ligand 810	NR-11c|bivalent_ligand_810	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NR-11c (VHL:VHL ligand --- MAPK14:PH-797804)	-
